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1. Abstract 
 
In	vitro	infection	of	human	quiescent	B	cells	with	Epstein-Barr	Virus	(EBV)	activates	them	and	 leads	 to	 infinitely	 proliferating	 lymphoblastoid	 B	 cell	 lines	 (LCL),	 in	 which	 the	 virus	establishes	a	stable	 latent	 infection.	 In	this	process,	 the	virus	triggers	dramatic	changes	 in	the	host	 cell	biology	 to	allow	 its	 long-term	persistence	and	guarantee	 the	 survival	of	 its	host	 cell.	During	 latency,	 EBV	 encoded	 proteins	 mimic	 activating	 physiological	 cellular	 pathways	 and	processes	promoting	viral	success.	In	my	PhD	thesis,	I	wished	to	investigate	the	very	early	steps	of	EBV	infection	focusing	on	changes	in	the	host	cell	biology.	I	investigated	the	early	phenotypes	of	 the	 infected	 cells,	 which	 grow	 in	 cell	 volume	 and	 massively	 induce	 RNA	 and	 proteins	synthesis,	initially.	Within	the	first	two	days,	the	cells	show	stable	metabolic	activity	and	do	not	proliferate.	 On	 day	 three	 post	 infection	 (p.i),	 the	 cells	 initiate	 DNA	 replication	 and	 divide	followed	by	a	phase	of	intense	cellular	proliferation.	Starting	at	day	four	p.i.,	the	cells	show	very	high	 metabolic	 activities	 characterized	 by	 an	 increased	 uptake	 of	 glucose	 and	 enhanced	mitochondrial	activity.	To	monitor	the	obvious	alterations	in	the	biology	of	the	EBV-infected	B	cells,	 I	 devised	 well-controlled	 and	 time-resolved	 RNA	 expression	 profiling	 (RNA-seq)	experiments.	The	analyses	of	these	experiments	identified	seven	different	clusters	of	genes	with	very	specific	gene	expression	patterns	in	EBV-infected	cells	compared	with	uninfected	cells.	My	results	document	that	the	virus	governs	all	important	cellular	processes	including	proliferation,	cell	 metabolism,	 various	 epigenetic	 mechanisms,	 and	 ncRNAs	 biosynthesis	 in	 a	 very	 strictly	time-controlled	manner	during	infection.	The	virus	delivers	its	epigenetically	naïve	genomic	DNA	to	the	host	cell	upon	infection,	but	in	 latently	 infected	 cells	 the	 viral	 DNA	 is	 extrachromosomaly	 maintained	 and	 organized	identical	to	cellular	chromatin	with	nucleosomes	including	mostly	repressive	histone	marks.	In	my	PhD	work	I	wanted	to	investigate	the	kinetics	of	nucleosome	assembly	on	viral	DNA	as	well	as	 the	 specific	 positioning	 of	 nucleosomes.	 Within	 24	 hours	 after	 infection,	 EBV	 DNA	 had	acquired	 nucleosomal	 structures,	 which	 accumulated	 and	 became	 more	 prevalent	 until	 day	three	 p.i..	 Nucleosome	 acquisition	 did	 not	 appear	 to	 be	 random,	 but	 I	 found	 pre-defined	locations	occupied	with	nucleosomes	very	early	after	 infection.	 In	my	MNase-seq	experiments	nucleosome	occupancy	at	certain	cellular	loci	also	changes	dramatically	indicating	that	dynamic	alterations	in	nucleosome	positioning	might	cause	the	profound	changes	in	the	transcriptome	of	the	virally	infected	B	cells.		
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2. Introduction 
 
2.1.  EBV - its life cycle and the reprogramming of its host cell  
 
2.1.1. EBV and its ingenious life cycle 
 Epstein-Barr	 virus	 (EBV)	 is	 a	 ubiquitous	 human	 pathogen	 and	 a	 member	 of	 the		γ herpesviruses	 family.	 EBV	 has	 a	 very	 strong	 tropism	 towards	 human	 B	 cells	 probably	because	 the	 major	 viral	 glycoprotein	 gp350/220	 binds	 CD21	 on	 the	 surface	 of	 B	 cells	 to	facilitate	 virus	 attachment.	 EBV’s	 genome	 is	 composed	 of	 a	 single	 double-stranded	 DNA	molecule	 contained	 in	 an	 icosahedral	 nucleocapsid,	which	 is	 surrounded	by	 a	 tegument	 and	contained	 in	a	membranous	envelope.	The	viral	DNA	 is	 approximately	170	kb	 length	 in	 size	and	codes	for	about	80	proteins	(Speck	et	al.,	2000;	Young	and	Rickinson,	2004).			EBV	was	described	as	the	first	human	oncovirus	and	is	now	classified	as	a	WHO	group	I	carcinogen,	because	EBV	 is	 causally	associated	with	several,	diverse	human	 tumours	 (Henle,	1968;	Esau,	2017;	Pagano,	1999).	EBV	 is	known	to	be	 involved	 in	a	number	of	malignancies	including	 Burkitt’s	 lymphoma	 (BL),	 nasopharyngeal	 carcinoma	 (NPC),	 Hodgkin’s	 Lymphoma	(HL),	 gastric	 cancer,	 and	 certain	 T/NK	 cell	 lymphomas	 (Carbone	 et	 al.,	 2008).	 In	immunocompromised	 patients,	 EBV	 can	 cause	 non-Hodgkin	 lymphomas	 such	 as	 post-transplant	lymphoproliferative	diseases	(PTLD).		In	 healthy	 individuals,	 the	 virus	persists	 as	 an	 asymptomatic,	 lifelong	 infection.	This	 is	because	the	virus	establishes	a	 latent	 infection	in	mostly	resting,	quiescent	B	cells,	but	 it	can	also	replicate	its	genome	in	concert	with	the	cellular	genome	in	proliferating	cells.	More	than	90	%	 of	 the	 population	 is	 seropositive	 for	 EBV,	 but	 the	 infection	mostly	 goes	 unnoticed.	 In	
vitro,	the	virus	infects	mature	resting	B	lymphocytes,	activates	them,	induces	cell	division	and	their	infinite	proliferation	as	lymphoblastoid	cell	lines	(LCL).		EBV	 is	 a	 very	 successful	 pathogen.	 The	 virus	 has	 evolved	 an	 inventive	 life	 cycle	 that	consists	 of	 three	 distinct	 phases	 of	 infection:	 the	 pre-latent,	 latent,	 and	 lytic	 phase.	 Upon	infection,	 EBV’s	 genome	 enters	 the	 cell	 as	 a	 linear,	 naked,	 and	 epigenetically	 naïve	 DNA	molecule,	which	rapidly	circularizes	in	the	nucleus	of	the	infected	cell.	During	the	initial	pre-latent	 phase,	 certain	 latent	 genes	 are	 already	 expressed,	 but	many	 viral	 lytic	 genes	 are	 also	temporary	transcribed.	Certain	lytic	genes	seem	to	have	an	essential	role	in	the	early	survival	
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of	 the	 virus	 regulating	 important	 host	 cell	 processes	 that	 will	 support	 viral	 long-term	persistence	(Altmann	and	Hammerschmidt,	2005).	The	naked,	histone-free	DNA	supports	the	permissive	viral	gene	expression,	but	lytic	viral	genes	need	to	become	silenced	to	escape	from	the	host	 immune	 responses	 as	well	 as	 to	 establish	 the	 stable,	 latent	phase.	To	 support	 gene	silencing	 the	viral	 genome	acquires	 a	 very	high	nucleosome	occupancy	with	 specific,	mostly	repressive	 histone	marks	 and	DNA	CpG	methylation	 (Woellmer	 and	Hammerschmidt,	 2013;	Woellmer	et	al.,	2012).	These	mechanisms	lead	to	the	establishment	of	the	latent	phase	of	EBV	infection,	when	several	copies	of	 the	viral	genome	are	maintained	 in	 the	cell	as	plasmid-like	chromosomes,	called	episomes.	During	this	stable	latent	state,	the	virus	expresses	only	a	small	subset	of	viral	genes	that	is	characteristic	for	the	distinct	type	of	latency	induced	during	EBV	infection.	In	an	EBV-infected	individual,	four	types	of	latency	programs	are	known:	latency	0,	I,	II,	and	latency	III.	Latency	0	is	found	in	quiescent	B	cells,	when	no	viral	proteins	but	only	viral	noncoding	 RNAs	 are	 expressed.	 The	 remaining	 latency	 programs	 share	 the	 expression	 of	Epstein-Barr	virus	Nuclear	Antigen	1	(EBNA1),	but	differ	in	the	expression	of	latent	membrane	proteins	(LMPs)	and	additional	EBNA	genes.	The	 latency	programs	I	and	II	are	characteristic	for	 certain	malignancies	 such	as	NPC	or	BL,	 respectively.	 In	vitro	 established	LCLs	 show	 the	latency	III	program,	which	includes	the	expression	of	six	EBNAs,	two	LMPs,	two	EBERs,	and	up	to	44	miRNAs.	This	discrete	program	is	the	consequence	of	the	well-regulated	silencing	of	the	EBV	genome	during	the	latent	phase	of	infection.		Eventually,	 latently	 infected	 cells	 can	 switch	 to	 the	productive	 lytic	 phase	of	EBV	after	induction	 of	 the	 signalling	 cascades	 upon	 B	 cell	 receptor	 activation.	 The	 viral	 lytic	 phase	requires	the	expression	of	the	BZLF1	gene	(Countryman	and	Miller,	1985;	Takada	et	al.,	1986),	which	encodes	a	viral	sequence-specific	transcription	factor.	It	preferentially	binds	to	an	AP-1-like	sequence	and	to	a	second	class	of	sequences	containing	CpG	methylated	motifs,	commonly	called	BZLF1	responsive	elements	(ZREs)	(Kalla	et	al.,	2012).	Together	with	the	second	viral	factor	BRLF1,	BZLF1	induces	the	very	rapid	expression	of	early	lytic	genes,	which	are	mostly	involved	 in	 lytic	 EBV	 DNA	 replication	 from	 the	 origin	 of	 lytic	 replication	 (oriLyt)	 element.	Finally,	48	hours	after	reactivation,	all	viral	lytic	genes	are	expressed,	which	are	essential	for	the	synthesis	of	structural	proteins,	packaging	of	the	new	EBV	DNA	into	viral	capsids,	and	the	release	of	virus	progeny.			
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	Fig.	1.	Schematic	overview	of	EBV’s	life	cycle.	The	scheme	depicts	the	three	main	phases	of	EBV	infection.	B	cells	infected	with	EBV	enter	the	pre-latent	phase,	which	 leads	to	establishment	of	 the	stable	 latent	phase	after	about	two	weeks	p.i..	Upon	antigen	encounter	and	the	 subsequent	 expression	of	 viral	 transactivator	BZLF1	 latently	 infected	 cells	 can	enter	 the	 lytic	phase.	 In	 the	lytic	 phase,	 the	 viral	 genome	 replicates	 independently	 of	 the	 cell	 cycle	 phase,	 is	 encapsidated	 and	 released	 to	allow	 infection	of	 the	neighbouring	 cells.	The	 lower	panel	of	 the	 figure	 indicates	 the	 changes	of	EBV	DNA.	The	virus	delivers	 its	 linear,	naked	DNA	to	 the	cell,	where	 it	 rapidly	circularizes	and	acquires	a	 fully	chromatinized	and	methylated	 episome,	which	 is	 a	 prerequisite	 for	 establishing	 the	 virus	 latent	 phase.	 During	 asynchronous	viral	DNA	replication	 in	 the	 lytic	phase	the	viral	DNA	loses	all	 its	epigenetic	modifications	and	virus	progeny	 is	released	that	contain	linear,	unmethylated	viral	DNA	free	of	histones.		
2.1.2. B cell reprograming during EBV infection 
 	 The	 success	of	EBV	 to	establish	and	maintain	a	 lifelong	 infection	 in	B	 cells	 lies	 in	 the	complex	viral	strategy	to	reprogram	the	cellular	host.	Initially,	the	virus	has	to	find	an	efficient	way	to	escape	from	the	host	immune	responses	that	encompasses	many	defence	lines	such	as	the	innate	and	adaptive	immunity	or	induction	of	apoptosis.	On	the	other	hand,	the	virus	has	to	manipulate	 host	 cell	 processes	 to	 create	 a	 favourable	 environment	 that	 allows	 the	 virus	 to	persist	in	the	infected	cell	and	to	replicate	its	genome	in	synchrony	with	the	dividing	cell,	but	also	enables	virus	to	effectively	switch	to	the	productive	lytic	phase	if	needed.	Several	reports	describe	viral	 factors	and	mechanisms	 that	 control	 immune	responses	against	EBV	or	 foster	the	process	of	B	cell	growth	transformation	and	the	regulation	of	host	gene	expression.		 	
B cell infection 
 and pre-latent phase
latent phase lytic phase
establishment reactivation
BZLF1
virion DNA virion DNAviral chromatin
days months/years about 48 hours
time
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Immune	responses	against	EBV	
		 EBV	can	persist	in	the	host	B	cell	despite	strong	and	efficient	immune	responses	against	EBV	antigens	and	viral	T	cell	epitopes	presented	on	the	surface	of	the	infected	cell.	Especially	during	 the	early	phase	of	EBV	 infection,	when	viral	 latency	 is	not	 fully	established,	 the	virus	has	to	evade	from	the	rapid	cellular	defence	against	the	invading	pathogen.	Several	viral	genes	are	expressed	immediately	after	infection	to	fulfil	this	task.	The	viral	gene	BCRF1	mimics	the	host	cytokine	IL-10,	which	has	an	anti-inflammatory	function	as	 it	controls	the	expression	of	the	 transporter	 proteins	 associated	 with	 antigen	 presentation	 (TAP)	 (Zeidler	 et	 al.,	 1997).	Additionally,	 the	BNLF2a	gene	reduces	the	recognition	of	 the	 infected	cell	by	CD8+	T	cells	 in	the	pre-latent	phase	of	infection,	because	BNLF2a	diminishes	the	surface	presentation	of	EBV	antigens	(Jochum	et	al.,	2012a).	EBV	also	expresses	two	homologs	of	the	cellular	anti-apoptotic	B	cell	 lymphoma	2	protein	(BCL-2):	BALF1	and	BHRF1.	The	expression	of	these	genes	allows	the	virus	to	evade	immediate	apoptosis	and	to	establish	the	subsequent	latent	phase	(Altmann	and	Hammerschmidt,	2005).	Yet	another	process,	which	is	used	by	EBV	during	the	early	phase	of	 EBV	 infection	 is	 RNA	 interference	mediated	 by	 EBV’s	 44	miRNAs.	 Viral	 RNA	 interference	reduces	protein	 levels	by	neutralizing	 the	encoding	 transcripts.	Certain	viral	miRNAs	have	a	role	 in	 inhibiting	 the	 recognition	 of	 EBV-infected	 cells	 by	 NK	 cells	 or	 limit	 pro-apoptotic	interleukins	of	the	host	cell	(Seto	et	al.,	2010;	Jochum	et	al.,	2012b).	 In	addition,	several	EBV	miRNAs	control	the	recognition	of	EBV	infected	B	cells	by	CD8+	and	CD4+	T	cells.	Directly	or	indirectly,	viral	miRNAs	target	HLA	molecules,	the	pro-inflammatory	IL-12	cytokine,	lysosomal	enzymes,	 and	TAP	 transporters	 to	efficiently	prevent	EBV	antigen	presentation	 (Albanese	et	al.,	 2017;	 Tagawa	 et	 al.,	 2016;	 Albanese	 et	 al.,	 2016).	 Clearly,	 EBV	 has	 evolved	 a	 variety	 of	ingenious	mechanisms	to	promote	its	escape	from	complex	host	cell	immune	responses.			
B	cell	growth	transformation	and	host	gene	regulation	
		 B	 cells	 infected	 with	 EBV	 are	 immediately	 activated	 and	 enter	 a	 highly	 proliferative	state	before	the	latent	phase	is	established,	eventually.	Certain	viral	genes	trigger	and	control	this	extraordinary	process.	A	well-known	example	of	one	of	the	cell	transforming	viral	factors	is	the	latent	membrane	protein	1,	LMP1.	It	has	constitutive	activating	functions	and	mimics	the	activated	ligand-bound	cellular	CD40	receptor,	which	stimulates	and	activates	B	cells.	LMP1	is	constitutively	active	and	thus	drives	B	cell	transformation	supporting	their	survival,	activation,	
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and	 continuous	 proliferation	 (Dent	 et	 al.,	 1997).	 LMP1	was	 also	 found	 to	 have	 functions	 in	different	 processes	 such	 as	 cytokine	 and	 chemokine	 release,	 immune	 modulation	 or	 gene	regulation	(Kieser	and	Sterz,	2015).	The	LMP2	viral	protein	is	also	involved	in	B	cell	signalling	but	in	contrast	to	LMP1,	it	induces	a	basic	level	of	activation	similar	to	the	tonic	signalling	of	a	non-engaged	B	cell	receptor	(BCR)	(Mancao	and	Hammerschmidt,	2007).		EBNA	 proteins	 have	 additional	 and	 very	 important	 roles	 in	 activating	 B	 cells	 and	regulating	 host	 genes.	 EBNA2	 is	 a	 viral	 transcription	 factor,	 which	 together	 with	 its	 co-activator	EBNA-LP	 are	 transcriptional	 activators	 of	many	 cellular	 genes	 and	 are	 responsible	for	the	establishment	of	a	stable	latent	phase.	Among	the	EBNA-LP	and	EBNA2	regulated	genes	are	 the	proto-oncogene	 c-MYC	 and	 the	 cellular	 transcription	 factor	PU.1,	which	promote	 the	proliferation	of	EBV-infected	genes.	EBNA2	acts	by	binding	to	enhancer	regions	of	 its	targets	inducing	subsequent	alterations	of	the	chromatin	architecture	(Zhao	et	al.,	2011;	Kempkes	and	Ling,	2015).	EBV’s	EBNA3	proteins	consist	of	EBNA3A,	EBNA3B,	and	EBNA3C.	EBNA3A	and	3C	are	 believed	 to	 function	 as	 oncoproteins	 by	 affecting	 cellular	 proliferation,	 survival,	 and	immune	responses.	They	are	found	to	be	essential	for	the	regulation	of	cellular	proliferation	by	targeting	important	tumour	suppressor	pathways	constituents	such	as	the	pro-apoptotic	BIM	or	 cyclin-dependent	 kinase	 inhibitor	 (CDKI)	 p16INK4a	(Paschos	 et	 al.,	 2012).	 EBNA3A	 and	3C	are	co-activators	together	with	EBNA2	and	interact	with	many	cellular	factors	to	facilitate	gene	expression	 and	 chromatin	 organization	 (Allday	 et	 al.,	 2015).	 The	 EBNA3B	 protein	 is	dispensable	for	B	cell	transformation	by	EBV	and	functions	as	a	tumour	suppressor	promoting	for	 instance	chemokines	expression	(White	et	al.,	2012).	EBNA1	protein	 is	a	viral	 factor	 that	has	a	crucial	function	in	maintaining	the	EBV	episome,	thus	promoting	cell	survival	during	the	stable	latent	phase	(Frappier,	2012).		EBV	 uses	 a	 very	 complex	 network	 of	 viral	 strategies,	 which	 together	 reprogram	 the	infected	B	cell	and	permit	virus	persistence	in	the	host	cell	during	latency.	As	mentioned	in	the	previous	 paragraph,	 there	 are	 many	 reports	 about	 viral	 factors	 and	 their	 functions,	 which	modulate	 cellular	 mechanisms,	 but	 our	 knowledge	 is	 still	 incomplete.	 In	 my	 PhD	 thesis,	 I	focused	 on	 the	 phenotypes	 of	 B	 cell	 reprogramming	 at	 very	 early	 time-points	 after	 EBV	infection,	but	I	also	investigated	the	dynamic	changes	of	the	cellular	transcriptome	induced	by	the	virus.	I	aimed	at	verifying	already	known	principles	of	EBV	infection	and	at	identifying	new	time-resolved	processes	 that	are	essential	 for	 the	establishment	of	EBV’s	 latent	phase.	A	key	component	 of	 EBV’s	 latent	 phase	 is	 the	 function	 of	 viral	DNA,	which	 includes	 acquisition	 of	
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nucleosomes	and	other	chromatin	constituents	and	occurs	early	in	the	pre-latent	phase	after	infection.		
2.2.  Epigenetic changes during viral infection 
 	 Epigenetics	is	a	very	dynamic	and	fast	developing	field	of	research,	which	investigates	the	molecular	basics	of	epigenetic	control	in	different	types	of	cells	and	epigenetic	regulation	of	 various	 diseases.	 Initially,	 the	 term	 “epigenetics”	 described	 apparent	 differences	 in	phenotypes	that	do	not	stem	from	changes	of	the	underlying	DNA	sequence,	i.e.	the	genotype	(Weinhold,	 2006).	 Epigenetics	 implements	 heritable	 changes	 in	 gene	 expression	 that	 result	from	how	cells	“read”	their	genes.	Several	epigenetic	mechanisms	regulate	the	entire	cellular	transcriptome	 and	 they	 govern	 the	 identities	 of	 differentiated	 cells	 and	 tissues.	 Moreover,	epigenetic	 mechanisms	 are	 critically	 involved	 in	 the	 dynamic	 response	 to	 changes	 in	 the	cellular	 environment.	 The	most	 important	 levels	 of	 epigenetic	 controls	 include	 nucleosome	occupancy,	 positioning	 and	 their	 mobility,	 histone	 modifications,	 DNA	 CpG	 methylation,	chromatin	 architecture,	 and	 lncRNAs.	 Epigenetics	 also	 plays	 an	 important	 role	 in	 the	interaction	 between	 the	 host	 and	 its	 pathogens	 during	 different	 phases	 of	 infection	 with	viruses,	bacteria,	or	parasites	(Allis	and	Jenuwein,	2016).	
2.2.1. Histone acquisition and the histone “code” 
 
Nucleosomes and their acquisition to DNA 
 	 Histone	proteins	are	the	basic	“bricks”	that	together	with	double-stranded	DNA	form	an	octameric	complex	called	the	nucleosome.	It	consists	of	two	copies	each	of	the	histone	proteins	H2A,	 H2B,	 H3,	 and	H4.	 	 Nucleosomes	 package	 genomic	 DNA	 into	 a	 bead-like	 structure	 that	consists	of	units	of	exactly	147	bp	of	DNA	wrapped	around	the	histone	octamer	in	1.65	turns	of	a	 left-handed	superhelix	 (Luger	et	al.,	1997;	Thomas	and	Kornberg,	1975).	Nucleosomes	are	formed	in	mostly	regularly-spaced	arrays,	in	which	individual	nucleosomes	are	separated	by	a	DNA	linker	region,	which	is	occupied	by	H1,	a	special	linker	histone.	From	a	wider	perspective,	chromatin	is	a	complex	of	DNA	and	nucleosomes,	which	together	form	chromatin	fibres,	which	are	coiled	and	condensed	to	form	a	chromosome.	In	principle,	nucleosomes	compact	the	DNA	genome,	but	they	also	act	as	a	physical	barrier	preventing	the	binding	of	cellular	transcription	factors	to	DNA	and	therefore	regulate	gene	expression	indirectly.		Nucleosome	acquisition	on	DNA	is	a	very	tightly	controlled	process,	which	is	essential	for	transcription,	 differentiation,	 DNA	 replication,	 and	 genome	 stability.	 The	 most	 important	
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cellular	protein	complexes	involved	in	the	mechanisms	of	nucleosome	acquisition	are	histone	chaperones.	This	class	of	enzymes	deposits	one	tetramer	of	H3-H4	histone	proteins	onto	DNA	forming	a	tetrasome,	which	assembles	almost	one	turn	of	the	DNA	helix.	In	the	following	step,	two	dimers	of	H2A-H2B	histones	are	loaded	on	the	tetrasome	to	complete	the	wrapping	of	the	remaining	DNA	on	the	nucleosomal	octamer	(Richmond	and	Davey,	2003;	Burgess	and	Zhang,	2010).	Dedicated	histone	chaperones	act	on	specific	histone	dimers,	tetramers	or	even	distinct	histone	 variants,	 and	 they	 have	 two	modes	 of	 action:	 replication-dependent	 or	 replication-independent	 assembly	 of	 histones.	 CAF-1	 and	 ASF1	 belong	 to	 the	 group	 of	 replication-dependent,	S	phase	related	histone	chaperones.	Canonical	histones	are	newly	synthesized	 in	the	S	phase	of	 the	cell	 cycle,	 they	are	 transported	 into	 the	nucleus	and	bound	by	ASF1.	This	chaperone	 transfers	 the	H3-H4	 tetramers	onto	CAF-1,	which	 interacts	with	proliferating	 cell	nuclear	 antigen	 (PCNA)	 directly	 behind	 the	 replication	 forks	 and	 assembles	 histones	 onto	newly	 synthesized	 DNA	 (Krude,	 1999;	 Burgess	 and	 Zhang,	 2013).	 NAP-1,	 another	 S	 phase	chaperone,	is	presumably	involved	in	the	transport	and	deposition	of	H2A-H2B	dimers	on	DNA	during	replication.		Histone	 loading	 can	 also	 take	 place	 independent	 of	 the	 cell	 cycle	 by	 a	 special	 class	 of	replication-independent	histone	 chaperones	 (Henikoff	 and	Smith,	2015).	They	mostly	 act	on	variants	of	histone	proteins	such	as	CenH3	(centromere	variant	histone),	H3.3,	H2A.Z,	H2A.X,	H2A.Bbd	(Barr	body	deficient	histone),	or	MacroH2A.	HIRA	and	 the	Daxx-ATRX	complex	are	examples	 of	 chaperones	 specific	 for	 histone	 H3.3	 variants	 and	 are	 associated	 with	transcriptionally	active	sites	but	also	silenced	regions	such	as	telomeres.	Histone	variants	and	their	chaperones	are	involved	in	histone	turnover,	which	is	 important	for	activity-dependent	but	cell	cycle-independent	gene	expression	during	differentiation	or	 in	age-related	signalling	processes	 in	neurons	(Voon	and	Wong,	2016;	Bano	et	al.,	2017;	Deaton	et	al.,	2016).	Histone	variants	 presumably	 play	 a	 role	 in	 the	 stability	 of	 histone	 octamers	 and	 their	 strength	associating	with	DNA	(Jin	and	Felsenfeld,	2007;	Henikoff,	2009).			
Nucleosome	dynamics			 The	 term	 “nucleosome	 dynamics”	 combines	 features	 of	 nucleosomes	 such	 as	positioning	 and	 occupancy	 on	 the	 genome,	 post-translational	 modifications	 of	 histones	 and	their	mobility.	Nucleosome	dynamics	results	from	a	combination	of	different	parameters	and	players	that	include	DNA	sequence	preferences,	the	dynamic	actions	of	chromatin	remodelling	
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enzymes,	cellular	transcription	factors	(TFs),	and	the	RNA	polymerase	II	(PolII)	transcription	machinery.	Transcriptionally	active	promoters	or	enhancer	regions	are	often	characterised	by	constitutive	 nucleosome	 free	 regions	 (NFR)	 or	 conditionally	 regulated	 nucleosome	 depleted	regions	(NDR);	both	of	which	ensure	DNA	accessibility	for	PolII,	TFs,	and	the	DNA	replication	machineries.	Throughout	the	entire	genome,	nucleosome	binding	and	spacing	is	dynamic	and	can	affect	different	chromatin	functions	by	nucleosomes	sliding	(their	fuzziness),	dissociation	from	DNA	and	histone	nucleosome	compositions,	which	can	also	alter	their	stability	(Lai	and	Pugh,	 2017;	 Struhl	 and	 Segal,	 2013).	 Nucleosome	 occupancy	 is	 operationally	 defined	 as	 the	average	 amount	 of	 nucleosomes	 on	 a	 specific	 region	 in	 the	 genome,	 i.e.	 it	 describes	 the	probability	 that	 nucleosomes	 are	 present	 or	 absent	 at	 a	 certain	 location.	 In	 contrast,	nucleosome	positioning	describes	the	probability	that	a	nucleosome	is	placed	at	a	given	locus	with	discrete	genomic	 coordinates;	 this	 term	defines	 the	exact	point	of	nucleosome	binding.	Nucleosome	 positioning	 is	 a	 feature	 that	 is	 strongly	 dependent	 on	 the	 action	 of	 chromatin	remodelers.	 Both,	 nucleosome	 occupancy	 and	 positioning	 allow	 to	 properly	 regulate	 the	accessibility	of	DNA	regions	and	thus	influence	gene	expression.	This	chromatin	plasticity	is	a	mechanism,	with	which	the	genome	of	a	cell	can	quickly	respond	to	external	stimuli	or	which	can	regulate	a	recovery	from	internal	transcription	or	replication	defects	(Allis	and	Jenuwein,	2016).	In	 addition	 to	 nucleosome	 dynamics,	 histone	 proteins	 carry	 a	 vast	 variety	 of	 post	translational	modifications	 (PTMs),	which	play	 a	 role	 in	processes	 involved	 in	 transcription,	replication,	or	DNA	damage	response	(DDR).	Most	post-translational	modifications	of	histones	appear	on	their	highly	basic	N-terminal	tails,	which	stick	out	from	the	core	of	the	nucleosome	and	thus	are	presented	to	specific,	histone-modifying	enzymes.	The	best	known	and	described	histone	 PTMs	 are	 acetylation,	methylation,	 and	 phosphorylation	 (Bannister	 and	 Kouzarides,	2011;	Zentner	and	Henikoff,	2013).	In	addition,	recent	studies	have	revealed	a	number	of	novel	modifications	 such	 as	 propionylation,	 butyrylation,	 crotonylation,	 2-hydroxyisobutyrylation,	malonylation,	 and	 succinylation	 (Kebede	et	 al.,	 2015;	Lawrence	et	 al.,	 2016). The	majority	of	these	 recently	 identified	 modification	 does	 not	 yet	 have	 assigned	 functions	 in	 chromatin	biology	and	gene	expression	regulation;	therefore,	I	will	concentrate	on	histone	modifications	with	well-known	functions.		Histone	 acetylation	was	 identified	 as	 the	 first	 histone	modification	 by	 Phillips	 in	 1963	(Phillips,	1963).	Further	studies	 found	 the	correlation	of	histone	acetylation	and	active	gene	transcription,	which	initiated	the	search	for	new	histone	PTMs	and	their	roles	 in	modulating	
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genes	 expression	 (Verdone	 et	 al.,	 2005;	 Allfrey	 et	 al.,	 1964).	 Acetylation	 is	 based	 on	 the	enzymatic	addition	of	an	acetyl	group	(COCH3)	derived	from	acetyl	coenzyme	A	and	promoted	by	 histone	 acetyltransferases	 (HATs).	 Lysine	 acetylation	 neutralizes	 the	 positive	 charge	 of	lysine	 residues,	 which	 weakens	 DNA-nucleosome	 interactions	 and	 increases	 chromatin	accessibility	 for	 different	 cellular	 factors	 involved	 in	 transcription	 or	 replication.	 Histone	acetylation	 is	 a	 very	 dynamic	 modification	 and	 can	 be	 removed	 by	 enzymes	 called	 histone	deacetylases	 (HDACs),	which	were	 also	 found	 to	have	 a	 role	 in	 cancer	progression	 (Zentner	and	Henikoff,	2013;	Verdone	et	al.,	2005).		Histone	 methylation	 catalyses	 the	 addition	 of	 mono-,	 di-	 or	 tri-	 methyl	 groups	 from		S-adenosyl-L-methionine	to	lysine	or	arginine	residues,	a	chemical	reaction,	which	is	mediated	by	 a	 group	 of	 enzymes	 called	 histone	 methyltransferases	 (HMTs)	 (Greer	 and	 Shi,	 2012).	Histone	 trimethylation	 at	 H3K4me3	 and	 H3K36me3	 are	marks	 linked	 to	 gene	 activation	 in	regulatory	modules	of	a	certain	genomic	context.	H3K4me3	has	an	antirepressor-like	function	as	 this	 modification	 counteracts	 the	 repressive	 H3K27me3	 modification	 introduced	 by	Polycomb	repressive	complex	(PRC)	proteins.	Yet	another	activation	mark,	H3K36me3,	might	have	 a	 role	 in	 DNA	 Mismatch	 Repair	 and	 DDR.	 H3K9me3	 is	 a	 histone	 mark	 indicative	 of	constitutively	repressed	chromatin	and	has	an	important	role	in	gene	silencing	together	with	H3K27me3	 introduced	 by	 PRC	 proteins.	 These	 methylation	 marks	 at	 the	 N-terminus	 of	histones	 increase	 the	affinity	 to	 certain	protein	modules	 such	as	HP1	 chromodomain,	which	results	in	the	destabilization	of	nucleosomes	(Zentner	and	Henikoff,	2013;	Li	and	Wang,	2017).		Similar	 to	 histone	 acetylation,	 histone	 phosphorylation	 interferes	 with	 the	 negatively	charged	phosphates	on	the	DNA	backbone,	which	reduces	the	interactions	between	DNA	and	nucleosome	and	 thus	 increases	DNA	accessibility.	 Phosphorylation	marks	play	 an	 important	role	 in	 many	 biological	 processes	 such	 as	 DDR	 or	 chromatin	 remodelling	 (Rossetto	 et	 al.,	2012).	 In	 more	 general	 terms,	 nucleosome	 occupancy	 and	 histone	 modifications	 define	 two	major	 states	 of	 chromatin:	 euchromatin,	 which	 is	 characterized	 by	 decondensed	 and	transcriptionally	 accessible	 regions,	 and	 heterochromatin	 with	 condensed	 regions	 and	transcriptionally	silenced	or	repressed	genes	(Allis	and	Jenuwein,	2016).	Specific	 combinatorial	 patterns	 of	 histone	 modifications	 create	 the	 so-called	 “histone	code”	(Peterson	and	Laniel,	2004).	This	additional	 information	 is	used	to	recruit	numbers	of	functionally	 different	 histone	 modifying	 factors,	 which	 are	 chromatin	 “readers”	 (e.g.	chromodomain,	PWWP	domain	proteins),	chromatin	“writers”	(e.g.	HAT,	HMT),	and	chromatin	
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“erasers”	 (HDACs).	 The	 histone	 code	 provides	 an	 epigenetic	 marking	 that	 stores	 the	instructions	 for	 regulating	 fundamental	mechanisms	 such	 as	 transcription,	 replication,	 DNA	repair	and	imprinting,	which	regulates	cell	differentiation	and	the	cell	fate	(Jenuwein	and	Allis,	2001).		
		Fig.	2.	Examples	of	epigenetic	modifications	and	their	functions.	The	 graph	 depicts	 four	 nucleosomes	 in	 its	 centre,	 which	 include	 different	 epigenetic	 features	 such	 as	 histone	modifications	(Mod),	DNA	methylation	(Me),	chromatin	remodelling	and	histone	turnover	(yellow	nucleosome),	and	lncRNAs	(blue	lines).	These	modifications	are	associated	with	their	known	and	presumable	functions	on	the	chromatin	 landscape	 (grey	 boxes).	 Examples	 of	 factors	 involved	 in	 theses	mechanisms	 are	 provided	 (adapted	from,	Allis	and	Jenuwein,	2016).			
2.2.2. Transcriptome regulation – functions of the chromatin architecture and 
lncRNAs  
 	
Chromatin	architecture	
	 	 Combined	 and	 complex	 interactions	 between	 DNA	 and	 chromatin	 control	 the	transcription	 of	 all	 metazoan	 cells.	 The	 communication	 between	 promoter	 and	 enhancer	
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regions	 is	 another	 layer	 of	 complexity	 that	 affects	 gene	 expression	 and	 is	 mediated	 by	 the	dynamic	 chromatin	 structure.	 Gene	 transcription	 initiates	 at	 promoter	 elements,	where	 TFs	commonly	bind	upstream	of	 transcription	 start	 sites	 (TSS)	 and	promote	binding	of	 the	RNA	Polymerase	 II	 (PolII)	 preinitiation	 complex	 again	 supported	 by	 TFs	 and	 their	 co-regulators.	Efficient	transcription	elongation	needs	additional	signals,	which	will	help	RNA	Polymerase	II	to	escape	from	pausing	and	to	continue	transcription.	This	complex	regulation	depends	also	on	distal	cis-regulatory	elements	such	as	enhancers	or	insulators	(Hu	and	Tee,	2017;	Kolovos	et	al.,	2012).		Enhancers	 are	 important	 regulatory	 regions	 of	 the	 genome,	which	 are	 able	 to	 interact	with	their	promoters	bridging	 long	distances.	Enhancers	shape	the	gene	expression	program	in	 a	 specific	 cell	 type	 and	 biological	 context.	 The	 program	 depends	 on	 the	 exact	 chromatin	state,	 i.e.	 accessible	 local	 chromatin	 structure	 for	 TFs	 binding	 and	 higher	 order	 chromatin	structure	 (chromatin	 architecture).	 The	 latter	 facilitates	 physical	 interactions	 between	enhancers	and	their	cognate	promoters.	Epigenetic	marks	define	different	types	of	enhancers:	active	 enhancers	 are	 decorated	 with	 H3K27ac	 and	 H3K4me1,	 while	 silent	 enhancers	 are	marked	with	H3K27me3,	the	typical	repression	mark.	Poised	enhancers	are	characterized	by	both	types	of	histone	modifications,	repressive	and	activating	marks	such	as	H3K27me3	and	H3K4me1,	respectively	(Shlyueva	et	al.,	2014).	Gene	expression	during	development	 is	often	characterized	by	poised	enhancers	that	modulate	gene	expression	in	embryonic	stem	cells	and	at	various	stages	of	differentiation.		Chromatin	accessibility	is	a	very	important	feature	for	enhancer	mediated	regulation	and	thus	enhancers	 recruit	 several	 chromatin	 remodelers	and	 transcription	 factors,	 in	particular	pioneer	 transcription	 factors	 (Calo	 and	 Wysocka,	 2013).	 Together	 with	 these	 properties,	enhancers	 also	 promote	 the	 three-dimensional	 shaping	 (looping)	 of	 chromatin	 to	 make	physical	contacts	with	their	cognate	promoter	regions.	Specific	 interactions	are	facilitated	by	compartmentalizing	and	 insulating	 the	genome	 into	regulatory	domains	called	“topologically	associated	domains”	 (TADs).	TADs	are	able	 to	arrange	and	bring	 together	 specific	activating	regions	 including	promoter-enhancer	 loops	via	 intra-TAD	chromatin	 interactions	preventing	interactions	between	different	TADs	 (inter-TADs)	 and	 separating	 these	 interaction	domains.	TAD	 borders	 are	 bound	 by	 architectural	 proteins	 such	 as	 CTCF	 and	 cohesins	 (Hu	 and	 Tee,	2017).	Within	TADs	enhancers	 can	also	 form	groups	of	 enhancers	 (super	enhancers),	which	can	 massively	 amplify	 the	 expression	 of	 genes	 depending	 on	 the	 activating	 signal.	 On	 the	contrary,	 a	 disruption	 or	 changes	 in	 certain	 enhancers	 are	 known	 to	 cause	 disease	 such	 as	
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sporadic	Parkinson’s	disease	or	pancreatic	agenesis,	an	extremely	rare	anomaly	(Dekker	et	al.,	2013;	Hu	and	Tee,	2017).			
lncRNAs	and	epigenetic	regulation	
	 	 During	the	last	ten	years,	the	interest	in	ncRNAs	and	their	functions	in	cellular	biology	has	increased	dramatically.	lncRNA	are	defined	as	transcripts	that	do	not	encode	proteins	and	are	longer	than	200	nt.	Initially,	lncRNAs	were	described	as	junk	or	artefactual	RNAs,	but	they	have	 been	 recognized	 to	 provide	 a	 new	 level	 of	 complexity	 in	 the	 regulation	 of	 gene	expression.	lncRNAs	were	found	to	act	in	cis	targeting	the	transcripts	of	genes	from	which	they	originate.	lncRNAs	can	also	work	in	trans	on	transcripts,	which	are	unrelated.	By	now,	lncRNAs	are	described	to	be	cell	specific	and	to	have	roles	in	cell	growth,	apoptosis,	development,	and	cell	differentiation	(Rinn	and	Chang,	2012).	The	molecular	mechanisms	that	support	lncRNAs	in	 epigenetic	 regulation	 of	 the	 gene	 expression	 are	 diverse.	 For	 example,	 lncRNAs	 can	efficiently	 interact	with	 chromatin	modifiers,	 serve	 as	 guide	RNAs,	 locate	 to	 complementary	region	 and	 change	 the	 local	 chromatin	 structure.	 Xist	 was	 described	 as	 the	 first	 functional	lncRNA,	 which	 is	 essential	 for	 the	 inactivation	 of	 the	 X	 chromosome	 and	 gene	 dosage	compensation.	 Silencing	 of	 the	 X	 chromosome	 is	 promoted	 by	 binding	 of	 Xist	 to	 the	 PRC2	complex	via	a	repetitive	motif	in	5’	end	of	the	lncRNA.	Xist	was	also	found	to	directly	bind	to	SHARP,	a	 transcriptional	repressor,	and	SMRT,	which	activates	HDAC3	and	mediates	histone	deacetylation	of	the	X	chromosome	(McHugh	et	al.,	2015).		Interactions	 of	 lncRNAs	 and	 proteins	 can	 guide	 the	 complexes	 to	 specific	 chromatin	regions	 (as	 in	 case	 of	 Xist)	 or	 act	 as	 decoy	 for	 chromatin	 modifying	 enzymes	 preventing	repressive	modifications	of	a	specific	genomic	region.	lncRNAs	can	provide	a	scaffold	to	tether	more	 than	 one	 protein	 complex	 and	 synchronize	 their	 activity.	 A	 prominent	 example	 is	HOTAIR	 lncRNA,	 which	 guides	 the	 PRC2	 complex	 to	HOX	 genes	 and	 subsequently	 interacts	with	the	histone	demethylase	LSD1,	which	removes	activation	mark	from	this	locus	(Marchese	and	Huarte,	2014;	Flynn	and	Chang,	2014).	Besides	chromatin	modifications,	the	lncRNA	SRA	is	able	to	bind	to	and	enhance	the	insulator	function	of	CTCF,	which	together	with	cohesins	are	involved	 in	 chromatin	 looping	 and	 long	 range	 interactions	 (Yao	 et	 al.,	 2010).	 The	 known	mechanisms	of	lncRNA	molecules	and	their	functions	are	still	incomplete	and	gene	regulation	mediated	by	non-coding	transcripts	might	be	even	more	diverse	and	complex.			 	
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2.2.3. The epigenetic mechanisms during γ herpesvirus infection  
 	 As	 discussed	 in	 the	previous	 chapter,	 epigenetics	 has	 an	 important	 role	 in	 regulating	cellular	mechanisms	including	transcription.	Therefore,	it	is	not	surprising	that	pathogens	and	in	particular	viruses	use	this	layer	of	regulation	to	promote	their	infection	and/or	alter	cellular	processes.	 Viruses	 can	 indirectly	 control	 epigenetic	 regulation	 of	 the	 infected	 cell	 by	modulating	 host	 cell	 signalling	 or	 transcription	 of	 chromatin	 constituents	 with	 enzymatic	functions.	 Viruses	 can	 also	 directly	 impact	 on	 epigenetic	 mechanisms	 including	 histone	modifications,	 DNA	 methylation,	 and	 chromatin	 structure.	 A	 recent	 report	 suggested	 that	viruses	are	able	to	control	each	and	every	step	of	the	virus	life	cycle	by	epigenetic	processes	(Milavetz	 and	 Balakrishnan,	 2015).	 As	 different	 viruses	 clearly	 have	 diverse	 life	 styles	 that	necessitate	 distinct	 mechanisms,	 I	 would	 like	 to	 concentrate	 here	 on	 known	 principles	 of	epigenetic	regulation	in	the	group	of	γ	herpesviruses	focusing	on	KSHV	and	EBV.		The	 first	 step	 of	 infection	 is	 the	 entry	 of	 viral	 DNA	 into	 the	 nucleus	 of	 the	 host	 cell.	Herpesviruses	deliver	their	genomes	to	the	nucleus	as	linear,	epigenetically	naïve	DNAs	free	of	CpG	methylations	and	lack	of	histones.	The	viral	genome	circularizes	immediately,	which	can	be	 a	 very	 important	 step	 to	 prevent	 an	 antiviral	 DDR	 response	 that	 might	 emerge	 upon	detection	of	free	DNA	ends	in	the	infected	cell.	During	infection	with	certain	α	herpesviruses,	the	viral	DNA	rapidly	acquires	the	histone	variant	H3.3,	which	seems	to	have	an	important	role	in	the	ensuing	lytic	phase	of	infection	(Oh	et	al.,	2012).	The	process	of	chromatinization	of	viral	DNA	of	γ	herpesviruses	might	be	different	since	they	commonly	establish	a	stable	latent	phase	upon	 infection	 and	 persist	 in	 the	 host	 cell.	 	 Tegument	 proteins,	 which	 are	 well-conserved	among	herpesviruses,	might	have	a	functional	role	in	this	process.	Certain	tegument	proteins	bind	 to	 cellular	 factors	 in	 promyelocytic	 leukemia	 nuclear	 bodies	 (PML	 NB),	 which	 contain	chromatin	factors	such	as	Daxx,	ATRX,	or	SP100.	It	was	described	that	EBV’s	tegument	protein	BNRF1	can	interact	with	Daxx	and	prevent	its	binding	to	ATRX.	These	two	cellular	proteins	are	known	as	the	histone	variant	H3.3	chaperone	complex.	Thus,	inhibiting	their	binding	interferes	with	 the	 loading	 of	H3.3	 histone	 onto	 viral	DNA	 (Tsai	 et	 al.,	 2014;	Huang	 et	 al.,	 2016).	 This	mechanism	was	interpreted	to	prevent	the	silencing	of	latent	genes,	which	the	histone	variant	H3.3	 might	 induce,	 but	 this	 report	 does	 not	 explain	 how	 and	 when	 the	 nucleosomes	 are	actually	 assembled	 on	 viral	 DNA.	 The	 exact	 timing	 and	 the	 mechanisms	 of	 the	chromatinization	of	EBV’s	genomic	DNA	remain	to	be	explored.	
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The	most	 critical	 step	 in	 γ	herpesvirus	 infection	 is	 the	 establishment	of	 a	 stable	 latent	phase,	which	allows	the	pathogen	to	persist	in	the	host	cell	long-term.	The	latent	state	has	to	be	strictly	controlled,	because	only	a	small	and	distinct	group	of	viral	genes	is	expressed,	while	all	 lytic	 viral	 genes	 must	 be	 repressed	 to	 escape	 from	 immune	 surveillance.	 This	 state	 of	infection	 was	 investigated	 in	 more	 detail	 in	 both	 viruses	 EBV	 and	 KSHV.	 Mechanisms	 that	tightly	 control	 epigenetic	 gene	 regulation	 during	 this	 phase	 encompass	 DNA	 methylation,	nucleosome	occupancy,	histone	modifications,	and	chromatin	architecture.	During	latency,	the	EBV	 genome	 is	 fully	 methylated	 at	 CpG	 sites,	 densely	 occupied	 by	 nucleosomes	 with	 the	histone	 marks	 H3K27me3	 and,	 at	 a	 lower	 level,	 H3K9me3.	 During	 reactivation	 of	 the	 lytic	phase	 the	 repressive	 modification	 H3K27me3	 seems	 to	 be	 removed	 as	 compared	 with	H3K9me3,	which	remains	unchanged	(Woellmer	et	al.,	2012).	KSHV,	similar	to	EBV,	acquires	CpG	methylation,	but	 the	post-translational	modifications	of	histones	differ	during	 the	 latent	phase	of	infection.	Latent	KSHV	genes,	which	are	expressed	in	this	phase	acquire	active	histone	marks	such	as	H3K9ac	or	H3K4me3;	late	lytic	genes,	which	have	to	be	silenced	are	associated	with	H3K9me3	and	H3K27me3	(Toth	et	al.,	2013).	Viral	genes,	which	are	 important	 for	 lytic	reactivation	 and	 escape	 from	 latency	 contain	 bivalent	 epigenetic	 marks	 (H3K4me3	 plus	H3K27me3).	This	strategy,	which	differs	from	EBV,	allows	KSHV	to	enter	the	 lytic	phase	in	a	very	short	 time,	but	 this	 strategy	can	promote	a	certain	 level	of	 leakiness	of	viral	genes	and	provoke	antiviral	immune	responses	in	vivo.		Recently,	 the	three-dimensional	structure	of	the	viral	episome	was	causally	 linked	with	viral	gene	regulation	during	latency.	Proteins	involved	in	chromatin	architecture	such	as	CTCF	and	cohesins	were	also	found	on	the	viral	genome.	CTCF	might	play	also	a	role	 in	disrupting	nucleosome	positioning	and	preventing	the	spread	of	specific	histone	marks	(Tempera	et	al.,	2010),	but	CTCF	also	flanks	TADs	and	might	contribute	to	the	three-dimensional	structure	of	EBV	DNA.	During	latency,	chromatin	loops	between	transcriptional	regulatory	elements	were	found	in	EBV	as	well	as	KSHV.	Interactions	between	the	oriP	enhancer	element	with	the	latent	Cp	and	LMP1	promoters	enhance	the	expression	of	these	EBV	genes	(Arvey	et	al.,	2012).	In	the	KSHV	genome,	CTCF-mediated	loops	were	identified	between	LANA	and	the	3’	end	of	the	K12	gene	 and	 between	 lytic	 genes	 encoding	 the	 transcripts	 of	 ORF50	 and	 ORF45.	 These	 loops	presumably	repress	lytic	gene	expression	(Kang	et	al.,	2011).	Escape	from	latency	and	reactivation	of	the	productive,	lytic	phase	allows	herpesviruses	to	replicate	and	synthesize	viral	progeny	to	infect	neighbouring	cells.	This	process	is	very	fast	and	has	to	be	extremely	efficient.	All	repressive	modifications	have	to	be	erased	or	replaced	by	
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activation	marks,	 but	 also	 the	 entire	 viral	 chromatin	has	 to	be	 rearranged	 to	promote	 rapid	viral	 lytic	 gene	 expression.	 These	 mechanisms	 involve	 global	 epigenetic	 regulators	 such	 as	HDACs,	histone	demethylases,	or	chromatin	remodelers	(Lieberman,	2013).	Clearly,	there	are	several	studies	that	describe	various	epigenetic	mechanisms	employed	by	γ	herpesviruses,	but	there	 are	many	 crucial	 steps	 such	 as	 histone	 acquisition	 and	de	novo	 nucleosome	 formation	that	are	largely	unknown.		
2.3.  Potential metabolic changes in the course of viral infection 
 Metabolic	pathways	play	 very	 important	 roles	during	 all	 processes	 in	 the	 cell,	 because	they	 provide	 a	 constant	 source	 of	 energy	 and	 basic	 components	 used	 for	 nucleic	 acid	biosynthesis,	 protein	 synthesis	 or	 yield	 precursors	 for	 other	 specific	 biochemical	 processes.	Cells	 adapt	 to	 various	 environmental	 stresses	 by	 modulating	 cellular	 metabolic	 pathways,	which	 support	 the	 physiological	 development	 and	 differentiation	 of	 the	 cell,	 or	 result	 from	responses	 to	 pathological	 situations.	 There	 are	 many	 reports	 that	 describe	 changes	 in	 the	metabolism	of	glucose	or	energy	consumption	during	the	development	of	cancer	cells	or	 the	activation	 and	 differentiation	 of	 T	 cells.	 There	 is	 an	 increasing	 interest	 to	 understand	 these	cellular	processes	and	their	alterations	in	more	detail	during	acute	or	latent	viral	infections.	
2.3.1. The glucose metabolism 	 Glucose	 is	 the	 ubiquitous	 fuel	 in	 the	 biology	 of	 many	 organisms.	 It	 is	 used	 as	 a	 basic	source	of	energy	for	cellular	respiration.	This	simple	carbohydrate	is	catabolized	in	a	process	called	glycolysis.	Briefly,	this	pathway	converts	one	molecule	of	glucose,	which	is	taken	up	by	a	transporter	mediated	pathway	and	initially	converted	to	glucose-6-phosphate	(G6P).	It	further	breaks	down	 into	 two	molecules	 of	 pyruvic	 acid,	which	 is	metabolised	 to	 finally	 release	 the	energy	in	the	form	of	ATP	and	reduced	NADH	molecules.	The	conjugate	base	of	pyruvic	acid	is	pyruvate,	 which	 is	 a	 key	 intermediate	 in	 several	 metabolic	 pathways.	 The	 most	 important	pyruvate	 pathway	 is	 the	 import	 into	mitochondria,	 the	 conversion	 to	 acetyl-CoA,	 and	 entry	into	the	tricarboxylic	acid	(TCA)	cycle.	As	a	product	of	this	reaction	cascade,	NADH	and	FADH2	are	 produced,	which	 can	 be	 immediately	 used	 for	 ATP	 production	 in	 the	 electron	 transport	chain	reaction	(ETC).	During	glycolysis,	the	TCA	yields	several	precursors,	which	can	be	used	in	diverse	biosynthesis	pathways	such	as	serine	biosynthesis,	the	pentose	phosphate	pathway	(PPP),	or	fatty	acid	synthesis	(FAS)	(Berg	et	al.,	2002).	The	alternative	pathway	for	pyruvate	is	its	 reduction	 to	 lactate	 in	 the	 cytosol	 mediated	 by	 lactate	 dehydrogenase	 (LDH)	 especially	
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under	 limited	oxygen	conditions.	During	 this	process,	NAD+	can	be	produced	 independently	from	mitochondria,	which	is	a	very	fast	but	less	efficient	mechanism.	This	process	can	be	also	used	 under	 normal	 oxygen	 (aerobic)	 conditions,	 called	 the	Warburg	 effect,	 which	 was	 first	identified	in	cancer	cells	(DeBerardinis	et	al.,	2008;	Warburg,	1925).		Interestingly,	 the	modulation	of	 the	glucose	metabolism	pathways	plays	a	decisive	role	during	 the	 activation	 of	 naïve	 T	 cells	 upon	 antigen	 encounter	 and	 activation	 of	 the	 T	 cell	receptor.	Naïve	T	cells	are	in	the	quiescent	state,	where	they	do	not	undergo	clonal	divisions,	do	 not	 secrete	 significant	 amounts	 of	 cytokines,	 and	 hence	 have	 limited	 requirements	 for	inducing	catabolic	and	anabolic	pathways.	As	a	consequence,	they	use	available	nutrients	and	produce	 energy	 using	 standard	 glycolysis	 supported	 by	 mitochondrial	 respiration	 (Finlay,	2012;	 Almeida	 et	 al.,	 2016).	 T	 cell	 activation	mediated	 by	 antigen	 recognition	 induces	 their	intense	 proliferation	 and	 their	 differentiation	 to	 T	 effector	 cells.	 T	 cell	 receptor	 (TCR)	stimulation	 significantly	 increases	 the	 uptake	 of	 glucose	 and	 glycolysis	 in	 these	 cells.	Additionally,	glycolysis	related	pathways	are	also	activated	such	as	the	pentose	phosphate	and	the	hexosamine	pathways,	which	are	important	for	the	biogenesis	of	nucleic	acids,	NADPH,	and	UDP-N-acetylglucosamine	 (UDP-GlcNac)	 (Fig.	 6).	 The	 latter	 is	 essential	 for	 the	 post-translational	 glycosylation	 of	 proteins	 and	 is	 involved	 in	 intracellular	 signalling.	Activated	T	cells	make	 use	 of	 both	 aerobic	 and	 anaerobic	 glycolysis,	 which	 is	 not	 fully	 understood,	 but	supposedly	 contributes	 to	 the	 synthesis	 of	 different	 biomolecules.	 Another	 regulated	mechanism	is	fatty	acid	synthesis	(FAS)	providing	the	cell	with	phospholipids,	which	are	used	during	T	 cell	 proliferation	 and	 cell	 divisions	 (Fig.	 3)	 (Almeida	 et	 al.,	 2016;	 Lunt	 and	Vander	Heiden,	2011;	Buck	et	al.,	2015).		There	are	extensive	studies	on	 the	metabolic	pathways	 induced	upon	T	cells	activation	and	differentiation,	but	details	about	B	cells	and	their	bioenergetic	metabolism	are	incomplete.	It	was	shown	that	BCR	crosslinking	rapidly	 increases	glucose	uptake,	aerobic	glycolysis,	and	upregulates	 specific	 glycolytic	 enzymes.	 Regulation	 of	 glucose	 utilization	 is	 driven	 by	 PI3	kinase	 signalling	 and	 c-Myc	 dependent	 transcription	 of	 glycolytic	 genes,	 which	 together	 are	involved	in	B	cell	growth	(Doughty	et	al.,	2006).	Additionally,	B	cell	activation	mediated	by	IL-4	and	 toll-like	 receptor	 (TLR)	 also	 leads	 to	 an	 induction	 of	 similar	 metabolic	 changes	 as	described	for	BCR	cross-linking	(Dufort	et	al.,	2007).	Cancer	cells	display	an	abnormally	high	proliferation	rate	and	an	increased	cell	volume,	which	 stem	 from	 alterations	 in	 cancer	 cell	 metabolism	 supporting	 the	 cell	 with	 essential	nutrients	 and	 biochemical	 energy.	 Cancer	 cells	 change	 all	metabolic	 programs	 and	 show	 an	
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increase	in	glucose	uptake,	enhanced	glutaminolysis	or	fatty	acid	synthesis.		Characteristic	for	many	malignant	cells	is	the	switch	from	glycolysis	to	the	Warburg	effect,	which	produces	less	energy	but	 is	 faster	 than	mitochondrial	 respiration.	This	process	might	be	 also	beneficial	 to	cancer	cells,	because	it	provides	intermediates	for	many	biosynthetic	pathways	such	as	amino	acid	 and	 nucleic	 acid	 precursors.	 The	Warburg	 effect	 is	 supposedly	 triggered	 by	 the	 c-Myc	oncogene,	 which	 also	 drives	 cellular	 proliferation	 (Fadaka	 et	 al.,	 2017).	 The	 described	processes	illustrate	that	glucose	metabolism	and	its	regulation	are	crucial	for	cell	survival	and	determination	of	a	cell	 fate.	Thus,	glucose	metabolism	is	also	likely	to	play	an	important	role	during	infection	with	EBV,	which	is	able	to	activate	and	to	transform	the	host	cell.	
2.3.2. The mitochondrial activity 
 Mitochondria,	 which	 are	 essential	 organelles	 in	 all	 metazoan	 cells,	 contain	 a	 specific	double	 membrane	 (outer	 OMM-	 and	 inner	 mitochondrial	 membrane	 –	 IMM).	 The	 inner	membrane	of	 the	mitochondrion	 is	more	 complex	 and	 comprises	 a	 number	 of	 enzymes	 and	proteins	that	are	involved	in	carbohydrate	and	fat	processing	to	finally	release	energy	via	the	ATP	 synthetase	 complex.	This	membrane	 is	 surrounded	by	 the	mitochondrial	matrix,	where	the	 TCA	 cycle	 generates	 electrons	 that	 can	 be	 transported	 to	 the	 cascade	 of	 IMM	 protein	complexes.	This	process	is	called	electron	transport	chain	(ETC),	which	produces	water	as	the	last	 acceptor	 of	 electrons	 and	 energy	 in	 the	 form	 of	 ATP.	 Alternatively,	 this	 process	 is	 also	called	oxidative	phosphorylation	(OXPHOS)	(Kühlbrandt,	2015).	The	number	of	mitochondria	in	a	cell	differs	and	depends	on	the	cell	state,	because	mitochondria	biosynthesis	is	stimulated	by	 a	 greater	 energy	 expenditure	 of	 the	 cell.	 Mitochondria	 also	 play	 an	 important	 role	 in	maintaining	the	proper	concentration	of	calcium	ions	within	cellular	compartments,	which	is	crucial	for	the	efficient	communication	with	the	cytosol.		Recently,	 it	 was	 found	 that	 T	 cells	 activation	 triggers	 an	 increase	 in	 mitochondrial	respiration	(Sena	et	al.,	2013;	Liu	and	Ho,	2017).	Clearly,	activated	T	cells	need	more	energy	and	molecular	 precursors	 during	 activation	 and	 proliferation,	 additionally	 the	 generation	 of	reactive	oxygen	species	(ROS)	also	play	a	role	during	 this	activation.	ROS	are	by-products	of	mitochondrial	 respiration	 and	 are	 essential	 for	 the	 optimal	 induction	 of	 the	 transcription	factor	NFAT	(nuclear	factor	of	activated	T	cells)	as	well	as	the	release	of	cytokines	(Sena	et	al.,	2013;	Weinberg	et	al.,	2015).	Another	important	mitochondrial	function	is	calcium	flux,	which	is	 supportive	 during	 naïve	 T	 cells	 stimulation.	 Upon	 TCR	 engagement	 the	 mitochondria	increase	the	uptake	of	cytosolic	calcium	to	stabilize	its	concentration.	Thus,	mitochondria	act	
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	Fig.	3.	The	scheme	of	metabolic	pathways	during	T	cell	activation	(adapted	from	Buck,	O’Sullivan	and	Pearce,	2015).		The	 glycolysis	 pathway	 in	 green,	 intersects	 with	 other	 biosynthesis	 pathways	 such	 as	 the	 pentose	 phosphate	pathway	(PPP,	blue)	and	serine	biosynthesis	(red).	Pyruvate,	the	end	product	of	the	catabolic	glucose	breakdown,	can	be	used	directly	 for	 lactate	synthesis	or	 is	 transported	to	mitochondria	(in	yellow)	where	 it	enters	the	TCA	cycle	followed	by	OXPHOS	production	of	ATP	(brown).	Other	substrates	can	be	also	metabolized	via	the	TCA	cycle	such	 as	 glutamine	 (purple)	 or	 fatty	 acid	 synthesis	 (FAS,	 light	 blue),	 which	 yields	 acetyl-CoA	 via	 fatty	 acid	 ß-oxidation	 (FAO,	 grey).	 All	 these	 pathways	 are	 tightly	 connected	 providing	 the	 efficient	 cellular	 metabolic	machinery.		as	 a	 local	buffering	 system.	 It	 supports	 the	 cell	 to	 sustain	 the	 continuous	 calcium	 influx	and	express	calcineurin,	a	protein	that	 initiates	the	migration	of	NFAT	from	the	cytoplasm	to	the	nucleus.	Mitochondria	can	also	actively	support	the	import	of	calcium	via	purinergic	receptors	that	work	as	ATP-gated	calcium	channels.	This	will	 lead	to	the	 increase	of	calcium	uptake	to	the	cell	and	therefore	promote	the	activation	of	the	T	cell.		There	 are	 also	 reports	 that	 link	 the	 highly-synchronized	 program	 of	 mitochondria	biogenesis	 and	 proteome	 remodelling,	 which	 can	 generate	 a	 specific	 type	 of	 mitochondria	(Ron-Harel	 et	 al.,	 2016).	 The	 distinct	mitochondria	 population	 is	 supporting	 the	 one-carbon	(1C)	metabolism,	a	pathway	responsible	for	the	synthesis	of	precursors	for	purine,	NADPH	and	glutathione.	This	mechanism	is	actively	responsible	for	cell	growth	and	proliferation	during	T	
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cell	activation.	Cycling	of	NADH	and	NAD+	might	also	be	important	in	downstream	pathways,	since	NAD+	is	a	necessary	co-factor	in	many	enzymatic	reactions	(Almeida	et	al.,	2016).		Recent	 reports	 claim	 that	mitochondrial	activation	has	a	distinct	 function	during	B	cell	activation	 to	 allow	 the	 cells	 to	 accommodate	 the	 phenotypic	 and	 environmental	 changes	encountered	 over	 their	 lifespan	 (Sandoval	 et	 al.,	 2017).	 Class-switch	 recombination	 of	activated	B	 cells	 correlates	with	 an	 increase	 of	 the	mitochondria	mass	 and	 their	membrane	potential,	while	 the	differentiation	 to	plasma	cells	 is	 in	 line	with	a	decrease	 in	mitochondria	biomass.	 These	 changes	 result	 from	 increased	ROS	 levels,	which	 act	 as	 additional	 signalling	molecules	and	suppress	the	synthesis	of	haeme,	promoting	plasma	cell	differentiation	(Jang	et	al.,	2015;	Sandoval	et	al.,	2017).	The	increased	mitochondrial	activity	 in	activated	B	cells	 is	a	consequence	 of	 an	 elevated	 glycolysis	 and	 OXPHOS	 activity	 indicating	 that	 mitochondrial	homeostasis	is	crucial	during	B	cell	activation	and	differentiation.		
2.3.3. Viral infection and metabolism 
 Viruses	rely	on	 the	metabolic	machinery	of	 their	host	cells,	because	even	 large	viruses,	e.g.	 herpes	and	poxviruses	 lack	 the	 capacity	 to	 encode	many	enzymes	 involved	 in	metabolic	processes	in	the	infected	cell.	Recently,	several	reports	highlighted	the	importance	of	studying	and	describing	the	impact	of	viral	infection	on	the	host	cell	metabolism	(Freyberg	and	Harvill,	2017;	 Miyake-Stoner	 and	 O’Shea,	 2014;	 Sanchez	 and	 Lagunoff,	 2015).	 Many	 viruses	 induce	glycolysis,	fatty	acid	synthesis	and	glutaminolysis,	which	are	clearly	universal	mechanisms	of	the	 cell,	 but	 virally	 induced	 metabolic	 processes	 are	 also	 cell	 type	 specific	 as	 viruses	 have	evolved	to	adapt	to	the	very	specialized	and	differentiated	host	cells.	It	is	common	knowledge	that	 closely	 related	viruses	 can	promote	different	metabolic	 alterations	 in	 the	 infected	 cells,	but	very	different	viruses	can	also	cause	similar	metabolic	perturbations.	It	is	very	likely	that	individual	viruses	 follow	unique	strategies	 to	promote	 their	 successful	 infection	and	de	novo	synthesis	(Sanchez	and	Lagunoff,	2015).	Enveloped	 viruses,	 which	 turn	 the	 infected	 cell	 into	 a	 virus	 factory,	 regulate	 cellular	lipogenesis	 required	 for	 the	 biosynthesis	 of	 lipid	 membranes	 of	 the	 virus.	 Human	cytomegalovirus	 (HCMV)	 requires	 also	 aerobic	 glycolysis,	which	 leads	 to	 lactate	 production,	glutaminolysis	as	well	as	 fatty	acid	synthesis	 (FAS)	 that	 is	supported	by	metabolites	derived	from	the	TCA	cycle.	The	expression	of	early	viral	genes	promotes	these	metabolic	changes.	An	increased	glucose	uptake	is	necessary	to	support	the	replication	of	the	HCMV	genome	and	is	mediated	 by	 a	 specific	 glucose	 transporter	 (GLUT4)	 	 (Yu	 et	 al.,	 2011a).	 In	 contrast,	 herpes	
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simplex	virus	1	(HSV-1)	does	not	induce	aerobic	glycolysis,	but	uses	the	TCA	cycle	to	promote	pyrimidine	 synthesis	 rather	 than	 FAS	 	 (Vastag	 et	 al.,	 2011).	 Finally,	 vaccina	 virus	 uses	glutaminolysis	to	support	its	synthesis,	thus	the	glucose	metabolism	is	not	critical	for	this	virus	and	its	production	(Fontaine	et	al.,	2014).		There	are	very	few	reports	that	focus	on	latent	viral	 infection	and	the	consequences	of	metabolic	 alterations.	 One	 example	 is	 the	 latent	 infection	 of	 endothelial	 cells	 with	 KSHV	(Lagunoff,	2016;	Sanchez	and	Lagunoff,	2015).	In	this	report	changes	in	three	major	pathways	of	 central	 carbon	 metabolism,	 glycolysis,	 fatty	 acid	 synthesis,	 and	 glutaminolysis	 were	described	similar	to	metabolic	alterations	found	in	cancer	cells.		KSHV	induces	the	production	and	release	of	 lactate	at	 the	expense	of	 the	OXPHOS	pathway,	but	 this	virus	 can	also	 induce	many	anabolic	pathways.	Most	importantly,	inhibition	of	each	of	the	three	major	pathways	of	carbon	 metabolism	 leads	 to	 the	 induction	 of	 cell	 death	 in	 infected	 cells	 compared	 with	uninfected	cells	indicating	that	metabolic	perturbations	are	critical	for	the	survival	of	latently	infected	 cells.	 Interestingly,	 it	 was	 also	 found	 that	 KSHV’s	 latent	 miRNAs	 are	 involved	 in	reducing	 OXPHOS	 and	 activation	 of	 aerobic	 glycolysis	 (Yogev	 et	 al.,	 2014).	 In	 EBV-infected	Nasopharyngeal	 carcinoma	 (NPC)	 cell	 lines,	 high	 levels	 of	 glycolysis	were	 reported	 to	 result	from	LMP1	expression.	LMP1	induces	the	hexokinase	2	(HK2)	enzyme	and	its	knock-down	in	these	 cells	 leads	 to	 cell	 death	 confirming	 that	 glycolysis	 is	 critical	 for	 the	 survival	 of	 the	infected	cells	(Xiao	et	al.,	2014).	The	 metabolic	 state	 of	 the	 cell	 has	 an	 important	 role	 in	 each	 of	 the	 many	 cellular	processes	 with	 a	 strong	 impact	 on	 cell	 fate,	 differentiation	 and	 response	 to	 environmental	factors.	Viruses	are	able	to	modulate	these	mechanisms	to	their	advantage	providing	optimal	conditions	 for	 their	 replication,	 spreading,	 or	persistence	 in	 the	 infected	host	 cell.	We	know	little	about	EBV-induced	metabolic	 changes	 in	newly	 infected	B	 lymphocytes,	when	 the	cells	undergo	 massive	 phenotypic	 changes.	 Thus,	 it	 was	 interesting	 to	 study	 the	 metabolic	parameters	in	this	phase	of	EBV’s	life	cycle.	
2.4.  Scope of my thesis 
 Viral	infection	has	a	strong	impact	on	the	biology	of	the	host	cell.	The	pathogen	induces	changes	that	will	support	 its	persistence	in	the	host	cell,	 its	genome	replication,	and	prepare	for	 the	 productive	 lytic	 phase	 reactivation.	 It	 is	 clear	 that	 the	 virus	 has	 to	 evade	 from	 the	immune	responses	of	the	infected	cell	and	organism	as	EBV	does	using	its	viral	proteins	and	miRNAs,	which	can	support	cell	survival,	diminish	the	viral	antigen	presentation,	or	antiviral	
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processes	(Jochum	et	al.,	2012a;	Albanese	et	al.,	2016;	Tagawa	et	al.,	2016).	Recently,	several	reports	identified	changes	in	the	cell	metabolism	or	epigenetic	processes	upon	viral	infection	(Milavetz	and	Balakrishnan,	2015;	Sanchez	and	Lagunoff,	2015).	The	knowledge	about	changes	in	the	host	cell	during	the	early	steps	of	EBV’s	infection	is	still	poor	and	incomplete.	The	main	aim	of	my	PhD	thesis	was	to	examine	the	kinetics	of	alterations	in	the	host	cell	biology	that	are	triggered	by	EBV	during	the	pre-latent	phase	of	infection.	First,	 I	 focused	 on	 the	 phenotypes	 of	 the	 uninfected	 primary	 B	 cells	 and	 cells	 infected	with	EBV	 at	 different	 days	 post	 infection	 looking	 at	 the	 cell	 size	 and	 cell	 content,	 but	 I	 also	considered	already	existing	data	from	our	lab	regarding	cell	cycle	distribution	during	infection.	Since	 the	 cells	 seemed	 to	 change	dramatically	upon	EBV	 infection,	 I	wanted	 to	elucidate	 the	mechanisms,	which	are	responsible	 for	 this	effect.	Second,	 I	 investigated	 the	basic	metabolic	activities	in	EBV	infected	B	cells	and	compared	these	phenotypes	with	described	processes	and	documented	models	such	as	T	cells	activation	or	cancer	cells.	I	studied	the	kinetics	of	glucose	uptake	 and	 mitochondrial	 activity	 to	 decipher	 when	 exactly	 the	 virus	 redirects	 cellular	metabolic	 mechanisms.	 Third,	 I	 designed	 and	 performed	 a	 comprehensive	 time-course	transcriptome	analysis	(RNA-seq)	to	gain	a	broader	overview	of	cellular	processes	regulated	at	different	days	after	EBV	 infection.	 I	 found	seven	specific	clusters	of	genes,	which	comprise	a	plethora	of	cellular	mechanisms	altered	by	the	infection	with	EBV.	The	expression	kinetics	of	these	clusters	suggested	that	cellular	genes	are	very	strictly	controlled	in	time	to	support	the	viral	 pre-latent	 phase.	 The	 virus	 not	 only	 modulates	 its	 host	 cell,	 but	 also	 explores	 basic	cellular	mechanisms	such	as	epigenetics	to	establish	and	to	maintain	latency	and	to	efficiently	reactivate	during	the	productive	lytic	phase	of	infection	(Woellmer	et	al.,	2012;	Woellmer	and	Hammerschmidt,	 2013).	 Fourth,	 I	 investigated	 the	 kinetics	 of	 nucleosome	 assembly	 on	 EBV	DNA	and	their	exact	positioning	at	viral	loci	using	an	MNase-seq	approach.	I	wanted	to	define	the	exact	timing	of	nucleosome	acquisition	and	viral	genome	chromatinization	in	the	course	of	the	pre-latent	phase	of	infection	with	EBV.		 	
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3. Results 
 
3.1. Model of early EBV infection – the experimental design 
 EBV	 infects	 human	 B	 cells	 and	 establishes	 a	 life-long	 but	 generally	 asymptomatic	infection	 in	 us.	 Most	 B	 cells	 are	 latently	 infected	 and	 the	 virally	 infected	 cells	 are	 well	controlled	by	the	immune	system	of	the	host.	EBV	is	also	associated	with	several	malignancies	such	as	Burkitt's	lymphoma	(BL),	nasopharyngeal	carcinoma	(NPC),	Hodgkin	lymphoma	(HL),	and	non-Hodgkin	 lymphomas	 (NHL)	 (Young	 and	Rickinson,	 2004;	 Young	 et	 al.,	 2016).	 In	 all	infected	cells	EBV	 initiates	 its	 latent	phase,	during	which	several	copies	of	 the	genomic	viral	DNA	persist	as	episomes	that	replicate	in	synchrony	with	cellular	DNA.	Latently	EBV	infected	cells	 express	 a	 small	 subset	 of	 viral	 genes,	 only,	which	 are	 essential	 for	 the	 success	 of	 viral	infection.	Latently	infected	B	cells	can	initiate	the	lytic	phase	after	expression	of	BZLF1,	a	viral	transcription	factor,	which	is	induced	when	the	infected	cell	encounters	and	binds	its	cognate	antigen	via	its	surface	immunoglobulin.	Antigen	binding	induces	the	B	cell	receptor	signalling	pathway	 and	 readily	 starts	 the	 productive	 phase,	 during	 which	 all	 viral	 lytic	 genes	 are	expressed	 that	 are	 essential	 for	 replicating	 and	 packaging	 of	 viral	 DNA	 and	 release	 of	 viral	progeny	 (Countryman	 and	Miller,	 1985;	 Kalla	 et	 al.,	 2010).	 EBV’s	 life-cycle	 is	 regulated	 in	 a	very	 strict	 and	 ingenious	 way	 that	 involves	 many	 fundamental	 host	 cell	 processes	 such	 as	epigenetics,	transcription,	metabolism,	and	immune	responses.		In	vivo,	only	a	small	subset	of	human	memory	B	cells	are	infected	with	EBV,	which	makes	it	 impossible	 to	 investigate	 the	 infection	 process	 and	 perform	 a	 high-throughput	molecular	analysis	 in	 the	 small	 and	rare	population	of	 cells.	 Suitable	animal	 in	vivo	models	also	do	not	exist	that	mimic	EBV	infection	in	humans.	A	close	relative	is	the	murine	gamma	herpes	virus	MHV68,	which	shares	many	features	with	EBV	but	lacks	homologs	of	critical	oncoproteins	such	as	LMP1,	LMP2A/B	or	the	EBNAs	encoding	genes	(Olivadoti	et	al.,	2007;	Aligo	et	al.,	2015).	In	contrast,	the	in	vitro	model	of	EBV	infection	is	very	well	established,	which	allows	to	study	the	early	phase	of	EBV	infection	in	great	detail	in	mature	human	B	lymphocytes	isolated	ex	vivo.		Adenoids	 surgically	 removed	 from	 children’s	 nasopharynx	 contain	 large	 numbers	 of	primary	B	cells,	which	can	be	easily	 isolated.	B	cells	can	be	separated	 from	other	cells	 types	such	 as	 T	 cells,	 granulocytes,	 or	 erythrocytes	 using	 Ficoll-Hypaque	 density	 gradient	
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centrifugations.	 The	 cells	 can	 be	 further	 purified	 and	 fractionated	 to	 enrich	 non-activated,	naïve	B	cells	by	FACS	sorting	using	specific	antibodies	against	CD38	and	IgD	surface	proteins	or	with	magnetic	beads	to	remove	activated	or	memory	B	cells	and	other	cell	types.	Wild-type	(wt)	EBV	(2089	or	B95-8)	readily	infect	these	cells,	which	can	be	tracked	to	record	phenotypic	changes	during	the	very	early	stages	of	viral	infection.		It	was	known	from	previous	experiments	in	our	lab	that	in	vitro	infected	cells	first	grow	in	 size.	 Around	 day	 four	 post	 infection	 (p.i.)	 they	 enter	 a	 phase	 of	 very	 rapid	 proliferation,	which	 leads	 to	established	 lymphoblastoid	cell	 line	 (LCL)	after	about	 two	weeks	p.i.	 (Fig.	4).	During	 the	 first	days	after	 infection,	 in	 the	so-called	pre-latent	phase,	 the	host	 cells	undergo	very	dramatic	changes,	which	the	virus	induces	to	establish	a	latent	phase	in	them,	eventually.	It	is	also	obvious	that	the	virus	itself	has	to	go	through	rapid	changes	to	adapt	its	DNA	genome	to	the	environment	of	the	cellular	nucleus	and	to	escape	from	immune	responses	of	the	host	cell.	With	this	in	vitro	infection	model,	I	focussed	on	the	daily	changes	of	the	infected	cells	and	compared	 them	 to	 non-infected	 cells	 with	 respect	 to	 metabolic,	 transcriptomic,	 as	 well	 as	epigenetic	criteria.	My	experiments	demonstrate	that	dramatic	metabolic,	transcriptional,	and	epigenetic	changes	occur	during	the	pre-latent	phase	of	B	cell	infection	with	EBV.			
	Fig.	4.		Schematic	overview	of	primary	B	cells	during	the	early	phase	of	EBV	infection.	B	 cells	 infected	with	EBV	directly	 enter	 the	pre-latent	phase,	 during	which	 the	 cells	 become	 reprogrammed	 to	proliferating,	activated	lymphoblastic	cells.	Initially,	the	cells	grow	in	size	and	enter	a	phase	of	rapid	proliferation	on	 day	 four	 post	 infection	 (p.i.).	 After	 about	 eight	 to	 ten	 days	 p.i.	 cell	 proliferation	 decelerates	 and	 constantly	proliferating	 lymphoblastoid	 cell	 lines	 (LCL)	 emerge.	 The	 linear	 genomic	 DNA	 of	 EBV	 virions	 is	 epigenetically	naïve	and	free	of	histones	(left),	but	it	circularizes	immediately	after	infection,	acquires	cellular	histones,	becomes	fully	chromatinized	and	undergoes	extensive	DNA	CpG	methylation	(right).		
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3.2. Phenotypic changes during the first eight days of EBV infection 
 The	 phenotypic	 changes	 that	 occur	 after	 EBV	 infection	 were	 tracked	 on	 a	 daily	 basis	employing	 mainly	 fluorescence-activated	 cell	 sorting	 (FACS)	 based	 methods	 together	 with	other	techniques	to	assess	several	biophysical	parameters	of	 the	cells.	First,	 I	 focused	on	the	size	 of	 the	 cells,	 their	 cell	 cycle	distribution	 as	well	 as	 the	 content	 of	 total	 cellular	RNA	and	protein.	Freshly	prepared	donor	B	cells	and	infected	B	cells	were	checked	every	day	and	viable	cells	were	physically	enriched	using	a	FACS	Aria	IIIu	sorter	with	established	gating	strategies,	which	allowed	to	exclude	cell	debris	and	disintegrating	cells	from	the	subsequent	analyses.		For	 infecting	 naïve,	 quiescent	 B	 cells	 I	 used	 the	 wt	 EBV	 (2089)	 strain	 at	 an	 optimal	multiplicity	of	infection	(MOI).	The	infected	cells	grew	in	size	until	day	four	p.i.	(Fig.	5	A)	with	an	increase	in	cellular	granularity	according	to	forward	scatter	(FSC-A)	and	sideward	scatter	criteria	 (SSC-A),	 respectively.	 Five	 days	 p.i.,	 the	 cells	 started	 to	 form	 a	 more	 homogenous	population	and	from	day	eight	onwards	the	cells	 located	to	the	gate	that	 is	characteristic	 for	established	 lymphoblastoid	 cell	 lines.	 The	 absolute	 numbers	 of	 gated	 living	 cells	 changed	accordingly.	Until	day	three,	the	numbers	of	viable	cells	decreased	considerably,	but	from	day	four	onwards	the	cells	started	to	divide	and	proliferated	such	that	the	cell	numbers	increased	(data	 not	 shown).	 The	 exact	 diameters	 of	 uninfected	 and	 infected	 cells	 were	 measured	 by	Dagmar	Pich.	Uninfected	B	cells	were	small	with	a	diameter	of	5.5	µm,	whereas	infected	cells	grew	gradually	to	reach	a	maximum	diameter	of	9	µm	at	day	four	p.i.,	but	shrank	a	bit	in	the	following	days	to	reach	a	cell	size	in	the	range	of	7.5-8	µm	(Fig.	5	B).		EBV	 infected	 cells	 did	 not	 only	 change	 in	 size,	 but	 the	 infection	 also	 strongly	 affected	their	resting	state.	The	cell	cycle	distribution	of	the	cells	was	measured	by	Dagmar	Pich	(Pich	et	al.,	 to	be	published)	using	short-term	BrdU	incorporation,	which	was	recorded	by	FACS.	B	cells	infected	for	one	or	two	days	stayed	arrested	in	GO/G1	compared	with	non-infected	cells	(Fig.	5	C).	Starting	on	day	three,	a	small	 fraction	of	cells	entered	the	S	phase	of	the	cell	cycle	and	this	fraction	increased	further	on	day	four.	From	day	five	to	seven	p.i.	the	cells	underwent	a	 very	 rapid	 phase	 of	 DNA	 synthesis	 and	 proliferation	 by	 dividing	 every	 10-12	 hours.	Thereafter,	they	decelerated	and	adopted	a	generation	time	of	about	24	to	36	hours.		The	dynamic	phenotypic	changes	and	 the	entry	of	 the	activated	cells	 into	 the	cell	cycle	led	 to	 impressive	 alterations	 in	 the	 content	 of	 cellular	 macromolecules	 such	 as	 RNAs	 and	proteins.	I	measured	the	amount	of	total	protein	contained	in	one	million	cells	and	compared	it	with	established	LCLs	infected	for	14	days	(Fig.	5	D).	The	protein	amounts	increased	up	to	2.5	
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times	 from	 day	 two	 until	 day	 four	 and	 reached	 a	 stable	 level	 after	 about	 one	 week	 post	infection.	 Additionally,	 the	 total	 RNA	 content	 showed	 a	 similar	 kinetics,	 but	 the	 differences	were	much	more	prominent.	Uninfected	B	cells	contained	several	hundred	ng	of	RNA	per	one	million	cells.	The	RNA	content	 increased	up	 to	10,000	ng	at	day	 four	p.i.,	 a	 ten	 fold	 increase	compared	 to	 non-infected	 cells	 (Fig.	 5	 E).	 As	 observed	 in	 the	 previous	 experiments,	 the	amounts	of	total	RNA	appeared	to	be	stable	from	day	eight	p.i.	onwards.		
	Fig.	5.	Phenotypic	changes	of	the	host	cell	during	the	first	two	weeks	of	EBV	infection.	B	cells	were	purified	from	adenoid	tissue	and	infected	with	wt	EBV	(2089)	with	an	MOI	0.1.	Every	day	p.i.	the	cells	were	collected	and	analysed	for	multiple	parameters.	
A. Time-resolved	phenotypic	changes	of	EBV-infected	cells	analysed	using	FACS	and	FSC-A	(x-axis)	and	SSC-A	 (y-axis)	 criteria.	Newly	 infected	 cells	on	day	one	p.i.	 formed	a	homogenous	population	of	 small	 cells	with	low	granularity.	The	cells	increased	in	size	and	reached	maximal	size	and	granularity	four	days	p.i.	From	then	on,	the	cells	adopted	a	more	discrete	population.	On	day	eight	and	14	post	infection	the	cells	were	indistinguishable	(data	not	shown).	
B. The	panel	shows	the	changes	of	the	cellular	diameter	during	the	first	eight	days	after	EBV	infection.	Mean	and	 standard	 deviation	were	 calculated	 from	 the	 images	 of	 about	 thousand	 cells	 at	 the	 specified	 time	points	 p.i..	 Uninfected	 cells	 (n.i)	were	 small,	whereas	 infected	 cells	 grew	 constantly	 until	 they	 reached	their	maximum	at	 day	 four	 p.i..	 At	 day	 five,	 the	 cells	 became	 smaller	 and	 from	 this	 time	point	 the	 cell	diameter	was	stable.	
C. B	cells	after	wt	EBV	(2089)	 infection	were	 incubated	with	BrdU	 for	one	hour	 followed	by	 intracellular	staining	 with	 a	 BrdU	 specific	 antibody.	 The	 cells	 were	measured	 by	 FACS	 to	 determine	 the	 cell	 cycle	distribution.	Until	day	three	the	cells	did	not	proliferate	and	stayed	arrested	in	GO/G1	cell	cycle	phase.	
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From	day	three	p.i.	the	cells	started	to	synthesize	cellular	DNA	indicated	by	the	fraction	of	the	cells	in	the	S	 phase	 of	 the	 cell	 cycle.	 (Experiments	 in	 panels	 B	 and	 C	were	 performed	 by	Dagmar	 Pich;	 panel	 B	 is	based	on	three	independent	replicates)	
D. Uninfected	cells	and	cells	infected	with	wt	EBV	(2089)	were	collected	daily	and	total	protein	lysates	were	obtained.	The	 samples	were	measured	using	 the	Bradford	assay.	The	graph	shows	 the	 total	 amount	of	proteins	(µg)	obtained	from	one	million	cells.	Measurements	were	performed	every	day	after	infection	as	indicated.	 	 The	 protein	 content	 increased	 slowly,	 peaked	 at	 day	 four	 p.i.	 and	 decreased	 again	 in	 the	following	 days.	 The	 solid	 blue	 lines	 show	 the	mean	 average	 from	 cells	 prepared	 from	 three	 different	donors,	individual	samples	are	represented	as	single	dots.	
E. Amounts	of	total	RNA	(ng)	obtained	from	one	million	cells	were	measured	using	the	Shimadzu	MultiNA	Electrophoresis	System	for	DNA/RNA	analysis.	The	RNA	content	increased	up	to	ten	times	until	day	four	p.i.,	 but	on	day	 five	 and	onwards	 it	 decreased	over	 time.	 Solid	black	 lines	 represent	 the	mean	average	from	four	different	donors.	Each	donor	is	displayed	as	a	single	dot.		 My	data	documented	that	the	infection	with	EBV	triggers	many	profound	changes	in	the	host	cell,	which	are	highly	dynamic	during	the	first	eight	days	of	infection.	The	most	dramatic	changes	with	respect	to	cell	size,	RNA	and	protein	content	took	place	within	the	first	four	days	after	 infection,	 and	 the	 cells	 adopted	 a	 less	 dynamic,	 established	 state	 from	 day	 eight	 p.i.	onwards.		The	cell	cycle	distribution	was	also	very	dynamic	during	the	first	eight	days	of	infection.	Initially,	 the	 infected	 cells	 did	 not	 synthesize	 cellular	DNA,	 but	 starting	 from	day	 three	 they	underwent	 very	 rapid	 rounds	 of	 DNA	 replication	 and	 cell	 divisions	 to	 slow	 down	 later	 and	enter	a	stable	state	equivalent	to	that	of	established	lymphoblastoid	cell	lines.		
3.3. Regulation of the cellular metabolism in the course of EBV infection 	Alterations	 in	 the	 cellular	 metabolism	 affect	 many	 biological	 processes	 such	 as	cancerogenesis	or	activation	and	differentiation	of	 immune	cells.	 Interestingly,	many	viruses	are	also	able	 to	 trigger	changes	 in	 the	cellular	metabolism	to	promote	 their	productive,	 lytic	phase	 or	 to	 support	 their	 replication	 and	 long-term	 infection.	 This	 is	 the	 reason	 why	 I	investigated	certain	selected	metabolic	processes	and	their	kinetics	during	the	early	stages	of	EBV	infection.	B	cells	from	adenoid	tissue	were	isolated	and	purified	using	a	commercial	B	cell	isolation	kit	that	yields	“untouched”,	non-manipulated	B	cells,	but	removes	all	other	cell	types	present	in	the	 preparation.	 The	B	 cells	were	 infected	with	wt	EBV	 (B95-8),	which	 lacks	 a	 fluorescence	marker	gene	that	would	had	interfered	with	the	subsequent	FACS	analyses.	Uninfected	B	cells	as	well	as	cells	collected	at	certain	time	points	post	infection	were	incubated	with	TMRE	and	Annexin	 V	 and	 analysed	 by	 FACS.	 TMRE	 (tetramethylrhodamine	 ethyl	 ester)	 is	 a	 red-
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fluorescent,	 positive-charged	 dye,	 which	 is	 sequestered	 and	 accumulated	 by	 active	mitochondria	 due	 to	 their	 negative	 charge	 and	 polarized	 membranes.	 Apoptotic	 cells	 with	depolarized	mitochondrial	membranes	will	fail	to	incorporate	TMRE	and	will	not	emit	its	red	colour.	 Annexin	 V	 staining	 allows	 to	 detect	 early	 stages	 of	 cellular	 apoptosis.	 It	 binds	 to	exposed	 phosphatidylserine	 residues	 (PS),	which	 translocate	 from	 the	 plasma	membrane	 to	the	surface	of	the	cell	in	the	early	phase	of	cellular	apoptosis.	Established	LCLs	(LCL40	in	the	first	row,	Fig.	6)	contained	a	minor	fraction	of	Annexin	V	positive	cells	(2-5	%),	the	majority	of	the	 cells	 (about	 85	%)	 stained	 intensively	with	 TMRE	 indicating	 a	 very	 high	mitochondrial	activity;	very	few	cells	(about	1	%)	showed	a	low	level	of	TMRE	staining.	Cells	 collected	 at	 different	 time	 points	 after	 EBV	 infection	 revealed	 very	 different	characteristics.	 Fewer	 than	 10	 %	 of	 the	 non-infected	 cells	 were	 Annexin	 V	 positive	immediately	 after	 preparation,	 but	 this	 fraction	 increased	 to	 almost	 20	 %	 one	 day	 post	infection	(Fig.	6).	Annexin-positive	cells	decreased	to	about	5	to	7	%	on	day	five	and	day	eight.	The	 majority	 of	 the	 infected	 and	 living	 cells	 incorporated	 TMRE,	 but	 two	 subpopulations,	TMRE_high	 (PE)	 and	 TMRE_low	 (PE),	 were	 obvious	 (third	 column;	 Fig.	 6).	 The	 TMRE_low	population	was	rather	consistent	 in	 infected	cells	compared	with	 the	non-infected	cells	until	day	three	post	infection,	but	decreased	dramatically	starting	from	day	four	to	become	a	minor	fraction	later	 in	well-established	cells.	This	subpopulation	consisted	of	small	cells	with	a	 low	granularity,	indicative	of	non-activated,	probably	quiescent	and	resting	cells	(fifth	columns	in	Fig.	6).	The	summary	of	my	four	independent	experiments	using	B	cells	from	different	donors	is	 shown	 in	 Fig.	 7	 A.	 The	 graph	 indicates	 that	 the	 fraction	 of	 the	 cells	 with	 a	 strong	mitochondria	 activity	 (TMRE_high)	 increased	 starting	 on	 day	 four	 p.i.	 to	 eventually	 reach	 a	level	 of	 more	 than	 80	%.	 On	 the	 contrary,	 Annexin	 V-positive	 cells	 decreased	 over	 time	 to	reach	a	level	lower	than	5	%.			The	mitochondrial	activity	depends	on	a	constant	supply	of	the	cells	with	nutrients	and	the	 subsequent	 catabolic	 processes.	 One	 of	 the	 basic	 compounds	 is	 glucose,	which	 the	 cells	readily	 take	 up	 from	 their	 environment.	 I	 wanted	 to	 examine	 if	 EBV-infected	 B	 cells	 show	glucose	uptake	kinetics	 that	differ	 from	uninfected	B	cells	or	established	LCLs.	To	scrutinize	the	dynamics	of	glucose	uptake	in	the	EBV	infection	model,	I	used	fluorescently	labelled	(FITC)	deoxyglucose	analogue	2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)	amino]-2-deoxy-D-glucose	(2-NBDG),	which	is	transported	into	the	cell	via	the	glucose	transporter	and	is	phosphorylated	by	the	cellular	hexokinase	1	(HK1)	mimicking	glucose	uptake	and	the	very	first	step	of	glycolysis,		
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	Fig.	6.	Tracking	of	apoptosis	and	mitochondrial	activity	during	the	first	eight	days	after	EBV	infection.	The	FACS	plots	 show	the	apoptosis	 rate	 (Annexin	V	staining)	and	mitochondrial	activity	 (TMRE)	of	 the	cells	at	early	time	points	after	EBV	infection.	5x105	uninfected	or	EBV	infected	B	cells	collected	at	different	time	points	after	infection	were	incubated	with	100	nM	TMRE	for	30	min	followed	by	incubation	with	APC-coupled	Annexin	V	for	another	10	min.	The	percentages	of	positive	cells	measured	by	FACS	are	indicated.		
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The	 first	 row	shows	established	LCLs	as	a	control,	 the	remaining	rows	represent	uninfected	primary	B	cells	or	cells	on	different	days	p.i..	In	the	first	column,	I	compared	the	forward	and	sideward	scatter	of	the	different	cell	samples.	The	next	two	columns	compare	untreated	cells	(0	nM)	with	cells	 incubated	with	100	nM	TMRE	for	30	min.	Columns	four	to	six	show	the	results	after	back-gating	of	the	cell	populations	indicating	the	fraction	of	cells	that	were	 Annexin	 V	 positive	 (red),	 TMRE_low	 positive	 (blue)	 or	 TMRE_high	 positive	 (green).	 During	 the	 first	three	 days,	 10-20	 %	 of	 the	 cells	 were	 Annexin	 V	 positive	 and	 from	 day	 five	 this	 fraction	 decreased.	 TMRE	incorporation	 revealed	 two	 clearly	 positive	 populations	 in	 uninfected	 B	 cells	 (Day0).	 The	 population	 of	TMRE_high	cells	became	dominant	 from	day	 four	p.i.	 indicating	a	high	mitochondrial	 activity	of	 stably	 infected	cells.	The	figure	shows	the	results	of	one	representative	experiment	out	of	four	biological	replicates.		respectively.	 Glucose	 uptake	 and	 its	 catabolic	 breakdown	 to	 pyruvate	 is	 one	 pathway	 to	regulate	the	metabolic	cellular	rate.			
	Fig.	7.	Summary	of	the	metabolic	activities	of	B	cells	early	after	EBV	infection.	
A. The	fractions	of	Annexin	V	binding	cells	and	cells	that	take	up	TMRE	as	a	measure	of	their	mitochondrial	activity.	The	fraction	of	Annexin	V-positive	and	TMRE_low	cells	decreased	in	the	course	of	EBV	infection.	The	fraction	of	TMRE_high	cells	stayed	constant	until	day	three	p.i.,	but	increased	starting	on	day	four	to	constitute	more	than	80	%	one	week	p.i..	Mean	and	standard	deviations	from	four	independent	biological	replicates	are	shown.		
B. Uptake	of	the	glucose	analogue	(2-NBDG)	in	the	course	of	early	EBV	infection.	During	the	first	three	days	p.i.	 the	 fraction	of	 cells	 that	 took	up	glucose	was	 constant.	 Starting	on	day	 four	 the	 fraction	of	 glucose	analogue-positive	cells	 increased	up	to	100	%	indicating	a	very	high	rate	of	glucose	uptake.	Bars	in	the	graph	display	mean	and	standard	deviation	from	four	independent	experiments.		 Identical	numbers	of	freshly	purified	uninfected	B	cells	and	cells	infected	with	EBV	were	plated	in	a	low-glucose	media	and	incubated	with	2-NBDG	for	one	hour.	After	incubation,	the	cells	 were	 washed	 with	 ice-cold	 PBS	 and	 kept	 on	 ice	 to	 inhibit	 the	 dephosphorylation	 and	export	of	2-NBDG	from	the	cells.	Samples	were	analysed	at	the	indicated	time-points	by	FACS	using	the	FITC	channel	to	record	the	uptake	of	the	glucose	analogue.	Established	LCLs	showed	a	very	efficient	glucose	analogue	uptake	(more	than	90	%	positive	cells)	in	a	distinct	positive	population	compared	with	cells	that	were	not	incubated	with	the	glucose	analogue	(2-NBDG)	
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	Fig.	8.	Uptake	of	the	glucose	analogue	2-NBDG	during	B	cells	infection	with	EBV.	FACS	analysis	of	the	glucose	uptake	in	B	cells	at	different	days	after	EBV	infection.	5x105	of	uninfected	and	EBV	infected	B	cells	were	incubated	with	100	µM	2-NBDG	at	the	indicated	time	points	p.i.	 for	one	hour	at	37	°C.	The	cells	were	washed	with	PBS	and	analysed	by	FACS	including	the	untreated	samples	(no	2-NBDG).	The	first	row	
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shows	an	established	LCL	as	a	reference,	the	remaining	seven	rows	represent	uninfected	B	cells	and	cells	infected	for	different	time	periods	as	indicated.	The	first	column	compares	forward	and	sideward	scatter	of	cells	incubated	with	2-NBDG.	The	next	three	columns	show	the	analysis	of	untreated	cells	(no	2-NBDG)	and	cells	incubated	with	2-NBDG.	 During	 the	 first	 three	 days	 after	 viral	 infection	 the	 cells	 did	 not	 show	 significant	 changes	 in	 glucose	uptake.	Starting	 from	day	 four	p.i.,	 the	glucose	uptake	activity	 increased	substantially	 to	reach	more	than	85	%	cells	with	 increased	glucose	uptake.	The	figure	depicts	one	experiment	out	of	 four	performed	with	B	cells	 from	different	donors.		(first	row	in	Fig.	8).	The	populations	of	the	uninfected	B	cells	and	cells	infected	with	EBV	for	three	days	contained	about	40	%	2-NBDG	positive	cells.	Starting	from	day	four,	the	fraction	of	FITC	positive	cells	constantly	increased.	After	eight	days	p.i.,	more	than	80	%	of	the	cells	(Fig.	8)	 were	 2-NBDG-positive	 indicating	 an	 efficient	 glucose	 uptake	 and	 an	 increased	 energy	consumption.	Fig.	7	B	summarizes	the	results	from	four	independent	donors.	My	data	 revealed	 that	during	 the	 first	 three	days	after	EBV	 infection	 the	population	of	cells	 did	 not	 seem	 to	 undergo	 dramatic	 changes	 in	 their	 uptake	 of	 glucose.	 Similarly,	mitochondrial	 activity	 was	 undistinguishable	 from	 uninfected	 cells	 during	 this	 infection	period.	However,	from	day	four	onwards	there	was	a	detectable	gain	in	cell	activity	as	revealed	by	a	larger	fraction	of	cells	with	active	mitochondria	and	a	rise	in	the	percentage	of	the	cells	that	efficiently	took	up	glucose.	When	the	cells	reached	the	stable	stage	of	LCLs	most	of	them	had	active	mitochondria	and	took	up	glucose	 in	a	short	period	of	time	(Fig.	7).	These	results	need	to	be	more	intensively	 investigated	in	the	future	focusing	on	other	metabolic	pathways	such	 as	 the	Warburg	 effect	 or	 glutamate	 metabolism,	 which	 likely	 are	 also	 involved	 in	 the	reprogramming	of	primary	B	cells	and	their	dynamic	metabolic	program	after	EBV	infection.		
3.4. Histones and histone chaperones dynamics in the early phase of EBV 
infection 
 The	 EBV	 genome	 enters	 the	 cell	 nucleus	 as	 an	 epigenetically	 naïve,	 linear,	 double-stranded	 DNA	 molecule,	 which	 circularizes	 immediately.	 From	 previous	 work	 by	 Anne	Wöllmer	in	our	lab	we	learnt	that	EBV	DNA	methylation	occurs	late	after	infection,	reaching	a	stable,	high	level	about	three	weeks	p.i..	CpG	methylation	of	viral	DNA	plays	a	very	important	role	 during	 lytic	 phase	 reactivation,	 but	 does	 not	 seem	 to	 contribute	 to	 transcriptional	regulation	 in	 	 the	 first	week	of	 infection	(Woellmer	and	Hammerschmidt,	2013;	Woellmer	et	al.,	2012).	Nucleosome	occupancy	appears	to	be	a	much	earlier	event	that	is	completed	already	at	 the	 end	 of	 the	 first	 week	 p.i..	 Nucleosome	 occupancy	 could	 be	 important	 for	 the	
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establishment	of	the	latent	phase	and	the	downregulation	of	the	initial,	promiscuous	viral	gene	expression	to	escape	from	antiviral	immune	responses	of	the	human	host.		It	is	unknown	if	nucleosome	acquisition	of	viral	DNA	takes	place	prior	to	the	first	round	of	DNA	replication	and	cell	division	(prior	to	day	three	p.i.)	or	later	during	infection.	Histone	variants	proteins	(e.g.	H3.3,	H2A.Z),	which	can	be	synthesized	independently	of	the	cell	cycle	might	play	a	role	prior	to	day	three	p.i.	together	with	histones	that	stem	from	the	small	pool	of	freely	available	histones.	Alternatively,	nucleosome	transcription	is	likely	linked	with	the	first	S	phase	and	cell	division	(after	day	three	p.i.),	when	all	canonical	histone	proteins	such	as	H2A,	H2B,	H3	and	H4	are	synthesized	at	the	beginning	of	the	S	phase.	Initially,	 I	 analysed	 the	 protein	 levels	 of	 the	 histone	 variants	H3.3,	H2A.Z	 and	 selected	histone	chaperones	in	the	course	of	EBV	infection	(Fig.	9	A	and	B).	The	protein	levels	of	histone		H3.3	peaked	at	day	three	p.i.,	prior	to	the	first	cell	division	and	decreased	at	later	time	points.		
	Fig.	9.	Immunoblots	of	chromatin	constituents	in	the	course	of	EBV	infection.	One	million	uninfected	B	cells	or	B	cells	infected	with	wt	EBV	(2089)	were	collected	at	the	indicated	time	points	and	prepared	for	total	protein	lysates.	Lysates	obtained	from	5x105	B	cells	were	loaded	per	lane.	
A. Histone	variant	H3.3	protein	levels	increased	early	after	infection,	peaked	at	day	three	and	were	reduced	later	during	infection.	Levels	of	the	histone	variant	H2A.Z	protein	levels	seemed	to	be	constant	over	time.	ß-actin	served	as	a	protein	loading	control.	One	representative	experiment	out	of	two	is	shown.	
B. Levels	of	histone	chaperone	proteins	varied	during	the	early	phase	of	EBV	infection.	Daxx	and	HIRA	are	two	 chaperones	of	histone	variant	H3.3,	whereas	NAP-1	 is	 a	 chaperone	of	 the	 canonical	H2A	and	H2B	histones.	Levels	of	Daxx	and	HIRA	chaperone	proteins	peaked	at	day	 three	and	 then	decreased	slowly.	NAP-1	showed	 low	 levels	during	 the	 first	 three	days	p.i.	but	 increased	noticeably	on	day	 four	and	was	stable	later	after	infection.	Levels	of	the	PCNA	protein,	which	is	a	hallmark	of	DNA	replication	increased	from	 day	 four	 p.i.	 and	 stayed	 high	 on	 days	 five	 and	 seven,	 when	 cells	 proliferate	 intensively.	 GAPDH	protein	was	used	as	a	protein	loading	control.	One	representative	experiments	out	of	two	is	shown.	
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In	 contrast,	 expression	 of	 the	 histone	 variant	 H2A.Z	 protein	 was	 constant	 (Fig.	 9	 A).	Furthermore,	 the	 histone	 H3.3	 specific	 chaperones	 Daxx	 and	 HIRA	 showed	 a	 similar	expression	over	 time	as	 the	histone	H3.3	variant	protein,	but	with	a	 stronger	expression	on	day	three	and	reduced	protein	levels	later	during	infection.	The	Daxx	histone	chaperone		retained	higher	protein	levels	from	day	three	till	day	five	p.i.	The	canonical	histone	chaperone	NAP-1,	which	acts	in	the	S	phase	of	the	cell	cycle,	showed	elevated	protein	levels	from	day	four	to	 five	 in	a	period	when	 the	cells	proliferated	rapidly.	PCNA	 is	an	essential	DNA	replication-associated	 factor,	 that	 had	 higher	 steady	 state	 levels	 during	 the	 intense	 proliferation	 phase	that	started	on	day	four	until	day	seven	after	EBV	infection	(Fig.	9	B).		These	results	may	suggest	that	histone	variants	and	their	specific	chaperones	play	a	role	in	 the	 process	 of	 nucleosome	 acquisition	 of	 the	 EBV	 genome	 in	 the	 early	 period	 of	 viral	infection.	 Immunodetection	 of	 proteins	 is	 not	 a	 very	 robust	 and	 comprehensive	 approach,	because	it	is	highly	dependent	on	the	specificity	and	quality	of	the	antibodies.	Thus,	I	decided	to	 investigate	 changes	 triggered	 by	 EBV	 infection	 further	 applying	 genome-wide,	 high-throughput	 experiments	 such	 as	 ribonucleic	 acid	 sequencing	 (RNA-seq)	 and	 micrococcal	nuclease	sequencing	(MNase-seq),	which	are	described	in	following	chapters	of	my	thesis.		
3.5.  Global transcriptional regulation in the host cell after viral infection 
 Every	 viral	 infection	 triggers	 a	 number	 of	 host	 cell	 responses	 and	biological	 processes	that	viral	factors	modify,	repress,	or	control.	The	encounter	between	host	and	pathogen	results	in	very	complicated	interactions,	which	can	cause	diverse	alterations	 in	the	transcriptome	of	the	infected	host	cell.	In	this	PhD	work	I	focused	on	the	pre-latent	phase	of	EBV	infection,	when	the	cells	are	on	their	way	to	become	reprogramed	to	investigate	the	dynamics	of	these	changes	in	the	cellular	transcriptome.	
3.5.1. Preparation, design and quality control of the time-resolved RNA-seq 
experiment 
 
3.5.1.1. Sample collection and library preparations for NGS  	The	 development	 of	 the	 high-throughput	 technologies	 based	 on	 the	 Next	 Generation	Sequencing	 (NGS)	 such	 as	 RNA-seq	 opens	 a	 wide	 range	 of	 possibilities	 analysing	 cellular	transcriptomes.	This	method	combines	a	high	resolution,	a	wide	dynamic	range	and	superior	precision	to	identify	nearly	all	existing	transcripts	and	quantify	them	accurately	(Wang	et	al.,	2009;	Nagalakshmi	et	al.,	2010).	I	wanted	to	employ	this	powerful	technique	to	investigate	the	
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alterations	of	the	cellular	transcriptomes	of	B	cell	infected	with	EBV	and	identify	the	biological	processes	that	lead	to	the	successful	implementation	of	EBV’s	latent	phase,	eventually.	Primary	 B	 cells	 isolated	 from	 adenoid	 tissue	 obtained	 from	 surgically	 removed	 nasal	polyps	of	young	children	were	stained	with	CD38	and	 IgD	antibodies	 to	allow	 the	sorting	of	quiescent,	primary	and	naïve	B	cells.	As	uninfected	control	samples,	one	million	of	the	sorted	cells	 from	 each	 donor	 were	 collected,	 washed,	 immediately	 frozen	 in	 TRIZOL	 reagent,	 and	stored	at	 -80	°C.	The	remaining	cells	were	 infected	with	wt	EBV	(2089)	with	an	MOI	0.1	and	incubated	overnight	at	37	°C.	The	next	day,	cells	were	washed	to	remove	unbound	virus	and	resuspended	in	fresh	medium	with	cyclosporine	to	inhibit	contaminating	antiviral	T	cells	from	being	 activated.	 Each	 day	 after	 infection	 the	 cells	 were	 sorted	 according	 to	 the	 established	gating	strategy	to	collect	living	cells,	only,	and	remove	cellular	debris	as	schematically	shown	in	Fig.	10	A.	One	million	sorted	cells	were	washed,	resuspended	in	TRIZOL	reagent	and	stored	at	 -80	°C.	 The	daily	 samples	 from	 three	different	 donors	were	processed	 together	 to	 extract	total	 cell	 RNA.	 To	 control	 this	 and	 subsequent	 steps,	 certain	molar	 amounts	 of	 commercial	External	RNA	Controls	Consortium	(ERCC)	spike-in	controls	were	added	to	each	sample.	They	allowed	tracking	every	step	of	library	preparation	as	well	as	monitoring	the	sequencing	depth.	Extracted	 total	 RNA	 samples	 were	 then	 split	 into	 two	 aliquots	 for	 preparing	 two	complementary	types	of	cDNA	libraries:	polyA	enriched	libraries	and	rRNA	depleted	random	hexamer	enriched	libraries	(Fig.	10	B).	With	these	two	alternative	approaches	I	was	aiming	to	identify	and	quantify	all	RNAs	in	EBV	infected	cells	including	also	the	subset	of	lncRNAs	(Zhang	et	 al.,	 2014)	or	histone	gene	RNAs	 that	 commonly	are	not	polyadenylated	 (Kari	 et	 al.,	 2013;	Marzluff	et	al.,	2008).		The	next	steps	in	library	preparation	included	cDNA	amplification	and	ligation	of	specific	adaptors	 to	 allow	 multiplex	 sequencing.	 The	 finished	 libraries	 were	 sequenced	 in	 a	single	 flow	 cell	 using	 the	 Illumina	 HiSeq4000	 platform.	 From	 all	 samples	 100	 base	 -	 long	paired-end	 sequence	 information	 was	 obtained.	 A	 thorough	 bioinformatic	 analysis	 was	 the	next	step	that	included	mapping	to	the	human	and	EBV	genomes,	counting	reads	for	each	gene	combined	with	data	normalization	(Fig.	10	C).	The	main	aim	of	this	experiment	was	to	identify	time-resolved	 clusters	 of	 co-expressed	 genes	 and	 to	 reveal	 their	 biological	 functions	 using	standard	 gene	 ontology	 (GO)	 enrichment	 analyses.	 My	 results	 confirmed	 obvious	 biological	processes	 such	 as	 metabolic	 pathways	 and	 DNA	 replication	 but	 also	 identified	 unexpected		
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Fig.	 10.	 Schematic	 overview	 of	 the	 workflow	 and	 the	 analytical	 steps	 of	 my	 time-resolved	 RNA-seq	
experiments.	
A. Sample	 collection	 and	 preparation	 for	 RNA-seq	 experiments.	 B	 cells	 isolated	 from	 adenoids	 tissue	were	sorted	to	obtain	naïve,	resting	B-cell	populations.	One	million	non-infected	cells	were	collected,	lysed	 in	TRIZOL	 and	 immediately	 frozen	 at	 -80	°C.	 The	 remaining	 cells	were	 infected	with	wt	EBV	(2089)	virus	with	MOI	0.1.	At	 the	 indicated	time	points	cells	were	sorted	according	to	 the	 forward	and	 sideward	 scatter	 criteria	 of	 physically	 intact	 cells.	 One	million	 alive	 cells	 were	 pelleted,	 snap	frozen	in	TRIZOL	reagent	and	stored	at	-80	°C.	
B. Total	RNA	was	extracted	from	each	sample	that	had	been	supplemented	with	ERCC	spike-in	control	RNAs.	The	prepared	RNA	samples	were	used	to	prepare	two	types	of	NGS	libraries:	polyA	enriched	libraries	and	rRNA	depleted	 libraries.	All	 libraries	were	sequenced	together	 in	a	single	 flow	cell	by	paired-end	sequencing	of	100	nucleotides	followed	by	bioinformatic	analyses.	
C. The	scheme	illustrates	the	main	steps	of	the	bioinformatic	analyses	of	the	RNA-seq	data	(QC,	quality	control;	DE,	differentially	expressed;	GO,	gene	ontology).	
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pathways	 such	 as	 ncRNAs	 processing	 and	 chromatin	 silencing	 including	 novel,	 interesting	targets	for	an	analysis	in	the	future.   
 
3.5.1.2. Quality controls of the sequenced libraries 
 In	general,	RNA-seq	experiments	provide	an	enormous	amount	of	sequencing	data,	when	designed	and	performed	carefully.	RNA-seq	experiments	are	demanding	as	they	require	many	individual	 and	 sophisticated	 steps	 such	 as	 RNA	 isolation,	 reverse	 transcription,	 adaptor	ligation,	 limited	 rounds	 of	 PCR	 amplification,	 etc..	 To	 minimize	 possible	 biases	 in	 the	downstream	RNA-seq	data,	comprehensive	quality	controls	have	to	be	applied	from	the	very	beginning	 and	 after	 each	 step	 of	 data	 analysis.	 Starting	 from	 the	 raw	 sequencing	 data,	 it	 is	highly	 recommended	 to	 perform	 a	 FastQC	 analysis	 https://www.bioinformatics	.babraham.ac.uk/projects/fastqc/	or	FastQC	on	the	Galaxy	platform).	This	analysis	provides	a	rapid	control	of	the	sequencing	output	including	quality	scores	per	base,	GC	content,	etc..	In	the	next	steps	of	my	experiments,	I	relied	on	externally	added	trace	amounts	of	artificial	RNA	sets	(ERCC	spike-in	RNAs)	purchased	from	ThermoScientific.		The	 RNA-seq	 data,	 obtained	 from	 the	 many	 samples	 of	 my	 time-course	 infection	experiments	 were	 initially	 checked	 for	 raw	 sequencing	 reads	 quality,	 as	 mentioned	 above,	followed	 by	 the	 analysis	 of	 the	 ERCC	 spike-in	 control	 samples	 and	 post-mapping	 quality	controls.	 The	 set	 of	 ERCC	 spike-in	 RNAs	 consists	 of	 92	 polyadenylated,	 artificial	 RNAs	 of	various	 lengths	 and	 different	 concentrations	 mimicking	 the	 complexity	 of	 eukaryotic	transcripts.	Figure	8	A	presents	dose-response	plots	with	log2	concentrations	of	ERCC	spike-ins	 versus	 log2	 of	 their	 FPKM	 values	 to	 analyse	 their	 linear	 regression	 equations.	 My	sequencing	approach	detected	about	70%	of	 all	 spike-in	RNAs	 in	 the	 samples	missing	 those	that	 are	 present	 in	 very	 low	 concentrations.	 These	 results	 indicated	 the	 lower	 limit	 of	detection	of	the	RNA-seq	experiments	and	their	very	wide	dynamic	range	covering	about	12-14	 log2	 of	 their	 initial	 concentrations.	 After	 mapping	 to	 the	 human	 and	 EBV	 genomes	 all	samples	were	also	analysed	 for	certain	additional	parameters	 to	check	 the	overall	quality	of	the	libraries.	The	library	size	graph	(Fig.	11	B)	shows	that	different	samples	were	sequenced	with	similar	depth	about	60	million	reads	per	library	with	the	exception	of	sample	day8_1	that	had	many	more	reads	in	contrast	to	all	other	samples.		
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 Fig.	11.	Quality	control	of	the	sequenced	libraries.	
A. Detection	of	the	ERCC	spike-in	RNAs	to	assess	the	lower	limit	of	detection	and	the	dynamic	range	of	the	 sequenced	 libraries.	 Artificial	 ERCC	 spike-in	 control	 RNAs	 were	 added	 according	 to	 the	manufacturer’s	recommendations	to	each	RNA	sample	prior	to	library	preparation.	The	three	graphs	are	representative	examples	of	regression	curves.	The	x-axis	indicates	the	log2	concentrations	of	the	spike-in	 RNAs	 added	 to	 the	 samples,	 the	 y-axis	 depicts	 the	 log2	 of	 Fragments	 Per	 Kilobase	 of	transcript	 per	Million	mapped	 reads	 (FPKM)	 per	 individual	 ERCC	 spike-in	 RNA.	 The	 coefficient	 of	determination	(R2),	the	slope	of	the	regression	line	and	the	numbers	of	spike-in	RNAs	(n)	identified	out	of	92	added	to	the	samples	are	indicated.		
B. The	quality	 control	graph	provides	 information	about	 the	 size	of	 the	 sequenced	 libraries	prepared	from	 the	 different	 samples	 from	 three	 independent	 donors.	 The	 majority	 of	 the	 samples	 shows	comparable	 sequencing	 depth	 except	 sample	 Day8_1.	 This	 sample	 was	 further	 investigated	 for	 a	possible	 bias	 and	 excluded,	 finally;	 see	 Supplementary	 Figure	 1	 for	 additional	 information	 in	 the	Appendix.	
C. The	bar	plot	depicts	the	numbers	of	detected	genes	with	a	threshold	of		>	10	reads	per	million	(RPM)	in	each	sequenced	sample.	The	numbers	of	detected	genes	were	comparable.	
D. Ratios	 of	 the	 numbers	 of	 viral	 genes	 versus	 the	 numbers	 of	 cellular	 genes	 at	 each	 day	 for	 three	replicates	are	shown.	Viral	genes	were	absent	in	uninfected	cells	(Day0)	as	expected,	 in	contrast	to	day	 one	 and	 two,	 when	 the	 ratio	 of	 detected	 viral	 genes	 was	 very	 high.	 From	 day	 three	 on,	 the	numbers	 of	 detected	 EBV	 genes	 decreased	 to	 reach	 a	 stable	 level	 at	 day	 four	 p.i..	 Sample	 Day8_1	appears	 to	 be	 an	 outlier	 because	 of	 its	 high	 ratio	 of	 viral	 versus	 cellular	 genes	 fraction	 (see	Supplementary	Figure	1	for	more	information).	
 The	numbers	of	mapped	and	identified	genes	(Fig.	11	C)	seemed	to	be	very	similar	in	all	samples	encompasing	around	7000	genes.	The	ratios	of	the	detected	viral	versus	cellular	genes	were	dynamic	during	the	course	of	infection	(Fig.	11	D).	In	the	samples	from	uninfected	cells	
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(Day0),	 no	 viral	 transcripts	 were	 found	 as	 expected.	 In	 contrast,	 the	 samples	 from	 cells	infected	for	one	and	two	days	reached	level	of	3-3.5x10-4	viral/cellular	genes.	Starting	at	day	three	 p.i.,	 the	 ratios	 of	 viral	 genes	 decreased	 to	 reach	 an	 almost	 stable	 level.	 Again,	 sample	Day8_1	 looked	 different	 and	 revealed	 almost	 five-times	 more	 viral	 versus	 cellular	 genes	compared	to	the	other	two	replicates	at	this	day	p.i..	A	Principal	Component	Analysis	(PCA)	as	described	in	the	following	chapter	documented	that	this	sample	differed	dramatically	from	all	other	samples	(Supplementary	Figure	1	in	Appendix).	I	decided	to	exclude	it	from	my	further	analyses	to	eliminate	this	outlier	to	prevent	a	bias	in	the	final	results.	The	data	shown	in	Fig.	11	were	derived	from	polyA	enriched	libraries.	The	quality	controls	of	the	rRNA	depleted	libraries	were	very	comparable	and	are	shown	in	Supplementary	Figure	2	in	the	Appendix.		
3.5.1.3. Principal Component Analysis (PCA) 
 The	 comparison	 of	 RNA-seq	 data	 collected	 at	 different	 time-points	 after	 EBV	 infection	should	 reveal	 the	 differences	 and	 dynamics	 in	 the	 host	 cell	 transcriptome	 in	 the	 course	 of	infection.	 PCA	 is	 a	 statistical	method	 that	 can	 reduce	 the	 large	number	of	 variables	 that	 are	present	 within	 multivariate	 data	 sets	 such	 as	 sequencing	 samples,	 by	 identifying	 the	orthogonal	directions	(called	Principal	Components	-	PC)	that	explain	most	of	the	variations	in	the	data	set.	The	PCA	analysis	was	performed	on	the	basis	of	the	log-transformed	expression	matrix,	 and	 in	 Fig.	 12	 A	 and	 B	 the	 first	 two	 Principal	 Components	 (those	 that	 express	 the	highest	fraction	of	variance)	are	plotted.	The	PCA	plot	reveals	that	the	largest	contribution	to	the	variation	in	the	data	is	the	infection	status	of	the	cells	(PC2)	followed	by	the	progression	of	the	viral	infection	over	time	(PC1).	Samples	obtained	from	day	five,	eight	and	14	are	closer	to	each	other	than	the	earlier	time-points,	indicating	reduced	variances	present	in	samples	from	these	later	time	points.		PCA	 from	 my	 two	 different	 types	 of	 RNA-seq	 libraries	 (polyA	 enriched	 and	 rRNA	depleted)	showed	almost	identical	characteristics	in	the	PCA	plots	(Fig.	12	A).	The	well-defined	and	clear	 changes	between	different	days	after	EBV	 infection	 suggested	 that	discrete	 sets	of	genes	 contributed	 to	 specific	 PC1	 or	 PC2	 variances.	 From	 the	 ranked	 PC1	 or	 PC2	 matrix	 I	investigated	the	top	entries	of	the	two	lists	to	look	at	these	potentially	interesting	candidates	(Fig.	12	C,	D).	Four	examples	of	the	gene	candidates	(the	full	lists	of	the	top	30	candidates	are	provided	 in	 Supplementary	 Table	 1	 of	 the	 Appendix),	 which	 were	 highly	 expressed	 in	 the	
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uninfected	cells	 is	a	chemokine	receptor	and	three	transcription	factors	that	may	control	the	quiescent	state	of	the	non-activated	B	cells	(Fig.	12	C).	
	Fig.	12.	Principle	Component	Analysis	(PCA)	of	the	time-resolved	RNA-seq	data.	
A. The	PCA	plot	shows	samples	from	all	polyA	enriched	libraries	at	the	given	time	points	p.i..	With	the	exception	 of	 day	 8	 p.i.	 each	 day	 is	 represented	 by	 three	 replicates.	 The	 samples	 are	 shown	 as	 a	function	 of	 the	 first	 (PC1)	 and	 the	 second	 (PC2)	 principal	 components.	 X	 and	 y	 axes	 show	 the	percentages	of	variance	explained	by	PC1	and	PC2.		
B. The	 PCA	 plot	 indicates	 PC1	 and	 PC2	 from	 RNA-seq	 data	 obtained	 from	 rRNA	 depleted,	 random	hexamer	enriched	libraries.	The	results	were	very	similar	to	the	data	in	panel	A.	Again,	PC2	defined	changes	between	uninfected	and	EBV-infected	cells	and	PC1	depicted	differences	between	different	days	after	infection.	
C. The	 bar	 plots	 show	 the	 time-resolved	 expression	 of	 selected	 genes,	which	 primarily	 contribute	 to	sample	 variances	 as	 defined	 by	 PC2.	 The	 x-axis	 displays	 samples	 from	 different	 days	 and	 three	different	donors,	whereas	y-axis	depicts	normalized	reads	counts.	All	genes	are	highly	expressed	in	uninfected	cells	but	are	strongly	repressed	shortly	after	EBV	infection.	CXCR4	and	SOX5	showed	also	significantly	lower	expression	level	at	day	one	compared	with	the	uninfected	cells.		
D. Examples	of	 four	genes	that	stand	for	variances	according	to	PC1.	The	indicated	genes	were	barely	expressed	in	uninfected	cells	but	became	activated	at	different	time	points	post	EBV	infection.		
	
CXCR4	 is	a	chemokine	receptor	 that	 is	 involved	 in	haematopoiesis,	migration	of	resting	leukocytes,	and	in	maintaining	the	undifferentiated	state	of	hematopoietic	stem	cell	(Zou	et	al.,	
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1998;	Sugiyama	et	al.,	2006).	Another	candidate	was	SOX5,	a	transcription	factor	(TF)	mainly	associated	with	embryonic	development	and	cell	 fate	determination,	but	it	 is	apparently	also	involved	in	B	cell	differentiation	reducing	their	proliferative	capacity	(Rakhmanov	et	al.,	2014).	
KLF4	encodes	a	transcription	factor	of	the	larger	family	of	zinc-finger	SP-1	like	TFs.	It	is	mainly	known	as	one	of	 the	 factors	 that	can	 lead	to	 induced	pluripotent	stem	cells	 (iPS)	(Takahashi	and	 Yamanaka,	 2006),	 but	 it	 also	 has	 many	 important	 functions	 in	 processes	 such	 as	proliferation,	 apoptosis,	 or	 cell	 reprograming	 and	 is	 highly	 expressed	 in	 non-dividing,	 cell	cycle-arrested	 cells	 (Chen	 et	 al.,	 2001).	 Another	 example,	 the	 ZBTB16	gene,	 also	 known	 as	
PLZF,	 is	a	member	of	yet	another	subfamily	of	zinc-finger	TFs,	which	is	 involved	in	cell	cycle	processes	as	well	 as	B	cell	malignancies	 (Parrado	et	al.,	2000).	 It	 also	 interacts	with	histone	deacetylases,	 which	 together	 with	 other	 factors	 were	 reported	 to	 induce	 innate	 immune	responses	 (Xu	et	al.,	 2009;	 Sadler	et	al.,	 2015).	 In	 contrast	 to	 transcripts	 that	 contributed	 to	PC2	of	 the	uninfected	samples,	 the	PC1	coordinates	of	 the	 transcripts	 from	samples	 infected	for	 two	 or	 three	 days	 increased	 gradually	 to	 become	 rather	 invariant	 on	 day	 four	 and	 later	(Fig.	12	A,	B).	One	of	the	interesting	genes	in	samples	infected	for	eight	days	was	SPARC,	which	encodes	a	glycoprotein	and	has	emerged	to	correlate	with	progression	of	many	cancers	such	as	ovarian	or	prostate	cancer,	for	example	(Chen	et	al.,	2012).	In	addition,	there	are	reports	that	claim	a	role	of	SPARC	in	B	cell	malignancies	(Sangaletti	et	al.,	2014).	TMEM173,	also	known	as	STING	 encodes	 a	 transmembrane	 protein	 that	 promotes	 innate	 immune	 response	 by	stimulating	the	secretion	of	interferon	type	I	as	a	response	to	DNA-containing	pathogens	suchas	 DNA	 viruses	 or	 bacteria	 (Ishikawa	 et	 al.,	 2009).	 On	 the	 contrary,	 the	 TMEM173	 protein	might	support	the	success	of	HSV-1	in	certain	cell	and	animal	models	of	herpesvirus	infection	(Kalamvoki	and	Roizman,	2014).	The	PIR	gene	that	encodes	pirin	is	also	expressed	late	during	EBV	 infection.	 It	 is	 a	nuclear	protein,	which	presumably	acts	as	a	 transcriptional	 cofactor.	 It	was	 found	to	 interact	with	B	cell	 lymphoma	3-encoded	oncoprotein	(BCL-3)	and	 to	promote	gene	 transcription	 (Dechend	 et	 al.,	 1999).	 Another	 candidate	 is	 LOC643401,	 a	 lncRNA	 also	known	as	PURPL.	Recently,	it	was	found	that	PURPL	suppresses	basal	p53	levels	in	colorectal	cancer	 cells	 by	 preventing	 the	 interaction	 of	 p53	 with	 MYBBP1A,	 which	 can	 activate	expression	of	p53	in	the	nucleoplasm	(Li	et	al.,	2017).		The	PCA	analysis	 identified	 linear	 combinations	of	different	genes	 that	explain	most	of	the	variations	in	the	data	(PC1	and	PC2).	The	component	scores	along	PC1	and	PC2	of	the	top	30	 candidates	 suggested	 that	 these	 transcripts	 are	 critically	 involved	 in	 the	 steps	of	 cellular	reprogramming	(Supplementary	Table	1	in	the	Appendix).	Their	functions	as	a	group	of	genes	
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are	 not	 immediately	 obvious,	 but	 my	 analysis	 revealed	 that	 they	 act	 in	 a	 time-dependent	manner	during	infection	of	primary	human	B	cells	with	EBV.		
3.5.1.4. Comparison of the two types of NGS libraries 
 	 I	analysed	two	different	types	of	sequencing	libraries	in	my	RNA-seq	experiments.	One	set	of	samples	with	three	replicates	where	each	was	polyA	enriched	prior	to	cDNA	synthesis,	the	 second	 set	 with	 two	 replicates	 each	 was	 based	 on	 rRNA	 depleted	 random	 hexamer	enriched	RNA	 samples	 to	 generate	 the	NGS	 libraries.	 These	 two	 techniques	 together	 should	maximize	 the	coverage	of	cellular	 transcripts.	This	 is	because	certain	cellular	 transcripts	are	non-polyadenylated	including	histone	RNAs	and	certain	non-coding	RNAs	(ncRNAs).	RNA-seq	samples	obtained	from	both	 libraries	entered	the	same	bioinformatic	analysis	pipeline.	After	processing	with	DEseq2,	I	looked	for	transcripts	detected	in	both	libraries	and	ones	that	were	uniquely	contained	in	one	of	the	two	libraries,	only.		The	 comparison	of	 significant	differentially	 expressed	 (DE)	 genes	 from	polyA	enriched	libraries	with	rRNA	depleted	libraries	is	summarized	in	the	Venn	diagram	(Fig.	13).	Only	in	the	rRNA	 depleted	 libraries	 I	 detected	 29	 viral	 transcripts	 and	 a	 number	 of	 different	 types	 of	cellular	 ncRNA	 (miRNAs,	 lncRNAs,	 snoRNAs	 etc.)	 that	 were	 absent	 in	 the	 polyA	 enriched	libraries.	 More	 than	 400	 transcripts	 from	 this	 list	 could	 not	 be	 classified	 to	 a	 known	 gene.	Interestingly,	 in	 this	 type	of	 library	 I	exclusively	discovered	eleven	additional	histone	genes,	which	were	unique	in	the	rRNA	depleted	libraries.			Fig.13.	Comparison	between	the	polyA	enriched	and	
the	 rRNA	 depleted	 random	 hexamer	 primed	 RNA-
seq	libraries	displayed	as	a	Venn	diagram.		The	two	sets	of	transcripts	show	the	intersection	of	7699	genes	 found	 in	 both	 types	 of	 libraries.	 The	 rRNA	depleted	 samples	 differed	 from	 the	 polyA	 enriched	samples	by	1777	genes,	about	19	%	of	all	entries	of	the	list.	The	polyA	enriched	libraries	contained	1298	unique	and	differentially	 expressed	 transcripts,	which	were	14	%	of	all	entries.					In	the	group	of	transcripts	identified	in	the	polyA	enriched	libraries,	only,	I	could	not	find	any	 EBV	 specific	 mRNAs	 but	 certain	 ncRNAs	 although	 fewer	 than	 in	 the	 rRNA	 depleted	
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libraries.	In	the	set	of	genes	identified	in	the	rRNA	depleted	libraries	more	than	250	genes	did	not	have	a	specific	gene	name	but	an	alphanumerical	code.	The	entries	from	these	lists	do	not	point	 to	 obvious	 functions	 or	 molecular	 mechanisms,	 which	might	 be	 specifically	 enriched.	This	comparison	and	additional,	previously	performed	quality	controls	 led	me	 to	choose	 the	RNA-seq	results	from	the	polyA	enriched	libraries	for	my	further	analyses.	These	libraries	rely	on	 three	 independent	 donors	 and	 technical	 replicates	 and	 apparently	 contain	 sufficient	information	 including	 chromatin	 components	 such	 as	 histone	 genes,	 some	 of	which	 are	 not	polyadenylated,	 which	 was	 my	 greatest	 concern.	 My	 interest	 was	 on	 daily	 changes	 of	 the	cellular	 transcriptomes,	 thus	 the	 polyA	 enriched	 libraries	 contained	 all	 the	 information	 I	wanted	 to	 collect.	 The	 rRNA	 depleted	 libraries	 can	 be	 used	 in	 the	 future	 to	 look	 more	specifically	for	changes	of	ncRNAs	levels	during	viral	infection.		
3.5.2. Dynamic regulation of specific biological processes in the course of EBV 
infection 
 As	 mentioned	 previously,	 the	 main	 goal	 of	 my	 RNA-seq	 experiments	 was	 to	 identify	significant	differentially	regulated	genes	and	classify	them	into	functional	groups	that	share	a	similar	timely-resolved	pattern	of	gene	expression	in	the	early	phase	of	EBV	infection.	Time-course	RNA-seq	experiments	are	very	valuable	in	understanding	dynamic	biological	processes,	but	 on	 the	 other	 hand,	 they	 also	 introduce	 additional	 experimental	 and	 computational	challenges	 during	 the	 different	 steps	 of	 data	 analysis	 (Spies	 and	 Ciaudo,	 2015).	 In	 a	conventional	RNA-seq	experiment	that,	for	example,	compares	two	different	states	of	a	given	cell,	the	identification	of	differentially	expressed	genes	is	the	main	task	of	data	analysis.	In	an	experiment	 in	 which	 time-resolved	 RNA-seq	 data	 are	 key	 to	 understand	 the	 underlying	processes	differentially	expressed	genes	have	to	be	identified	across	different	time	points.	My	RNA-seq	 experiments	 consisted	 of	 eight	 time	 points	 collected	 at	 specific	 days	 after	 EBV	infection	as	indicated	in	Fig.	10.		In	the	 initial	step	of	my	data	analysis,	genes	that	are	expressed	at	very	 low	levels	were	excluded	from	the	subsequent	analyses.	Filtering	of	genes	was	followed	by	the	identification	of	genes	 that	were	 differentially	 expressed	 (DE)	 between	 at	 least	 one	 pair	 of	 time	 points.	 The	applied	criteria	were	a	false	discovery	rate	(FDR)	of	<	0.1	and	an	estimated	fold	change	(FC)	greater	 than	2	or	 smaller	 than	0.5,	 as	 estimated	by	 the	DEseq2	analysis	 package	 for	R.	This	approach	 led	 to	 the	 identification	 of	 8997	 DE	 genes,	 which	 were	 used	 to	 create	 a	 distance	matrix	 between	 them	 followed	 by	 a	 hierarchical	 clustering.	 The	 number	 of	 clusters	 was	
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estimated	 with	 a	 dynamic	 hybrid	 cut	 algorithm	 (Langfelder	 et	 al.,	 2008;	 van	 Dongen	 and	Enright,	2012).	This	analysis	yielded	seven	different	clusters	named	according	to	an	arbitrary	colour	 code.	 The	 clusters	 demonstrated	 peculiar	 patterns	 of	 genes	 expression	 during	 the	course	 of	 EBV	 infection	 (Fig.	 14	 and	 Fig	 15).	 Upon	 first	 visual	 inspection,	 three	 clusters	appeared	 to	 be	 related	 (Fig.	 14	A,	B,	 C),	 but	 in	 each	 of	 these	 three	 clusters	 gene	 expression	peaked	 at	 different	 days	 post	 infection.	 Two	 other	 clusters	 showed	 high	 gene	 expression	 in	uninfected	cells	(Day	0)	followed	by	a	gradual	decrease	of	gene	expression	during	the	first	four	days	after	EBV	infection	(Fig.	15	A	and	B).	The	two	remaining	clusters	depicted	very	individual	gene	expression	patterns.	The	yellow	cluster	encompassed	genes	with	expression	 levels	 that	constantly	increased	over	time	(Fig.	15	D).	Genes	in	the	brown	cluster	were	highly	expressed	in	uninfected	cells	but	dropped	on	the	first	day	p.i.	to	rise	thereafter	(Fig.	15	C).	The	clustering	of	 the	 identified	differentially	 expressed	genes	allowed	 to	 reduce	 the	high	 complexity	of	 the	sequencing	data	 and	 to	 find	a	 specific	 expression	pattern	of	host	 transcripts	 altered	by	EBV	infection.	Next,	 the	defined	clusters	were	analysed	 if	 they	are	enriched	 for	 certain	biological	processes	using	a	common	gene	ontology	(GO)	enrichment	algorithm.	GO	studies	can	identify	groups	of	genes	sharing	the	same	biological	function	and/or	pathway	in	complicated	data	sets.		GO	analyses	can	be	performed	with	several	 freely	available	online	 tools	and	databases,	which	 in	 principle	 translate	 gene	 lists	 into	 biological	 functions.	 To	 characterize	 specific	biological	processes,	which	occur	within	each	of	the	seven	clusters,	I	analysed	the	lists	of	genes	from	 a	 single	 cluster	 in	 comparison	 to	 a	 set	 of	 background	 genes	 using	 the	 GOrilla	 online	platform	 (Eden	 et	 al.,	 2009).	 The	 union	 of	 genes	 that	 were	 tested	 by	 DEseq2	 across	 the	pairwise	 comparisons	 were	 implemented	 as	 the	 “background	 genes”	 set.	 The	 GOrilla	 tool	employs	 rigorous	 statistics	 using	 the	 minimum	 hypergeometric	 (mHG)	 model	 to	 calculate	enrichment	p-values	for	each	identified	GO	term.	In	addition,	I	set	the	p-value	threshold	to	p	≤	10-7.	 To	 increase	 the	 precision	 and	 specificity	 of	 the	 identified	 GO	 terms	 they	were	 further	analysed	using	the	“reduce	and	visualize	gene	ontology”	(REViGO)	online	tool.	This	program	is	designed	 to	 work	 with	 the	 long	 lists	 of	 GO	 terms	 to	 remove	 redundant	 ones.	 It	 also	 offers	different	 visualization	 options	 that	 can	 help	 to	 display	 the	 data	 in	 a	 more	 transparent	 and	attractive	way	(Supek	et	al.,	2011).	The	RNA-seq	data	enriched	GO	terms	characteristic	 for	a	specific	 gene	 expression	 cluster	were	displayed	as	REViGO	 tree	maps	 (Figs.	 14	 and	15	 right	panels). The	plots	display	graphs	with	the	identified	enriched	GO	terms	with	background	colour	codes	 reflecting	 the	 name	 of	 the	 cluster.	 Each	 diagram	 consists	 of	 tiles	 representing	 “super	
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groups”	of	related	GO	terms.	The	sizes	of	the	tiles	reflect	the	defined	p-values	as	absolute	log10	terms.	 Each	 cluster	 was	 indicative	 of	 very	 specific	 biological	 pathways,	 which	 differed	dramatically	 among	 all	 seven	 identified	 clusters.	 Three	 clusters	 were	 combined	 in	 Fig.	 14,	because	they	revealed	very	similar	pattern,	but	differed	with	regard	to	the	timing	of	the	peak	values.	 In	 contrast	 to	 this	 almost	 congruent	 pattern,	 the	 clusters	 belonged	 to	 very	 different	individual	 sets	 of	 GO	 terms.	 Interestingly,	 the	 turquoise	 cluster	 was	 enriched	 in	 pathways	involved	 in	 ncRNA	 metabolism	 and	 processing	 (Fig.	 14	 A).	 In	 line	 with	 the	 metabolic	experiments	shown	in	Fig.	7,	the	black	cluster	highlighted	catabolic	processes	and	biochemical	energy	 metabolism	 in	 particular	 the	 mitochondrial	 respiratory	 chain	 complex	 (Fig.	 14	 B),	which	peaked	at	day	three	p.i..	Genes	from	the	red	cluster	peaked	at	day	four	p.i.,	when	DNA	synthesis	 is	 way	 up	 and	 the	 cells	 divide	 rapidly	 (Fig.	 5).	 Very	 accurately,	 this	 cluster	encompassed	 genes	 involved	 in	 chromosome	 organization,	 cell	 cycle	 processes,	 and	 DNA	replication	(Fig.	14	C).		 Four	 additional,	 more	 heterogeneous	 clusters	 represent	 diverse	 expression	 patterns	that	 lack	clear	expression	peaks	in	contrast	to	the	three	clusters	shown	in	Fig.	14.	The	green	cluster	(Fig.	15	A)	is	characterized	by	a	rapid	and	later	constant	loss	of	gene	expression.	The	identified	 processes	 are	 typical	 of	 uninfected	 resting	 cells	 as	 the	 enriched	 pathways	 were	indicative	of	cell	differentiation	and	development	processes	(Fig.	15	A).	On	the	contrary,	in	the	blue	cluster,	 terms	characteristic	of	DNA-templated	 transcription	dominated	(Fig.	15	B).	The	two	 last	 clusters	 summarized	 biological	 pathways	 that	 are	 commonly	 involved	 in	 antiviral	responses:	 the	brown	cluster	encompassed	 leukocyte	activation	and	other	 systemic	 immune	processes	 (Fig.	 15	 C).	 The	 yellow	 cluster	 showed	 an	 increase	 in	 pathways	 regulating	 type	 I	interferon	signalling	and	responses	to	common	external	stimuli	(Fig.	15	D).		In	 summary,	 my	 RNA-seq	 data	 and	 their	 bioinformatic	 analyses	 nicely	 reflected	 the	biological	 phenotypes	 of	 B	 cells	 infected	 with	 EBV.	 The	 data	 indicated	 that	 EBV	 triggers	 a	plethora	of	substantial	changes	in	the	biology	of	the	entire	cell.	In	very	defined	and	short	time	intervals,	the	virus	drastically	overturns	the	transcriptional	program	of	resting	and	quiescent	B	cells	and	induces	many	different	biological	processes	and	pathways.		Some	were	anticipated	according	 to	 the	 biological	 phenotypes	 observed	 in	 the	 course	 of	 viral	 infection	 such	 as	 cell	activation,	DNA	 replication,	mitosis,	 etc..	My	RNA-seq	 data	 confirmed	 all	 these	 processes.	 In	addition,	the	cluster	analyses	pointed	to	additional,	unexpected	and	therefore	very	interesting	processes	(and	genes	involved	therein)	that	warrant	further	investigation.			
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Fig.	14.	Cluster	analyses	of	differentially	expressed	(DE)	genes	in	the	course	of	EBV	infection	define	peak	
expression	pathways	and	a	group	of	three	clusters	of	biological	processes.		A	cluster	analysis	was	performed	to	 identify	gene	groups	with	similar	expression	pattern	during	 infection.	 In	a	pair-wise	 comparison	 of	 all	 cluster	 sets,	 a	 group	 of	 significant	 differentially	 expressed	 genes	 between	 every	possible	pair	of	the	days	p.i.	was	found	using	DESeq2.	Across	all	samples,	the	Spearman’s	correlation	coefficient	between	pairs	of	genes	was	calculated	followed	by	a	hierarchical	clustering	analysis	in	R.	The	program	identified	seven	clusters	that	differed	in	their	specific	expression	pathways	in	the	course	of	infection.	Three	cluster	pathway	schemes	are	shown	on	the	left	side	with	their	arbitrarily	assigned	colour	name	codes.	The	y-axis	represents	Mean	Normalized	Expression	as	a	function	of	time	(days	p.i.)	on	the	x-axis.	The	numbers	on	top	of	the	plots	(N)	indicate	the	numbers	of	the	genes	that	form	the	cluster.	The	circles	indicate	average	expression	levels,	while	the	dashed	lines	delineate	the	standard	deviations,	 the	red,	dashed	lines	point	to	the	expression	peak	of	certain	cluster.	All	genes	 within	 a	 given	 specific	 cluster	 were	 used	 to	 perform	 a	 gene	 ontology	 (GO)	 analysis	 using	 the	 online	
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platform	(“GOrilla”,	http://cbl-gorilla.cs.technion.ac.il/).	The	GO	analysis	is	summarized	in	a	TreeMap	plot	(right	side)	 created	 using	 the	 REVIGO	 online	 tool	 that	 reduces	 the	 redundancy	 in	 the	 GO	 terms.	 The	 plots	 contain	rectangles	of	different	sizes	indicating	the	absolute	log10	of	the	calculated	p-values	of	the	shown	GO	terms.	The	colour	background	of	the	tree	maps	is	related	to	the	colour	name	of	the	clusters.	
A. The	graph	depicts	 the	expression	pathway	of	 the	 turquoise	cluster.	This	group	contains	genes	 that	peaked	on	day	two	p.i.,	decreased	until	day	five	and	showed	stable	levels	thereafter.	The	GO	analysis	identified	the	most	significant	biological	processes	involved	in	ncRNAs	metabolism,	RNA	processing	and	ribonucleoprotein	complex	assembly.	
B. The	black	cluster	is	similar	to	the	previous	cluster,	but	the	genes	peaked	on	day	three	p.i..	Within	this	group,	the	most	frequently	found	GO	terms	were	cell	metabolism	and	mitochondrial	processes	linked	to	 energy	 production	 such	 as	 respiratory	 electron	 transport	 chain	 or	 generation	 of	 precursor	metabolites.	
C. In	 the	 red	 cluster	 of	 expression	 pathways,	 genes	 peaked	 on	 day	 four	 after	 EBV	 infection	 and	decreased	 slightly	 thereafter.	 The	 analysis	 pointed	 to	 the	 biological	 processes	 in	 the	 categories	 of	chromosome	organization,	DNA	replication,	cell	cycle,	and	mitotic	processes.		 The	 time-controlled	 expression	 of	 EBV	 genes	 is	 another	 very	 interesting	 aspect,	which	was	 already	 described	 and	 reviewed	 in	 the	 literature	 (Price	 and	 Luftig,	 2014).	My	 RNA-seq	data	confirmed	most	of	the	known	expression	kinetics	of	EBV	genes	(Supplementary	Figure	3	in	Appendix),	but	has	to	be	improved	since	a	self-made	annotation	file	of	EBV	genes	was	used,	which	 lacks	certain	viral	 transcripts.	My	main	 interest	was	 to	explore	an	unknown	aspect	of	the	 early	 phase	 of	 EBV	 infection,	which	 describes	 dynamic	 time-related	 changes	 in	 the	 host	transcriptome	upon	the	EBV	infection.	
3.5.1. ncRNAs and target genes involved in chromatin processing or host cell 
metabolism during early EBV infection 
 As	described	in	the	previous	chapters,	my	data	analyses	 identified	previously	unknown	aspects	 and	 mechanisms	 that	 act	 in	 the	 early	 phase	 of	 EBV	 infection	 including	 changes	 in	metabolic	 pathways	 or	 chromatin	 dynamics.	My	 transcriptome	data	 revealed	 the	 kinetics	 of	specific	pathways	and	allowed	the	 identification	of	 individual	 targets,	which	might	be	key	 to	the	success	of	EBV	infection	and	the	establishment	of	 its	 latent	phase	 later.	For	example,	 the	RNA-seq	data	in	the	red	cluster	(Fig.	14	C)	confirmed	phenotypic	observations	regarding	cell	cycle	 entry	 and	 cell	 division	 on	 day	 four	 (Fig.	 5).	 GO	 terms	 on	 this	 day	 highlighted	 key	processes	such	as	the	cell	cycle,	cell	division	and	DNA	replication.	This	example	confirmed	that	NGS	data	indeed	reflected	the	processes	that	take	place	in	the	cell	after	EBV	infection.	The	next	very	important	step	is	to	look	more	closely	at	interesting	clusters	to	try	to	define	target	genes	that	are	essential	for	the	regulation	of	specific	biological	pathways.	In	the	next	subchapters,	I	would	 like	 to	 focus	 on	 three	 broad	 aspects	 of	 transcriptomic	 changes	 after	 EBV	 infection:	energy	metabolism,	chromatin	regulation	and	ncRNA	processing.		
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	Fig.	 15.	 Four	 clusters	 of	 differentially	 expressed	 genes	 during	 the	 early	 phase	 of	 EBV	 infection	 with	
individual	expression	dynamics.		The	specific	expression	clusters	were	identified	as	described	in	Fig.	14.		
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A. The	 graph	 displays	 pathway	 common	 to	 the	 green	 cluster.	 It	 encompasses	 genes	 that	 are	 highly	expressed	in	uninfected	cells	but	downregulated	in	 infected	cells	until	day	four	p.i.	when	the	genes	adapted	a	 reduced	but	 stable	 expression	 level.	GO	 terms	enriched	 in	 this	 group	of	 genes	 indicated	processes	of	cell	differentiation	and	development.	
B. Compared	to	non-infected	(Day	0)	cells,	a	precipitous	loss	of	the	gene	expression	until	day	three	p.i.		was	obvious	 in	the	blue	cluster	pathway	followed	by	a	recovery	on	day	five	p.i..	 In	this	group,	very	broad	GO	terms	were	found,	which	almost	all	belong	to	the	category	of	DNA-templated	transcription	and	their	regulation.	
C. The	group	of	genes	in	the	brown	cluster	is	also	characterized	by	an	initial	loss	of	expression	on	the	first	 days	 after	 infection	 and	 a	 rapid	 recovery	 until	 day	 five.	 The	 GO	 analysis	 of	 this	 cluster	highlighted	 biological	 processes	 related	 to	 leukocyte	 activation,	 systemic	 immune	 processes	 or	regulation	of	small	GTPase	mediated	signal	transduction.		
D. The	yellow	cluster	summarized	genes	that	constantly	but	slowly	increased	during	infection.	Most	of	these	 identified	genes	belong	 to	 the	 type	 I	 interferon	signalling	pathway	or	are	genes	 that	 react	 to	various	stimuli	or	are	involved	in	general	immunological	processes.		
3.5.1.1. The early regulation of energy metabolism in EBV-infected B cells 
 The	 cellular	 metabolism	 consists	 of	 a	 very	 tightly	 controlled	 network	 with	 numerous	pathways.	It	allows	the	cell	to	generate	sufficient	chemical	energy	and	biochemical	precursors	that	are	needed	for	the	different	steps	in	resting	or	cycling	cells.	Pathogens	also	depend	on	the	host	 cell	 metabolism	 as	 a	 source	 for	 basic	 precursors,	 components,	 or	 energy	 that	 are	 all	required	to	support	viral	genome	replication	and	protein	synthesis,	but	also	virion	assembly	inside	the	cell.	Recently,	many	reports	have	described	different	mechanisms	that	viruses	use	to	manipulate	the	host	cell	metabolism	for	their	purposes.	Some	of	them	follow	similar	alteration	in	 the	metabolic	pathways,	which	were	observed	 in	 cancer	 cells	 such	as	 the	Warburg	effect.	Many	viruses	apply	also	their	own,	specific	mechanisms	that	differ	depending	on	the	type	of	the	viral	infection	such	as	latent	or	lytic	infection.	Certain	aspects	of	energy	metabolism	during	EBV	 infection	 became	 apparent	 in	 this	 thesis	 work	 (Fig.	 7).	 EBV	 induced	 the	 activation	 of	mitochondrial	 pathways	 and	 led	 to	 a	 substantial	 increase	 in	 the	uptake	of	 glucose	 from	day	four	 post	 infection	 onwards.	 The	 transcriptome	 analysis	 identified	 one	 cluster	 of	 similarly	regulated	genes	(black	cluster)	with	GO	terms	that	pointed	 to	respiratory	electron	 transport	chain,	nucleotide	metabolism,	NADH	dehydrogenase	complex	assembly,	and	the	generation	of	precursor	for	metabolites	and	energy	(Fig.	14	B	and	Fig.	16	A).	These	processes	form	a	large	group	of	selected	GO	terms	indicating	their	abundance.	I	selected	eight	different	genes,	which	these	GO	terms	contained	(Fig.	16	B).	All	eight	genes	followed	very	similar	expression	kinetics	during	the	course	of	EBV	infection.	They	were	expressed	at	low	levels	in	uninfected	cells,	but	increased	 dramatically	 until	 day	 three	 p.i..	 Thereafter,	 their	 expression	 levels	 declined	 and	seemed	 to	 stabilize	 later.	 Four	 depicted	 examples	 relate	 directly	 to	 the	 very	 early	 steps	 of	glucose	 metabolism.	 These	 are	 hexokinase	 1	 (HK1),	 which	 phosphorylates	 glucose	 to	
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Fig.	16.	Detailed	GO	analysis	of	genes	in	the	black	cluster	and	selected	examples	of	regulated	genes.		The	set	of	genes	characteristic	for	the	black	cluster	underwent	a	GO	analysis	using	the	GOrilla	tool	followed	by	a	reduction	of	redundant	GO	terms	by	REViGO.	(A)	The	graph	visualizes	the	GO	enrichment	of	certain	terms	using	a	scatterplot.	(B)	Selection	and	visualization	of	the	expression	levels	(normalized	counts)	of	selected	genes.	
A. The	scatterplot	displays	GO	terms	as	circles	in	a	semantic	space,	where	similar	or	related	GO	terms	will	be	 arranged	 closer	 to	 each	other.	 Specific	 colours	 indicate	 the	 log10	p-values	 calculated	by	 the	GOrilla	tool	as	indicated	in	the	legend	on	the	right.	The	different	sizes	of	the	circles	indicate	the	frequency	of	the	GO	term	in	the	underlying	database	(smaller	circles	represent	terms	that	are	more	specific).	Three	main	groups	 of	 GO	 terms	 that	 consist	 of	 sets	 of	 partially	 overlapping	 or	 adjacent	 circles	 denote	 respiratory	electron	transport	chains,	NADH	dehydrogenase	complex	assembly,	and	translational	elongation.		
B. The	 bar	 plots	 show	 mean	 expression	 levels	 of	 normalized	 counts	 (y-axis)	 of	 individual	 genes	 in	 the	course	of	EBV	infection	(days	p.i.,	x-axis).	Each	colour	is	specific	for	a	certain	time-point	as	indicated.			glucose-6-phosphate	 (G6P)	 in	 the	 very	 first	 step	 of	 glycolysis	 or	 glucose-6-phosphate	isomerase	(GPI),	which	converts	G6P	to	fructose-6-phosphate	(F6P)	(Berg	et	al.,	2002).		GSR	is	a	glutathione	reductase,	which	is	important	in	preventing	oxidative	stress	in	different	types	of	human	 cells	 (Garrett	 and	 Grisham,	 2005).	 Lactate	 dehydrogenase	 A	 (LDHA)	 catalyses	 the	reduction	of	pyruvate	to	L-lactate	and	was	reported	to	play	an	important	role	in	cancer	cells	metabolism	 or	 during	 embryonic	 development	 (Valvona	 et	 al.,	 2016).	 The	 second	 selected	group	 of	 four	 genes	 contained	 important	 components	 involved	 in	 the	 mitochondrial	respiratory	 activities.	 The	 encoded	 enzymes	 are	 key	 players	 in	 the	 electron	 transport	 chain	
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such	 as	 cytochrome	 c	 oxidase	 subunit	 6A1	 (COX6A1)	 or	 NADH	 dehydrogenase	 1	 alpha	subcomplex	 (NDUFA2).	 FASTKD1	 is	 the	 AST	 kinase	 domain-containing	 protein	 1,	which	 can	 modulate	 the	 energy	 balance	 of	 stressed	 mitochondria	 (Friedman	 and	 Nunnari,	2014).	On	the	other	hand,	cytidine	monophosphate	kinase	(CMPK1)	is	an	enzyme	involved	in	the	cellular	nucleic	acid	biosynthesis	(Liou	et	al.,	2002).	Together,	these	examples	indicate	that	the	EBV	infected	cells	consume	a	lot	of	energy	and	need	basic	cellular	components	especially	at	day	 three	 p.i..	 Which	 gene	 products	 that	 are	 absolutely	 necessary	 for	 the	 activation	 and	survival	 of	 the	 cell	 or	 for	 the	 establishment	 of	 the	 latent	 phase	 of	 infection	 are	 currently	unknown.				
3.5.1.2. Chromatin components and their regulation during early EBV infection 
 Chromatin	does	not	 only	 function	 to	package	 the	 long	 cellular	DNA	molecules	 into	 the	nuclear	space	of	chromosomes,	but	chromatin	also	works	as	an	additional	and	very	important	layer	regulating	global	gene	expression.	This	adjustment	can	be	achieved	by	nucleosomes	that		occupy	 and	 block	 the	 access	 to	 DNA	 but	 also	 by	 post-translationally	modified	 histones	 that	mark	active	or	repressed	genes.	Many	processes	related	to	chromatin	remodeling	depend	on	certain	phases	of	the	cell	cycle.	Newly	synthesized	DNA	acquires	canonical	histones	during	the	S	phase	of	the	cell	cycle.	EBV	infects	resting,	quiescent	cells,	which	are	in	G0	phase,	activates	them	and	induces	their	DNA	synthesis	and	mitosis.		The	 red	 cluster	 identified	 on	 the	 basis	 of	my	 RNA-seq	 data	 consists	 of	 genes	 that	 are	involved	mainly	in	chromosome	organization,	DNA	replication,	cell	cycle	processes,	and	gene	silencing.	Genes	found	in	this	cluster	showed	a	very	high	expression	on	day	three	and/or	on	day	four	p.i.	(Fig.	14	B).	The	group	of	GO	terms,	which	are	generally	involved	in	chromosome	organization	 (Fig.	 17	 A)	 encompasses	many	 different	 histone	 proteins	 such	 as	 HIST1H4I	 or	HISTH2AB,	which	were	highly	upregulated	 starting	on	day	 four	 after	EBV	 infection.	Histone	chaperones	 were	 also	 present	 in	 this	 group	 for	 instance	 chromatin	 assembly	 factor	 1	(CHAF1A),	which	is	responsible	for	assembling	histone	proteins	onto	newly	synthesised	DNA,	a	 prerequisite	 for	 efficient	 DNA	 replication	 during	 S	 phase.	 Another	 example	 of	 histone	chaperones	 is	 HIRA,	 which	 has	 a	 role	 in	 placing	 the	 histone	 H3.3	 variant	 onto	 DNA	independent	of	 the	cell	cycle	(Burgess	and	Zhang,	2010).	Histone-lysine	N-methyltransferase	(SUV39H1)	 is	 a	 very	 interesting	 candidate	 that	 acts	 in	 chromatin	 silencing	 and	heterochromatin	 formation.	 It	 was	 also	 found	 that	 SUV39H1	 might	 have	 a	 special	 role	 in	
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transcriptional	 silencing	 of	 BZLF	 in	 the	 EBV	 genome	 during	 established	 latency	 (Imai	 et	 al.,	2014).	Two	smaller	groups	of	GO	terms	depicted	in	the	scatter	plot	of	the	red	cluster	(Fig.	17	A)	are	involved	in	many	important	steps	during	DNA	replication.	The	three	selected	genes	act	during	 the	 early	 stage	 of	 DNA	 replication:	 the	 origin	 replication	 complex	 subunit	 1	 (ORC1),	DNA	 polymerase	 alpha	 (POLA1),	 and	 polo-like	 kinase	 1	 (PLK-1),	 which	 triggers	 the	 G2/M	transition.	 PLK1	 also	 has	 a	 potential	 oncogenic	 function	 and	 correlates	 with	 cell	 cycle	
Fig.	17.	GO	analysis	of	the	red	cluster	genes	and	examples	of	interesting	candidates.		The	plots	were	generated	as	described	in	Fig.	16.		
A. The	scatterplot	displays	four	large	groups	of	GO	terms.	A	first	group	of	terms	indicates	functions	related	to	 chromosome	 organization,	 nucleosome	 assembly	 and	 chromatin	 remodelling.	 The	 second	 more	heterogeneous	group	encompasses	terms	with	diverse	functions	in	the	cell	cycle	including	chromosome	segregation	 and	 DNA	 damage	 responses.	 A	 third	 group	 relates	 to	 terms	 with	 a	 distinct	 role	 in	 DNA	replication.	The	fourth	very	homogenous	group	deals	with	the	global	term	“cell	cycle	process”.	
B. The	bar	plots	show	the	expression	levels	as	the	mean	of	normalized	counts	of	ten	genes	in	non-infected	B	cells	and	cells	at	different	days	after	EBV	infection.	With	the	exception	of	HIRA,	the	majority	of	the	genes	are	rapidly	activated	on	the	second	day	after	EBV	infection.	Their	levels	increased	further	until	day	four	p.i.	and	decreased	thereafter.	
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progression	(Bell	and	Dutta,	2002).	The	TIMELESS	gene	is	mostly	related	to	the	circadian	clock	regulation,	 but	 also	 plays	 an	 important	 role	 in	maintaining	many	 other	 biological	 processes	such	as	cell	cycle	functions,	DNA	replication	and	DNA	damage	response	(DDR)	(Engelen	et	al.,	2013).	The	last	example	is	a	lymphoid-specific	helicase	(HELLS),	which	plays	an	essential	role	in	regulating	the	expansion	and	survival	of	lymphoid	cells	during	leukemogenesis	(Geiman	et	al.,	1998).		Additionally,	my	RNA-seq	data	were	used	by	my	collaboration	partners	to	predict	the	cell	cycle	phases	 from	the	RNA-seq	data	according	to	a	modified	algorithm	established	for	single	cell	sequencing	samples	(Scialdone	et	al.,	2015).	Briefly,	this	algorithm	identifies	pairs	of	genes	whose	relative	expression	changes	with	the	cell	cycle	phase.	The	obtained	data	confirmed	our	biochemical	analysis,	in	which	uninfected	cells	and	cells	at	day	one	and	two	p.i.	are	arrested	in	the	 G0/G1,	 whereas,	 starting	 from	 day	 three	 onwards	 S	 phase	 related	 transcripts	 were	identified,	 which	 is	 in	 line	 with	 our	 findings	 (Fig.	 5	 C;	 Supplementary	 Figure	 4	 in	 the	Appendix).		The	 ten	 genes	 exemplified	 in	 Fig.	 17	 B	 emphasize	 the	 important	 connections	 between	epigenetic	 regulation	 and	 cell	 cycle	 progression.	 Clearly,	 it	 is	 very	 important	 for	 the	 newly	introduced	 EBV	 DNA	 to	 replicate	 and	 to	 acquire	 cellular	 histones	 with	 the	 proper	modifications	to	establish	the	 latent	phase	in	the	infected	and	proliferating	host	cell.	Histone	deposition	 and	nucleosome	 formation	 on	 viral	DNA	will	 be	 discussed	 in	more	details	 in	 the	next	chapter	of	this	thesis	using	a	different	technique	–	MNase-seq.				
3.5.1.3. The presumable functions of non-coding RNAs (ncRNAs) during the first days 
after EBV infection 
 My	 data	 documented	 that	 EBV	 alters	 the	 expression	 of	 cellular	 ncRNAs,	 which	 are	thought	to	play	essential	roles	 in	gene	regulation	at	various	levels	and	to	control	the	cellular	machineries.	ncRNAs	make	up	a	large	group	of	transcripts	that	include	transfer	RNAs	(tRNAs),	ribosomal	RNAs	(rRNAs),	microRNA	(miRNAs),	small	nuclear	RNA	(snRNAs),	small	nucleolar	(snoRNAs),	and	long	non-coding	RNAs	(lncRNAs).	EBV	expresses	its	own	set	of	ncRNAs,	which	consists	of	44	miRNAs,	two	lncRNAs	(EBER1	and	EBER2),	and	a	single	snoRNA.	Viral	miRNAs	have	a	prominent	role	in	viral	immunoevasion	and	the	regulation	of	host	genes	expression.	Interestingly,	 RNA-seq	 data	 that	 defined	 the	 turquoise	 cluster	 of	 genes	 (Fig.	 14	 A)	revealed	GO	terms,	which	are	predominantly	involved	in	ncRNA	processing,	ncRNA	metabolic	
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processes,	 rRNA	 modifications,	 or	 ribonucleoprotein	 complex	 assembly	 (Fig.	 18	 A).	 The	majority	of	these	genes	was	activated	very	early	after	EBV	infection	already	at	day	one	or	two	p.i.	 indicating	that	they	might	have	a	crucial	role	shortly	after	virus	entry.	The	group	of	eight	genes	 displayed	 in	 Fig.	 18	 panel	 B	 comprises	 potential	 viral	 targets	 that	 are	 involved	 in	important	 processes	 mediated	 by	 cellular	 ncRNAs.	 The	 first	 example,	 argonaute	 1	 protein	(AGO1),	is	a	component	of	the	RNA-induced	silencing	complex	(RISC),	which	has	a	function	in	gene	silencing	mediated	by	miRNAs	(Okamura	et	al.,	2004;	Winter	and	Diederichs,	2011).	The	other	depicted	genes	are	also	involved	in	general	RNA	processing	such	as	Exosome	Component	5	(EXOSC5),	which	is	a	non-catalytic	component	of	the	RNA	exosome	complex	participating	in	
Fig.	18.	The	turquoise	GO	cluster	and	examples	of	regulated	genes.		The	plots	were	generated	with	the	workflow	described	in	Fig.	16.		
A. The	scatterplot	displays	many	groups	of	GO	terms	dedicated	to	the	regulation	of	ncRNA	processing,	rRNA	modifications	 and	 translation	 besides	 NIK/NF-kappaB	 signalling	 and	 metabolic	 processes	 involved	 in	heterocycle	synthesis	and	methylation.		
B. The	 bar	 plots	 show	 examples	 of	 dynamically	 regulated	 genes	 in	 the	 turquoise	 cluster	 during	 different	days	 after	 EBV	 infection.	 The	 majority	 of	 these	 genes	 peak	 at	 day	 two	 to	 three	 p.i.	 and	 decrease	thereafter.		maturation	of	many	ncRNA	types	and	degradation	of	defective	transcripts	(Vanacova	and	Stefl,	2007).	ATP-dependent	RNA	helicase	(DDX1)	has	a	role	in	processes	regulating	RNA	secondary	
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structures	to	facilitate	translation	initiation	(Cordin	et	al.,	2006;	Bléoo	et	al.,	2001).	Genes	such	as	BOP1	or	RBFA	are	implicated	in	the	biogenesis	of	eukaryotic	and	mitochondrial	rRNAs	or	in	ribosome-binding	 and	 therefore	 have	 a	 role	 in	 the	 cell	 cycle	 process	 (Hölzel	 et	 al.,	 2005;	Rozanska	et	al.,	2017).	POP1	is	a	Ribonucleases	P/MRP	protein	subunit	localized	and	activated	in	the	nucleus	during	pre-RNA	processing	(Lygerou	et	al.,	1994).	Mitochondrial	RNAs	are	also	altered	 by	 EBV	 infection.	 	 RNA	methyltransferase-like	 protein	 1	 (RNMTL1,	 known	 also	 as	 a	MRM3)	 is	 a	 mitochondrial	 rRNA	 methyltransferase,	 which	 is	 crucial	 in	 the	 biogenesis	 and	function	of	the	large	subunit	of	the	mitochondrial	ribosome	(Rorbach	et	al.,	2014).	The	MRM3	protein	was	recently	found	to	be	manipulated	by	HCMV	to	support	its	replication	(Karniely	et	al.,	 2016).	 EBV	 not	 only	 impairs	 transcription	 or	 modification	 of	 ncRNAs	 but	 also	 splicing	events.	 One	 of	 the	 example	 is	 SF3A3,	which	 is	 the	 Splicing	 factor	 subunit	 3A	 related	 to	 the	broad	aspect	of	mRNA	splicing	(Tanackovic	and	Krämer,	2005).		Obviously,	changes	in	ncRNAs	processing	are	very	important	for	EBV	to	control	the	very	early	phase	of	viral	 infection.	The	virus	may	use	 this	 initial	mechanism	to	alter	downstream	biological	processes.	Recently,	many	reports	have	indicated	that	lncRNAs	might	play	important	roles	 in	 regulating	 the	 virus-host	 cell	 relationship	 including	 epigenetic	 and	 metabolic	processes.	 These	 phenomena	 could	 also	 be	 very	 important	 steps	 in	 establishing	 the	 latent	phase	of	infection,	eventually.		
3.6. Dynamic nucleosome assembly during the first days of EBV infection 
 The	nucleosome	 is	 a	 nucleoprotein	with	 a	 core	 structure,	which	 consist	 of	 an	 octamer	with	 two	molecules	 from	each	of	 the	 four	histone	proteins	H2A,	H2B,	H3,	and	H4.	147	bp	of	DNA	is	wrapped	in	approximately	1.65	turns	around	it	to	form	the	nucleosome.	Nucleosomes	are	separated	by	linker	fragments	with	a	length	of	approximately	80	bp,	which	are	bound	by	linker	 histone	 1	 (H1).	 Nucleosomes,	 DNA	 and	 also	 certain	 RNAs	 create	 a	 highly	 ordered	structure	 called	 chromatin	 (Mondal	 et	 al.,	 2010;	 Luger	 et	 al.,	 1997).	 The	 main	 function	 of	chromatin	 is	 to	 organize	 and	 condense	 the	 long	 genome	 segments	 of	 the	 individual	chromosomes	to	pack	them	into	the	small	volume	of	the	nucleus.	An	additional,	important	role	of	 this	complex	 is	 the	tight	regulation	of	gene	expression.	Nucleosomes	are	physical	barriers	for	many	transcription	factors	and	other	proteins	involved	in	DNA	transcription.	Consequently,	chromatin	 can	 modulate	 gene	 transcription	 through	 the	 regional	 accessibility	 of	 the	nucleosome-bound	DNA.	 Yet	 another	 important	mechanism	 is	 histone	 protein	modifications	
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such	 as	 acetylation,	 methylation,	 phosphorylation,	 and	 others.	 They	 act	 in	 combination	creating	the	so-called	“histone	code”,	which	together	with	numerous	enzyme	complexes	define	the	 status	 of	 gene	 expression	 depending	 on	 cell	 differentiation	 and	 the	 biological	 context	(Jenuwein	 and	Allis,	 2001).	 In	 general,	 the	 acquisition	of	 canonical	 histones	 takes	place	 in	 a	replication-dependent	process	during	the	S	phase	of	the	cell	cycle.	In	contrast,	histone	variants	can	 also	 be	 assembled	 independently	 of	 the	 cell	 cycle	 (Henikoff	 and	 Smith,	 2015).	 Histone	variants	also	play	an	important	role	in	the	alteration	of	the	nucleosomal	structure,	its	stability,	dynamics	and	consequently	gene	expression	(Weber	and	Henikoff,	2014)	When	viruses	with	double-stranded	DNA	genomes	infect	metazoan	cells,	histone	variants	might	also	play	a	role	in	the	 acquisition	 of	 chromatin	 of	 the	 incoming	 viral	 DNA	 during	 latent	 and	 lytic	 infection	(Albright	and	Kalejta,	2016;	Placek	et	al.,	2009).		Little	 is	 known	 about	 nucleosomes	 on	EBV	DNA.	 In	 the	 established	 latent	 phase,	 	 EBV	DNA	 is	 very	 densely	 occupied	 with	 histone	 octamers	 comprising	 mostly	 repressive	modifications	 (Woellmer	 et	 al.,	 2012).	 During	 the	 induction	 of	 the	 lytic	 phase,	 the	 viral	chromatin	 is	very	dynamically	 remodelled	 to	ensure	 the	rapid	and	efficient	expression	of	all	viral	lytic	genes	(Woellmer	and	Hammerschmidt,	2013).	A	single	report	found	a	possible	role	of	the	viral	tegument	protein	BNRF1,	which	can	hijack	a	component	of	the	histone	H3.3	variant	chaperone	 Daxx	 and	 use	 it	 to	 prevent	 loading	 of	 H3.3	 histone	 variant	 onto	 viral	 DNA	 and	therefore	avoid	silencing	of	viral	latent	genes	(Tsai	et	al.,	2014).		One	of	the	goals	of	my	thesis	was	to	study	the	acquisition	of	chromatin	constituents	on	EBV	DNA	and	its	kinetics	during	the	early	phase	of	viral	infection.	I	employed	the	MNase-seq	approach	and	could	identify	and	localize	mononucleosomes	at	fixed	positions	on	viral	DNA	at	certain	 genomic	 loci	 very	 early	 after	 infection.	 I	 also	 observed	 dynamic	 rearrangements	 of	nucleosomes	on	certain	host	genes,	which	might	reflect	alterations	in	gene	expression	during	the	pre-latent	phase	of	EBV	infection.	
3.6.1. MNase-seq experiments identify mononucleosomes on viral DNA very 
early after infection 
 One	of	the	most	common	and	reliable	experiments	to	determine	nucleosome	occupancy	and	positioning	is	the	limited	digestion	of	chromatin	with	micrococcal	nuclease	followed	by	a	high-throughput	 DNA	 sequencing	 technique.	 Micrococcal	 nuclease	 (MNase)	 is	 an	 endo-exonuclease	generating	double-strand	breaks	preferentially	 in	accessible,	hence	nucleosome-free	 DNA	 and	 inter-nucleosomal	 linker	 DNA.	 After	 the	 double-strand	 break,	 the	 enzyme	
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“nibbles”	on	the	DNA	molecule	until	 it	reaches	a	physical	obstruction,	such	as	a	nucleosomal	structure.	Therefore,	it	is	a	reliable	tool	to	analyse	nucleosome	occupancy,	because	MNase	cuts	only	 linker	 fragment	 DNA,	 but	 spares	 nucleosome-bound	 DNA.	 DNA	 wrapped	 around	 the	histone	octamer	 is	 inaccessible	and	protected	 from	digestion.	 In	 the	next	 steps,	nucleosomal	DNA	can	be	isolated	and	identified	using	for	instance	a	next	generation	sequencing	approach.	This	 technique,	 termed	 MNase-seq	 allows	 to	 look	 for	 nucleosome	 occupancy	 or	 even	mononucleosomes	 positioning	 using	 single-base	 resolution	 (Wei	 et	 al.,	 2012;	 Cui	 and	 Zhao,	2012).	 I	 used	my	 infection	model	 to	 examine	 the	 dynamic	 chromatin	 acquisition	 during	 the	first	 eight	 days	 p.i.	with	EBV.	 In	 the	 first	 step,	 I	 briefly	 fixed	 the	 cells	with	 formaldehyde	 to	preserve	 or	 freeze	 the	 protein-DNA	 interactions	 by	 introducing	 covalent	 bounds.	 Chromatin	was	 prepared	 from	 the	 cells	 infected	 for	 the	 indicated	 time	 periods	 and	 digested	with	 pre-adjusted	 concentration	 of	 MNase	 and	 increasing	 time.	 The	 reaction	was	 stopped	 by	 adding	EGTA	to	the	samples.	Digested	chromatin	was	then	de-crosslinked,	protein	was	removed	and	the	DNA	was	 isolated	using	 the	phenol-chloroform	extraction	method.	 Samples	were	 loaded	onto	 an	 agarose	 gel	 to	 analyse	 the	 partial	 digestion	 of	 chromatin	 with	 MNase	 and	 reveal	mononucleosomal	 DNA	 with	 a	 length	 of	 approximately	 147	 bp	 as	 well	 as	 multimers	 of	nucleosomes.	Mononucleosomal	DNA	fragments	were	cut	out	and	purified	 from	agarose	gels	(Fig.	19	A).	As	a	control,	I	used	protein-free	genomic	DNA	from	established	lymphoblastoid	cell	lines	 from	different	 donors.	 Extracted	DNA	was	 sonicated	 to	 obtain	 randomly	 sheared	DNA	fragments	with	a	length	of	approximately	150	bp.	Sonicated	DNA	fragments	were	then	isolated	after	size	fractionation	on	agarose	gels	(Fig.	19	B).	MNase	digested	and	randomly	shared	DNA	fragments	 were	 used	 for	 library	 preparation	 and	 subsequently	 sequenced	 on	 an	 Illumina	platform.	The	paired-end	reads	of	50	bases	were	mapped	to	the	human	and	EBV	genomes	and	mapping	 data	were	 further	 processed	 to	 identify	 nucleosomal	 fragments	 using	 the	DANPOS	Python	package.	At	early	time-points	post	EBV	infection,	detection	of	the	 incoming	EBV	DNA	was	expected	to	be	challenging,	because	only	a	small	fraction	of	the	B	cells	was	thought	to	be	successfully	infected.		Latently	infected	established	B	cell	lines	harbour	several	genomic	copies	of	EBV	DNA	per	cell,	but	the	copy	number	of	EBV	DNA	in	newly	infected	cells	 is	probably	in	the	order	of	one	per	cell.	Limited	MNase	digestions	were	expected	to	decreases	the	molar	concentration	of	viral	DNA	further,	because	we	hypothesized	that	it	is	predominantly	free	of	nucleosomes	and	thus	prone	to	become	degraded.	This	setting	makes	it	difficult	to	ensure	a	sufficient	read	coverage	of	 viral	 DNA	 by	 NGS	 to	 obtain	 sufficient	 number	 of	 reads	 for	mapping	 and	 the	 subsequent	
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bioinformatics	analysis.	In	well-established	LCLs,	the	fraction	of	sequencing	reads	that	mapped	to	the	EBV	genome	was	about	0.1	%,	 in	newly	 infected	B-lymphocytes	 it	was	 in	the	range	of	0.01-0.03	%	of	the	total	numbers	of	reads	(Fig.	20	A).		 Fig.	 19.	 Preparation	 of	 MNase-seq	
samples.	
A. Chromatin	 obtained	 from	 EBV-infected	cells	was	digested	with	1.5	U	of	MNase	for	different	time	periods	(10,	12,	and	 15	 min)	 at	 37	 °C.	 After	 protein	removal	 and	 DNA	 purification,	 samples	were	 separated	 on	 an	 agarose	 gel	 and	visualized	 by	 UV	 light	 after	 ethidium	bromide	 staining.	 Partial	 digestion	 of	chromatin	on	the	agarose	gel	results	in	a	nucleosomal	 ladder.	 Mononucleosomes	with	 a	 length	 of	 about	 150	 bp	 and	multimers	 (di,	 tri	 and	 tetra)	 are	indicated	 on	 the	 right	 side	 of	 the	 panel.	White	 rectangles	 depict	 samples,	 which	were	 excised	 from	 the	 gel,	 purified	 and	used	for	NGS	libraries	preparation.	
B. Protein-free	 genomic	DNA	 from	three	LCL	 samples	 (LCL_32,	 LCL_55	 and	LCL_110)	 were	 prepared	 with	 a	commercial	 kit	 followed	 by	 two	 rounds	of	 phenol-chloroform	 DNA	 extraction.	DNA	samples	were	then	sonicated	for	30,	120,	 and	 240	 min	 in	 10	 min	 intervals	using	 a	 Bioruptor	 instrument.	 Samples	were	loaded	on	agarose	gels	and	sheared	DNA	fragments	of	approximately	150	bp	were	 excised	 (white	 rectangles).	 DNA	fragments	 were	 purified	 and	 used	 for	NGS	 library	 preparation	 as	 described	 in	panel	A.		 Despite	 the	 low	 viral	 coverage,	 it	 was	 possible	 to	 identify	 reads	 that	 indicated	 single	nucleosomes	 on	 EBV	 DNA.	 The	 results	 from	 a	 single	 set	 of	 MNase	 experiments	 and	 three	independent	sonicated	LCL	control	DNAs	are	shown	in	the	Integrative	Genomics	Viewer	(IGV).	Fig.	20	B	visualizes	specific	positions	of	fragments	of	nucleosomal	length	on	EBV	and	cellular	DNA.	EBV	DNA	contains	 several	 regions	with	 repetitive	 sequences	of	various	 lengths,	where	reads	cannot	be	unequivocally	allocated	and	which	appear	to	be	free	of	nucleosomes.	Hence,	these	gaps	are	of	technical	nature,	only.	The	 global	 view	 of	 the	 DANPOS	 results	 revealed	 massive	 changes	 in	 nucleosome	occupancy	on	EBV	DNA	in	the	course	of	viral	infection	(Fig.	20	A,	B).	On	day	0,	the	non-infected	cells,	which	served	as	negative	controls	had	no	reads	on	EBV	DNA	as	expected.	Starting	already	on	day	one	after	infection,	single	nucleosomes	were	present	on	EBV	DNA,	but	with	very	small	
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numbers	of	reads	(Fig.	20	A).	From	day	two	onwards,	mapped	reads	indicative	of	nucleosomes	increased	steadily	 to	 reach	a	stable	 level	at	day	 five	p.i.	On	day	eight	p.i.	 fewer	nucleosomes	were	identified	as	compared	with	the	previous	time	points	of	analysis.	Controls	with	sonicated	DNA	prepared	from	LCLs	showed	higher	numbers	of	reads	that	mapped	to	EBV	DNA.		The	 length	 distribution	 of	 mononucleosomal	 fragments	 were	 determined	 and	 plotted	(Fig.	 21)	 to	 obtain	 quantitative	 and	 qualitative	 data.	 The	 graphs	 confirmed	 my	 previous	observations	that	nucleosomes	on	the	EBV	genome	were	already	detectable	one	day	p.i..	They	increased	considerably	on	day	two	p.i.	to	accumulate	later	during	infection	until	day	five.	The	analysis	of	the	frequency	of	length	distributions	of	the	fragments	clearly	indicated	a	maximum	at	exactly	147	bp	even	at	early	time	points	of	infection	confirming	the	presence	and	identity	of	nucleosomal	DNA	fragments.	In	contrast,	the	sonicated	samples	had	wider	read	distributions	with	a	maximum	frequency	of	 length	about	125	bp,	which	reflects	a	size-selected	but	 rather	random	population	of	DNA	fragments	isolated	from	the	agarose	gels	(Fig.	19	B).	According	to	these	 observations,	 I	 concluded	 that	 the	 sonicated	 samples	 contained	 randomly	 sheared	fragments,	 whereas	 the	 MNase-digested	 DNA	 contained	 fragments	 indicative	 of	mononucleosomes	with	an	expected	length	of	147	bp.	
3.6.2. Kinetics of nucleosome positioning on viral and cellular DNAs 
 My	 MNase	 experiment	 revealed	 that	 the	 assembly	 of	 mononucleosomes	 on	 EBV	 DNA	 was	apparent	 already	 24	 hours	 after	 viral	 infection	 suggesting	 a	 very	 rapid	 process.	 The	nucleosome	density	on	EBV	DNA	of	the	infected	B	cells	increased	further	during	the	next	three	days.	 From	 the	 PhD	work	 of	 Anne	Wöllmer	 in	 our	 lab	we	 knew	 that	 the	 acquisition	 of	 the	nucleosomes	at	the	oriP	locus	of	the	dyad	symmetry	(DS)	element	in	EBV’s	DNA	(Zhou	et	al.,	2005)	took	place	very	early	after	infection.	In	her	work,	which	was	based	on	a	qPCR	approach,	three	 nucleosomes	 accumulated	 gradually	 over	 time	 to	 reach	 a	 stable	 level	 about	 one	week	after	infection.	The	well	described	oriP	element	served	as	a	positive	control	in	my	MNase-seq	experiments	to	identify	exactly	positioned	nucleosomes.		The	mapped	and	normalized	MNase-seq	results	were	further	used	to	accurately	calculate	fragments	 that	can	be	considered	as	nucleosomes.	DANPOS	 is	a	comprehensive,	widely	used	bioinformatic	 pipeline	 (Python)	 that	 allows	 to	 achieve	 a	 significant	 enhancement	 of	nucleosomes	occupancy	and	their	dynamics	of	single-nucleotide	resolution	(Chen	et	al.,	2013).			Evaluated	nucleosome	peaks	after	DANPOS	processing	were	displayed	in	the	IGV	Browser	to	
 3 Results  60 
Fig.	 20. The kinetics	 of	 nucleosome	 acquisition	 on	 EBV	
DNA	in	the	course	of	infection.	MNase-seq	analysis	of	non-infected	cells	and	cells	infected	for	the	indicated	time	intervals	are	shown.	As	a	control,	protein-free	genomic	DNAs	extracted	from	three	different	LCLs	were	sonicated	 to	 yield	 randomly	 shared	 DNA	 fragments	 with	 a	length	 of	 approximately	 150	 bp.	 DNA	 fragments	 of	mononucleosomal	 size	 (about	 147	 bp)	 were	 isolated	 from	agarose	 gels,	 purified,	 and	 used	 further	 to	 prepare	 the	libraries	for	NGS.	All	samples	(a	single	donor	with	seven	time	points	 and	 three	 sonicated	 samples	 from	 different	 donors)	were	paired-end	sequenced	using	the	Illumina	platform	with	a	read	length	of	50	bases.		
	
A. Percentage	of	reads	mapped	on	the	EBV	genome	as	a	function	of	total	read	counts.	At	early	time-points,	the	 percentages	 of	mapped	 viral	 reads	were	 low	but	 they	 increased	 during	 EBV	 infection.	 Reads	 from	randomly	 shared	LCL	DNAs	amounted	 to	0.12	 to	0.16	%	of	EBV	mapped	 reads	of	 the	 total	 sequencing	reads.	
B. A	 snapshot	 of	 the	 IGV	 browser	 window	 with	 the	 entire	 wt	 EBV	 (2089)	 genome	 map.	 The	 first	 track	displays	 an	 annotation	 of	 selected	 viral	 genes.	 The	 next	 seven	 tracks	 represent	 results	 from	mapped	MNase-seq	 samples	 obtained	 from	B	 cells	 from	 a	 single	 donor	 at	 the	 indicated	 day	 p.i..	 The	 last	 three	tracks	show	mapped	sequencing	reads	from	randomly	sonicated	LCL	DNAs.		visualize	 and	 inspect	 certain	 selected	 loci.	Within	 the	 EBV	 genome,	my	MNase-seq	 analysis	confirmed	 that	 the	oriP	 element	was	 occupied	 at	 the	 known	positions	 and	 that	 this	 binding	was	 clearly	 detectable	 within	 24	 hours	 p.i..	 The	 three	 clearly	 and	 accurately	 positioned	nucleosomes	accumulated	further	from	day	two	p.i.	onwards	(Fig.	22	A	and	B).		I	used	this	approach	to	investigate	whether	the	acquisition	of	viral	chromatin	is	a	random	process	or	if	nucleosomes	preferentially	assemble	at	fixed,	specific	loci,	creating	regions	with	nucleosome	 “hot	 spots”.	 It	 seemed	as	 if	nucleosome	positioning	was	not	an	entirely	 random	
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Fig.	21.	Distribution	of	mononucleosomal	fragments	on	EBV	and	cellular	genomes.	
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A. The	 plots	 represent	 the	 read	 length	 distributions	 in	 a	window	of	 50-250	 bps	 (x-axis)	 indicating	 reads	mapped	to	viral	(dark	grey)	and	cellular	genomic	DNA	(light	grey)	calculated	as	the	log10	occurrence	of	mapped	fragments	(y-axis)	within	samples	collected	from	different	days	after	EBV	infection	as	indicated.	The	MNase-digested	 samples	 clearly	 peaked	 exactly	 at	 the	 expected	 length	 of	 mononucleosomal	 DNA	fragments	(about	147	bp),	which	start	to	appear	already	at	day	one	p.i..	Red	lines	indicate	mean	average	and	standard	deviation	of	length	distribution,	the	grey	boxes	contain	basic	statistic	data	on	the	length	of	cellular	and	viral	DNA	fragments.	
B. The	three	graphs	indicated	LCL_32,	LCL_55	and	LCL_110	show	the	fragment	distributions	of	the	control	samples	 after	 sonication	 and	 size	 fractionation.	 Randomly	 shared	 LCL	 DNAs	 exhibited	 a	 wider	distribution	of	fragments	within	the	window	of	50	to	250	bps	with	a	peak	frequency	in	the	range	of	125-135	bps.	
C. Summary	of	the	DNA	fragment	length	distribution	shown	as	boxplots.	The	x-axis	displays	samples	from	different	days	post	 infection	or	sonicated	LCL	samples.	On	the	y-axis,	 the	 lengths	of	DNA	fragments	are	indicated	with	mononucleosomal	fragment	of	147	bp	depicted	as	a	horizontal	line.	Each	box	represents	Inter	Quartile	Range	 (IQR),	which	contains	50	%	of	 the	data,	 the	 top	of	 the	box	 is	defined	as	an	upper	quartile	and	bottom	of	the	box	is	described	as	a	lower	quartile.	The	line	within	a	box	is	a	median	of	IQR.	The	upper	whiskers	define	the	largest	value	within	the	area	described	as	(upper	quartile)	+	1.5	x	IQR	and	lower	whiskers	indicate	the	area	with	the	lowest	values,	which	are	(lower	quartile)	-	1.5	x	IQR.	Outliers	were	 excluded	 from	 the	 plots.	 The	 left	 and	 right	 panels	 represent	 data	 from	 the	 EBV	 and	 the	 cellular	genomes,	respectively.	process.	 Certain	 loci	 acquired	 single	 nucleosomal	 DNA	 structures	 rapidly	 and	 the	 initially	defined	positions	were	maintained	throughout	the	observation	period.		Another	example	shows	an	IGV	snapshot	of	the	EBV	genome	with	the	gene	loci	LMP2A,	BNLF2a	 and	 BNLF2b.	 We	 knew	 from	 our	 unpublished	 data	 that	 a	 prominent	 nucleosome	depleted	 region	 (NDR)	 is	 present	 between	 LMP2A	 and	 BNLF2b	 in	 a	 latently	 infected	lymphoma	B	cell	 line.	This	NDR	at	about	nucleotide	coordinate	176,800	bp	is	obvious	also	in	my	data	(Fig.	22	C).	Flanking	the	NDR,	well-pointed	nucleosomes	become	visible,	which	were	gradually	acquired	starting	from	day	two	p.i.	(Fig.	22	C,	#1,	2	and	3).	The	sonicated	LCL	DNAs	revealed	 mostly	 chaotic	 or	 inconsistent	 random	 fragments	 distribution	 covering	 the	 entire	EBV	 genome,	 which	 supports	 the	 correctness	 and	 specificity	 of	 my	 MNase	 data	 and	 their	interpretation.		The	nucleosome	positioning	on	the	cellular	genome	in	response	to	EBV	infection	was	also	an	 intriguing	 aspect.	 It	was	 not	 clear	 if	 the	 virus	 is	 capable	 of	 altering	 the	 host	 nucleosome	occupancy	 or	 even	 their	 positioning.	 Nucleosomes	 could	 become	 more	 dynamic	 as	 a	consequence	of	viral	infection	and	the	noticed	transcriptomic	changes	or	certain	viral	factors	might	 provoke	 or	 induce	 a	 reorganization	 of	 cellular	 chromatin.	 Regions	 with	 positioned	nucleosomes	in	the	host	chromatin	were	selected	and	shown	in	Fig.	23.	The	CRIP1	 locus	had	very	sharp	and	clear	positions	of	two	nucleosomes	upstream	from	the	TSS	of	the	gene,	but	the	nucleosome	location	at	the	indicated	position	#1	was	inconsistent	during	infection	(Fig.	23	A).	The	analysis	of	the	region	between	two	histone	genes	(Fig.	23	B)	showed	few,	better	organized	
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	Fig.	22.	Visualization	of	positioned	nucleosomes	on	EBV	DNA	at	different	days	after	infection.	The	 normalized	 and	mapped	DNA	 sequencing	 data	were	 analysed	with	DANPOS	 to	 define	 the	 nucleosomes	 and	their	 inspected	positions	 (dashed	grey	 line)	on	 the	viral	 genome.	The	 results	 are	 shown	as	 snapshots	of	 the	 IGV	browser	 looking	 at	 three	 discrete	 regions	 of	 the	wt	 EBV	 (2089)	 genome.	 The	 bars	 indicate	 the	 scale	 of	 a	 single	nucleosome	(150	bp).	
A. The	three	positions	of	individual,	well-described	mononucleosomes	(#1,	#2,	#3)	at	the	DS	element	of	EBV	were	occupied	at	very	early	time-points	p.i	(day	one	and	two).	The	density	of	these	nucleosomes	increased	
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further	during	infection.	The	sonicated	samples	(LCL_32,	LCL_55	and	LCL_110)	did	not	show	these	clearly	defined,	MNase-protected	regions	as	expected.		
B. A	 distant	 view	 of	 the	 dyad	 symmetry	 element	 and	 its	 flanks	 to	 compare	 nucleosome	 positioning	 in	 the	vicinity	of	the	DS	element.	The	nucleosomes	flanking	oriP	((#1,	#2	and	#3)	have	the	highest	and	sharpest	defined	patterns	within	a	region	of	around	3500	bp	of	 the	EBV	genome	compared	to	other	 indicated	but	putative	nucleosomes	(#4,	#5	and	#6).	
C. A	second	example	of	well-defined	and	positioned	nucleosomes	(#1,	#2,	#3)	at	the	LMP2A	and	BNLF2a	loci.	Chromatin	acquisition	increased	gradually	within	the	first	four	to	five	days	p.i..		nucleosomes	(Fig.	23	B,	position	#1,	5)	as	compared	with	other	positions	(Fig.	23	B,	position	#2,	3	and	4),	which	seemed	to	experience	a	loss	or	a	gain	of	nucleosomes	during	late	steps	of	EBV	infection.	 The	 analysis	 of	 the	MYC	 locus	 suggested	 that	 there	 might	 be	 dynamic	 changes	 of	nucleosome	positions	(Fig.	23	C),	but	it	also	appeared	as	if	two	depicted	nucleosomes	of	the	MYC	locus	were	mostly	stable	during	EBV	infection	(Fig.	23	C,	position	#2,	6).		Many	stable	nucleosomes	in	uninfected	B	cells	appeared	to	become	mobile	and	seemed	to	change	their	position	over	time.	(Fig.	23	C,	positions:	#1,	3,	4,	5,	7	or	8).	From	the	three	selected	loci	 in	 the	host	 genome,	 all	 of	 them	displayed	 certain	 changes	 in	 the	nucleosome	positioning.	The	MYC	gene	seemed	to	undergo	many	and	various	nucleosomes	rearrangements,	which	might	be	critical	 for	 its	expression	 regulation	 in	 the	EBV-infected	B	cell.	These	 findings	 suggest	 that	EBV	is	able	to	influence	different	levels	of	the	cellular	processes,	having	also	substantial	role	in	the	epigenetic	landscape	of	the	host	cell.		Summing	up,	this	experiment	helped	me	to	study	the	dynamics	of	nucleosome	occupancy	on	 viral	 DNA	 in	 the	 early	 time	 points	 after	 EBV	 infection.	 It	 appeared	 that	 the	 positions	 of	certain	nucleosomes	on	EBV	DNA	are	pre-defined	at	certain	viral	loci	and	that	there	is	a	gain	of	signal	strength	in	the	course	of	infection.	Acquisition	of	viral	chromatin	seemed	to	start	already	on	the	very	first	day	p.i..	The	mechanism	that	might	trigger	this	process	is	enigmatic	and	needs	to	be	investigated	in	further	experiments,	because	nucleosome	formation	precedes	cellular	DNA	replication	and	hence	the	de	novo	synthesis	of	most	canonical	histones.	It	 is	 necessary	 to	 improve	 the	 significance	 of	my	 results	with	 additional	 biological	 replicates,	since	the	MNase-digested	data	stem	from	a	single	donor,	only.	Biological	replicates	will	help	to	judge	 the	 inconsistent	 behaviour	 of	 the	 sample	 collected	 at	 day	 eight	 after	 infection.	Another	aspect,	which	should	be	considered	is	to	include	additional	time	points	within	the	first	24	hours	after	infection	to	define	the	exact	timing	of	the	onset	of	nucleosome	acquisition	on	EBV	DNA	and	chromatin	rearrangements	in	the	cell. 			
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	Fig.	23.	Visualization	of	nucleosome	positions	at	selected	cellular	loci	during	EBV	infection.	The	normalized	DNA	sequencing	data	were	analysed	with	DANPOS	to	define	the	nucleosomes	and	their	positions	on	the	cellular	genome.		
A. The	 snapshot	 from	 the	 IGV	browser,	which	displays	 three	well-positioned	nucleosomes	upstream	of	 the	
CRIP1	gene.	It	appears	that	there	are	certain	changes	of	nucleosome	positioning	at	location	#1	on	day	one	and	two	p.i.,	but	nucleosomes	at	positions	#2	and	3	were	stable	after	EBV	infection.	The	last	three	tracks	indicate	randomly	distributed	peaks	derived	from	sonicated	DNA	of	LCLs	samples.	
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B. A	more	distant	view	of	possible	nucleosome	positions	 in	 the	genomic	region	between	two	histone	genes	(HIST1H3A	 and	HIST1H4A).	 Most	 of	 the	 nucleosomes	 altered	 their	 positions	 during	 the	 course	 of	 EBV	infection,	only	nucleosomes	#1	and	5	appeared	to	be	stable.		
C. The	 graph	 depicts	 possible	 nucleosomes	 that	 are	 present	 in	 the	 region	 of	 4500	 bp	 encompassing	 the	
CASC11/MYC	genes.	Only	two	nucleosomes	positions	(#2	and	6)	appeared	to	be	stable,	 in	contrast	to	the	other	indicated	nucleosomes	(#1,	3,	4,	5,	7	and	8).		
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4. Discussion 
 
4.1. Scope and aims of my thesis 
 EBV	establishes	 a	 stable	 latent	 infection	 in	 cells	 that	 forms	 a	 long-lasting	 virus-host	 cell	relationship.	In	vitro,	B	cell	infection	with	EBV	transforms	the	B	cell	and	gives	rise	to	infinitely	proliferating	 lymphoblastoid	cell	 lines	(LCLs).	Many	years	of	research	 identified	multiple	viral	factors,	which	mimic	cellular	signalling	processes	supporting	EBV’s	long-term	persistence	in	the	host	 cell	 (Young	and	Rickinson,	2004;	Fields	 et	 al.,	 2007).	EBV	 is	 able	 to	 efficiently	 evade	 the	host	 immune	 responses	 with	 immunoevasive	 cytokine-like	 viral	 proteins	 such	 as	 BCRF1	 or	BNLF2a	and	by	reducing	antigen	presentation	by	a	set	of	viral	miRNAs	(Jochum	et	al.,	2012a;	Albanese	et	al.,	2017).	Infection	with	EBV	promotes	cell	proliferation,	because	most	of	the	viral	EBNA	proteins	bind	several	cellular	transcription	factors	and	induce	cellular	proto-oncogenes.	In	addition,	at	least	two	cellular	receptor	pathways	of	B	cells,	i.e.	CD40	and	BCR,	are	activated	by	LPM1	and	LMP2A,	respectively	(Münz,	2015;	Young,	Arrand	and	Murray,	2007).	Much	is	known	about	the	situation	in	stable	and	latently	EBV-infected	cells,	but	the	initial	events	that	lead	to	B	cell	activation	and	transformation	are	less	well	studied	and	incomplete.		In	my	thesis,	I	focused	on	the	alterations	in	the	host	cell	during	the	early	time-points	after	EBV	infection.	 I	examined	the	kinetics	of	 the	cellular	changes,	which	result	 in	 latently	 infected	and	 immortalized	 B	 cells,	 eventually.	 My	 interest	 was	 also	 on	 epigenetic	 processes,	 which	regulate	viral	and	cellular	chromatin	such	as	nucleosome	acquisition	and	positioning	over	time.	I	 used	 a	 well-established	 in	 vitro	 infection	 model,	 in	 which	 primary	 B	 cells	 obtained	 from	children’s	 adenoid	 biopsies	were	 infected	with	wt	 EBV.	 Uninfected	 samples	 as	well	 as	 seven	samples	of	infected	cells	were	collected	daily	on	day	one	to	five,	eight	and	two	weeks	p.i.,	which	provided	 a	 broad	 view	 of	 the	 changes	 in	 the	 biology	 of	 the	 infected	 cell.	 My	 prime	 interest	focused	 on:	 (i)	 phenotypic	 changes,	 (ii)	 metabolic	 processes,	 (iii)	 global	 transcriptome	alterations,	 and	 (iv)	 nucleosome	 positioning	 during	 the	 first	 days	 after	 EBV	 infection.	 High-throughput	 techniques	 used	 for	 the	 analyses	 of	 gene	 expression	 and	 nucleosome	 acquisition	yielded	 comprehensive	 results,	 which	 were	 confirmed	 by	 additional	 biochemical	 methods.	 I	found	 very	 specific	 and	 compelling	 phenotypes	 of	 the	 infected	 B	 cells	 and	 identified	 key	parameters	of	 their	biology,	which	were	mediated	by	 the	viral	 infection	 in	 the	pre-latent	 and	latent	phases	of	EBV	infection.	
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4.2. Phenotypic and metabolic changes during the first days of viral infection 
 It	is	known	that	EBV	infection	of	primary	B	cells	yields	bulk	or	even	clonal	lymphoblastoid	cell	lines,	but	it	was	not	clear	when	and	how	this	process	initiates	after	EBV	infection.	In	recent	years,	 our	 lab	 has	 investigated	 the	 early	 phenotypes	 of	 primary	 B	 cells	 infected	 with	 EBV,	studying	the	contributions	of	the	known	latent	viral	genes	with	various	virus	mutants.	From	this	study	and	our	published	work	 (Woellmer	et	 al.,	 2012)	we	 learnt	 that	 the	viral	 genes	 that	 are	essential	 in	LCLs	are	dispensable	 in	 the	early	phase	of	 infection,	which	we	 termed	“pre-latent	phase”	(Pich	et	al.,	to	be	published).	Naïve	B	cells	isolated	from	adenoid	tissues	were	very	small,	quiescent	(Fig.	5	A,	B),	and	arrested	in	the	G0/G1	phase	of	the	cell	cycle	(Fig.	5	C).	In	the	course	of	EBV	 infection,	 the	cells	gradually	grew	 in	size	 to	become	substantially	 larger	(Fig.	5	B)	and	more	granular	(Fig.	5	A).	The	infected	cells	reached	the	maximum	of	their	size	on	day	four	p.i.	and	 then	 shrank	 slightly	 to	 a	 stable	 level	 at	 day	 five	 and	 onwards.	 These	 changes	 strictly	correlated	with	differences	in	the	cell	content	at	different	time	points	post	infection.	Protein	as	wells	as	total	RNA	amounts	per	cell	peaked	at	day	four	p.i.	(Fig.	5	D	and	E).	At	this	time	point	the	infected	 cells	 entered	 the	 S	 phase	 of	 the	 cell	 cycle	 and	 initiated	 a	 short	 period	 of	 cellular	hyperproliferation	starting	on	day	five	(Fig.	5	C).	These	observations	are	very	comparable	to	the	cascade	of	events	that	take	place	after	antigen	encounter	or	artificial	activation	of	the	CD3	and	CD28	surface	molecules	of	naïve	T	cells.	Initially,	inactive	T	cells	are	quiescent	and	non-dividing,	but	 require	 the	 cytokines	 IL-7	 and	 IL-15	 for	 their	 survival.	 After	 activation	 the	 cells	 undergo	coordinated	changes	in	their	cell	size	and	rates	of	macromolecules	synthesis	such	as	RNA,	DNA,	or	proteins	and	showed	alterations	 in	the	patterns	of	surface	 immune	receptors	and	adhesion	molecules	(Teague	et	al.,	1993;	Berard	and	Tough,	2002).	T	cells	respond	to	the	engagement	of	their	 T	 cell	 receptor	 (TCR)	 within	 minutes,	 but	 the	 process	 continues	 for	 hours	 afterwards.	Activation	 of	 naïve	 T	 cells	 induces	 not	 only	 their	 intensive	 proliferation	 but	 also	 their	subsequent	differentiation	to	i.e.	effector	or	helper	T	cells.	When	antigen	is	no	longer	available	most	of	 the	activated	T	 cells	undergo	apoptosis,	 but	 a	 small	 fraction	of	 the	 cells	 survives	 and	persists	long-term	as	memory	T	cells	(Pennock	et	al.,	2013).		Changes	 in	 the	 cellular	biomass	 such	as	 cell	 size	 and	 cell	 content	 result	 from	an	altered	metabolism	 of	 the	 host	 cell.	 Many	 reports	 define	 the	metabolic	 changes,	 which	 occur	 during		T	 cells	 activation	 and	 support	 the	 bioenergetically	 demanding	 processes	 of	 their	 growth	 and	proliferation.	 Clearly,	metabolic	 conversions	 determine	 the	 T	 cell	 fate.	 Naïve	 T	 cells	 use	 only	available	 nutrients	 to	 maximize	 energy	 production	 in	 catabolic	 pathways	 such	 as	 oxidative	phosphorylation	(OXPHOS),	whereas	activated	T	cells	use	both	OXPHOS	and	the	Warburg	effect.	
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T	cell	activation	induces	fatty	acid	synthesis	(FAS)	and	supports	high	mitochondrial	activity	and	their	biogenesis	(Ron-Harel	et	al.,	2016;	Almeida	et	al.,	2016).	It	is	also	well-known	that	cancer	cells	 activate	 many	 metabolic	 pathways	 to	 obtain	 rapid	 access	 to	 energy	 and	 molecular	precursors,	which	 are	 essential	 for	 the	 synthesis	 of	 biomolecules	 in	 highly	 proliferating	 cells.	Hallmarks	of	the	metabolism	of	cancer	cells	include	the	increased	transport	and	consumption	of	glucose,	 which	 is	 metabolized	 to	 lactate	 under	 aerobic	 conditions,	 a	 process,	 which	 is	 well	known	as	the	Warburg	effect,	which	is	far	less	efficient	in	ATP	production	than	OXPHOS.	Cancer	cells	have	a	high	glucose	uptake	and	rate	of	glycolysis,	but	they	also	manipulate	FAS	and	engage	glutaminolysis	(DeBerardinis	et	al.,	2008;	Fadaka	et	al.,	2017).		Similarly,	 many	 viruses	 reshape	 the	metabolism	 of	 the	 infected	 cells	 during	 productive	lytic	 infection	 to	 gain	 energy	 and	 materials	 for	 the	 replication	 of	 the	 viral	 genomes,	 their	packaging	 and	 release	 of	 virus	 progeny.	 There	 are	 also	 viruses	 such	 as	 Kaposi	 Sarcoma-associated	 Herpesvirus	 (KSHV)	 that	 manipulates	 the	 cellular	 metabolism	 during	 the	establishment	 of	 its	 latent	 phase	 of	 infection	 by	 increasing	 glucose	 uptake,	 FAS	 and	glutaminolysis	 (Delgado	 et	 al.,	 2010;	 Lagunoff,	 2016).	 In	 EBV-associated	 nasopharyngeal	carcinoma	 (NPC),	 which	 is	 an	 example	 of	 type	 I	 EBV	 latency,	 LMP1	 controls	 the	 cellular	metabolism,	 in	 particular	 glycolysis	 (Xiao	 et	 al.,	 2014).	 My	 experimental	 model	 leads	 to	 a	different	type	of	EBV	latency	(type	III),	which	depends	on	the	expression	of	several	latent	viral	genes	including	LMP1.	Together,	they	govern	important	host	cell	processes,	which	presumably	induce	 also	 cell	 metabolism.	 Interestingly,	 the	 expression	 of	 LMP1	 was	 reported	 to	 be	dispensable	in	the	early	phase	of	infection	prior	to	the	establishment	of	the	latent	phase	(Price	and	Luftig,	2014).	Therefore,	 it	 is	not	 fully	understood	what	metabolic	host	cell	 functions	EBV	induces	 during	 latency	 as	 compared	 with	 the	 pre-latent,	 initial	 phase	 of	 infection.	 Three	scenarios	 in	 the	 latently	 infected	 cells	 could	 argue	 for	 a	 regulation	 of	 the	 cellular	 metabolic	pathways.	 (i)	 Latent	 viral	 infection	 can	 cause	 cellular	 stress,	 to	 which	 the	 cells	 respond	 by	alterations	in	the	cellular	metabolic	pathways.	(ii)	Latently	infected	cells	can	switch	to	the	lytic	productive	 phase,	 which	 requires	 synthesis	 of	 many	 metabolites.	 (iii)	 To	 support	 long-term	persistence	in	the	host	cell,	the	virus	needs	to	modulate	cellular	metabolic	activity.	EBV	seems	to	pursue	third	strategy	by	altering	several	metabolic	pathways.		In	my	PhD	work	I	tracked	changes	in	certain	basic	metabolic	processes	during	the	course	of	EBV	infection.	I	used	samples	from	uninfected	cells	and	daily	collected	samples	of	infected	B	cells	 to	 investigate	 the	uptake	of	 the	glucose	analogue	(2-NBDG)	and	mitochondrial	activation	using	TMRE,	which	 is	 sequestered	by	active	mitochondria.	Similar	 to	 the	uninfected	state,	 the	
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cells	 did	 not	 seem	 to	 be	 highly	 metabolically	 active	 during	 the	 first	 three	 days	 after	 EBV	infection.	The	uptake	of	glucose	analogue	2-NBDG	did	not	differ	(Fig.	7	B	and	8),	nor	did	the	cells	show	 an	 increased	 mitochondrial	 activity	 (Fig.	 6	 and	 7	 A).	 In	 uninfected	 cells	 and	 in	 cells	infected	for	up	to	three	days	TMRE	incorporation	revealed	two	distinct	populations,	TMRE_high	and	TMRE_low	(Fig.	6).	The	TMRE_low	population	was	always	represented	by	small,	probably	quiescent	cells,	which	might	suggest	 that	 they	were	not	 infected	with	EBV	and	were	prone	 to	die.	Alternatively,	 these	cells	could	be	delayed	 in	 their	response	 to	viral	 infection	and	became	fully	 active	 later.	 After	 day	 four	 and	 onwards,	 the	 cells	 grew	 and	 entered	 the	 phase	 of	 rapid	proliferation,	 which	 was	 linked	 to	 the	 strong	 activation	 of	 all	 analysed	 metabolic	 processes.	Around	day	eight	the	TMRE_low	population	was	significantly	reduced,	whereas	the	TMRE_high	cell	 population	 increased	 rapidly	 to	 reach	 a	 level	 at	which	 the	majority	 of	 the	 cells	 had	 fully	active	mitochondria.	A	similar	kinetics	was	observed	analysing	the	uptake	of	glucose	analogue.	After	day	four	the	cells	increased	the	uptake	of	glucose	and	probably	other	nutrients	necessary	for	 the	 intensively	 proliferating	 cells	 (Fig.	 8	 and	 7	 B).	 My	 observations	 revealed	 that	 B	 cell	infection	with	 EBV	 promotes	 substantial	 phenotypic	 changes,	which	 are	 comparable	 to	 those	observed	during	the	activation	of	T	cells.	In	 principle,	 the	metabolic	 phenomena	 in	 activated	 B	 and	 T	 cells	 do	 not	 differ,	 but	 the	timing	does:	antigen	encounter	of	T	cells	induces	the	rapid	proliferation	of	T	cells	within	hours,	but	B	 cells	 infected	with	EBV	 take	 four	days	 to	 enter	 their	proliferating	mode.	The	molecular	differences	are	unknown,	but	seem	to	be	physiological.	Naïve	B	lymphocytes	activated	by	CD40	receptor	engagement	in	combination	with	IL-4	start	to	proliferate	also	about	three	to	four	days	post	 induction,	 although	both	 stimuli	 are	genuine	 signals	 in	B	cells	and	mediated	by	T	helper	cells	during	a	germinal	centre	reaction	(Pich	et	al.,	unpublished	data).			
4.3.  Global changes in the host transcriptome as a consequence of viral infection 
 I	wanted	to	 look	at	global	changes	 in	central	cellular	processes	at	early	time	points	after	EBV	infection.	The	kinetics	and	alterations	in	gene	expression	prior	to	and	after	EBV	infection	were	 investigated	 using	 time-resolved	 RNA-seq	 experiments.	 I	 used	 my	 infection	 model	 and	collected	the	identical	numbers	of	physically	intact,	uninfected,	and	quiescent	B	cells	as	well	as	cells	infected	with	EBV	at	the	indicated	time	points	(Fig.	10)	from	day	one	to	five,	day	eight,	and	day	14.	RNA	was	extracted	from	the	cell	samples	and	used	to	prepare	suitable	libraries	followed	by	NGS	 sequencing.	 The	 sequencing	data	were	 very	 carefully	 controlled	 and	 entered	detailed	
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bioinformatics	analyses.	My	emphasis	in	analysing	the	RNA-seq	data	was	on	the	dynamics	of	the	changes	 triggered	 by	 EBV	 and	 the	 active	 processes	 during	 the	 early	 time	 points	 of	 B	 cell	transformation.	During	stable	 latent	 infection,	 the	cells	are	reprogrammed	by	 the	pathogen	 to	retain	 the	viral	genome	and	successfully	establish	a	long-term	infection.	There	are	many	examples	in	the	literature	 that	 describe	 differences	 that	 occur	 after	 viral	 entry	 altering	 the	 expression	 and	regulation	 of	 protein-coding	 genes	 as	 well	 as	 genes	 encoding	 ncRNAs.	 THP-1	 cells	 latently	infected	with	Human	Cytomegalovirus	 (HCMV)	display	a	 significant	number	of	 genes	 that	 are	assigned	 to	pathways	 involved	 in	 apoptosis,	 inflammatory	 response,	 and	 the	 cell	 cycle,	which	seem	 essential	 during	 infection.	 Additionally,	 many	 known	 and	 newly	 identified	 non-coding	RNAs	were	found	up-	or	downregulated	in	the	HCMV	infected	cells	indicating	their	distinct	roles	during	 the	 latent	 phase	 establishment	 (Zhang	 et	 al.,	 2016;	 Cheng	 et	 al.,	 2017).	 The	 closest	relative	of	EBV,	KSHV	induces	changes	in	the	host	cell	transcriptome	during	the	latent	infection,	which	 are	 very	much	 related	 to	 changes	 observed	 in	 conditions	 of	 hypoxia	 including	 glucose	metabolism	and	ncRNAs	including	human	miRNAs		(Viollet	et	al.,	2017,	2015).		There	 are	 numerous	 reports,	which	 characterize	 the	 changes	 in	 the	 viral	 transcriptome	during	infection	or	in	the	already	established	latent	phase	(Purushothaman	et	al.,	2015;	Sijmons	et	al.,	2014).	The	studies	describe	the	kinetics	and	the	role	of	EBV	genes	during	the	process	of	B	cell	 immortalization	with	a	special	 focus	on	the	genes	encoding	the	EBNAs,	LMPs	and	ncRNAs	(Price	and	Luftig,	2014;	Young	and	Rickinson,	2004;	Humme	et	al.,	2003).	However,	it	is	still	not	fully	 understood	 how	 EBV	 reprograms	 the	 B	 cell	 and	 which/when	 cellular	 pathways	 are	induced,	modified,	or	regulated	by	viral	infection.		
4.3.1. The dynamics of the cellular pathways 
 Studying	 the	 kinetics	 of	 transcriptomic	 changes	 is	 important	 to	 understand	 the		time-related	 interactions	 that	 take	place	between	 the	pathogen	and	 the	host	 cell.	 Interpreting	the	 alterations	 in	 gene	 expression	 of	 the	 infected	 cell	 are	 crucial	 to	 identify	 the	 molecular	components	 and	 biological	 processes	 that	 coordinate	 the	 initial	mechanisms	 supporting	 viral	persistence	 in	 the	 infected	 B	 cell,	 eventually.	 There	 are	 no	 reports	 to	 my	 knowledge	 that	describe	the	kinetics	of	the	host	transcriptome	as	a	response	to	EBV	infection.		The	 PCA	 analysis	 of	 my	 time-resolved	 RNA-seq	 experiments	 suggested	 that	 the	 most	dramatic	variances	exist	between	resting,	uninfected	B	cells	and	cells	infected	with	EBV	(Fig.	12	A,	B).	 	The	distant	position	of	 the	non-infected	compared	with	 the	 infected	samples	 indicated	
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that	 there	 is	 a	 well-defined	 transcriptome	 characteristic	 of	 quiescent	 B	 cells,	 which	 is	immediately	 lost	 upon	 EBV	 infection	 probably	 as	 a	 direct	 response	 to	 viral	 infection	 and	 the	activating	 signals.	 Lymphocytes	 in	 a	 quiescent	 state	 are	non-dividing	 cells	 of	 small	 sizes	with	reduced	 macromolecular	 synthesis	 and	 energy	 requirements	 but	 elevated	 stress	 resistance	(Yusuf	and	Fruman,	2003).	My	data	also	suggest	that	the	quiescence	state	of	the	cells	is	clearly	not	 an	 arbitrary	 transcription	 program,	 but	 is	 actively	 and	well	 controlled.	 There	 are	 several	reports	describing	T	and	NK	cells	and	the	regulation	of	their	resting	states,	but	the	exact	factors	and	 mechanisms	 that	 determine	 the	 state	 of	 quiescent	 B	 cells	 are	 not	 comprehensively	investigated.  My	 PCA	 analysis	 identified	 a	 number	 of	 genes,	 which	 were	 highly	 expressed	 in	 the	uninfected	cells	and	probably	define	the	resting	state	of	naïve	B	cells	(Fig.	12	C).	Certain	genes	have	been	already	described	to	have	a	role	in	maintaining	the	dormant	state	of	B	cells	such	as	
ZBTB16	or	KLF4	 (Fig.	12	C),	which	were	 initially	 identified	 in	murine	and	human	B	cells	 to	be	strongly	 downregulated	 upon	 activation.	 Additionally,	 the	 ectopic	 expression	 of	 KLF4	 and	
ZBTB16	in	proliferating	or	memory	B	cells	lead	to	their	cell	cycle	arrest	in	the	G1	phase	or	their	delayed	entry	into	the	S	phase	and	cell	division	(Yusuf	et	al.,	2008;	Good	and	Tangye,	2007).	The	role	 of	 CXCR4	 was	 suggested	 to	 be	 an	 universal	 control	 switch	 regulating	 the	 quiescence	 in	various	somatic	stem	cells	(Nie	et	al.,	2008).	 In	B	cells,	CXCR4	was	found	to	be	downregulated	upon	different	B	cell	stimulation	factors	such	as	IL-21	or	CD63	(Yoshida	et	al.,	2011).	SOX5	was	recently	 defined	 as	 a	 transcription	 factor	 (TF),	 which	 limits	 the	 proliferation	 of	 B	 cells	 but	promotes	 plasma	 blasts	 differentiation	 (Rakhmanov	 et	 al.,	 2014).	 Thus,	 it	 seems	 that	 EBV	downregulates	a	number	of	cellular	genes	such	as	SOX5	 to	support	B	cell	proliferation	and/or	differentiation.	EBV	must	have	a	special	interest	to	downregulate	certain	factors	that	drive	B	cell	differentiation	to	maintain	the	balance	of	the	virus	and	its	host	cell	and	to	prevent	the	onset	of	the	lytic	phase	of	EBV	or	antibodies	synthesis.	Both	processes,	B	cells	differentiation	to	plasma	cells	and	antibodies	synthesis,	would	be	incompatible	with	EBV’s	latent	phase	of	infection.	It	is	speculative	but	most	 genes,	which	were	 found	 in	 the	green	 cluster	 (Fig.	 15	A)	 and	are	highly	expressed	 in	 uninfected	 B	 cells	 but	 downregulated	 immediately	 after	 EBV	 expression,	 might	predominantly	act	as	“quiescence	factors”	to	maintain	the	resting	state	of	the	B	cells.	Samples	 collected	 from	 EBV-infected	 B	 cells	 at	 different	 time	 points	 after	 infection	contributed	to	variances	defined	by	PC1	(Fig.	12	A,	B).	Clearly,	samples	from	day	one	to	three	differed	 from	 each	 other	 as	 compared	 with	 samples	 collected	 on	 days	 four	 to	 14,	 which	appeared	 as	 an	 almost	 homogenous	 population.	 Genes	 that	 were	 defined	 by	 PC1	 variances	
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encompass	various	genes	with	more	diverse	biological	 functions.	For	example,	PIR	and	SPARC	have	a	role	in	cancer	progression,	whereas	TMEM173	modulates	innate	immune	responses	(Fig.	12	 D).	 There	 is	 also	 a	 prominent	 representative	 of	 lncRNAs,	 LOC643401,	 which	was	 recently	identified	 to	 suppress	p53	expression	 (Li	 et	 al.,	 2017)	 that	might	have	 an	obvious	 role	 in	 the	activation	and	induced	proliferation	of	B	cells.		The	 comparison	 of	 the	 transcriptomic	 profiles	 at	 different	 days	 after	 infection	 was	 an	intriguing	 point	 of	 my	 research.	 I	 wanted	 to	 investigate	 how	 the	 infection	 promotes	 specific	alterations	 in	 the	 host	 gene	 expression	 and	 when	 the	 most	 dramatic	 changes	 in	 the	transcriptomes	 occur.	 I	 applied	 a	 visualization	 tool	 to	 identify	 the	 intersecting	 sets	 using	 the	UpSet	 package	 for	 R	 (Fig.	 24).	 This	 tool	 is	 based	 on	 the	 “set	 theory”	 and	 replaces	 the	 better	known,	conventional	Venn	diagrams	to	visualize	numerous	data	sets	(Lex	et	al.,	2014;	Conway	et	 al.,	 2017).	 The	 UpSet	 tool	 employs	 a	 matrix-based	 layout	 to	 display	 differences	 and	intersections	 from	multiple	 data	 sets.	 I	 identified	 the	 genes	 differentially	 expressed	 between	different	days	post	 infection	using	 the	DESeq2	package	(Love	et	al.,	2014).	Genes	are	called	 if	their	differential	expression	was	found	to	be	statistically	significant	according	to	a	model	used	in	DESeq2	comparing	any	combination	of	two	different	time	points	(days	p.i.).	I	observed	very	specific	 changes	 in	 the	 gene	 expression	 at	 different	 days	 after	 EBV	 infection	 (Fig.	 24).	 The	largest	 group	with	more	 than	 8000	DE	 genes	was	 identified	 comparing	 uninfected	 cells	with	cells	infected	for	one	day	(Day0_1).	The	pairwise	comparison	of	the	following	days	p.i.	(Day1_2,	Day2_3	 etc.)	 identified	 a	 rapid	 decrease	 in	 the	 numbers	 of	 DE	 genes	 over	 time.	 This	 finding	suggested	 that	 the	most	 profound	 changes	 in	 the	 host	 transcriptomes	 occur	within	 24	 hours	post	infection.	I	analysed	the	pairwise	sets	of	DE	genes	 in	more	detail	using	the	UpSet	tool,	 to	visualize	their	intersections.	Briefly,	each	row	of	the	UpSet	plot	shows	the	number	of	DE	genes	from	the	pairwise	 comparison.	The	 columns	 in	 the	matrix	 visualize	 the	 indicated	 intersections	 and	 the	bars	 in	 the	 graph	 depict	 the	 cardinality,	 which	 is	 the	 number	 of	 elements	 in	 a	 given	 set	 of	intersections	(Fig.	24).		The	 viral	 infection	 causes	 a	 profound	 and	 immediate	 shift	 in	 host	 gene	 expression	 and	further	 modulates	 it	 to	 strictly	 control	 the	 biological	 processes	 in	 the	 infected	 cell.	 This	interaction	is	supported	by	the	analysis	shown	in	Figure	24.	Intersections	between	all	data	sets	are	virtually	not	existing,	but	the	UpSet	matrix	points	to	the	early	time	points	after	infection	that	differ	substantially	from	later	time	points.	The	Day0_1	set	of	genes	contained	2163	genes,	which	were	unique	for	this	pairwise	comparison	and	did	not	intersect	with	any	set	of	later	time	points.	
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This	unique	group	of	genes	might	govern	the	switch	from	the	quiescent	to	the	activated	B	cell	state.	The	intersection	between	the	two	comparisons	Day0_1	and	Day1_2	of	DE	genes	displayed	the	second	highest	cardinality	(n=1142)	indicating	that	the	data	sets	are	still	related	in	terms	of	their	 DE	 genes	 (Fig.	 24	 B),	 although	 there	 are	 many	 unique	 genes	 within	 each	 of	 these	 two	comparisons.	Day1_2	and	Day2_3	shared	a	considerable	number	of	DE	genes	(n=329),	but	 the	pairwise	 intersection	of	 later	 time	points	 identified	gradually	 lower	numbers	of	 intersections.	These	results	suggested	that	the	infection	with	EBV	triggers	dynamic	changes	in	the	host	gene	expression	 within	 the	 early	 days	 p.i.	 (day	 one	 to	 four),	 but	 later	 modulations	 of	 the	 host	transcriptome	 were	 less	 extensive.	 It	 seems	 as	 if	 already	 at	 day	 five	 p.i.	 the	 latent	 phase	 of	infection	is	fully	implemented.	
4.3.2. Biological processes identified during B cell transformation 
 Dynamic	 changes	 in	 gene	 expression	 indicated	 that	 various	 biological	 processes	 are	altered	during	the	early	phase	of	EBV	infection.	To	decrease	the	complexity	of	the	RNA-seq	data,	DE	genes	were	grouped	into	sets,	which	displayed	similar	expression	profiles	during	the	course	of	 EBV	 infection.	 I	 observed	 seven	 different	 clusters	 encompassing	 very	 individual,	 time-dependent	patterns	of	gene	expression	(Fig.	14	and	15).	Three	of	the	seven	identified	clusters	showed	 very	 similar	 expression	 pathways	 in	 principle,	 but	 differed	 with	 respect	 to	 the	individual	peaks	of	maximal	gene	expression	(Fig.	14).	Very	specific	biological	processes	were	enriched	in	the	three	individual	clusters.	The	clusters	correlated	perfectly	with	the	phenotypes	I	identified	 with	 my	 different	 techniques	 confirming	 the	 recent	 literature	 (Price	 et	 al.,	 2017;	Hatton	et	al.,	2014).		Cell	proliferation	and	division	were	found	to	be	activated	starting	on	day	three	to	four	p.i.	(Fig.	5	C)	along	with	an	activation	of	cellular	metabolic	pathways	(Fig.	5).	Genes	identified	in	the	red	cluster	referred	to	chromosome	organization,	DNA	replication,	and	cell	division.	Moreover,	this	cluster	represented	genes,	which	are	involved	in	the	chromatin	acquisition	such	as	histone	genes,	histone	chaperones,	and	chromatin	modifiers,	which	might	indicate	important	epigenetic			alterations	including	chromatin	silencing	in	the	cellular	and	perhaps	also	viral	chromatin	at	day	four	p.i.	(Fig.	17).	The	black	cluster	peaked	on	day	three	post	EBV	infection	and	encompassed	a	large	group	of	genes	indicative	of	common	mitochondrial	activities,	respiratory	chain	complex	assembly	 and	 genes	 involved	 in	 the	 glucose	metabolism	 (Fig.	 14	 B	 and	 13).	 These	 processes	likely	are	the	consequences	of	the	high	energy	requirements	of	the	cell	and	correlate	with	the		
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																													Fig.	 24.	 Visualization	 of	 intersecting	 sets	 of	
differentially	 expressed	 genes	 at	 different	
time	points	after	EBV	infection.	
A. The	 three	 Venn	 diagrams	 serve	 only	 as	examples	 to	 illustrate	 the	 syntax	 of	 the	 single	dots	and	 interconnecting	vertical	 lines	 in	panels	B	 and	 C,	 which	 form	 the	 intersection	 matrix.	Paired	 intersections	 are	 depicted	 as	 black	 dots,	grey	dots	indicate	the	sets,	which	are	not	part	of	the	 intersection.	 Black	 lines	 connecting	 two	 or	more	 black	 circles	 indicate,	which	 sets	 are	 part	of	the	intersections.		
B. UpSet	 plot	 with	 the	 numbers	 of	 genes	found	 in	 the	 pairwise	 comparison	 by	 DESeq2,	ranging	 from	 304	 to	 8022.	 Groups	 of	 DE	 genes	obtained	 from	 the	 pairwise	 comparison	(DESeq2)	 as	 indicated	 (Day0_1,	 Day1_2,	 etc.)	formed	seven	sets	in	the	UpSet	matrix,	which	are	depicted	as	black	horizontal	bars	with	 “Number	of	DE	genes”	 to	 indicate	 the	 set	 sizes.	 Each	 row	represents	 a	matrix	 set.	 The	 columns	 show	 the	intersections	depicted	as	areas	 in	 the	schematic	Venn	diagrams	in	the	panel	A.	The	heights	of	the	black	 columns	 emphasize	 the	 cardinality	(number	 of	 elements)	 in	 the	 indicated	intersections.	
C. UpSet	 plot	 with	 the	 same	 input	 sets	 of	data	 as	 panel	 B,	 but	 ordered	 according	 to	 the	cardinality	of	intersections.	
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metabolic	 assays	 (Fig.	 7),	 which	 showed	 significantly	 increased	 glucose	 uptake	 and	mitochondrial	activity	 from	day	 four	p.i	onwards.	Activation	of	cellular	metabolic	pathways	 is	important	during	the	cell	growth	preparing	for	the	subsequent	intensive	cellular	proliferation.	Many	 reports	 identified	 alterations	 in	 the	 metabolic	 transcriptome	 to	 be	 an	 important	 step	during	 viral	 infection.	 For	 example,	 HCMV	 regulates	 the	 expression	 of	 glucose	 transporter	(GLUT4)	 during	 infection,	 induces	 mitochondrial	 biogenesis	 and	 respiration	 presumably	mediated	by	several	viral	factors	(Yu	et	al.,	2011b;	Karniely	et	al.,	2016;	Sanchez	and	Lagunoff,	2015).	The	turquoise	cluster,	which	showed	a	peak	of	gene	expression	at	day	two	p.i.,	 identified	pathways	 in	 ncRNA	 processing	 and	 ribonucleoprotein	 complex	 assembly	 (Fig.	 14	 C	 and	 15).	Genes	 in	 this	 cluster	 were	 involved	 in	 a	 variety	 RNA-coupled	 processes	 such	 as	 pre-RNA	processing,	RNA	helicases,	RNA	methyltransferases,	splicing	factors,	and	exosome	components	needed	for	RNA	degradation	(Fig.	18).	In	the	last	years,	the	research	focus	on	non-coding	RNAs	increased	substantially	and	a	 large	number	of	ncRNAs,	especially	 long	ncRNAs	 (lncRNA)	have	been	 identified	 to	 encompass	 very	 diverse	 and	 essential	 regulatory	 functions	 in	 almost	 all	biological	processes	(Fortes	and	Morris,	2016;	Liu	and	Ding,	2017).	Recently,	several	 lncRNAs	were	found	to	play	a	role	during	viral	infection	introducing	repressive	epigenetic	marks	via	the	PRC	complex	(Flynn	and	Chang,	2014)	or	DNA	methylation	(Zhao	et	al.,	2016),	which	might	both	stabilize	 the	 latent	phase	of	viral	 infection.	 lncRNAs	supposedly	play	a	 role	 in	 regulating	viral	replication	 (Ge	 and	 Lin,	 2014),	 which	 is	 advantageous,	 because	 RNAs	 are	 normally	 not	recognized	by	the	antiviral	mechanisms	and	immune	responses	of	the	host	cell	much	in	contrast	to	 viral	 proteins.	 My	 data	 support	 the	 view	 that	 EBV	 induces	 cellular	 ncRNAs	 and	 RNA	processing	factors	very	early	after	 infection,	which	might	be	crucial	 for	preparing	the	cells	 for	the	subsequent	steps	such	as	hyperproliferation,	metabolic	alterations,	or	epigenome	changes.	Many	 EBV-induced	 ncRNAs,	 which	 I	 found,	 lack	 appropriate	 annotations,	 which	 make	 their	identification	 and	 functional	 analysis	 uncertain.	 More	 work	 is	 needed	 to	 unravel	 their	importance	during	the	pre-latent,	but	also	during	the	latent	phase	of	EBV’s	life	cycle.		My	 RNA-seq	 analysis	 identified	 two	 clusters	 with	 high	 gene	 expression	 in	 non-infected	cells,	which	were	found	to	be	downregulated	during	EBV	infection	(Fig.	15	A	and	B).	In	the	green	cluster,	genes	with	discrete	 functions	 in	cell	differentiation	were	prominent,	whereas	the	blue	cluster	 identified	 a	 group	 of	 genes	 referring	 to	DNA-templated	 transcription.	 EBV	 suppresses	the	 differentiation	 of	 latently	 infected	 B	 cells	 into	 plasma	 cells	 by	 epigenetic	 mechanisms	triggered	by	EBNA3A	and	3C	(Styles	et	al.,	2017).	 In	 this	 recent	report,	EBNA3A	and	EBNA3C	
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can	mediate	 the	removal	of	activation-associated	histone	marks	and	promote	gene	repression	inducing	H3K27me3	marks	via	the	EZH2	component	of	the	PRC2	complex.	Thus,	during	latency,	EBV	can	prevent	B	cell	differentiation	to	favour	long-term	latency	and	enable	virus	persistence.	In	 my	 study,	 I	 observed	 the	 very	 rapid	 and	 early	 downregulation	 of	 several	 cellular	 genes	involved	in	differentiation,	which	might	indicate	the	presence	of	additional	mechanisms,	which	EBV	induces	in	the	newly	infected	B	cells.		The	downregulation	of	cellular	genes	in	the	blue	cluster	point	to	a	viral	function	that	might	repress	 certain	 antiviral	 factors,	 which	 could	 counteract	 B	 cell	 transformation.	 A	 similar	function	was	 reported	 in	productively	HSV-1	 infected	cells.	HSV-1	can	negatively	 regulate	 the	host	RNA	PolII	transcription	in	the	majority	of	cellular	genes,	which	requires	several	immediate	early	 genes	 of	HSV-1	 (Spencer	 et	 al.,	 1997).	 It	 is	 currently	 unclear	 if	 EBV	 factors	 are	 directly	involved	in	transcriptional	repression	of	selected	cellular	genes	and	how	this	mechanism	might	work.		Two	gene	clusters	found	in	my	RNA-seq	data	showed	a	rather	constant	gradual	increase	in	gene	 expression	 as	 a	 response	 to	 EBV	 infection.	 The	 yellow	 cluster	 included	 functions	 with	respect	 to	 type	 I	 interferon	 signalling	 and	 responses	 to	 external	 stimuli,	 the	 brown	 cluster	included	 pathways	 with	 genes	 primary	 involved	 in	 leukocyte	 activation	 (Fig.	 15	 C,	 D).	 EBV	initially	 suppresses	 an	 interferon-mediated	 immunity	 by	 the	 tegument	 protein	 LF2,	 which	interacts	 with	 the	 central	 domain	 of	 interferon	 regulated	 factor	 7	 (IRF7)	 (Wu	 et	 al.,	 2009).	Unpublished	genetic	analysis	from	my	lab	challenge	this	view	but	point	to	viral	miRNAs,	which	regulate	the	interferon	response	in	EBV-infected	B	cells.	On	the	contrary,	it	seems	as	if	LMP-1,	a	latent	 EBV	 protein,	may	 promote	 the	 interferon	 production	 later	 during	 infection,	which	 can	have	 a	 role	 in	 the	 establishment	 of	 the	 latent	 phase	 of	 infection	 (Xu	 et	 al.,	 2006).	 These	processes	nicely	correlate	with	my	RNA-seq	data	and	are	 in	 line	with	 the	reported	kinetics	of	the	 type	 I	 interferon	 signalling	 pathways.	 Infection	 of	 naïve	 B	 cells	 with	 EBV	 leads	 to	 cell	activation	identified	in	the	brown	cluster	(Fig.	15	D),	which	includes	genes	that	promote	cellular	proliferation	and	establishment	of	the	latent	phase	(Calender	et	al.,	1987;	Hatton	et	al.,	2014).	A	recent	 report	covers	alterations	 in	 the	host	 transcriptome	and	proteome	during	KSHV	infection	 and	 identified	 global	 changes	 in	 the	 cellular	 networks	 that	 are	 essential	 for	 virus	latency	 (Sychev	 et	 al.,	 2017).	The	 authors	 identified	 alterations	 in	 approximately	17	%	of	 the	host	transcriptome	and	13	%	of	the	cellular	proteome	that	includes	also	dramatic	changes	in	the	phosphoproteome	 48	 hours	 after	 KSHV	 infection	 of	 endothelial	 cells.	 This	 analysis	 identified	multiple	cellular	pathways	highlighting	the	complexity	of	the	host-virus	interactions.		
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Cell	 activation	mediated	 by	BCR	 or	 TCR	 signalling	 promotes	 a	 large	 set	 of	 transcription	responses	 such	 as	 the	 recruitment	 of	 RNA	 PolII	 to	 promoters,	 the	 acquisition	 of	 H3K4me3	activation	mark,	or	the	binding	of	mutually	exclusive	transcription	factors	to	boost	cellular	gene	expression	(Garruss	and	Fowler,	2015;	Fowler	et	al.,	2015).	The	virus	might	mimic	the	general	processes	 in	 B	 cells	 that	 occur	 during	 activation	 of	 the	 B	 cell	 receptor	 (BCR)	 upon	 antigen	encounter	and	modulate	the	different	steps	during	the	activation	of	the	infected	B	cell	according	to	 its	 requirements.	 This	 can	 be	 achieved	 by	 the	 time-dependent	 expression	 of	 certain	 viral	latent	 genes	 (Price	 and	 Luftig,	 2014),	 which	 might	 have	 a	 role	 in	 regulating	 cellular	 gene	expression.		My	comprehensive	RNA-seq	experiment	allowed	me	to	examine	the	very	dynamic	changes	in	the	biological	processes,	which	EBV	regulates	during	the	early	phase	of	infection.	The	results	are	 summarized	 schematically	 in	 Fig.	 25	 indicating	 that	 the	 virus	 regulates	 the	 majority	 of	cellular	mechanisms	in	a	very	strictly	time-controlled	mode	to	promote	the	establishment	of	the		latent	phase	of	infection.	My	data	provided	a	deep	insight	into	the	transcriptomic	profiles	of	the	host	cell	that	reflect	the	complex	interplay	between	EBV	and	the	infected	B	cell.		
4.4. Chromatin alterations in the course of viral infection - nucleosome 
occupancy and positioning 
4.4.1. Viral chromatin assembly 	EBV	enters	the	B	cell	with	a	naked,	epigenetically	naïve	double-stranded	DNA,	which	in	the	course	 of	 establishing	 the	 latent	 phase	 acquires	 nucleosomes	 with	 mostly	 repressive	modifications	and	gains	a	high	level	of	CpG	methylation	(Woellmer	and	Hammerschmidt,	2013;	Woellmer	 et	 al.,	 2012).	 These	 events	 are	 thought	 to	 be	 essential	 for	 the	 virus	 to	 successfully	persists	in	the	host	cell	and	escapee	from	latency	to	later	induce	the	lytic	phase.	How	and	when	exactly	 EBV	 acquires	 nucleosomes	 is	 neither	 known	 nor	 understood.	 In	my	 PhD	work	 I	 was	interested	 in	 the	 kinetics	 of	 nucleosome	 acquisition	 on	 viral	 DNA	 at	 early	 time	 points	 post	infection.	 Three	 scenarios	 of	 viral	 DNA	 chromatinization	 in	 the	 course	 of	 infection	 appear	plausible:	(i)	The	virus	can	enter	the	cell,	circularizes	its	DNA	and	waits	until	the	cell	will	start	DNA	 replication	 and	 synthesis	 of	 the	 new	 histone	 proteins,	 which	 can	 then	 be	 used	 and	assembled	on	the	viral	genome.	(ii)	The	virus	directly	acquires	histone	variants,	which	can	be	synthesized	 independent	 of	 the	 cell	 cycle	 (Weber	 and	 Henikoff,	 2014)	 and	 uses	 cellular	chaperons	to	deposit	histones	on	viral	DNA,	or	(iii)	the	virus	can	make	use	of	the	relatively	small		
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	Fig.	25.	Schematic	overview	of	seven	discrete	biological	processes	at	early	time-points	after	EBV	infection.	The	 figure	 schematically	 summarizes	 the	 results	 obtained	 from	 RNA-seq	 experiments	 and	 their	 bioinformatic	analyses.	The	x-axis	indicates	the	time	points	(days	p.i.),	whereas	the	y-axis	displays	mean	normalized	expression	values,	 which	were	 used	 in	 the	 clusters	 created	 in	 this	 thesis	 and	 shown	 in	 Fig.	 14	 and	 15.	 The	 coloured	 lines	represent	 the	expression	pathways	of	 the	seven	 individual	clusters	with	 their	arbitrarily	assigned	cluster	names.	The	 ellipses	 point	 to	 the	 peaks	 of	 individual	 cluster	 and	 provide	 the	most	 prominent	 GO	 terms	 of	 the	 depicted	clusters.				pool	 of	 free	 and	 available	 nucleosomes,	 which	 stem	 from	 nucleosome	 eviction	 and	 the	continuous	 exchange	 of	 histones	 during	 cellular	 transcription	 or	 (iv)	 histones	 that	 might	 be	directly	mobilized	by	the	viral	infection	(Adam	et	al.,	2014;	Venkatesh	and	Workman,	2015).		It	is	 evident,	 that	 cells	 infected	with	EBV	start	 their	DNA	replication	at	 the	end	of	day	 three	p.i.	(Fig.	5	C),	which	would	concomitantly	 foster	 the	synthesis	of	new	canonical	histones	 (Lipford	and	Bell,	2001).	It	is	not	clear	how	the	virus	copes	with	this	situation.	Anne	Wöllmer	from	our	lab	 tried	 to	 address	 this	 question	 in	 her	 PhD	 work	 using	 a	 qPCR	 approach	 and	 three	 well-defined	nucleosomes	flanking	EBV’s	dyad	symmetry	(DS)	element	(Zhou	et	al.,	2005).	She	found	that	 the	 three	highly	ordered	and	exactly	positioned	nucleosomes	are	gradually	 assembled	at	around	day	two	to	three	days	post	infection	and	that	this	process	is	completed	within	one	week.		I	 used	 her	 data	 as	 a	 positive	 control	 for	 my	 high-throughput	 MNase-seq	 analysis	 with	freshly	infected	B	cells	collected	at	different	days	after	infection.	I	wanted	to	study	not	only	the	kinetics	of	nucleosomes	assembly	on	viral	DNA,	but	also	 to	understand	 the	mechanism	of	 the	
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initial	 chromatinization	of	 viral	 genes.	 In	my	experiments,	nucleosomal	occupancy	of	 the	EBV	genome	seemed	to	be	a	very	rapid	process,	which	started	already	on	the	first	day	and	gradually	increased	 until	 day	 four	 p.i.	 (Fig.	 20	 B,	 C).	 High	 nucleosome	 occupancy	 correlates	 with	 gene	silencing	(Arvey	et	al.,	2012),	which	is	required	during	latency,	when	the	majority	of	viral	genes	has	to	be	repressed.		My	results	are	in	line	with	published	work	on	nucleosome	acquisition	during	herpesviral	infection.	During	 its	 lytic	 phase	 of	 infection,	HSV-1	 acquires	 histones	 as	 fast	 as	 3	 hours	 p.i.,	 a	process,	which	is	mediated	by	the	Asf1	histone	chaperone	(Oh	et	al.,	2012).	Later	reports	using	this	acute	model	of	lytic	infection	also	identified	differences	in	the	mobilization	of	the	canonical	H3.1	histone	and	the	histone	variant	H3.3.	Initially,	the	histone	variant	H3.3	binds	to	the	HSV-1	genome,	but	histone	H3.1	molecules	are	subsequently	acquired	after	the	initiation	of	HSV-1	DNA	replication	(Conn	et	al.,	2013).	 	This	 finding	suggests	an	 important	role	of	H3.3	histone	 in	 the	very	early	phase	of	HSV-1	infection.	The	rapid	association	of	herpesviral	DNA	with	nucleosomes	seems	 to	 play	 an	 important	 role	 during	 the	 lytic	 as	 well	 as	 latent	 infection	with	 HCMV.	 The	HCMV	 genome	 successively	 acquires	 replication-independent	 and	 replication-dependent	histone	proteins.	Additionally,	both	H3.1	and	H3.3	are	deposited	on	HCMV	DNA	in	both	types	of	infection	indicating	possibly	similar	functions	of	histone	variants	in	regulating	the	expression	of	the	viral	genome	(Albright	and	Kalejta,	2016;	Lee	et	al.,	2011).		Nucleosome	 assembly	 is	 a	 general	 mechanism	 of	 epigenetic	 regulation,	 which	 also	depends	 on	 the	 exact	 nucleosome	 positioning	 on	 the	 DNA	 molecule.	 It	 is	 not	 clear,	 which	mechanisms	 EBV	 employs	 during	 the	 rapid	 chromatinization	 of	 its	 genome:	 (i)	 nucleosome	acquisition	 can	be	 a	 random	process,	which	modulates	 or	 even	 controls	 silencing	 of	 the	 viral	genome	 independent	 of	 the	 exact	 position.	 Alternatively,	 (ii)	 nucleosomes	 might	 be	preferentially	 and	 actively	 positioned	 on	 pre-defined	 viral	 loci	 creating	 so-called	 nucleosome	“hot	 spots”.	 Later	 during	 infection,	 the	 “hot	 spots”	 may	 serve	 as	 platforms	 from	 which	 the	residual	 genome	 is	 organized	 to	 acquire	 chromatin	 and	 to	 complete	 the	 process.	 Using	 my	MNase-seq	 approach,	 I	 was	 able	 to	 identify	 several	 exact	 nucleosome	 positions	 on	 EBV’s	genomic	DNA	(Fig.	22).	Upon	EBV	 infection,	 I	observed	nucleosomal	 footprints	on	certain	 loci	already	on	day	one,	which	became	more	pronounced	and	stronger	in	the	course	of	infection.	The	three	nucleosomes	flanking	the	control	locus	with	the	DS	element	confirmed	that	the	DANPOS	program	can	authentically	and	reliably	identify	nucleosomal	DNA.	These	results	suggested	that	nucleosome	 positioning	 on	 viral	 DNA	 at	 certain	 loci	 take	 place	 at	 specific	 and	 well-defined	positions.	It	seems	as	if	the	localization	of	nucleosomes	is	 important	during	the	early	phase	of	
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infection,	which	warrants	functional	studies	in	the	future	with	better	resolution.	Additionally,	I	found	that	histone	H3.3	protein	levels	are	not	stable	during	different	days	p.i..	The	levels	peaked	around	day	three	together	with	the	histone	variant	chaperones	Daxx	and	HIRA,	which	displayed	the	highest	protein	expression	between	day	 two	and	 four	p.i.	 (Fig.	9).	These	results	support	a	functional	 role	of	 the	histone	H3.3	variant	 in	EBV’s	pre-latent	phase,	but	did	not	explain	how	complete	nucleosomes	form	and	become	deposited	after	the	first	day	of	infection.	The	HIRA	and	Daxx	chaperones	were	identified	as	 important	players	 in	the	acquisition	of	histones	onto	viral	DNA	during	HCMV,	HSV-1	but	also	EBV	infection	(Rai	et	al.,	2017;	Tsai	et	al.,	2014).	Tsai	et	al.	identified	EBV’s	tegument	protein	BNRF1	to	replace	ATRX	and	bind	to	the	Daxx	histone	variant	H3.3	 chaperone	 disrupting	 the	Daxx-ATRX	 complex.	 As	 a	 consequence,	 BNRF1	 is	 expected	 to	interfere	with	silencing	of	viral	 latent	genes,	which	 is	mediated	by	 loading	H3.3	onto	the	viral	genome	in	the	early	phase	of	infection.	BNRF1	thus	seems	to	ensure	the	expression	of	important	viral	 latent	 genes.	 This	mechanism	 appears	 to	 be	 counter-intuitive	 in	 the	 pre-latent	 phase	 of	EBV	infection,	when	most	latent	viral	genes	are	well	expressed	(Supplementary	Figure	4	in	the	Appendix)	but	 it	might	be	 important	 for	 the	virus	 to	escape	 from	 latency	 later.	More	effort	 is	needed	to	investigate	the	function	of	BNRF1	and	its	effect	on	H3.3	binding	on	viral	DNA	in	the	early	days	of	infection.		Nucleosome	assembly	on	DNA	is	the	central	epigenetic	mechanism,	but	post-translational	histone	modifications	also	play	an	important	role	in	the	regulation	of	the	viral	gene	expression	(Bannister	and	Kouzarides,	2011).	Repressive	histone	modifications	are	characteristic	of	latent	herpesvirus	 infections.	For	example,	HCMV	maintains	a	 low-average	histone	occupancy	 in	 the	early	 stages	 of	 infection,	 but	 it	 increases	 further	 during	 infection	 and	 is	 associated	 with	 the	process	 of	 viral	 DNA	 replication	 (Nitzsche	 et	 al.,	 2008).	 Nothing	 is	 known	 about	 histone	modifications	in	the	pre-latent	phase	of	EBV	infection,	indicating	a	neglected	aspect.		 In	my	RNase-seq	analysis,	the	red	cluster	enriched	for	chromatin	organization	processes	peaking	 at	 day	 four	 p.i.,	 which	 does	 not	 correlate	 with	 my	 MNase-seq	 results.	 The	 initial	acquisition	 of	 nucleosomes	 to	 viral	 DNA	 is	 a	 much	 faster	 process	 suggesting	 that	 the	 viral	chromatin	 is	 established	 prior	 to	 cellular	 DNA	 replication,	 which	 begins	 on	 day	 three	 post	infection.	Timing	is	an	essential	component	of	biological	processes.	Viral	genome	circularization,	chromatinization	and	methylation	are	 time-controlled	mechanisms,	which	 are	 very	 important	for	the	viral	persistence	in	the	host	cell	(Fig.	26).					
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	Fig.	26.	Model	of	the	epigenetic	modifications	of	the	EBV	genome	during	the	pre-latent	phase	of	infection.	EBV	enters	the	B	cell	with	a	linear,	epigenetically	naïve	DNA,	which	immediately	circularizes.	It	seems	that	during	the	first	days	p.i.,	the	virus	acquires	nucleosomes	and	probably	also	histone	modifications.	Cytosine	methylation	of	viral	 DNA	 is	 a	 slower	 process,	 which	 is	 completed	 after	 about	 three	 weeks	 p.i..	 Additionally,	 in	 the	 course	 of	infection,	 viral	 chromatin	 acquires	 a	 three-dimensional	 conformation,	 which	 together	 with	 a	 dense	 nucleosome	occupancy	and	specific	histone	modifications	ensure	the	life-long	persistence	of	the	virus	in	the	host	cell	(adapted	from	Buschle,	2017).		
4.4.2. Cellular chromatin rearrangements as a response to viral infection 
 Chromatin	plays	an	important	role	during	the	different	phases	of	viral	 infection,	because	gene	expression	of	both	 the	virus	and	 the	host	cell	are	controlled	by	 the	chromatin	structure,	accessibility,	and	local	chromatin	constituents.	Pathogens	employ	factors	and	mechanisms	that	alter	viral	chromatin	(Knipe	et	al.,	2013).	It	is	still	intriguing	whether	viruses	can	also	modulate	the	 host	 cell	 chromatin,	 which	 might	 result	 in	 the	 activation	 or	 silencing	 of	 specific	 cellular	genes	or	affect	cellular	genes	globally.		Certain	 nucleosomes	 at	 selected	 cellular	 loci	 showed	 early	 dynamic	 changes	 upon	 EBV	infection	 (Fig.	 23).	 There	 are	 very	 stable	 nucleosomes	 at	 specific	 positions	 in	 the	 course	 of	infection,	but	certain	nucleosomes	seemed	to	be	evicted,	shifted	or	even	gained	at	different	time	points	p.i..	These	observations	 suggest	 that	 cellular	nucleosomes	are	 regulated	 in	 response	 to	viral	infection.	A	very	dynamic	nucleosome	mobilization	took	place	at	histone	genes	(Fig.	23	B)	and	 around	 the	 c-Myc	 locus	 (Fig.	 23	 C).	 Changes	 in	 the	 chromatin	 organization	 might	 be	 a	prerequisite	to	allow	the	dynamic	activation	of	cellular	gene	expression	following	the	infection	with	EBV.	My	MNase-seq	 experiments	 have	 to	 be	 repeated	with	more	 biological	 replicates	 to	
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confirm	my	 finding,	 but	 they	 also	 indicate	 that	 additional	 intermediate	 time	points	 should	be	analysed	very	early	after	EBV	infection	at	6	and	12h	p.i..		Viruses	have	developed	mechanisms	to	regulate	cellular	chromatin	by	high	jacking	cellular	enzymes	 and	molecular	machineries	 such	 as	 histone	 acetyltransferases,	 histone	 deacetylases,	and	 chromatin	 remodelling	 components	 (Wei	 and	 Zhou,	 2010).	 HSV-1	 is	 able	 to	 induce	chromatin	 remodelling	 via	 the	 viral	 transactivators	 ICP0	 and	 VP16,	 which	 recruit	 critical	chromatin	modifying	factors	such	as	SNF2h,	BRG/BRM,	or	CHD3.	They	are	involved	in	the	high	dynamics	 of	 viral	 and	 cellular	 chromatin	 in	 HSV-1	 infected	 cells,	 thus	 regulating	 their	 gene	expression	and	DNA	replication	(Conn	and	Schang,	2013;	Arbuckle	and	Kristie,	2014).	Hernando	et	 al.	 identified	 global	 changes	 in	 chromatin	 accessibility	 and	 a	 decrease	 of	 three	 repressive	marks	 (H3K27me3,	 H3K9me3,	 and	 H4K20me3)	 upon	 transformation	 of	 B	 cells	 by	 EBV	(Hernando	 et	 al.,	 2014).	 These	 processes	 are	 specific	 for	 EBV-induced	 B	 cell	 transformation,	because	 the	 stimulation	 of	 resting	 B	 cells	 with	 CD40L	 and	 IL-4,	 which	 promote	 their	proliferation	does	not	cause	a	substantial	decrease	of	heterochromatin	marks.	This	group	also	identified	dynamic	histone	modifications	and	altered	histone	protein	levels	in	the	course	of	EBV	infection	as	well	 as	 local	 changes	 in	 chromatin	 structure	at	 selected	 loci	using	 limited	DNaseI	and	 MNase	 digestions.	 In	 general,	 this	 earlier	 report	 supports	 my	 findings,	 but	 did	 not	investigate	nucleosome	positions	and	the	dynamics	of	chromatin	remodelling	(Fig.	23),	which	is	more	sensitive,	but	requires	more	and	comprehensive	experiments	for	completing	this	task.	B	cell	activation	itself	was	also	identified	to	trigger	global	changes	in	cell	chromatin.	It	was	shown	 recently	 that	 stimulated	 B	 lymphocytes	 can	 decondensate	 chromatin	 via	 different	mechanisms,	 which	 involve	 induced	 global	 acetylation	 and	 ATP-dependent	 de-compaction.	 It	was	 found	 that	 some	 of	 these	 mechanisms	 strictly	 dependent	 on	 c-Myc	 activation	 and	 a	continuous	energy	supply	(Kieffer-Kwon	et	al.,	2017).			 My	MNase-seq	experiments	suggest	that	EBV	triggers	also	changes	in	the	global	cellular	chromatin	 structure.	 Mobilization	 of	 cellular	 nucleosomes	 might	 be	 used	 by	 the	 virus	 to	assemble	 chromatin	 on	 its	 own	 genomic	 DNA	 or	 is	 used	 as	 yet	 another	 level	 of	 regulating	cellular	 gene	 expression	 to	 support	B	 cell	 transformation	 and	 the	 establishment	 of	 the	 latent	phase	of	EBV	infection.	
4.5. Open questions and outlook 
 This	thesis	contributed	to	a	better	understanding	of	the	global	changes	in	the	host	B	cell,	which	 take	place	and	are	 triggered	by	EBV	 infection.	My	experiments	 indicated	 that	 the	virus	
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alters	a	plethora	of	cellular	processes	including	host	cell	metabolism,	the	cellular	transcriptome,	and	 epigenome.	 These	 results	 gave	 rise	 to	 another	 set	 of	 questions,	 which	 have	 to	 be	investigated	and	answered	in	more	detail	in	the	future.	
4.5.1. Which specific metabolic processes are altered during EBV infection? 
 The	 results	 from	 this	 PhD	 thesis	 suggested	 that	 the	 metabolism	 of	 glucose	 and	 the	mitochondrial	 activity	 are	 modulated	 in	 the	 course	 of	 early	 infection	 with	 EBV.	 It	 will	 be	intriguing	 to	 examine	 whether	 EBV	 alters	 other	 metabolic	 processes	 such	 as	 FAS,	 Warburg	effect,	and	glutamine	metabolism	similar	 to	other	viruses	such	as	KSHV	(Delgado	et	al.,	2010;	Sanchez	 et	 al.,	 2017;	 Lagunoff,	 2016)	 or	 whether	 EBV-infected	 and	 activated	 B	 cells	 induce	pathways	 that	 are	 characteristic	 of	 T	 cell	 activation	 (Almeida	 et	 al.,	 2016)	 or	 cancerogenesis	(DeBerardinis	 et	 al.,	 2008;	 Biswal	 et	 al.,	 2017).	 EBV	 might	 trigger	 very	 individual	 metabolic	alterations,	which	are	essential	for	its	persistence	in	the	host	cell.	Additionally,	it	is	not	known	whether	specific	viral	 factors	such	as	EBNA2	or	LMP1	are	 involved	 in	 the	changes	of	 the	host	cell	 metabolism	 or	 whether	 the	 cell	 activation	 mediated	 by	 viral	 infection	 is	 sufficient	 to	modulate	biomolecules	synthesis	and	energy	production.		
4.5.2. Which cellular and viral genes identified in my RNA-seq experiments are 
crucial for the early phase of EBV infection? 
 My	 RNA-seq	 experiments	 identified	 very	 specific	 biological	 pathways,	 which	 were	regulated	during	the	indicated,	early	time-points	after	EBV	infection.	The	aim	of	this	thesis	was	to	look	at	changes,	which	occur	in	the	host	cell	transcriptome,	but	it	is	also	interesting	to	look	at	the	kinetics	of	viral	genes	 in	the	course	of	 the	pre-latent	phase	of	 infection.	The	RNA-seq	data	have	 to	 be	 re-mapped	 to	 a	 newly	 created	 wt	 EBV	 (2089)	 genome,	 which	 will	 provide	 more	reliable	 and	 precise	 information	 about	 time-related	 viral	 gene	 expression.	 This	 will	 help	 to	confirm	existing	data	(Price	and	Luftig,	2014)	and	to	identify	viral	genes,	which	might	be	crucial	at	 certain	 time-points	 during	 viral	 infection.	 In	 addition,	 experiments	 with	 different	 EBV	mutants	can	 identify	 the	viral	 factors	 that	are	essential	and/or	contribute	 to	 the	regulation	of	specific	 host	 genes.	 The	 recent	 development	 of	 single-cell	 transcriptome	 analyses	 will	 likely	increase	 our	 knowledge	 about	 the	 exact	 changes	 and	 cell	 fate	 pathways	 at	 the	 level	 of	 single	cells	(Grimes	et	al.,	2015;	Athanasiadis	et	al.,	2017).	To	confirm	that	the	global	changes	on	the	cellular	transcriptome	are	specific	effects	triggered	only	by	EBV	infection,	the	next	experiments	should	be	conducted	with	additional	controls.	Ex	vivo	 isolated	B	cells	do	not	survive	under	the	
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cell	 culture	 conditions	 for	 more	 than	 48	 hours.	 My	 experiments	 included	 the	 transcriptomic	profiles	of	these	uninfected	B	cells,	but	did	not	consider	the	possibility	that	a	fraction	of	the	B	cells	was	uninfected	on	day	one	or	two	p.i.,	which	is	an	uncertainty	and	needs	to	be	addressed.	The	use	of	samples	comprising	the	transcriptomes	of	the	non-infected	primary	B	cells	cultivated	for	 up	 to	 two	 days	 should	 definitely	 increase	 the	 specificity	 of	my	 results	 and	might	 provide	valuable	new	information	about	the	gene	regulation	of	these	prone	to	die	cells.	
4.5.3. When and where do histone modifications occur on viral DNA during the 
early phase of infection? 
 The	kinetics	of	nucleosome	acquisition	and	assembly	on	EBV	genome	has	to	be	confirmed	and	 refined	 with	 more	 biological	 replicates	 using	 my	 MNase-seq	 approach.	 Additional	 time	points	within	the	first	24	hours	of	infection	at	6	and	12	hours	p.i.	will	allow	to	define	the	exact	start	when	EBV	DNA	becomes	 chromatinized.	 To	 exclude	 a	 possible	 sequence-specific	MNase	bias,	an	additional	control	with	naked	DNA	digested	with	MNase	should	be	included	in	the	next	set	of	experiments.	The	role	of	histone	variants	has	to	be	studied	in	more	detail	 to	confirm	or	refute	published	data	 and	 the	 role	 of	BNRF1	viral	 protein	 in	 the	pre-latent	phase	 (Tsai	 et	 al.,	2014).	The	reported	deposition	of	H3.1	and	H3.3	histones	as	described	for	HSV-1	genomic	DNA,	needs	 to	 be	 revisited	 to	 understand	 the	 modulation	 and	 function	 of	 early	 EBV	 chromatin	(Albright	and	Kalejta,	2016).	Another	interesting	aspect	in	my	infection	model	is	how	and	when	viral	 lytic	 genes	 acquire	 their	 repressed	 state,	 which	 is	 a	 prerequisite	 to	 establish	 the	 latent	phase	and	to	persist	as	a	life-long,	asymptomatic	infection.	Close	to	nothing	is	known	about	this	process,	 which	 likely	 results	 from	 a	 dynamic	 interplay	 of	 the	 cell-mediated	 deposition	 of	repressive	 chromatin	 marks	 (histone	 H3K9	 and	 H3K27	 methylation)	 and	 the	 virally	implemented	modulation	of	histone	modifications	and	nucleosome	remodelling.	
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5. Material 
5.1. Oligonucleotides 
 
NEBNext	 Multiplex	 Oligos	 kit	 for	 Illumina	 (primers	 set	 2)	 used	 for	 library	 preparation	containing:	-	NEBNext	USER	enzyme	and	adaptor	for	Illumina		5’	-/Phos/GATCGGAAGAGCACACGTCTGAACTCCAGTC	/ideoxyU/	ACACTCTTTCCCTACACGACGCTCTTCCGATCT	–	3’	-	Universal	PCR	Primer		5’-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT-3’	-	12	oligos	with	different	barcodes	5’	–	CAAGCAGAAGACGGCATACGAGATTG	/barcode/	GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC-s-T	–	3’	In	this	PhD	work	the	following	oligos	were	used:	13,	14,	15,	16,	18,	19,	20,	22,	23,	25.	
5.2. Plasmids 
 The	two	plasmids,	p509	and	p2670,	were	used	to	induce	EBV’s	lytic	cycle	in	HEK293	2089	cells.	The	 p509	 plasmid	 expresses	 the	 BZLF1	 gene	 under	 the	 control	 of	 the	 CMV	 promoter	(Hammerschmidt	 and	 Sugden,	 1988),	 which	 is	 a	 trigger	 for	 the	 lytic	 phase	 reactivation.	 The	plasmid	p2670	contains	the	BALF4	gene	under	the	CMV	promoter	to	improve	the	virus	progeny	production	and	to	increase	the	virus	titer.	
5.3. Virus supernatants 
 Table	2.	Virus	supernatants	used	to	infect	B	cells	during	this	work.	
 
EBV	
SUPERNATANT	
DESCRIPTION	
2089	 Wild	type	maxi	EBV:	F	plasmid	(pMBO131)	with	eGFP	and	hygromycin	resistance	gene	in	B95-8	DNA.	Virus	supernatant	was	collected	from	the	stably	transfected	HEK293	cells.		
B95-8	 Wild	type	EBV	derived	from	the	marmoset	B-lymphoblastoid	cell	line	(B95-8)	(Miller	et	al.,	1972)	
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5.4. Antibodies 
 Table	3.	The	antibodies	from	different	suppliers	used	in	this	work	are	listed	in	the	table	below.		
 
TARGET	 APPLICATION	 SPECIES	 SUPPLIER	 DILUTION/AMOUNT	
USED	
ANTI-MOUSE	
IgG,	HRP	
WB	 goat	 CellSignaling	(#7076S) 1:10,000	
ANTI-RABBIT	
IgG,	HRP	
WB	 rabbit	 CellSignaling	(#7074S)	 1:10,000	
CD38	 FACS	sorting	 mouse	 eBioscience	(#25-0389-
42)	 70	µl	1:10	dilution/1x10^8	cells	
DAXX WB	 rabbit	 SantaCruz	(#sc-7152)	 1:1,000	
GAPDH	 WB	 mouse	 GeneTex	(#GT239)	 1:10,000	
HIRA	 WB	 rabbit	 Abcam	(#ab20655)	 1:2,000	
HISTONE	H2A.Z	 WB	 rabbit	 Abcam	(#ab4174)	 1:1,000	
HISTONE	H3.3	 WB	 rabbit	 Abcam	(#ab62642)	 1:1,000	
IgD	 FACS	sorting	 mouse	 BD Pharmingen 
(#555778)	 70	µl/1x10^8	cells	
IRDYE	ANTI-
MOUSE	680RD	
WB	 goat	 Licor	(#925-68070)	 1:15,000	
IRDYE	ANTI-
RABBIT	800CW	
WB	 donkey	 Licor	(#925-32210)	 1:15,000	
NAP-1	 WB	 rabbit	 Abcam	(#ab79490)	 1:1,000	
PCNA	 WB	 mouse	 SantaCruz	(#sc-56)	 1:1,000	
ß-ACTIN	 WB	 mouse	 Sigma	(#A5316)	 1:5,000	
 
5.5. Eukaryotic cell lines 
 Table	4.	All	stable	cell	lines	used	during	this	PhD	work	stem	from	the	collection	of	the	Research	Unit	Vectors	group	or	were	derived	from	adenoid	tissue	as	described	below.	
 
NAME	 DESCRIPTION	
B95-8	 Marmoset	lymphoblastoid	cell	line	immortalised	by	EBV	infection	(Miller	et	al.,	1972)		
HEK293	2089	 Human	embryonic	kidney	cell	line	(HEK293)	stably	transfected	with	the	maxi-EBV	plasmid	(p2089)	(Delecluse	et	al.,	1998)		
LCL	 Lymphoblastoid	cell	line	derived	from	B	cell	transformed	with	EBV			
PRIMARY	B	
CELLS	
B	cells	purified	from	human	adenoid	tissue	and	used	for	infection	with	EBV,	different	anonymous	donors		
RAJI	 Human	Burkitt-lymphoma	cell	line,	EBV-positive		
	
ELIJAH	
	EBV-	negative	Burkitt	lymphoma	cell	line	
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5.6. Cell culture media and additives 
 Table	5.	Media	and	media	supplementation	used	for	cultivating	eukaryotic	cell	lines.	
 
MEDIUM	 APPLICATION	 SUPPLIER	
ALPHA-	
THIOGLYCEROLE	
	
Antioxidant	reagent	as	an	additive	to	the	media	 Sigma-Aldrich,	Munich,	Germany	
FETAL	BOVINE	
SERUM	(FBS)	
	
Nutritive	additive	to	the	cell	media	(8%)	 BioSell,	Feuch/Nürnberg,	Germany	
HYGROMYCIN	 Antibiotics	used	for	cell	culture	selection	(for	HEK293	2089	cell	line)	 AppliChem,	Darmstadt,	Germany		
PENICILLIN/	
STREPTOMYCIN	
	
Antibiotics	used	as	an	additive	to	the	media	 Life	technologies	Corporation	(Gibco),	USA	
RPMI-1640	
	
Cell	culture	medium	used	for	cultivation	of	all	cell	lines	used	in	this	PhD	work	 Life	technologies	Corporation	(Gibco),	USA	
	 	 	
SODIUM	
PYRUVATE	
	
Antioxidant	reagent	as	an	additive	to	the	media	 Life	technologies	Corporation	(Gibco),	USA	
SODIUM	
SELENITE	
	
Antioxidant	reagent	as	an	additive	to	the	media	 Sigma-Aldrich,	Munich,	Germany	
TRYPSIN-EDTA	 0.05	%	solution	used	for	cell	dissociation	from	the	cell	culture	dish	 Life	technologies	Corporation	(Gibco),	USA	
 
5.7. Enzymes and other chemicals 
 Table	6.	The	list	of	enzymes	and	other	chemicals	used	in	this	PhD	thesis.	
 
ENZYME/CHEMICAL	 SUPPLIER	
2-NBDG	
	
Thermo	Scientific,	USA	
AGAROSE	
	
Invitrogen,	Karlsruhe,	Germany	
AMERSHAM	ECL	WESTERN	BLOTTING	DETECTION	
REAGENT	
	
GE	Healthcare,	USA	
AMMONIUM	PERSULFATE	(APS)	
	
SERVA,	Heidelberg,	Germany	
BETA-MERCAPTOETAHNOL	 Sigma-Aldrich,	Munich,	Germany	
BOVINE	SERUM	ALBUMIN	(BSA)	 Sigma-Aldrich,	Munich,	Germany	
BRADFORD	SOLUTION	 BioRad,	Munich	
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CIPROBAY	200	 Bayer	Vital,	Leverkusen,	Germany		
CYCLOSPORIN	A	 Sigma-Aldrich,	Munich,	Germany	
DNA	LADDERS	(GENE	RULER	1KB	AND	100	BP	PLUS)	
	
Thermo	Scientific,	USA	
ETHANOL	(ABSOLUTE,	PURE)	
	
Merck,	Darmstadt,	Germany	
ETHIDIUM	BROMIDE	
	
Roth,	Karlsruhe,	Germany	
FICOLL-HYPAQUE	 PAN	Biotech,	Aidenbach,	Germany	
FORMALDEHYDE	 Sigma-Aldrich,	Munich,	Germany	
LIGHTCYCLER	480	SYBR	GREEN	I	MASTER	MIX	
	
	
Roche	Diagnostics,	Unterhaching,	Germany	
MICROCOCCAL	NUCLEASE	(MNASE)	 Sigma-Aldrich,	Munich,	Germany	
MINI	PROTEASE	INHIBITIOR	COCKTAIL	(COMPLETE)	 Roche	Diagnostics,	Unterhaching,	Germany	
NONFAT	DRIED	MILK	POWDER	 AppliChem,	Darmstadt,	Germany	
NP-40	(IGEPAL)	 Sigma-Aldrich,	Munich,	Germany	
PAGE	RULER	PLUS	PRESTAINED	PROTEIN	LADDER	
	
Thermo	Scientific,	USA	
PBS	
	
Biochrome	AG,	Berlin	
POLYETHYLENIMINE	MAX	(PEI	MAX)	
	
Sigma-Aldrich,	Munich,	Germany	
PROTEINASE	K	
	
Roth,	Karlsruhe,	Germany	
RNASE	A	 AppliChem,	Darmstadt,	Germany	
ROTIPHORESE	GEL	A	POLYACRYLAMIDE	(30	%)	
	
Roth,	Karlsruhe,	Germany	
SODIUM	DODECYL	SULFATE	(SDS,	10	%)	
	
SERVA,	Heidelberg,	Germany	
SPERMIDINE	 Sigma-Aldrich,	Munich,	Germany	
SPERMINE	 Sigma-Aldrich,	Munich,	Germany	
TEMED	
	
Roth,	Karlsruhe,	Germany	
TMRE	(MITOSTATUS)	
	
BD	Pharmingen,	USA	
 5 Material  
 
 
90 
TRITON	X-100	
	
Sigma,	Steinheim,	Germany	
TRIZOL	REAGENT	 Thermo	Scientific,	USA	
5.8. Buffers 
 Table	7.	The	list	of	buffers	and	solutions	prepared	and	used	in	this	work.	
 
BUFFER	 COMPOSITION	 APPLICATION	
BLOCKING	
BUFFER	
	
5	%	nonfat	dried	milk	PBS-T		 Western	Blot	
BLOTTING	
BUFFER	(1	X)	
	
25	mM	Tris,	190	mM	glycine,	20	%	methanol	in	H2O		 Western	Blot	
DIGESTION	
BUFFER	
10	mM	Tris	pH	7.5,	15	mM	NaCl,	60	mM	KCl,	0.5	%	NP-40,	1	mM	CaCl2	in	ddH2O	add	fresh:	0.15	mM	Spermine,	0.5	mM	Spermidine	and	1	x	proteinase	inhibitor	cocktail	(Roche)	
MNase	digestion	
FACS	STAINING	
BUFFER	
	
0.5	%	BSA,	2mM	EDTA	in	PBS	 FACS	based	applications,	staining	
FIXATION	
BUFFER	
	
1	%	Formaldehyde,	10	%	FBS	in	PBS		 MNase	experiment	
LAEMMLI	
BUFFER	
2	%	SDS,	100	mM	DTT,	10	mM	EDTA,	10	%	glycerol,	60	mM	Tris/HCl	(pH	6.8),	0.01	%	bromophenol	blue,	1	mM	PMSF	in	H2O	 Western	Blot	
LOADING	
BUFFER	
10	mM	Tris-HCl	(pH	7.5),	60	%	glycerol,	60	mM	EDTA,	Orange	G		 Agarose	gel	electrophoresis	
	
NP-40	LYSIS		
BUFFER	
10	mM	Tris	pH	7.5,	10	mM	NaCl,	3	mM	MgCl2,	0.5	%	NP-40	in	ddH2O	add	fresh:	0.15	mM	Spermine,	0.5	mM	Spermidine	and	1	x	proteinase	inhibitor	cocktail	(Roche)	
	MNase	digestion	
PBS-T	 0.1	%	Tween-20	in	PBS		 Western	Blot	
	
RIPA	BUFFER	
	50	mM	Tris-HCl	pH8.0,	150	mM	NaCl,	0.1	%	SDS,	0.5	%	sodium	deoxycholate,	1	%	NP-40,	supplemented	with	1x	“Complete”	proteinase	inhibitor	cocktail	(Roche)		
	Western	Blot	
RUNNING	
BUFFER	(10	X)	
25	mM	Tris,	190	mM	glycine,	0.1	%	SDS	in	H2O		 Western	Blot	
	
SEPARATION	
GEL	(10	%	OR		
12	%)	
	
	Polyacrylamide	(30	%)	3.3	ml/4.0	ml,	1.66	ml	2M	Tris-HCl	pH	8.9,	66.7	µl	0.5	M	EDTA,	100	µl	10	%	SDS,	70	µl	10	%	APS,	10	µl	TEMED,	in	10	ml	ddH2O	
	Western	Blot	
STACKING	GEL	
(5	%)	
Polyacrylamide	(30	%)	1.34	ml,	1.5	ml	2M	Tris-HCl	pH	6.6,	80	µl	10	%	SDS,	70	µl	10	%	APS,	10	µl	 Western	Blot	
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TEMED,	in	10	ml	ddH2O		
STOP	BUFFER	
	
50	%	(v/v)	0.5	M	EDTA,	50	%	(v/v)	10	%	SDS	 MNase	digestion	
TAE	 40	mM	Tris-acetate,	1	mM	EDTA	in	H2O 	 Agarose	gel	electrophoresis		
TBE	 89	mM	Tris,	89	mM	boric	acid,	2	mM	EDTA,	in	H2O	 Agarose	gel	electrophoresis		
WASH	BUFFER	 10	mM	Tris	pH	7.5,	15	mM	NaCl,	60	mM	KCl,	0.5%	NP-40,	in	ddH2O	add	fresh:	0.15	mM	Spermine,	0.5	mM	Spermidine	and	1	x	proteinase	inhibitor	cocktail	(Roche)	
MNase	digestion	
5.9. Commercial kits 
 Table	8.	Commercial	kits	used	in	this	PhD	work.	
 
KIT	 SUPPLIER	
AGENCOURT	AMPURE	XP,	PCR	CLEAN-UP	 Beckman	Coulter,	Munich,	Germany	
AMERSHAM	ECL	SELECT	WESTERN	BLOTTING	DETECTION	
REAGENT	
	
GE	Healthcare,	USA	
B	CELL	ISOLATION	KIT	II,	HUMAN	
	
Miltenyi	Biotec	GmbH,	Bergisch	Gladbach,	Germany		
ERCC	RNA	SPIKE-IN	MIX	
	
Thermo	Fischer	Scientific,	USA	
NEBNEXT	MULTIPLEX	OLIGOS	FOR	ILLUMINA	(INDEX	
PRIMERS	SET	2)	
New	England	Biolabs,	USA	
NEBNEXT	ULTRA	II	LIBRARY	PREP	KIT	FOR	ILLUMINA	 New	England	Biolabs,	USA	
NUCLEOSPIN	EXTRACT	II	KIT	PCR/GEL	PURIFICATION	KIT	 Machery-Nagel,	Düren,	Germany	
QIAMP	DNA	MINI	KIT	
	
Qiagen,	Hilden	
QUBIT	dsDNA	HS	ASSAY	KIT	
	
Thermo	Fischer	Scientific,	USA	
RIBOZERO	rRNA	REMOVAL	KIT	 Illumina,	USA		
RNAEASY	MINI	KIT	
	
Qiagen,	Hilden	
TRUSEQ	DUAL	INDEX	SEQUENCING	PRIMER	BOX,	PAIR-END	 Illumina,	USA	
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5.10. Software and packages 
 Table	9.	Software	and	packages	used	for	data	analysis.	
 
SOFTWARE	 APPLICATION	 SOURCE	
ANACONDA	
COMMAND	
LINE	CLINET	
1.6.6	
	
Open	source	of	data	science	packages	 Anaconda	Inc.,	USA	https://anaconda.org/	
BD	FACSDIVA	
SOFTWARE	
	
FACS	analysis,	FACS	sorting	 BD	Biosciences,	USA	
BEDTOOLS	
2.25.0	
	
NGS	data	processing	 (Quinlan	and	Hall,	2010),	http://bedtools.readthedocs.io/en/latest/	
BOWTIE	1.1.0	
	
NGS	data	processing	 (Langmead	et	al.,	2009),	http://bowtie-bio.sourceforge.net/index.shtml	
BOWTIE	2.3.3	
	
NGS	data	processing	 (Langmead	and	Salzberg,	2012)	http://bowtie-bio.sourceforge.net/bowtie2/index.shtml	
DANPOS	2.2.2	 A	tool	for	Dynamic	Analysis	of	Nucleosome	and	Protein	Occupancy	by	Sequencing,	Python	package	
(Chen	et	al.,	2013)	https://sites.google.com/site/danposdoc/news	
DESEQ2	
	
NGS	data	processing	and	normalization	 (Love	et	al.,	2014),	https://bioconductor.org/packages/release/bioc/html/DESeq2.html	
dynamicTreeC
ut	1.63	
R	package	for	clusters	visualization	 (Langfelder	et	al.,	2008)	https://cran.r-project.org/web/packages/dynamicTreeCut/index.html	
FASTCLUSTER	
1.1.24	
R	package	for	clustering	 Daniel	Müllner,	https://cran.r-project.org/web/packages/fastcluster/index	
FLOWJO	10.4	
	
FACS	data	analysis	 FlowJo,	USA	
GALAXY	15.10	 NGS	data	processing	 (Afgan	et	al.,	2016),	https://galaxyproject.org/	
GGPLOT2	2.2.1	
	
R	package	for	graphs	construction	 Handley	Wickham,	http://ggplot2.tidyverse.org/reference/	
HOMEBREW	 Installation	helper	 Max	Howell,	https://brew.sh/	
HTSEQ		
(V	0.6.0)	
	
Python	program	to	count	mapped	sequencing	reads		 (Anders	et	al.,	2015)	https://htseq.readthedocs.io/en/release_0.9.1/	
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ILLUSTRATOR	
CS5	
PHOTOSHOP	
CS5	
	
Graphics	design	 Adobe	Systems	Inc.,	USA	
INTEGRATIVE	
GENOMICS	
VIEWER	(IGV)	
2.5.9	
Visualization	of	NGS	data	results	 (Thorvaldsdottir	et	al.,	2013;	Robinson	et	al.,	2011)	http://software.broadinstitute.org/software	/igv/		
MACVECTOR	
15.5	
	
	
Nucleic	acid	visualization,	cloning,	primer	design	 MacVector,	USA	
MENDELEY	
DESKTOP	
1.17.12	
	
Literature	citation	 Mendeley	Inc.,	USA,	https://www.mendeley.com/newsfeed/	
MICROSOFT	
OFFICE	2017	
	
Text,	tables	and	presentation	processing	 Microsoft,	USA	
PRISM	7	
	
Basic	statistics,	graphs	processing		 Graphpad	Software,	USA	
PYTHON	2.7.14	
	
Programing	language	 Python,	https://www.python.org/	
R	VERSION	
3.3.3	
	
Programming	language	for	statistical	computing	and	graphics	 The	R	Foundation,	Austria	https://www.r-project.org/	
RSTUDIO	
VERSION	
1.1.383	
	
Integrated	Development	Environment	for	R	 RStudio	Inc.,	USA,	https://www.rstudio.com/	
SAMTOOLS	
0.1.7	
	
NGS	data	processing	 (Li	et	al.,	2009)	http://samtools.sourceforge.net/	
STAR	ALIGNER	
(V	2.4.2A)	
	
Sequence	reads	alignment		 (Dobin	et	al.,	2013)	https://github.com/alexdobin/STAR/		
UPSETR	 R	package	 (Conway	et	al.,	2017;	Lex	et	al.,	2014)	https://cran.rproject.org/web/packages/UpSetR/README.html	
VENNDIAGRAM	
1.6.18	
R	package				
Hanbo	Chen,	https://cran.r-project.org/web/packages/VennDiagram/index.html	
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5.11. Devices and consumables 
 Table	10.	Special	devices	used	in	this	work	
DEVICE	 SUPPLIER	
BIORUPTOR	STANDARD	SONICATOR	 Diagenode,	Belgium		
CP1000	DEVELOPER	MACHINE	 AGFA	HealthCare	NV,	Belgium	HealthCare	NV,	Belgium		
FACS	CANTO	II,	FACS	FORTESSA,	FACS	ARIA	IIIU	 BD	Bioscience,	USA		
X-RAY	FILMS	 AGFA	HealthCare	NV,	Belgium		
ILLUMINA	HISEQ1500,	ILLUMINA	HISEQ4000	 Illumina,	USA		
LI-COR	ODYSSEY	9120	INFRARED	IMAGING	SYSTEM	 LI-COR,	USA		
MACS	LD	COLUMNS	AND	SEPARATOR	 Miltenyi	Biotec	GmbH,	Bergisch	Gladbach,	Germany		
MINI	PROTEAN	II	TETRA	GEL	ELECTROPHORESIS	
UNIT	
	
Bio-Rad,	Munich,	Germany		
NITROCELLULOSE,	0.45	µM	 Bio-Rad,	Munich,	Germany		
QUBIT	FLUOROMETRIC	QUANTITATION	 Thermo	Fischer	Scientific,	USA		
SHIMADZU	MICROCHIP	ELECTROPHORESIS	SYSTEM	
FOR	DNA/RNA	ANALYSIS	(MCE-202	MULTINA)	
Shimadzu	Group,	Japan	
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6. Methods 
 
6.1. Eukaryotic cell culture methods 
 
6.1.1. Cell culture conditions 
 Eukaryotic	 cell	manipulations	were	 performed	 in	 class	 II	 biosafety	 laminar	 flow	 hoods.	Cells	were	cultured	in	 incubators	at	37	°C	with	95	%	humidity	and	5	%	CO2.	Centrifugation	of	the	 cells	 was	 performed	 at	 300	 g	 for	 10	 min.	 Cells	 were	 cultivated	 in	 RPMI-1640	 medium	supplemented	 with	 8	 %	 FBS,	 100	 µg/ml	 streptomycin,	 100	 U/ml	 penicylin,	 1	 mM	 sodium	pyruvate,	 100	 nM	 sodium	 selenite,	 and	 0.43	 %	 α-thioglyceroles.	 Cells	 were	 counted	 using	 a	haemocytometer	(Neubauer	cell	chamber)	according	to	the	manufacturer’s	instructions.		The	 suspension	 cells	 were	 cultivated	 and	 kept	 at	 an	 average	 density	 of	 5x105	 cells/ml.	HEK293	2089	cells	were	cultured	using	100	µg/ml	of	hygromycin	selection	on	the	13	cm	dishes	until	the	cells	reached	around	80	%	confluency.	In	the	next	step,	the	cells	were	dissociated	from	the	 dish	 using	 a	 Trypsin-EDTA	 0.05	%	 solution	 and	 the	 detached	 cells	 were	 resuspended	 in	fresh	medium.	A	certain	fraction	of	the	cells	was	transferred	to	a	new	dish.		
6.1.2. Freezing and thawing of eukaryotic cells 
 Thawing	 of	 eukaryotic	 cells	 was	 performed	 by	 warming	 a	 frozen	 vial	 to	 37	 °C	 and	immediately	transferring	it	to	50	ml	of	pre-warmed	medium.	Cells	were	pelleted,	resuspended	in	 5	ml	 fresh	medium,	 and	 cultured	 overnight	 in	 the	 incubator.	 The	 next	 day	 the	 cells	 were	transferred	to	fresh	cell	culture	medium	containing	appropriate	antibiotic	for	selection.		To	 freeze	 eukaryotic	 cells,	 cold	 medium	 containing	 20	 %	 FBS	 and	 10	 %	 DMSO	 was	prepared.	Around	5x106	cells	were	collected	for	one	freezing	vial,	the	cells	were	centrifuged	and	resuspended	 in	1	ml	 of	 ice-cold	 freezing	medium.	The	 cell	 suspension	was	 transferred	 to	 the	pre-cooled	vial	and	stored	in	a	freezing-box	at	-80	°C	for	approximately	one	week.	Afterwards,	the	vials	were	transferred	to	a	liquid	nitrogen	tank	for	long	term	storage.	
6.1.3. Extraction of B cells from the adenoid tissue 
 The	adenoid	 tissues	were	 first	 cleaned	with	PBS	and	 then	 transferred	 to	a	 sterile	petri	dish.	In	the	next	steps,	the	adenoids	were	cut	extensively	using	two	sterile	scalpels	and	washed	
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with	2-3	ml	of	PBS.	The	cell	suspension	was	taken	up	with	a	Pasteur	pipette	and	filtered	through	a	100	µm	cell	strainer	into	a	new	falcon	tube.	This	procedure	was	repeated	multiple	times	until	the	adenoid	was	fully	disintegrated	to	 isolate	as	many	cells	as	possible.	The	50	ml	 falcon	tube	with	the	collected	cell	suspension	was	filled	with	PBS	and	centrifuged	at	300	g.	Afterwards,	the	cell	 pellet	 was	 resuspended	 in	 30	 ml	 fresh	 PBS	 and	 supplemented	 with	 0.5	 ml	 defibrinated	sheep	blood	to	deplete	most	of	the	T	cells	from	the	preparation	by	rosetting.	The	prepared	cell	suspension	 was	 loaded	 very	 carefully	 on	 top	 of	 15	 ml	 Ficol	 Hypaque	 to	 obtain	 two	 clearly	separated	phases.	Next,	the	samples	were	centrifuged	at	500	g	for	30	min	with	minimum	break	and	acceleration.	The	cells	were	carefully	collected	from	the	turbid	interphase	and	transferred	to	a	new	falcon	tube,	which	was	 filled	with	PBS.	The	cells	were	washed	with	PBS	three	times,	using	decreasing	centrifugation	speed	(450,	400	and	300	g	for	10	min).	After	the	final	wash,	the	cell	 pellet	 was	 resuspended	 in	 fresh,	 pre-warmed	 medium.	 The	 cells	 were	 counted	 and	immediately	used	for	further	experiment	such	as	cell	sorting	or	MACS	depletion.	
6.1.4. Collecting virus supernatants from the HEK293 2089 cell line 
 One	 day	 prior	 to	 transfection,	 HEK293	 2089	 cells	 were	 seeded	 on	 a	 13	 cm	 dish	 and	cultivated	until	they	reached	70-80	%	confluency.	The	transfection	mix	containing	6	µg	of	p509,	carrying	the	BZLF1	gene,	and	6	µg	of	p2670	with	the	BALF4	gene	in	RPMI	medium	was	mixed	with	PEI	Max	at	a	1:6	ratio.	The	mixed	solution	was	incubated	for	15	min	at	room	temperature	(RT)	and	added	dropwise	onto	the	HEK293	2089	cells.	Prior	this	step,	the	cell	culture	medium	was	replaced	to	fresh	medium	without	hygromycin.	Dishes	with	medium	were	carefully	mixed	and	 incubated	 for	another	 three	days	 in	 the	 incubator.	Afterwards,	 the	supernatants	 from	the	transfected	plates	were	collected	in	falcon	tubes	and	centrifuged	for	8	min	at	300	g	to	remove	cells	 from	 the	 medium.	 Then,	 the	 supernatant	 was	 transferred	 to	 a	 new	 falcon	 tube,	 and	centrifuged	once	more	at	1200	g	for	8	min.	Collected	virus	supernatants	were	stored	at	4	°C	and	used	to	determine	the	virus	concentration	with	Raji	cells	(Material	5.5).	
6.1.5. Collecting virus supernatant from the B95-8 cell line 
 For	 collecting	 EBV	 virus	 stocks,	 the	 B95-8	 cells	 were	 cultivated	 at	 higher	 density.	 A	fraction	of	the	cells	spontaneously	reactivates	the	lytic	phase	and	releases	virus	to	the	medium.	Medium	was	collected	from	the	cells,	centrifuged	two	times	at	300	and	1200	g	for	10	min	and	stored	at	4	°C.			
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6.1.6. Determining the virus titer 
 The	 virus	 titer	 of	 wt	 EBV	 (2089)	 was	 determined	 by	 infecting	 Raji	 cells	 with	 different	amounts	of	 the	virus	stock,	and	GFP-positive	Raji	cells	were	measured	after	 three	days.	1x105	Raji	 cells	 were	 seeded	 onto	 a	 24-well	 plate	 in	 100	 µl	 medium.	 Different	 amounts	 of	 virus	supernatant	were	added	to	the	Raji	cells	and	the	wells	were	filled	up	to	a	total	volume	of	2	ml.	On	the	next	day,	80	%	of	medium	was	removed	from	the	cells	and	replaced	by	fresh	RPMI.	Cells	were	 incubated	 for	another	two	days	and	analysed	with	a	FACS	Cano	for	GFP	expression.	The	Green	Raji	Units	(GRU)	were	calculated	by	considering	the	volume	of	the	added	supernatant,	the	percentage	 of	 the	 GFP-positive	 cells,	 and	 the	 total	 initial	 number	 of	 Raji	 cells	 (𝐺𝑅𝑈 =%	'()	*+,-.-/0	1022,344	% 𝑥 3444	627	62	+8	,9*0:;<.<;. 𝑥105).	GRU	per	ml	indicates	the	concentration	of	virus	in	a	given	sample.	This	titer	will	be	used	to	obtain	a	certain	multiplicity	of	infection	(MOI).		The	titers	of	wt	EBV	(B95-8)	were	obtained	by	a	different	method	performed	by	Dagmar	Pich.	Briefly,	Elijah	cells	were	infected	with	different	amounts	of	virus	supernatant	for	3	hours	at	4	°C	under	rotation	and	later	the	cells	were	stained	with	a	directly	coupled	antibody	directed	against	the	viral	envelop	protein	gp350,	which	binds	to	viral	particles	attached	to	the	cells.	The	fractions	 of	 gp350-positive	 cells	 infected	with	 B95-8	 virus	 stock	 were	 compared	 to	 the	 cells	infected	 with	 2089	 virus	 supernatant	 with	 the	 known	 titer,	 which	 reveal	 as	 a	 calibrated	reference. 
6.1.7. Purification of B cells on MACS columns  
 All	 the	 steps	were	 performed	 on	 ice	 and	with	 pre-cooled	 solutions.	 Cells	 obtained	 from	adenoid	 tissue	 were	 centrifuged	 (300	 g	 for	 10	 min)	 and	 washed	 once	 with	 ice-cold	 FACS	staining	 buffer.	 Samples	 were	 resuspended	 in	 FACS	 staining	 buffer	 in	 400	 μl/108	 cells	 and	100_μl	of	 the	Biotin-Antibody	Cocktail,	 provided	by	 the	B	 cell	 isolation	 kit	 from	Miltenyi,	was	added.	Non-B	 cells	were	 labelled	with	 a	mix	 of	 biotinylated	 antibodies	 directed	 against:	 CD2,	CD14,	 CD16,	 CD36,	 CD43,	 and	 CD235a	 surface	 markers.	 The	 cell	 suspension	 was	 mixed	 and	incubated	 for	 10	min	 on	 ice.	 In	 the	 next	 step,	 300	 μl	 FACS	 buffer	was	 added	 to	 the	 samples	followed	 by	 supplementation	 with	 200	 μl	 of	 anti-Biotin	 MicroBeads.	 The	 samples	 were	incubated	 for	 another	15	min	on	 ice.	Meanwhile,	 the	MACS	Separator	 and	MACS	LD	Columns	were	prepared	according	 to	 the	manufacturer’s	protocol.	Briefly,	 columns	were	placed	on	 the	magnetic	separator	and	pre-incubated	with	5	ml	FACS	staining	buffer	and	afterwards	they	were	loaded	with	the	cell-McroBeads	suspensions.	The	flow	through	containing	unlabelled	B	cells	was	
 6 Methods  
 
 
98 
collected	 and	 stored	 on	 ice.	 Further,	 the	 columns	were	washed	 two	 times	with	 5	ml	 of	 FACS	staining	buffer	and	the	flow	through	was	collected	into	the	pre-cooled	falcon	tubes.	Optionally,	columns	can	be	 removed	 from	 the	magnetic	 separator	and	washed	with	FACS	Staining	Buffer	using	a	column	plunge.	This	fraction	contained	the	labelled	non-B	cells.	Collected	cell	fractions	were	used	for	staining	with	an	appropriate	marker	(e.g.	CD19	for	B	cells)	to	control	the	purity	of	the	B	cell	purification.	Highly	pure	B	cells	were	obtained	by	this	depletion	strategy	were	used	for	my	infection	experiments.	
6.1.8. Primary B cells infection with EBV 
 Infection	 of	 primary	 B	 cells	 was	 performed	 using	 wt	 EBV	 (2089	 or	 B95-8)	 with	 a	multiplicity	of	infection	(MOI)	0.1,	which	refers	to	the	number	of	virions	that	are	added	per	cell.	The	next	day	the	cells	were	centrifuged	(300g	at	RT	for	10	min)	to	remove	unbound	virus	and	resuspended	in	the	fresh	medium.			
6.2. Flow cytometry measurements 
6.2.1. FACS sorting for primary B cells 
 Primary,	 naïve	 B	 cells	 were	 sorted	 using	 a	 FACS	 Aria	 IIIu	 device	 according	 to	 the	instructions	 of	 the	 manufacturer	 to	 get	 pure	 populations	 of	 cells	 with	 our	 staining	 strategy.	Briefly,	the	cells	were	washed	once	and	resuspended	in	FACS	staining	buffer	(chapter	5.8)	to	a	final	 concentration	 of	 1x108	 cells/ml.	 The	 cells	 were	 stained	 using	 fluorophore-coupled	antibodies	against	CD38	and	IgD	(chapter	5.8)	for	60	min	in	the	dark.	The	samples	were	washed	once	 with	 ice-cold	 FACS	 Staining	 buffer	 and	 resuspended	 in	 the	 same	 buffer	 followed	 by	filtration	through	35	µm	cell	strainer	to	obtain	single	cell	suspensions.	Sorting	was	performed	with	a	70	μm	nozzle	(for	primary	B	cells)	and	a	velocity	of	about	8,000	events/second	with	a	sorting	mask	of	“4-way	purity”.	The	gating	criteria	included:	(i)	living	cells,	(ii)	single	cells,	and	(iii)	 CD38-negative	 and	 IgD-positive	 cells.	 The	 cells	 were	 sorted	 to	 obtain	 20	 to	 30	 million	primary,	naïve	B	cells,	which	were	used	for	the	following	experiments.	Daily	sorting	for	infected	B	 cells	was	 performed	using	 the	 100	µm	nozzle	 and	 a	 velocity	 of	 about	 5,000	 events/second	with	the	sorting	mask	of	“4-way	purity”.			
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6.2.2. Staining with TMRE and Annexin V 
 Primary	B	cells	were	purified	using	the	MACS	B	cell	isolation	kit.	5x105	uninfected	B	cells	were	resuspended	in	1	ml	of	fresh	pre-warmed	medium	and	transferred	to	polypropylene	FACS	tubes.	Prepared	cells	were	directly	mixed	with	four	different	concentrations	of	TMRE	(0,	20,	50	and	100	nM).	The	samples	were	incubated	for	30	min	at	37oC	protected	from	light.	In	the	next	steps,	the	cells	were	washed	two	times	with	FACS	buffer	to	remove	the	uncoupled	dye.	Finally,	the	cells	were	resuspended	in	500	µl	Annexin	V	staining	buffer	and	incubated	with	APC-coupled	Annexin	 V	 for	 another	 10	 min	 in	 the	 dark.	 Co-stainings	 were	 measured	 on	 a	 FACS	 Fortessa	machine	 looking	 at	 TMRE	 incorporated	 cells	 in	 the	 PE	 channel	 and	 the	 Annexin	 V	 positive	population	in	the	APC	channel.	Measurements	were	performed	daily	for	the	first	eight	days	after	wt	EBV	(B95-8)	infection	as	described	above	(chapter	6.1.8).	The	experiment	was	performed	in	the	same	way	also	with	LCLs,	which	were	cultured	for	two	weeks	after	infection. 
6.2.3. Glucose analogue uptake analysis using 2-NBDG 
 The	 experiments	 were	 performed	 with	 primary	 B	 cells	 purified	 with	 the	 MACS	 B	 cell	isolation	kit	 (uninfected	 cells	 and	cells	 infected	with	wt	EBV	 (B95-8)	 collected	on	daily	basis:	day	 zero	 to	 day	 five	 and	 day	 eight).	 About	 5x105	 B	 cells	 were	 seeded	 into	 a		24-well	plate	and	resuspended	in	500	µl	of	glucose-free	medium	supplemented	with	1	%	FBS.		Three	 different	 concentrations	 (0,	 20	 and	 50	 µM)	 of	 the	 glucose	 analogue	 2-NBDG	 (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)	 amino]-2-deoxy-D-glucose)	 were	 added	 to	 the	 prepared	samples,	which	were	incubated	for	one	hour.	Afterwards,	the	cells	were	washed	two	times	with	ice-cold	 PBS	 to	 remove	 the	 remaining	 reagent	 from	 the	 medium.	 The	 treated	 samples	 were	resuspended	in	300	µl	ice-cold	PBS	and	measured	directly	on	the	FACS	Fortessa	machine	using	the	FITC	channel.		
6.3. Nucleic acid methods 
 General	nucleic	acid	methods	such	as	phenol/chloroform	extraction	and	DNA	precipitation	with	 ethanol	 or	 DNA	 electrophoresis	 were	 performed	 using	 standard	 laboratory	 protocols	(Sambrook	and	Russell,	2001).	
6.3.1. Genomic DNA purification from eukaryotic cells 
 Genomic	 DNA	 was	 isolated	 from	 eukaryotic	 cells	 by	 using	 the	 QIAamp	 DNA	 Mini	 Kit	(Qiagen)	following	the	manufacturer’s	instructions.	
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6.3.2. DNA purification from agarose gel 
 Purification	of	DNA	from	agarose	gels	was	performed	using	the	NucleoSpin	Extract	II	Kit	(Machery-Nagel)	according	to	the	instructions	in	the	manual.		
6.4.  Time-course RNA-seq experiments 
6.4.1. Sample collection 
 B	 cells	 were	 isolated	 from	 adenoid	 tissues	 and	 sorted	 to	 enrich	 for	 the	 naïve	 B	 cells	population	 as	 described	 above	 (6.1.3	 and	 6.2.1).	 The	 “Day	 0”	 samples	 with	 one	 million	 of	uninfected	 naïve	 B	 cells	 were	washed	 two	 times	with	 PBS	 and	 resuspended	 in	 1	ml	 TRIZOL	reagent	followed	by	snap	freezing	in	liquid	nitrogen.	The	cells	were	stored	for	further	analysis	at	-80	 °C.	 The	 remaining	 sorted	 cells	were	 bulk	 infected	with	wt	 EBV	 (2089)	 using	MOI	 0.1	 (as	described	 in	6.1.7).	 The	 cells	were	 kept	 overnight	 in	 the	 incubator	 at	 a	 final	 concentration	of	around	1x106	cells/ml	supplemented	with	10	µg/ml	Ciprobay	and	0.5g/ml	Cyclosporine	A.	On	the	next	day,	cells	were	spun	down	to	remove	unbound	viral	particles	and	resuspended	in	fresh	medium	with	Ciprobay	and	Cyclosporine	A.	Cells	were	 split	 to	 separated	bottles	 and	kept	 for	different	days	after	infection.	On	a	daily	basis,	the	cells	were	collected	and	resuspended	in	FACS	buffer.	Living	cells	were	sorted	according	to	the	established	gating	strategy	to	obtain	one	million	cells.	 Samples	 were	 washed	 two	 times	 with	 PBS,	 resuspended	 in	 TRIZOL	 reagent	 and	 snap	frozen	in	liquid	nitrogen.	Frozen	cells	were	further	used	for	RNA	extraction.	
6.4.2. RNA isolation, ERCC spike-in addition 
 Total	RNA	extractions	 from	sorted	and	 frozen	samples	(day	zero	to	 five,	day	eight,	and	day	 14)	were	 performed	by	 the	 company	Vertis	 Biotechnologie	AG	 (Lise-Meintner-Straße	30,	85354	 Freising).	 Before	 isolation	 of	 total	 RNA,	 all	 samples	 were	 supplemented	 with	 the	specified	 amounts	 of	 ERCC	 spike-ins	 according	 to	 the	 provided	 manual.	 Briefly,	 after	 the	addition	 of	 ERCC	 spike-in	 controls,	 the	 samples	were	 thawn	 and	mixed	 by	 vortexing.	 200	 µl	chloroform	was	 added	 to	 the	homogenate,	mixed	 and	 centrifuged	with	maximal	 speed	 for	20	min	at	4	°C.	The	aqueous	phase	was	carefully	transferred	to	a	new	sterile	RNase-free	tube	and	combined	with	an	equal	volume	of	100	%	RNA-free	ethanol.	Samples	were	then	loaded	onto	the	RNeasy	columns	and	 total	RNA	extraction	was	performed	using	 the	RNAeasy	Kit	 from	Qiagen	including	DNase	 treatment.	Total	RNA	quality	and	concentrations	were	measured	by	capillary	electrophoresis	using	the	Shimadzu	MultiNA	Electrophoresis	System	for	DNA/RNA	analysis.		
 6 Methods    
 
 
101 
6.4.3. Library preparation and sequencing  
 Preparation	of	sequencing	libraries	was	performed	by	the	company	Vertis	Biotechnologie	AG	(Lise-Meintner-Straße	30,	85354	Freising).	Extracted	total	RNA	samples	were	split	in	two	to	prepare	 two	 types	 of	 libraries:	 i)	 samples	 from	 three	 donors	 were	 used	 for	 polyA	 enriched	libraries,	which	were	primed	with	an	oligo(dT)	primer	 ii)	with	RNA	from	two	of	 three	donors	rRNA	depleted,	random	hexamer	enriched	libraries	were	established.	(i) For	the	preparation	of	polyA	enriched	libraries,	indicated	amounts	of	RNA	were	used	(30	ng	from	Day0,	50	ng	from	Day1,	100	ng	from	Day2	and	200ng	from	samples	collected	at	Day3-5,	8	and	14).	The	 first-strand	cDNA	was	synthesized	using	oligo(dT)	primer.	PolyA	enriched	 cDNA	 samples	 were	 fragmented	 and	 further	 used	 for	 the	 ligation	 of	 Illumina	TruSeq	sequencing	adapters	to	the	5´	and	3	´ends	of	the	cDNA	fragments.	Barcoded	cDNA	samples	 were	 finally	 amplified	 by	 PCR	 using	 a	 proof-reading	 enzyme	 with	 numbers	 of	cycles	 ranging	 from	 15-18.	 The	 primers	 used	 for	 PCR	 amplification	 were	 designed	 for	TruSeq	 Dual-Index	 sequencing	 according	 to	 the	 instructions	 by	 Illumina.	 The	 following	adapter	sequences	flank	the	DNA	inserts:	TruSeq_Sense_primer	i5	Index: 	5'-	AATGATACGGCGACCACCGAGATCTACAC-NNNNNNNN-ACACTCTTTCCCTACACGACGCTCTTCCGATCT-3’		TruSeq_Antisense_primer	i7	Index:	5’-CAAGCAGAAGACGGCATACGAGAT-NNNNNNNN-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3’		(ii) The	 remaining	 RNAs	 samples	 were	 used	 for	 preparing	 the	 rRNA	 depleted,	 random	hexamer	enriched	libraries.	rRNAs	were	depleted	using	the	Ribo-Zero	rRNA	Removal	Kit	GOLD	from	Illumina	according	to	the	manufacturer’s	instructions.	The	recovery	rates	after	rRNA	depletion	were	checked	on	a	capillary	electrophoresis	system	and	calculated	to	be	on	 average	2	%	of	 the	 initial	 rRNA.	 From	 these	 rRNA	depleted	 samples,	 the	 first	 strand	cDNA	 synthesis	was	 performed	using	 a	N6	 randomized	 primer.	 Afterwards	 the	 samples	were	 fragmented	 and	 TruSeq	 adapters	 were	 ligated	 to	 the	 5´and	 3´	 ends	 of	 cDNA	fragments.	Finally,	PCR	amplification	using	a	proof	 reading	enzyme	was	performed	with	15-18	cycles.	Primer	 sets	 for	TruSeq	Dual-Index	 sequencing	were	used	 for	amplification	similar	to	the	ones	used	for	polyA	enriched	libraries.	All	 amplified	 cDNA	 samples	 were	 later	 size	 fractionated	 to	 obtain	 a	 range	 of	 250-600	 bp	fragments	using	a	clean-up	system	from	Agencourt	AMPure	XP	kit.	The	aliquots	of	size	selected	
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cDNAs	were	measured	by	capillary	electrophoresis	to	confirm	the	correct	size	and	to	determine	the	 concentration	 of	 each	 sample.	 The	 prepared	 libraries	 were	 sequenced	 (paired-end,	 100	bases)	 on	 two	 flow	 cells	 of	 the	 Illumina	 HiSeq4000	 platform	 (Institute	 of	 Human	 Genetics,	Helmholtz	Zentrum	München).		
6.4.4. Bioinformatic analysis 
 Mapping	 and	 counting	 of	 the	 sequence	 files	 were	 performed	 with	 the	 help	 of	 Thomas	Schwarzmayr	(Institute	of	Human	Genetics,	Helmholtz	Zentrum	München).		
Mapping	of	the	sequencing	reads		Sequenced	 libraries	 on	 average	 yielded	 about	 15.7	 Gb	 of	 sequences	 per	 sample.	 STAR	aligner	(v	2.4.2a)	with	modified	parameter	settings	(--twopassMode=Basic)	was	used	for	split-read	alignment	against	the	human	genome	assembly	Hg19	(GRCh37)	combined	with	the	human	herpes	virus	v4	wild	type	genome	sequence	(AJ507799	from	GenBank)	and	the	ERCC	spike-in	transcript	 sequences	 (Thermo	Fischer	 Scientific).	 The	UCSC	 knownGene	 annotation	was	 used	together	 with	 the	 human	 herpes	 virus	 v4	 annotation	 (manually	 created	 by	 Dr.	 Takanobu	Tagawa)	to	provide	the	known	exon	boundaries	to	STAR.			
/usr/local/STAR \--runThreadN4\--
genomeDir/genomes/hg19_ebv7/chromosome/STARindex/ \--
readFilesIn<FASTQFILES_R1><FASTQFILES_R2>\-
outFileNamePrefix<OUTPUTFOLDER_PREFIX>\--readFilesCommand zcat \--outSAMtype BAM 
Unsorted \--chimSegmentMin 20 \--twopassMode Basic \--limitOutSJcollapsed 
10000000 \--limitIObufferSize 500000000 \--outSAMattrRGline READGROUPS4BAMFILE \-
-outSAMattributes All 
 
Gene	counting	In	order	to	quantify	the	number	of	reads	mapped	to	the	annotated	genes	the	HTseq-count	(v0.6.0)	program	was	used	with	the	default	settings.		
/usr/local/bin/htseq-count \-f bam \-t exon \-i gene_id \-m intersection-nonempty 
\-r name \--stranded=no <PATHTOBAMFILE> \ucsc_ebv_spikeins.gtf \> 
OUTPUTFILE.htseqcount 	 Before	 testing	 for	 the	 expression	 changes	 across	 the	 eight	 time	 points,	 gene	 expression	values	were	normalized.	Normalization	and	clustering	analysis	were	performed	with	 the	help	and	 expertize	 of	 Dr.	 Antonio	 Scialdone	 (Institute	 of	 Epigenetics	 and	 Stem	 Cells,	 Institute	 of	
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Computational	 Biology,	 Helmholtz	 Zentrum	 München).	 The	 R	 script	 for	 this	 analysis	 with	around	800	lines	of	code	can	be	found	on	the	CD	under	“RNA_seq/RNAseq_clusters_script.R”.			
Quality	control	and	data	normalization	As	a	first	assessment	of	sample	quality,	the	total	number	of	mapped	reads,	the	numbers	of	detected	genes,	 and	 the	 ratio	between	 the	 reads	mapped	 to	 viral	 genes	 and	 those	mapped	 to	endogenous	genes	were	computed.	The	data	were	normalized	for	sequencing	depth	using	size	factors	 (Anders	 and	Huber,	 2010),	which	will	 normalize	 the	 data	 according	 to	 the	 amount	 of	RNA	in	each	sample,	which	correlates	with	cell	size.	After	normalization,	principal	component	analysis	(PCA)	was	performed	on	the	log-transformed	expression	matrix.			
Differentially	expressed	genes	The	DESeq2	R	package	was	used	to	identify	differentially	expressed	genes	between	pairs	of	 samples	 from	 different	 days	 post	 infection.	 Before	 running	 DESeq2,	 low	 expressed	 genes	were	 removed	 by	 excluding	 all	 of	 those	 that	 had	 an	 average	 expression	 of	 lower	 than	 50	normalized	counts.	Next,	all	genes	that	were	statistically	significant	at	a	false	discovery	rate	of	lower	than	0.1	and	had	an	estimated	fold-change	greater	than	2	or	lower	than	0.5	were	selected.	
	
Gene	clustering	Identification	 and	 classification	 of	 genes	 with	 a	 dynamic	 expression	 pattern	 during	 the	time-course	of	infection	were	calculated	using	a	clustering	method.		In	the	first	step,	differentially	expressed	genes	between	all	possible	combination	of	pairs	of	days	were	identified	by	DESeq2.	From	this	analysis,	all	genes	(N=8997)	that	were	significantly	different	in	at	least	one	of	the	comparisons	were	selected	for	further	analytical	steps.		To	classify	these	8997	genes	into	clusters,	a	distance	matrix	between	genes	was	identified	as:		 (1 − 𝜌)/2,	where	𝜌	is	the	Spearman’s	correlation	coefficient	between	pairs	of	genes	across	all	 samples	 (van	 Dongen	 and	 Enright,	 2012).	 Hierarchical	 clustering	 was	 performed	 on	 this	distance	 matrix	 (“hclust”	 function	 in	 R,	 with	 an	 average	 method),	 followed	 by	 the	 dynamic	hybrid	cut	algorithm	(dynamicTreeCut	package,	with	minimum	cluster	size	of	500	and	default	value	of	“deepSplit”	parameter).	The	analysis	resulted	in	seven	clusters	with	specific	expression	patterns	of	cellular	genes	according	to	the	time-course	of	EBV	infection.			
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GO	analysis	The	 list	 of	 genes	 identified	 in	 each	 of	 the	 seven	 gene	 clusters	were	 used	 to	 look	 for	 the	enrichment	 of	 specific	 Gene	 Ontology	 (GO)	 terms	 using	 the	 GOrilla	 online	 tool	 (Eden	 et	 al.,	2009).	Additionally,	 a	 list	of	defined	background	genes	was	used	 to	 increase	 the	specificity	of	the	 enrichment	 analysis.	 The	 background	 genes	 were	 defined	 as	 union	 of	 differentially	expressed	(DE)	genes,	which	were	defined	in	all	pairwise	analyses	by	DESeq2.	For	the	search	of	specific	GO	 terms	 the	p-value	 threshold	was	 set	 to	10-7.	 The	defined	biological	 process	 terms	were	used	 for	 further	analysis	with	 the	REViGO	online	 tool	 (Supek	et	al.,	2011).	The	program	accepts	 long	 lists	 of	 Gene	 Ontology	 terms	 and	 summarizes	 them	 by	 removing	 redundant	 GO	terms.	 I	used	settings,	which	defined	medium	similarity,	database	used	 for	Homo	sapiens	and	SimRel	 as	 a	 default	 setting	 for	 calculating	 the	 semantic	 similarity	 of	 the	 GO	 terms.	 I	 used	 R	scripts	created	by	the	REViGO	tool	to	create	tree	plots	and	scatter	plots	 from	my	enriched	GO	terms.			
Venn	diagram	of	two	types	of	libraries	
	 The	Venn	diagrams	of	the	sets	of	differentially	expressed	(DE)	genes	from	polyA	enriched	library	and	rRNA	depleted	library	were	generated	using	R,	the	script	can	be	found	on	the	CD	under	“RNA_seq/VennDiagramm_script.R”.		
Cell	cycle	phases	prediction	from	RNA-seq	data	The	 analysis	 was	 performed	 by	 Ron	 Fechtner,	 a	 bachelor	 student	 from	 Dr.	 Antonio	Scialdone	using	a	published	algorithm	generated	originally	for	single	cell	sequencing	data.			 To	predict	the	cell	cycle	phase	of	each	RNA-seq	sample,	the	Pairs	algorithm	was	used	as	described	in	(Scialdone	et	al.,	2015)	and	optimized	for	the	data	of	bulk	human	cells	data.	In	brief,	the	method	 identifies	pairs	of	 genes	whose	 relative	expression	change	between	 the	phases	of	the	cell	cycle.	The	proportion	of	marker	pairs	 for	a	given	cell	cycle	phase	within	the	data	was	used	to	assign	scores	for	each	phase,	which	provided	a	prediction	on	the	most	likely	phase	of	the	sample.	The	three	phase	scores	(G1,	S	and	G2M	cell	cycle	phase)	in	the	range	of	0	to	1	describe	how	likely	a	certain	proportion	can	be	expected	by	chance.	By	shuffling	gene	counts	the	actual	proportion	was	compared	to	the	distribution	of	random	proportions.	Samples	with	G1	or	G2M	scores	 above	 0.5	 were	 assigned	 to	 the	 greater	 of	 both.	 If	 both	 were	 below	 0.5,	 S	 phase	 was	assigned.	Originally,	the	algorithm	was	designed	and	used	on	single-cell	RNA-seq	data	generated	
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from	human	embryonic	 stem	cells	 (Leng	et	al.,	2015),	 genes	associated	with	 the	cell	 cycle	GO	term	(GO:0007049)	were	considered	for	this	analysis.			 The	 pairs	 algorithm	 can	 be	 found	 and	 installed	 from	 the	 official	 Python	 Package	 Index	(PyPI)	using	pip	installer: pip install pypairs 
 
UpSet	analysis	of	the	DE	pairwise	comparisons	 	The	plots	were	generated	using	R	with	the	data	from	sets	of	differentially	expressed	genes	from	pairwise	comparisons	from	DESeq2.	The	adequate	R	script	can	be	found	on	the	CD	under	“RNA_se/UpSet_script.R”.		
	
6.5. MNase-seq experiment 
6.5.1. Sample preparation, MNase digestion 
 Uninfected	and	EBV-infected	B	cells	collected	at	certain	days	p.i.	(day	one	to	five	and	day	eight)	 were	 briefly	 fixed	 in	 1	 %	 fixation	 mix	 and	 rotated	 for	 5	 minutes	 at	 RT	 followed	 by	centrifugation	and	washing	with	FACS	staining	buffer.	Prepared	and	fixed	cells	were	sorted	to	obtain	1x106	cells	within	 the	 living	cell	gate	at	 the	day	of	harvest.	 In	 the	next	step,	cells	were	washed	with	cold	PBS.	The	fixed	cell	pellet	was	snap	frozen	and	stored	at	-80	°C.	After	collecting	all	samples,	the	following	steps	were	performed.	Cell	pellets	were	thawn	and	lysed	for	5	min	on	ice	using	600	µl	NP-40	lysis	buffer.	The	samples	were	centrifuged	for	7	min	at	300	g	and	4	°C.	The	pellets	were	washed	with	500	µl	MNase	wash	buffer,	spun	down,	and	finally	resuspended	in	650	µl	MNase	digestion	buffer.	50	µl	of	each	sample	were	taken	as	an	undigested	control	and	1.5	U	of	MNase	enzyme	was	added	to	the	remaining	sample	and	incubated	at	25	°C	for	certain	time	points.	From	this	bulk	reaction,	200	µl	were	collected	at	10	min,	12	min,	and	15	min	directly	into	prepared	 tubes	 with	 25	 µl	 of	 pre-warmed	 Stop	 buffer	 and	 incubated	 for	 another	 5	 min	 to	quench	the	MNase	digestion	reaction.	After	collecting	all	digested	and	undigested	samples,	80	µg	Proteinase	K	was	added	to	each	sample	and	incubated	over	night	at	65	°C.	The	next	day,	40	µg	of	RNAse	A	was	added	to	the	samples	and	 incubated	for	30	min	at	37	°C.	Afterwards,	DNA	was	 purified	 with	 phenol/chloroform,	 precipitated	 with	 ethanol	 and	 sodium	 acetate	 and	resuspended	in	TE.	The	samples	were	loaded	quantitatively	on	a	2	%	TAE	agarose	gel	to	purify	the	mononucleosomal	DNA.	Fragments	with	 the	 length	of	150	bp	were	excised	 from	 the	gels,	purified	 using	 the	 NucleoSpin	 Extract	 II	 Kit	 from	 Machery-Nagel,	 and	 resuspended	 in	 20	 µl	
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elution	buffer.		For	 the	preparation	of	 the	 sonicated	 samples,	 one	million	of	well-established	LCLs	 from	three	different	donors	 (LCL32,	LCL55,	 and	LCL110)	were	used	 to	 extract	 total	DNA	using	 the	QIAamp	DNA	Mini	 Kit.	 To	 ensure	 removal	 of	 the	 proteins,	 phenol/chloroform	 extraction	was	employed	 on	 the	 samples	 two	 times	 followed	 by	 ethanol	 precipitation,	 purification,	 and	resuspension	in	TE.	Two	µg	of	the	prepared	DNA	were	sheared	for	either	30,	120,	and	240	min	with	a	Bioruptor	device	(Diagenode)	to	obtain	DNA	fragment	in	similar	size	to	MNase	digested	DNA.	150	bp	fragments	after	240	min	sonication	were	excised	from	the	gel	and	purified	with	the	same	kit	as	MNase	digested	samples.	DNA	purified	from	the	gels	was	measured	to	determine	the	concentrations	using	 the	Qubit	 System	with	HS	DNA	kit	 and	 stored	at	 -20	 °C	until	 the	 library	preparation	step	was	performed.	
6.5.2. Library preparation and sequencing 
 I	 prepared	 the	 sequencing	 libraries	 in	 the	 lab	 of	 Dr.	 Helmut	 Blum	 in	 the	 Gene	 Center	(Feodor-Lynen-Straße	25,	81375	Munich)	using	the	NEBNext	Ultra	II	DNA	Library	Prep	Kit	and	adapters	 from	 the	 NEBNext	 Multiplex	 Oligos	 II	 kit	 for	 Illumina.	 50	 ng	 of	 MNase	 digested	 or	sonicated	 DNA	 samples	 were	 filled	 up	 to	 50	 µl	 with	 1	 x	 TE	 (pH	 8.0)	 and	 used	 for	 libraries	preparations.	All	steps	were	performed	according	to	the	manufacturer’s	protocol	(version	1.1,	11/15).	At	step	1.2	of	protocol	the	NEBNext	Adaptor	for	Illumina	was	diluted	1:10	according	to	the	 suggestion	 from	 the	 manual.	 AMPure	 XP	 Beads	 were	 used	 for	 size-selection	 clean-up	 of	adaptor	 ligated	 DNA.	 Samples	 were	 amplified	 using	 a	 universal	 primer	 and	 certain	 index	primers	 (including	 different	 barcodes	 for	 each	 sample)	 with	 11	 to	 12	 cycles.	 After	 the	 PCR	reactions,	 the	samples	were	cleaned	up	using	AMPure	XP	Beads	and	resuspended	 in	0.1	x	TE.	The	 concentrations	 of	 the	 prepared	 libraries	were	 checked	 on	 the	 Qubit	 System	with	 the	HS	DNA	Kit	and	frozen	at	-20	°C.	Before	loading	the	samples	onto	the	flow	cell,	they	were	checked	by	 Dr.	 Stefan	 Krebs	 from	 the	 Gene	 Centre	 for	 their	 quality	 on	 the	 capillary	 electrophoresis	system,	BioAnalyzer	2100	from	Agilent.	Sequencing	was	performed	with	50	bases	(paired-end)	on	an	Illumina	HiSeq	1500	platform	in	the	Dr.	Blum’s	lab	in	the	Gene	Center.	
6.5.3. Bioinformatic analysis 
 Mapping,	normalization	and	further	bioinformatic	analyses	were	performed	with	the	help	and	 advice	 from	Dr.	Alexander	Buschle.	 The	data	 from	 the	 Illumina	 sequencer	were	obtained	from	the	Galaxy	server	of	Dr.	Blum’s	laboratory.	The	processing	of	the	raw	sequencing	data	was	
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performed	 on	 this	 server.	 Initially,	 the	 data	 were	 split	 according	 to	 their	 unique	 indices	(demultiplexing)	used	during	the	libraries	preparation	with	the	Illumina	Demultiplex	tool.	Prior	to	 further	 downstream	 analyses,	 the	 quality	 of	 the	 sequencing	 reads	 was	 checked	 using	 the	FastQC	 tool.	 Since	 all	 of	 the	 samples	 passed	 the	 quality	 control	 test,	 they	 could	 be	 used	 for	further	bioinformatic	steps.	The	commands	described	in	the	methods	are	examples,	which	were	adapted	to	the	certain	input	file.		
Mapping	and	counting	of	sequencing	reads	Demultiplexed	 FASTQ	 data	 were	 downloaded	 from	 the	 Galaxy	 server.	 Mapping	 of	 the	sequencing	 reads	 to	 the	human	Hg19	 (GRCh37)	 and	2089	EBV	 (AGV	database)	 genomes	was	performed	with	the	help	of	the	command	line	program	Bowtie2.		
bowtie_index="-x path/Hg19_EBV2089.ebwt" 
bowtie_opts="-p 2 -X 250 --no-discordant --no-mixed --no-unal" 
bowtie2 $bowtie_opts -x $ bowtie_index -1 Input1.fastq -2 Input2.fastq > 
Output.sam 	In	the	next	step,	the	total	numbers	of	reads	were	counted	in	each	individual	SAM	file	(day	p.i.).	
 
for rows in `ls *.sam`; do 
wc -l $rows >> 0_sam_rows.txt; 
done 	 Data	were	normalized	according	to	the	libraries	sizes,	which	was	done	by	reducing	all	SAM	files	to	53960846	reads,	which	corresponds	to	reads	of	the	smallest	library.	Since	SAM	files	are	ordered	randomly,	no	bias	was	introduced	by	this	step.			
for rowstocut in `ls *.sam`;do 
sed -n 1,53960846p $rowstocut > 1_Sams_Cut/cutTo_53960846_$rowstocut; 
done 	 Columns	3	and	9	of	 the	normalized	data,	which	represent	chromosome	name	and	 insert	size,	respectively,	were	extracted	from	the	file.	For	further	analyses	reads	with	an	insert	length	greater	than	147-	30	bp,	or	smaller	than	147+30	bp	were	selected	and	used	for	further	analyses.			
for run in `ls *.sam`; do 
placeholder=`basename $run .sam` 
cut -f3,9 $run > /col_3_9_$placeholder.txt 
awk '( ($9 >= 117) && ( $9 <= 177 ) )' $run > plus_$run 
awk '( ($9 <= -117) && ( $9 >= -177 ) )' $run > minus_$run 
paste -d'\n' plus_$run minus_$run > stripped_$run 
samtools view -H $run > header_$run 
cat header_$run stripped_$run > stripped_H_$run 
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rm plus_$run 
rm minus_$run 
rm header_$run 
rm stripped_$run 	 The	 processed	 files	 were	 converted	 to	 BAM	 files	 using	 an	 additional	 filter	(filter.orphans.py).	In	this	step	all	reads,	which	were	not	paired	and	did	not	map	uniquely	to	the	genomes	 were	 excluded.	 The	 BAM	 files	 were	 further	 sorted	 by	 chromosome	 and	 nucleotide	coordinates.	
chmod +x filter_orphans.py 
 
samtools view -hf 0x2 Input.sam | grep -v "XS:i:" | filter_orphans.py | samtools 
view -b -o Output.bam 
samtools sort Input.bam -o Output_sort.bam 
 
	
Nucleosome	peak	calling	using	the	DANPOS	Python	program	Sorted	BAM	files	were	used	as	an	input	file	for	the	DANPOS	program.	The	dpos	function,	which	 is	 a	 peak-calling	 algorithm	 to	 accurately	 define	 occupancy	 and	 positioning	 of	nucleosomes.	The	function	was	used	with	the	default	settings	for	paired-end	sequencing	reads.	The	output	WIG	files	were	converted	to	TDF	files	for	faster	data	display	in	the	IGV	Browser.	The	called	nucleosomes	were	visualized	in	the	IGV	Browser	selecting	certain	viral	or	cellular	loci.		
python danpos.py dpos -m 1 Input_sort.bam -o /Results 
igvtools toTDF Input.wig Output.tdf /IGVTools/genomes/hg19_2089.chrom.sizes 
 
	
Analyses	of	DNA	fragment	length	distribution	
	 For	 this	 analysis,	 normalized	 SAM	 files	 were	 used	 to	 create	 a	 text	 file	 containing	 only	information	about	chromosome	number	(column	3)	and	insert	size	(column	9).	These	data	were	further	used	to	calculate	and	visualize	DNA	fragment	length	distribution.			
for col9 in `ls cutTo_*.sam`; do 
cut -f3,9 $col9 > /col_3_9_$col9.txt; 
done	
	 R	was	used	to	create	histograms	and	boxplots	with	DNA	fragment	length	distribution	and	their	 statistics	 on	 the	 cellular	 and	 EBV	 genomes	 to	 compare	 MNase	 digested	 samples	 with	sonicated	 LCLs	 controls.	 The	 R	 script	 used	 for	 these	 analyses	 can	 be	 found	 on	 the	 CD	 under	“MNase_seq/MNaseseq_plots_script.R”.		
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6.6. Protein analysis methods 
6.6.1. Whole cell lysate preparation 
 Preparation	 of	 the	 whole	 cell	 extracts	 was	 performed	 with	 exactly	 2x106	 of	 uninfected	cells	and	cells	collected	at	different	time	points	after	EBV	infection.	The	cells	were	washed	once	with	PBS	(6	min	at	300	g	and	4	°C)	and	lysed	in	a	volume	of	200	µl	RIPA	buffer	(Chapter	5.8)	for	30	minutes	on	ice.	The	lysates	were	sonicated	with	a	Bioruptor	Sonicator	(30	sec	on/30	sec	off,	HIGH	setting,	4	x	5	min,	on	 ice).	Afterwards,	 the	samples	were	centrifuged	 to	 remove	cellular	debris	(20	min	at	maximal	speed	at	4	°C)	and	the	supernatants	were	transferred	to	new	tubes.	The	 protein	 concentrations	 of	 the	 lysates	 were	 determined	 by	 Bradford’s	 protein	 assay.	 The	absorbance	 was	 measured	 at	 595	 nm	 on	 a	 photometer	 and	 protein	 concentrations	 were	determined	using	a	BSA	standard	curve. 
6.6.2. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
 The	SDS-PAGE	gels	were	prepared	beforehand	according	to	chapter	5.8.	The	gels	were	run	using	 the	Mini	Protean	Tetra	Cell	 System	(Bio-Rad).	The	samples	were	prepared	as	described	above,	diluted	with	Laemmli	buffer	(Chapter	5.8),	and	heat	denatured	for	seven	minutes	at	95	°C	in	a	thermomixer.	The	proteins	were	separated	in	the	sampling	gel	(Chapter	5.8)	at	90_V	until	the	samples	entered	the	separating	gel.	Afterwards,	the	voltage	was	increased	to	110-120_V	and	run	until	the	bromophenol	blue	dye	migrated	out	of	the	gel.		
6.6.3. Western Blot 
 The	separated	gels	were	used	for	transferring	proteins	to	nitrocellulose	membranes.	The	blotting	was	 performed	 in	 blotting	 buffer	 (chapter	 5.8)	 at	 100	 V	 for	 80	min.	 Afterwards,	 the	membrane	was	blocked	 for	45	min	with	blocking	 solution	 (chapter	5.8)	at	 room	 temperature	under	 agitation.	 The	 blocked	 membrane	 was	 incubated	 with	 selected	 primary	 antibodies	 at	certain	dilutions	(chapter	5.4)	overnight	at	4	°C.	The	next	day,	 the	membrane	was	extensively	washed	five	times	for	5	min	with	PBS-T	buffer	(chapter	5.8)	and	subsequently	 incubated	with	the	 secondary	 antibody	 (chapter	 5.4)	 for	 45	 min	 at	 room	 temperature.	 Thereafter,	 the	membrane	was	washed	three	times	with	PBS-T	for	5	min	and	used	for	the	downstream	analysis.	Protein	signals	were	visualized	by	chemiluminescence	using	the	ECL	reagent	(chapter	5.9)	and	either	 exposed	 to	 X-ray	 film	 (chapter	 5.11)	 or	 the	 LI-COR	 Odyssey	 Infrared	 System	 (chapter	5.11).	
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7. Abbreviations %	 percent	°C	 degree	Celsius	2-NBDG	 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)	amino]-2-deoxy-D-glucose	A	 adenine	AP-1	 activator	protein	1	APS	 ammonium	persulfate	ATP	 adenosine-5'-triphosphate	ATRX	 alpha	Thalassemia/Mental	Retardation	Syndrome	X-Linked	BAM	 Binary	Alignment	Map	BCL-2	 B	cell	lymphoma	2	protein	BCR	 B	cell	receptor	BED	 Browser	Extensible	Data	BL	 Burkitt's	lymphoma	bp	 base	pair	BSA	 bovine	serum	albumine	C	 cytosine	C-terminus	 carboxy-terminal	CAF-1	 chromatin	assembly	factor-1	CD		 cluster	of	differentiation	CDKI	 cyclin-dependent	kinase	inhibitor	cDNA	 complementary	DNA	CENPA	 centromer	protein	A	CMPK1	 cytidine	monophosphate	kinase	1	CO2	 carbon	dioxide	COX6A1	 cytochrome	C	Oxidase	Subunit	6A1	CpG	 cytosine-phosphatidyl-guanosine	CTCF	 CCCTC-binding	factor	CXCR4	 C-X-C	motif	chemokine	receptor	4	cytC	 cytochrome	C	Daxx	 death-associated	protein	6	DDR		 DNA	damage	response	DE	 differentially	expressed	DMSO	 dimethylsulfoxid	DNA	 deoxyribonucleic	acid	DNase		 deoxyribonuclease	DNMT	 DNA	methyltransferase	DS	 dyad	symmetry	dsDNA	 double	stranded	DNA	DTT	 dithiothreitol	e.g.	 exempli	gratia	EBER	 EBV-encoded	RNA	
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EBNA	 EBV-encoded	nuclear	antigen	EBV	 Epstein-Barr	virus	ECL	 enhanced	chemiluminescence	EDTA	 ethylenediaminetetraacetic	EGTA	 ethyleneglycoltetraacetic		ERCC	 external	RNA	controls	consortium	et	al.	 et	alii	ETC	 electron	transport	chain	etc.	 et	cetera	EtOH	 ethanol	EZH2	 human	enhancer	of	zeste	FACS		 fluorescence-activated	cell	sorting	FAS	 fatty	acid	synthesis	FBS	 fetal	bovine	serum	FC	 fold	change	FDR	 false	discovery	rate	Fig.		 figure	FPKM	 Fragments	Per	Kilobase	of	transcript	per	Million	mapped	reads	FSC-A	 forward	scatter	area	G	 guanine	g	 gram	G6P	 glucose-6-phosphate	GFP	 green	fluorescent	protein	GO		 Gene	Ontology	gp	 glycoprotein	GPI	 glucose-6-phosphate	isomerase	GSR	 gluthathione-disulfide	reductase	H2O	 dihydrogen	monoxide;	water	H3	 histone	H3	H3K27ac	 acetylated	histone	H3	at	lysine	27	H3K27me3	 trimethylated	histone	H3	at	lysine	27	H3K36me3	 trimethylated	histone	H3	at	lysine	36	H3K4me1	 monomethylated	histone	H3	at	lysine	4	H3K4me3	 trimethylated	histone	H3	at	lysine	4	H3K9me3	 trimethylated	histone	H3	at	lysine	9	HAT	 histone	acetyltransferase	HCMV	 Human	Cytomegalovirus	HDAC	 histone	deacetylase	HEPES	 (4-(2-hydroxyethyl)-1-piperazineethanesulfonic	acid	Hg19	 human	genome	19	HK	 hexokinase	HL	 Hodgkin’s	Lymphoma	HLA	 human	leukocyte	antigen	
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HMT	 histone	methyltransferase	HOX	 homeobox	HP1	 heterochromatin	protein	1	HRP	 horseradish	peroxidase	HSV-1	 Herpes	Simplex	Virus	1	i.e.	 id	est	IFN	 interferon	IgG	 immunoglobulin	G	IGV	 integrated	genome	viewer	IL	 interleukin	IMM	 inner	mitochondrial	membrane	IQR	 interquartile	range	kb	 kilo	base	kDa	 kilo	Dalton	KLF4	 Kruppel-like	factor	4	KSHV	 Kaposi	Sarcoma	associated	herpesvirus	l	 liter	LCL	 lymphoblastoid	cell	line	LDH	 lactate	dehydrogenase	LMP	 latent	membrane	protein	lncRNA	 long	non-coding	RNA	LSD1	 lysine-specific	histone	demethylase	1	M	 molar	MACS	 magnetic	activated	cell	sorting	MHC	 major	histocompatibility	complex	mHG	 minimum	hypergeometric	min	 minute	miRNA	 microRNA	ml	 mililiter	mM	 micromolar	MNase	 micrococcal	nuclease	MNase-seq	 micrococcal	nuclease	sequencing	MOI	 multiplicity	of	infection	mRNA	 messenger	RNA	N-terminus	 amino-terminus	NaCl	 sodium	chloride	NADH		 nicotinamide	adenine	dinucleotide	NADPH	 nicotinamide	adenine	dinucleotide	phosphate	NAP1	 nucleosome	assembly	protein	1	ncRNA	 non-coding	RNA	NDR	 nucleosome	depleted	region	NDUFA2	 NADH	dehydrogenase	1	alpha	subcomplex	subunit	2	NEB	 New	England	Biolabs	
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NFkB	 nuclear	factor	"kappa-light-chain-enhancer"	of	activated	B	cells	NFR		 nucleosome	free	regions	ng	 nanogram	NGS	 next	generation	sequencing	NK	 natural	killer		nmol	 nanomole	NPC	 nasopharyngeal	carcinoma	nt	 nucleotide	OMM	 outer	mitochondrial	membrane	ORC	 origin	recognition	complex	oriLyt	 origin	of	lytic	replication	oriP	 origin	of	plasmid	replication	OXPHOS	 oxydative	phosphorylation	p.i.	 post	infection	PAA	 polyacrylamide	padj	 adjusted	p-value	PBMCs	 peripheral	blood	mononuclear	cells	PBS	 phosphate	buffered	saline	PBS-T	 phosphate	buffered	saline	with	tween	PCA	 principal	component	analysis	PcG	 polycomb	group	PCNA	 proliferating	cell	nuclear	antigen		PCR	 polymerase	chain	reaction	PEI	 polyethylenimine	pH	 potential	of	hydrogen	PI3K	 phosphoinositide	3-kinase	PIC	 proteinase	inhibitor	cocktail	PTLD	 post-transplant	lymphoproliferative	diseases	PML	NB	 promyelocytic	leukemia	nuclear	bodies		Pol	II	 RNA	polymerase	II	PPP	 pentose	phosphate	pathway	PRC		 polycomb	repressive	complex	PS	 phosphatidylserine	residues	PTM	 posttranscriptional	modifications	QC	 quality	control	RNA	 ribonucleic	acid	RNA-seq	 ribonucleic	acid	sequencing	ROS	 reactive	oxygen	species	rpm	 rounds	per	minute	RPM	 Reads	Per	Million	RPMI	 Roswell	Park	Memorial	Institute	rRNA	 ribosomal	RNA	RT	 room	temperature	
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s	 second	SAM	 Sequence	Alignment	Map		SDS	 sodium	dodecyl	sulphate	SDS	page	 SDS	polyacrylamide	gel	electrophoresis	sec	 second		SSC-A	 sideward	scatter	area	SWI/SNF	 switch/sucrose	nonfermentable	T	 thymine	TAD	 topologically	associating	domains	TAP	 transporter	associated	with	antigen	processing	TBE	 buffer	containing	Tris	base,	boric	acid	and	EDTA	TCA	 tricarboxylic	acid	TCR	 T	cell	receptor	TE	 tris-EDTA	TEMED	 tetramethylethylenediamine	TF	 transcription	factor	TLR	 toll-like	receptor	TMRE	 tetramethylrhodamine	ethyl	ester	Tris		 2-amino-2-hydroxymethyl-propane-1,3-diol	tRNA	 transfer	RNA	TSS	 transcriptional	start	sites	U	 untis	U	 uracil	USA	 United	States	of	America	V	 Volt		WHO	 World	Health	Organization	wt	 wild	type	ZRE	 BZLF1-responsive	element	μg	 microgram	μl	 microliter	μM	 micromolar		
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Acad.	Sci.	U.	S.	A.	82:4085–9.	Cui,	K.,	and	K.	Zhao.	2012.	Genome-wide	approaches	to	determining	nucleosome	occupancy	in	metazoans	using	MNase-Seq.	Methods	Mol.	Biol.	833:413–419.	doi:10.1007/978-1-61779-477-3_24.	Deaton,	A.M.,	M.	Gómez-Rodrıǵuez,	J.	Mieczkowski,	M.Y.	Tolstorukov,	S.	Kundu,	R.I.	Sadreyev,	L.E.	Jansen,	and	R.E.	Kingston.	2016.	Enhancer	regions	show	high	histone	H3.3	turnover	that	changes	during	differentiation.	Elife.	5:e15316.	doi:10.7554/eLife.15316.	DeBerardinis,	R.J.,	J.J.	Lum,	G.	Hatzivassiliou,	and	C.B.	Thompson.	2008.	The	biology	of	cancer:	metabolic	reprogramming	fuels	cell	growth	and	proliferation.	Cell	Metab.	7:11–20.	doi:10.1016/j.cmet.2007.10.002.	Dechend,	R.,	F.	Hirano,	K.	Lehmann,	V.	Heissmeyer,	S.	Ansieau,	F.G.	Wulczyn,	C.	Scheidereit,	and	A.	Leutz.	1999.	The	Bcl-3	oncoprotein	acts	as	a	bridging	factor	between	NF-κB/Rel	and	nuclear	co-regulators.	Oncogene.	18:3316–3323.	doi:10.1038/sj.onc.1202717.	Dekker,	J.,	M.A.	Marti-Renom,	and	L.A.	Mirny.	2013.	Exploring	the	three-dimensional	organization	of	genomes:	interpreting	chromatin	interaction	data.	Nat.	Rev.	Genet.	14:390–403.	doi:10.1038/nrg3454.	Delecluse,	H.J.,	T.	Hilsendegen,	D.	Pich,	R.	Zeidler,	and	W.	Hammerschmidt.	1998.	Propagation	and	recovery	of	intact,	infectious	Epstein-Barr	virus	from	prokaryotic	to	human	cells.	Proc.	
Natl.	Acad.	Sci.	U.	S.	A.	95:8245–50.	Delgado,	T.,	P.A.	Carroll,	A.S.	Punjabi,	D.	Margineantu,	D.M.	Hockenbery,	and	M.	Lagunoff.	2010.	Induction	of	the	Warburg	effect	by	Kaposi’s	sarcoma	herpesvirus	is	required	for	the	maintenance	of	latently	infected	endothelial	cells.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	107:10696–701.	doi:10.1073/pnas.1004882107.	Dent,	A.L.,	A.L.	Shaffer,	X.	Yu,	D.	Allman,	L.M.	Staudt,	N.	Raab-Traub,	and	H.	Kikutani.	1997.	Control	of	inflammation,	cytokine	expression,	and	germinal	center	formation	by	BCL-6.	
Science	(80-.	).	276:589–592.	doi:10.1126/science.276.5312.589.	Dobin,	A.,	C.A.	Davis,	F.	Schlesinger,	J.	Drenkow,	C.	Zaleski,	S.	Jha,	P.	Batut,	M.	Chaisson,	and	T.R.	Gingeras.	2013.	STAR:	ultrafast	universal	RNA-seq	aligner.	Bioinformatics.	29:15–21.	doi:10.1093/bioinformatics/bts635.	van	Dongen,	S.,	and	A.J.	Enright.	2012.	Metric	distances	derived	from	cosine	similarity	and	Pearson	and	Spearman	correlations.	Doughty,	C.A.,	B.F.	Bleiman,	D.J.	Wagner,	F.J.	Dufort,	J.M.	Mataraza,	M.F.	Roberts,	and	T.C.	Chiles.	2006.	Antigen	receptor-mediated	changes	in	glucose	metabolism	in	B	lymphocytes:	role	of	phosphatidylinositol	3-kinase	signaling	in	the	glycolytic	control	of	growth.	Blood.	107:4458–65.	doi:10.1182/blood-2005-12-4788.	Dufort,	F.J.,	B.F.	Bleiman,	M.R.	Gumina,	D.	Blair,	D.J.	Wagner,	M.F.	Roberts,	Y.	Abu-Amer,	and	T.C.	Chiles.	2007.	Cutting	edge:	IL-4-mediated	protection	of	primary	B	lymphocytes	from	apoptosis	via	Stat6-dependent	regulation	of	glycolytic	metabolism.	J.	Immunol.	179:4953–7.	Eden,	E.,	R.	Navon,	I.	Steinfeld,	D.	Lipson,	and	Z.	Yakhini.	2009.	GOrilla:	a	tool	for	discovery	and	
 8 Literature  
 
 
118 
visualization	of	enriched	GO	terms	in	ranked	gene	lists.	BMC	Bioinformatics.	10:48.	doi:10.1186/1471-2105-10-48.	Engelen,	E.,	R.C.	Janssens,	K.	Yagita,	V.A.J.	Smits,	G.T.J.	van	der	Horst,	and	F.	Tamanini.	2013.	Mammalian	TIMELESS	is	involved	in	period	determination	and	DNA	damage-dependent	phase	advancing	of	the	circadian	clock.	PLoS	One.	8:e56623.	doi:10.1371/journal.pone.0056623.	Esau,	D.	2017.	Viral	causes	of	lymphoma:	the	history	of	Epstein-Barr	Virus	and	Human	T-Lymphotropic	Virus	1.	Virology	(Auckl).	8:1178122X17731772.	doi:10.1177/1178122X17731772.	Fadaka,	A.,	B.	Ajiboye,	O.	Ojo,	O.	Adewale,	I.	Olayide,	and	R.	Emuowhochere.	2017.	Biology	of	glucose	metabolization	in	cancer	cells.	J.	Oncol.	Sci.	3:45–51.	doi:10.1016/J.JONS.2017.06.002.	Fields,	B.N.,	D.M.	Knipe,	and	P.M.	Howley.	2007.	Fields	virology.	Wolters	Kluwer	Health/Lippincott	Williams	&	Wilkins.	86	pp.	Finlay,	D.K.	2012.	Regulation	of	glucose	metabolism	in	T	cells:	new	insight	into	the	role	of	Phosphoinositide	3-kinases.	Front.	Immunol.	3:247.	doi:10.3389/fimmu.2012.00247.	Flynn,	R.A.,	and	H.Y.	Chang.	2014.	Long	noncoding	RNAs	in	cell-fate	programming	and	reprogramming.	Cell	Stem	Cell.	14:752–61.	doi:10.1016/j.stem.2014.05.014.	Fontaine,	K.A.,	R.	Camarda,	and	M.	Lagunoff.	2014.	Vaccinia	virus	requires	glutamine	but	not	glucose	for	efficient	replication.	J.	Virol.	88:4366–74.	doi:10.1128/JVI.03134-13.	Fortes,	P.,	and	K.	V	Morris.	2016.	Long	noncoding	RNAs	in	viral	infections.	Virus	Res.	212:1–11.	doi:10.1016/j.virusres.2015.10.002.	Fowler,	T.,	A.S.	Garruss,	A.	Ghosh,	S.	De,	K.G.	Becker,	W.H.	Wood,	M.T.	Weirauch,	S.T.	Smale,	B.	Aronow,	R.	Sen,	and	A.L.	Roy.	2015.	Divergence	of	transcriptional	landscape	occurs	early	in	B	cell	activation.	Epigenetics	Chromatin.	8:20.	doi:10.1186/s13072-015-0012-x.	Frappier,	L.	2012.	Contributions	of	Epstein-Barr	nuclear	antigen	1	(EBNA1)	to	cell	immortalization	and	survival.	Viruses.	4:1537–47.	doi:10.3390/v4091537.	Freyberg,	Z.,	and	E.T.	Harvill.	2017.	Pathogen	manipulation	of	host	metabolism:	A	common	strategy	for	immune	evasion.	PLoS	Pathog.	13:e1006669.	doi:10.1371/journal.ppat.1006669.	Friedman,	J.R.,	and	J.	Nunnari.	2014.	Mitochondrial	form	and	function.	Nat.	2014	5057483.	505:335.	doi:10.1038/nature12985.	Garrett,	R.H.,	and	C.M.	Grisham.	2005.	Biochemistry.	Thomson	Brooks/Cole.	Garruss,	A.S.,	and	T.	Fowler.	2015.	Dataset	of	transcriptional	landscape	of	B	cell	early	activation.	
Genomics	Data.	5:238–240.	doi:10.1016/J.GDATA.2015.06.007.	Ge,	X.Q.,	and	H.	Lin.	2014.	Noncoding	RNAs	in	the	regulation	of	DNA	replication.	Trends	Biochem.	
Sci.	39:341–3.	doi:10.1016/j.tibs.2014.06.003.	Geiman,	T.M.,	S.K.	Durum,	and	K.	Muegge.	1998.	Characterization	of	gene	expression,	genomic	structure,	and	chromosomal	localization	of	Hells(Lsh).	Genomics.	54:477–483.	doi:10.1006/GENO.1998.5557.	Good,	K.L.,	and	S.G.	Tangye.	2007.	Decreased	expression	of	Kruppel-like	factors	in	memory	B	cells	induces	the	rapid	response	typical	of	secondary	antibody	responses.	Proc.	Natl.	Acad.	
Sci.	U.	S.	A.	104:13420–5.	doi:10.1073/pnas.0703872104.	Greer,	E.L.,	and	Y.	Shi.	2012.	Histone	methylation:	a	dynamic	mark	in	health,	disease	and	inheritance.	Nat.	Rev.	Genet.	13:343–357.	doi:10.1038/nrg3173.	Grimes,	H.L.,	S.	Harinder,	A.	Olsson,	N.	Salomonis,	B.J.	Aronow,	and	V.	Chaudhry.	2015.	Single	cell	RNA	seq	for	analysis	of	cell	fate	decisions.	Blood.	126.	Hammerschmidt,	W.,	and	B.	Sugden.	1988.	Identification	and	characterization	of	oriLyt,	a	lytic	origin	of	DNA	replication	of	Epstein-Barr	virus.	Cell.	55:427–33.	doi:10.1016/0092-
 8 Literature           
 
 
119 
8674(88)90028-1.	Hatton,	O.L.,	A.	Harris-Arnold,	S.	Schaffert,	S.M.	Krams,	and	O.M.	Martinez.	2014.	The	interplay	between	Epstein-Barr	virus	and	B	lymphocytes:	implications	for	infection,	immunity,	and	disease.	Immunol.	Res.	58:268–76.	doi:10.1007/s12026-014-8496-1.	Henikoff,	S.	2009.	Labile	H3.3+H2A.Z	nucleosomes	mark	“nucleosome-free	regions.”	Nat.	Genet.	41:865–866.	doi:10.1038/ng0809-865.	Henikoff,	S.,	and	M.M.	Smith.	2015.	Histone	variants	and	epigenetics.	Cold	Spring	Harb.	Perspect.	
Biol.	7:a019364.	doi:10.1101/cshperspect.a019364.	Henle,	W.	1968.	Evidence	for	viruses	in	acute	leukemia	and	Burkitt’s	tumor.	Cancer.	21:580–6.	Hernando,	H.,	A.B.M.M.K.	Islam,	J.	Rodriguez-Ubreva,	I.	Forne,	L.	Ciudad,	A.	Imhof,	C.	Shannon-Lowe,	and	E.	Ballestar.	2014.	Epstein-Barr	virus-mediated	transformation	of	B	cells	induces	global	chromatin	changes	independent	to	the	acquisition	of	proliferation.	Nucleic	Acids	Res.	42:249–263.	doi:10.1093/nar/gkt886.	Hölzel,	M.,	M.	Rohrmoser,	M.	Schlee,	T.	Grimm,	T.	Harasim,	A.	Malamoussi,	A.	Gruber-Eber,	E.	Kremmer,	W.	Hiddemann,	G.W.	Bornkamm,	and	D.	Eick.	2005.	Mammalian	WDR12	is	a	novel	member	of	the	Pes1-Bop1	complex	and	is	required	for	ribosome	biogenesis	and	cell	proliferation.	J.	Cell	Biol.	170:367–78.	doi:10.1083/jcb.200501141.	Hu,	Z.,	and	W.-W.	Tee.	2017.	Enhancers	and	chromatin	structures:	regulatory	hubs	in	gene	expression	and	diseases.	Biosci.	Rep.	37:BSR20160183.	doi:10.1042/BSR20160183.	Huang,	H.,	Z.	Deng,	O.	Vladimirova,	A.	Wiedmer,	F.	Lu,	P.M.	Lieberman,	and	D.J.	Patel.	2016.	Structural	basis	underlying	viral	hijacking	of	a	histone	chaperone	complex.	Nat.	Commun.	7:12707.	doi:10.1038/ncomms12707.	Humme,	S.,	G.	Reisbach,	R.	Feederle,	H.-J.	Delecluse,	K.	Bousset,	W.	Hammerschmidt,	and	A.	Schepers.	2003.	The	EBV	nuclear	antigen	1	(EBNA1)	enhances	B	cell	immortalization	several	thousandfold.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	100:10989–94.	doi:10.1073/pnas.1832776100.	Imai,	K.,	N.	Kamio,	M.E.	Cueno,	Y.	Saito,	H.	Inoue,	I.	Saito,	and	K.	Ochiai.	2014.	Role	of	the	histone	H3	lysine	9	methyltransferase	Suv39	h1	in	maintaining	Epsteinn-Barr	virus	latency	in	B95-8	cells.	FEBS	J.	281:2148–2158.	doi:10.1111/febs.12768.	Ishikawa,	H.,	Z.	Ma,	and	G.N.	Barber.	2009.	STING	regulates	intracellular	DNA-mediated,	type	I	interferon-dependent	innate	immunity.	Nature.	461:788–92.	doi:10.1038/nature08476.	Jang,	K.-J.,	H.	Mano,	K.	Aoki,	T.	Hayashi,	A.	Muto,	Y.	Nambu,	K.	Takahashi,	K.	Itoh,	S.	Taketani,	S.L.	Nutt,	K.	Igarashi,	A.	Shimizu,	and	M.	Sugai.	2015.	Mitochondrial	function	provides	instructive	signals	for	activation-induced	B-cell	fates.	Nat.	Commun.	6:6750.	doi:10.1038/ncomms7750.	Jenuwein,	T.,	and	C.D.	Allis.	2001.	Translating	the	histone	code.	Science.	293:1074–80.	doi:10.1126/science.1063127.	Jin,	C.,	and	G.	Felsenfeld.	2007.	Nucleosome	stability	mediated	by	histone	variants	H3.3	and	H2A.Z.	Genes	Dev.	21:1519–29.	doi:10.1101/gad.1547707.	Jochum,	S.,	A.	Moosmann,	S.	Lang,	W.	Hammerschmidt,	and	R.	Zeidler.	2012a.	The	EBV	immunoevasins	vIL-10	and	BNLF2a	protect	newly	infected	B	Cells	from	immune	recognition	and	elimination.	PLoS	Pathog.	8:e1002704.	doi:10.1371/journal.ppat.1002704.	Jochum,	S.,	R.	Ruiss,	A.	Moosmann,	W.	Hammerschmidt,	and	R.	Zeidler.	2012b.	RNAs	in	Epstein-Barr	virions	control	early	steps	of	infection.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	109:E1396-404.	doi:10.1073/pnas.1115906109.	Kalamvoki,	M.,	and	B.	Roizman.	2014.	HSV-1	degrades,	stabilizes,	requires,	or	is	stung	by	STING	depending	on	ICP0,	the	US3	protein	kinase,	and	cell	derivation.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	111:E611-7.	doi:10.1073/pnas.1323414111.	Kalla,	M.,	C.	Gobel,	and	W.	Hammerschmidt.	2012.	The	lytic	phase	of	Epstein-Barr	Virus	requires	
 8 Literature  
 
 
120 
a	viral	genome	with	5-Methylcytosine	residues	in	CpG	sites.	J.	Virol.	86:447–458.	doi:10.1128/JVI.06314-11.	Kalla,	M.,	A.	Schmeinck,	M.	Bergbauer,	D.	Pich,	and	W.	Hammerschmidt.	2010.	AP-1	homolog	BZLF1	of	Epstein-Barr	virus	has	two	essential	functions	dependent	on	the	epigenetic	state	of	the	viral	genome.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	107:850–855.	doi:10.1073/pnas.0911948107.	Kang,	H.,	A.	Wiedmer,	Y.	Yuan,	E.	Robertson,	and	P.M.	Lieberman.	2011.	Coordination	of	KSHV	latent	and	lytic	gene	control	by	CTCF-cohesin	mediated	chromosome	conformation.	PLoS	
Pathog.	7:e1002140.	doi:10.1371/journal.ppat.1002140.	Kari,	V.,	O.	Karpiuk,	B.	Tieg,	M.	Kriegs,	E.	Dikomey,	H.	Krebber,	Y.	Begus-Nahrmann,	and	S.A.	Johnsen.	2013.	A	subset	of	histone	H2B	genes	produces	polyadenylated	mRNAs	under	a	variety	of	cellular	conditions.	PLoS	One.	8:e63745.	doi:10.1371/journal.pone.0063745.	Karniely,	S.,	M.P.	Weekes,	R.	Antrobus,	J.	Rorbach,	L.	van	Haute,	Y.	Umrania,	D.L.	Smith,	R.J.	Stanton,	M.	Minczuk,	P.J.	Lehner,	and	J.H.	Sinclair.	2016.	Human	Cytomegalovirus	infection	upregulates	the	mitochondrial	transcription	and	translation	machineries.	MBio.	7:e00029.	doi:10.1128/mBio.00029-16.	Kebede,	A.F.,	R.	Schneider,	and	S.	Daujat.	2015.	Novel	types	and	sites	of	histone	modifications	emerge	as	players	in	the	transcriptional	regulation	contest.	FEBS	J.	282:1658–1674.	doi:10.1111/febs.13047.	Kempkes,	B.,	and	P.D.	Ling.	2015.	EBNA2	and	its	coactivator	EBNA-LP.	Springer,	Cham.	35–59.	Kieffer-Kwon,	K.-R.,	K.	Nimura,	S.S.P.	Rao,	J.	Xu,	S.	Jung,	A.	Pekowska,	M.	Dose,	E.	Stevens,	E.	Mathe,	P.	Dong,	S.-C.	Huang,	M.A.	Ricci,	L.	Baranello,	Y.	Zheng,	F.	Tomassoni	Ardori,	W.	Resch,	D.	Stavreva,	S.	Nelson,	M.	McAndrew,	A.	Casellas,	E.	Finn,	C.	Gregory,	B.G.	St	Hilaire,	S.M.	Johnson,	W.	Dubois,	M.P.	Cosma,	E.	Batchelor,	D.	Levens,	R.D.	Phair,	T.	Misteli,	L.	Tessarollo,	G.	Hager,	M.	Lakadamyali,	Z.	Liu,	M.	Floer,	H.	Shroff,	E.L.	Aiden,	and	R.	Casellas.	2017.	Myc	regulates	chromatin	decompaction	and	nuclear	architecture	during	B	Cell	activation.	Mol.	Cell.	67:566–578.e10.	doi:10.1016/j.molcel.2017.07.013.	Kieser,	A.,	and	K.R.	Sterz.	2015.	The	Latent	Membrane	Protein	1	(LMP1).	Springer,	Cham.	119–149.	Knipe,	D.M.,	P.M.	Lieberman,	J.U.	Jung,	A.A.	McBride,	K.	V.	Morris,	M.	Ott,	D.	Margolis,	A.	Nieto,	M.	Nevels,	R.J.	Parks,	and	T.M.	Kristie.	2013.	Snapshots:	Chromatin	control	of	viral	infection.	
Virology.	435:141–156.	doi:10.1016/J.VIROL.2012.09.023.	Kolovos,	P.,	T.A.	Knoch,	F.G.	Grosveld,	P.R.	Cook,	and	A.	Papantonis.	2012.	Enhancers	and	silencers:	an	integrated	and	simple	model	for	their	function.	Epigenetics	Chromatin.	5:1.	doi:10.1186/1756-8935-5-1.	Krude,	T.	1999.	Chromatin	assembly	during	DNA	replication	in	somatic	cells.	Eur.	J.	Biochem.	263:1–5.	doi:10.1046/j.1432-1327.1999.00508.x.	Kühlbrandt,	W.	2015.	Structure	and	function	of	mitochondrial	membrane	protein	complexes.	
BMC	Biol.	13:89.	doi:10.1186/s12915-015-0201-x.	Lagunoff,	M.	2016.	Activation	of	cellular	metabolism	during	latent	Kaposi’s	Sarcoma	herpesvirus	infection.	Curr.	Opin.	Virol.	19:45–9.	doi:10.1016/j.coviro.2016.06.012.	Lai,	W.K.M.,	and	B.F.	Pugh.	2017.	Understanding	nucleosome	dynamics	and	their	links	to	gene	expression	and	DNA	replication.	Nat.	Rev.	Mol.	Cell	Biol.	18:548–562.	doi:10.1038/nrm.2017.47.	Langfelder,	P.,	B.	Zhang,	and	S.	Horvath.	2008.	Defining	clusters	from	a	hierarchical	cluster	tree:	the	Dynamic	Tree	Cut	package	for	R.	Bioinformatics.	24:719–720.	doi:10.1093/bioinformatics/btm563.	Langmead,	B.,	and	S.L.	Salzberg.	2012.	Fast	gapped-read	alignment	with	Bowtie	2.	Nat.	Methods.	9:357–359.	doi:10.1038/nmeth.1923.	
 8 Literature           
 
 
121 
Langmead,	B.,	C.	Trapnell,	M.	Pop,	and	S.L.	Salzberg.	2009.	Ultrafast	and	memory-efficient	alignment	of	short	DNA	sequences	to	the	human	genome.	Genome	Biol.	10:R25.	doi:10.1186/gb-2009-10-3-r25.	Lawrence,	M.,	S.	Daujat,	and	R.	Schneider.	2016.	Lateral	Thinking:	How	Histone	Modifications	Regulate	Gene	Expression.	Trends	Genet.	32:42–56.	doi:10.1016/J.TIG.2015.10.007.	Lee,	S.-B.,	C.-F.	Lee,	D.S.-C.	Ou,	K.	Dulal,	L.-H.	Chang,	C.-H.	Ma,	C.-F.	Huang,	H.	Zhu,	Y.-S.	Lin,	and	L.-J.	Juan.	2011.	Host-viral	effects	of	chromatin	assembly	factor	1	interaction	with	HCMV	IE2.	
Cell	Res.	21:1230–47.	doi:10.1038/cr.2011.53.	Leng,	N.,	L.-F.	Chu,	C.	Barry,	Y.	Li,	J.	Choi,	X.	Li,	P.	Jiang,	R.M.	Stewart,	J.A.	Thomson,	and	C.	Kendziorski.	2015.	Oscope	identifies	oscillatory	genes	in	unsynchronized	single-cell	RNA-seq	experiments.	Nat.	Methods.	12:947–950.	doi:10.1038/nmeth.3549.	Lex,	A.,	N.	Gehlenborg,	H.	Strobelt,	R.	Vuillemot,	and	H.	Pfister.	2014.	UpSet:	Visualization	of	intersecting	sets.	IEEE	Trans.	Vis.	Comput.	Graph.	20:1983–92.	doi:10.1109/TVCG.2014.2346248.	Li,	H.,	B.	Handsaker,	A.	Wysoker,	T.	Fennell,	J.	Ruan,	N.	Homer,	G.	Marth,	G.	Abecasis,	R.	Durbin,	and	1000	Genome	Project	Data	Processing	Subgroup.	2009.	The	Sequence	Alignment/Map	format	and	SAMtools.	Bioinformatics.	25:2078–2079.	doi:10.1093/bioinformatics/btp352.	Li,	L.,	and	Y.	Wang.	2017.	Cross-talk	between	the	H3K36me3	and	H4K16ac	histone	epigenetic	marks	in	DNA	double-strand	break	repair.	J.	Biol.	Chem.	292:11951–11959.	doi:10.1074/jbc.M117.788224.	Li,	X.L.,	M.	Subramanian,	M.F.	Jones,	R.	Chaudhary,	D.K.	Singh,	X.	Zong,	B.	Gryder,	S.	Sindri,	M.	Mo,	A.	Schetter,	X.	Wen,	S.	Parvathaneni,	D.	Kazandjian,	L.M.	Jenkins,	W.	Tang,	F.	Elloumi,	J.L.	Martindale,	M.	Huarte,	Y.	Zhu,	A.I.	Robles,	S.M.	Frier,	F.	Rigo,	M.	Cam,	S.	Ambs,	S.	Sharma,	C.C.	Harris,	M.	Dasso,	K.	V	Prasanth,	and	A.	Lal.	2017.	Long	noncoding	RNA	PURPL	suppresses	basal	p53	levels	and	promotes	tumorigenicity	in	colorectal	cancer.	Cell	Rep.	20:2408–2423.	doi:10.1016/j.celrep.2017.08.041.	Lieberman,	P.M.	2013.	Keeping	it	quiet:	chromatin	control	of	gammaherpesvirus	latency.	Nat.	
Rev.	Microbiol.	11:863–75.	doi:10.1038/nrmicro3135.	Liou,	J.-Y.,	G.E.	Dutschman,	W.	Lam,	Z.	Jiang,	and	Y.-C.	Cheng.	2002.	Characterization	of	human	UMP/CMP	kinase	and	its	phosphorylation	of	D-	and	L-form	deoxycytidine	analogue	monophosphates.	Cancer	Res.	62:1624–31.	Lipford,	J.R.,	and	S.P.	Bell.	2001.	Nucleosomes	positioned	by	ORC	facilitate	the	initiation	of	DNA	replication.	Mol.	Cell.	7:21–30.	doi:10.1016/S1097-2765(01)00151-4.	Liu,	P.-S.,	and	P.-C.	Ho.	2017.	Mitochondria:	A	master	regulator	in	macrophage	and	T	cell	immunity.	Mitochondrion.	doi:10.1016/J.MITO.2017.11.002.	Liu,	W.,	and	C.	Ding.	2017.	Roles	of	lncRNAs	in	viral	infections.	Front.	Cell.	Infect.	Microbiol.	7:205.	doi:10.3389/fcimb.2017.00205.	Love,	M.I.,	W.	Huber,	and	S.	Anders.	2014.	Moderated	estimation	of	fold	change	and	dispersion	for	RNA-seq	data	with	DESeq2.	Genome	Biol.	15:550.	doi:10.1186/s13059-014-0550-8.	Luger,	K.,	A.W.	Mäder,	R.K.	Richmond,	D.F.	Sargent,	and	T.J.	Richmond.	1997.	Crystal	structure	of	the	nucleosome	core	particle	at	2.8	A	resolution.	Nature.	389:251–60.	doi:10.1038/38444.	Lunt,	S.Y.,	and	M.G.	Vander	Heiden.	2011.	Aerobic	glycolysis:	Meeting	the	metabolic	requirements	of	cell	proliferation.	Annu.	Rev.	Cell	Dev.	Biol.	27:441–464.	doi:10.1146/annurev-cellbio-092910-154237.	Lygerou,	Z.,	P.	Mitchell,	E.	Petfalski,	B.	Séraphin,	and	D.	Tollervey.	1994.	The	POP1	gene	encodes	a	protein	component	common	to	the	RNase	MRP	and	RNase	P	ribonucleoproteins.	Genes	
Dev.	8:1423–33.	Mancao,	C.,	and	W.	Hammerschmidt.	2007.	Epstein-Barr	virus	latent	membrane	protein	2A	is	a	B-cell	receptor	mimic	and	essential	for	B-cell	survival.	Blood.	110:3715–21.	
 8 Literature  
 
 
122 
doi:10.1182/blood-2007-05-090142.	Marchese,	F.P.,	and	M.	Huarte.	2014.	Long	non-coding	RNAs	and	chromatin	modifiers:	their	place	in	the	epigenetic	code.	Epigenetics.	9:21–6.	doi:10.4161/epi.27472.	Marzluff,	W.F.,	E.J.	Wagner,	and	R.J.	Duronio.	2008.	Metabolism	and	regulation	of	canonical	histone	mRNAs:	life	without	a	poly(A)	tail.	Nat.	Rev.	Genet.	9:843–54.	doi:10.1038/nrg2438.	McHugh,	C.A.,	C.-K.	Chen,	A.	Chow,	C.F.	Surka,	C.	Tran,	P.	McDonel,	A.	Pandya-Jones,	M.	Blanco,	C.	Burghard,	A.	Moradian,	M.J.	Sweredoski,	A.A.	Shishkin,	J.	Su,	E.S.	Lander,	S.	Hess,	K.	Plath,	and	M.	Guttman.	2015.	The	Xist	lncRNA	interacts	directly	with	SHARP	to	silence	transcription	through	HDAC3.	Nature.	521:232–6.	doi:10.1038/nature14443.	Milavetz,	B.I.,	and	L.	Balakrishnan.	2015.	Viral	epigenetics.	Methods	Mol.	Biol.	1238:569–96.	doi:10.1007/978-1-4939-1804-1_30.	Miller,	G.,	T.	Shope,	H.	Lisco,	D.	Stitt,	and	M.	Lipman.	1972.	Epstein-Barr	virus:	transformation,	cytopathic	changes,	and	viral	antigens	in	squirrel	monkey	and	marmoset	leukocytes.	Proc.	
Natl.	Acad.	Sci.	U.	S.	A.	69:383–7.	Miyake-Stoner,	S.J.,	and	C.C.	O’Shea.	2014.	Metabolism	goes	viral.	Cell	Metab.	19:549–50.	doi:10.1016/j.cmet.2014.03.022.	Mondal,	T.,	M.	Rasmussen,	G.K.	Pandey,	A.	Isaksson,	and	C.	Kanduri.	2010.	Characterization	of	the	RNA	content	of	chromatin.	Genome	Res.	20:899–907.	doi:10.1101/gr.103473.109.	Münz,	C.	2015.	Epstein	Barr	virus.	Volume	1 :	one	herpes	virus :	many	diseases.	391	pp.	Nagalakshmi,	U.,	K.	Waern,	M.	Snyder,	U.	Nagalakshmi,	K.	Waern,	and	M.	Snyder.	2010.	RNA-seq:	A	method	for	comprehensive	transcriptome	analysis.	In	Current	Protocols	in	Molecular	Biology.	John	Wiley	&	Sons,	Inc.,	Hoboken,	NJ,	USA.	4.11.1-4.11.13.	Nie,	Y.,	Y.-C.	Han,	and	Y.-R.	Zou.	2008.	CXCR4	is	required	for	the	quiescence	of	primitive	hematopoietic	cells.	J.	Exp.	Med.	205:777–83.	doi:10.1084/jem.20072513.	Nitzsche,	A.,	C.	Paulus,	and	M.	Nevels.	2008.	Temporal	dynamics	of	cytomegalovirus	chromatin	assembly	in	productively	infected	human	cells.	J.	Virol.	82:11167–80.	doi:10.1128/JVI.01218-08.	Oh,	J.,	N.	Ruskoski,	and	N.W.	Fraser.	2012.	Chromatin	assembly	on	herpes	simplex	virus	1	DNA	early	during	a	lytic	infection	is	Asf1a	dependent.	J.	Virol.	86:12313–21.	doi:10.1128/JVI.01570-12.	Okamura,	K.,	A.	Ishizuka,	H.	Siomi,	and	M.C.	Siomi.	2004.	Distinct	roles	for	Argonaute	proteins	in	small	RNA-directed	RNA	cleavage	pathways.	Genes	Dev.	18:1655–66.	doi:10.1101/gad.1210204.	Olivadoti,	M.,	L.A.	Toth,	J.	Weinberg,	and	M.R.	Opp.	Murine	Gammaherpesvirus	68:	A	model	for	the	study	of	Epstein-Barr	Virus	infections	and	eelated	diseases.	Pagano,	J.S.	1999.	Epstein-Barr	Virus:	The	first	human	tumor	virus	and	its	role	in	cancer.	Proc.	
Assoc.	Am.	Physicians.	111:573–580.	doi:10.1046/j.1525-1381.1999.t01-1-99220.x.	Parrado,	A.,	M.E.	Noguera,	A.	Delmer,	S.	McKenna,	J.	Davies,	I.	Le	Gall,	P.	Bentley,	J.A.	Whittaker,	F.	Sigaux,	C.	Chomienne,	and	R.A.	Padua.	2000.	Deregulated	expression	of	promyelocytic	leukemia	zinc	finger	protein	in	B-cell	chronic	lymphocytic	leukemias	does	not	affect	cyclin	A	expression.	Hematol.	J.		Off.	J.	Eur.	Haematol.	Assoc.	1:15–27.	doi:10.1038/sj/thj/6200012.	Paschos,	K.,	G.A.	Parker,	E.	Watanatanasup,	R.E.	White,	and	M.J.	Allday.	2012.	BIM	promoter	directly	targeted	by	EBNA3C	in	polycomb-mediated	repression	by	EBV.	Nucleic	Acids	Res.	40:7233–46.	doi:10.1093/nar/gks391.	Pennock,	N.D.,	J.T.	White,	E.W.	Cross,	E.E.	Cheney,	B.A.	Tamburini,	and	R.M.	Kedl.	2013.	T	cell	responses:	naive	to	memory	and	everything	in	between.	Adv.	Physiol.	Educ.	37:273–83.	doi:10.1152/advan.00066.2013.	Peterson,	C.L.,	and	M.-A.	Laniel.	2004.	Histones	and	histone	modifications.	Curr.	Biol.	14:R546-51.	doi:10.1016/j.cub.2004.07.007.	
 8 Literature           
 
 
123 
Phillips,	D.M.	1963.	The	presence	of	acetyl	groups	of	histones.	Biochem.	J.	87:258–63.	Placek,	B.J.,	J.	Huang,	J.R.	Kent,	J.	Dorsey,	L.	Rice,	N.W.	Fraser,	and	S.L.	Berger.	2009.	The	histone	variant	H3.3	regulates	gene	expression	during	lytic	infection	with	herpes	simplex	virus	type	1.	J.	Virol.	83:1416–21.	doi:10.1128/JVI.01276-08.	Price,	A.M.,	J.	Dai,	Q.	Bazot,	L.	Patel,	P.A.	Nikitin,	R.	Djavadian,	P.S.	Winter,	C.A.	Salinas,	A.P.	Barry,	K.C.	Wood,	E.C.	Johannsen,	A.	Letai,	M.J.	Allday,	and	M.A.	Luftig.	2017.	Epstein-Barr	virus	ensures	B	cell	survival	by	uniquely	modulating	apoptosis	at	early	and	late	times	after	infection.	Elife.	6:e22509.	doi:10.7554/eLife.22509.	Price,	A.M.,	and	M.A.	Luftig.	2014.	Dynamic	Epstein-Barr	virus	gene	expression	on	the	path	to	B-cell	transformation.	Adv.	Virus	Res.	88:279–313.	doi:10.1016/B978-0-12-800098-4.00006-4.	Purushothaman,	P.,	S.	Thakker,	and	S.C.	Verma.	2015.	Transcriptome	analysis	of	Kaposi’s	sarcoma-associated	herpesvirus	during	de	novo	primary	infection	of	human	B	and	endothelial	cells.	J.	Virol.	89:3093–111.	doi:10.1128/JVI.02507-14.	Quinlan,	A.R.,	and	I.M.	Hall.	2010.	BEDTools:	a	flexible	suite	of	utilities	for	comparing	genomic	features.	Bioinformatics.	26:841–2.	doi:10.1093/bioinformatics/btq033.	Rai,	T.S.,	M.	Glass,	J.J.	Cole,	M.I.	Rather,	M.	Marsden,	M.	Neilson,	C.	Brock,	I.R.	Humphreys,	R.D.	Everett,	and	P.D.	Adams.	2017.	Histone	chaperone	HIRA	deposits	histone	H3.3	onto	foreign	viral	DNA	and	contributes	to	anti-viral	intrinsic	immunity.	Nucleic	Acids	Res.	45:11673–11683.	doi:10.1093/nar/gkx771.	Rakhmanov,	M.,	H.	Sic,	A.-K.	Kienzler,	B.	Fischer,	M.	Rizzi,	M.	Seidl,	K.	Melkaoui,	S.	Unger,	L.	Moehle,	N.E.	Schmit,	S.D.	Deshmukh,	C.K.	Ayata,	W.	Schuh,	Z.	Zhang,	F.-L.	Cosset,	E.	Verhoeyen,	H.-H.	Peter,	R.E.	Voll,	U.	Salzer,	H.	Eibel,	and	K.	Warnatz.	2014.	High	levels	of	SOX5	decrease	proliferative	capacity	of	human	B	cells,	but	permit	plasmablast	differentiation.	PLoS	One.	9:e100328.	doi:10.1371/journal.pone.0100328.	Richmond,	T.J.,	and	C.A.	Davey.	2003.	The	structure	of	DNA	in	the	nucleosome	core.	Nature.	423:145–150.	doi:10.1038/nature01595.	Rinn,	J.L.,	and	H.Y.	Chang.	2012.	Genome	regulation	by	long	noncoding	RNAs.	Annu.	Rev.	
Biochem.	81:145–66.	doi:10.1146/annurev-biochem-051410-092902.	Robinson,	J.T.,	H.	Thorvaldsdóttir,	W.	Winckler,	M.	Guttman,	E.S.	Lander,	G.	Getz,	and	J.P.	Mesirov.	2011.	Integrative	genomics	viewer.	Nat.	Biotechnol.	29:24–26.	doi:10.1038/nbt.1754.	Ron-Harel,	N.,	D.	Santos,	J.M.	Ghergurovich,	P.T.	Sage,	A.	Reddy,	S.B.	Lovitch,	N.	Dephoure,	F.K.	Satterstrom,	M.	Sheffer,	J.B.	Spinelli,	S.	Gygi,	J.D.	Rabinowitz,	A.H.	Sharpe,	and	M.C.	Haigis.	2016.	Mitochondrial	biogenesis	and	proteome	remodeling	promote	one-carbon	metabolism	for	T	cell	activation.	Cell	Metab.	24:104–17.	doi:10.1016/j.cmet.2016.06.007.	Rorbach,	J.,	P.	Boesch,	P.A.	Gammage,	T.J.J.	Nicholls,	S.F.	Pearce,	D.	Patel,	A.	Hauser,	F.	Perocchi,	and	M.	Minczuk.	2014.	MRM2	and	MRM3	are	involved	in	biogenesis	of	the	large	subunit	of	the	mitochondrial	ribosome.	Mol.	Biol.	Cell.	25:2542–55.	doi:10.1091/mbc.E14-01-0014.	Rossetto,	D.,	N.	Avvakumov,	and	J.	Côté.	2012.	Histone	phosphorylation.	Epigenetics.	7:1098–1108.	doi:10.4161/epi.21975.	Rozanska,	A.,	R.	Richter-Dennerlein,	J.	Rorbach,	F.	Gao,	R.J.	Lewis,	Z.M.	Chrzanowska-Lightowlers,	and	R.N.	Lightowlers.	2017.	The	human	RNA-binding	protein	RBFA	promotes	the	maturation	of	the	mitochondrial	ribosome.	Biochem.	J.	474:2145–2158.	doi:10.1042/BCJ20170256.	Sadler,	A.J.,	F.J.	Rossello,	L.	Yu,	J.A.	Deane,	X.	Yuan,	D.	Wang,	A.T.	Irving,	M.	Kaparakis-Liaskos,	M.P.	Gantier,	H.	Ying,	H.C.H.	Yim,	E.L.	Hartland,	A.J.	Notini,	S.	de	Boer,	S.J.	White,	A.	Mansell,	J.-P.	Liu,	D.N.	Watkins,	S.	Gerondakis,	B.R.G.	Williams,	and	D.	Xu.	2015.	BTB-ZF	transcriptional	regulator	PLZF	modifies	chromatin	to	restrain	inflammatory	signaling	
 8 Literature  
 
 
124 
programs.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	112:1535–40.	doi:10.1073/pnas.1409728112.	Sambrook,	J.,	and	D.W.	(David	W.	Russell.	2001.	Molecular	cloning :	a	laboratory	manual.	Cold	Spring	Harbor	Laboratory	Press.	Sanchez,	E.L.,	and	M.	Lagunoff.	2015.	Viral	activation	of	cellular	metabolism.	Virology.	479–480:609–18.	doi:10.1016/j.virol.2015.02.038.	Sanchez,	E.L.,	T.H.	Pulliam,	T.A.	Dimaio,	A.B.	Thalhofer,	T.	Delgado,	and	M.	Lagunoff.	2017.	Glycolysis,	glutaminolysis,	and	fatty	acid	synthesis	are	required	for	distinct	stages	of	Kaposi’s	Sarcoma-Associated	Herpesvirus	lytic	replication.	J.	Virol.	91.	doi:10.1128/JVI.02237-16.	Sandoval,	H.,	S.	Kodali,	and	J.	Wang.	2017.	Regulation	of	B	cell	fate,	survival,	and	function	by	mitochondria	and	autophagy.	Mitochondrion.	doi:10.1016/J.MITO.2017.11.005.	Sangaletti,	S.,	C.	Tripodo,	P.	Portararo,	M.	Dugo,	C.	Vitali,	L.	Botti,	C.	Guarnotta,	B.	Cappetti,	A.	Gulino,	I.	Torselli,	P.	Casalini,	C.	Chiodoni,	and	M.P.	Colombo.	2014.	Stromal	niche	communalities	underscore	the	contribution	of	the	matricellular	protein	SPARC	to	B-cell	development	and	lymphoid	malignancies.	Oncoimmunology.	3:e28989.	doi:10.4161/onci.28989.	Scialdone,	A.,	K.N.	Natarajan,	L.R.	Saraiva,	V.	Proserpio,	S.A.	Teichmann,	O.	Stegle,	J.C.	Marioni,	and	F.	Buettner.	2015.	Computational	assignment	of	cell-cycle	stage	from	single-cell	transcriptome	data.	Methods.	85:54–61.	doi:10.1016/J.YMETH.2015.06.021.	Sena,	L.A.,	S.	Li,	A.	Jairaman,	M.	Prakriya,	T.	Ezponda,	D.A.	Hildeman,	C.-R.	Wang,	P.T.	Schumacker,	J.D.	Licht,	H.	Perlman,	P.J.	Bryce,	and	N.S.	Chandel.	2013.	Mitochondria	are	required	for	antigen-specific	T	cell	activation	through	Reactive	Oxygen	Species	signaling.	
Immunity.	38:225–236.	Seto,	E.,	A.	Moosmann,	S.	Grömminger,	N.	Walz,	A.	Grundhoff,	and	W.	Hammerschmidt.	2010.	Micro	RNAs	of	Epstein-Barr	Virus	promote	cell	cycle	progression	and	prevent	apoptosis	of	primary	human	B	cells.	PLoS	Pathog.	6:e1001063.	doi:10.1371/journal.ppat.1001063.	Shlyueva,	D.,	G.	Stampfel,	and	A.	Stark.	2014.	Transcriptional	enhancers:	from	properties	to	genome-wide	predictions.	Nat.	Rev.	Genet.	15:272–286.	doi:10.1038/nrg3682.	Sijmons,	S.,	M.	Van	Ranst,	and	P.	Maes.	2014.	Genomic	and	functional	characteristics	of	human	cytomegalovirus	revealed	by	next-generation	sequencing.	Viruses.	6:1049–72.	doi:10.3390/v6031049.	Speck,	P.,	K.M.	Haan,	and	R.	Longnecker.	2000.	Epstein–Barr	Virus	entry	into	cells.	Virology.	277:1–5.	doi:10.1006/VIRO.2000.0624.	Spencer,	C.A.,	M.E.	Dahmus,	and	S.A.	Rice.	1997.	Repression	of	host	RNA	polymerase	II	transcription	by	herpes	simplex	virus	type	1.	J.	Virol.	71:2031–40.	Spies,	D.,	and	C.	Ciaudo.	2015.	Dynamics	in	transcriptomics:	Advancements	in	RNA-seq	time	course	and	downstream	analysis.	Comput.	Struct.	Biotechnol.	J.	13:469–77.	doi:10.1016/j.csbj.2015.08.004.	Struhl,	K.,	and	E.	Segal.	2013.	Determinants	of	nucleosome	positioning.	Nat.	Struct.	Mol.	Biol.	20:267–73.	doi:10.1038/nsmb.2506.	Styles,	C.T.,	Q.	Bazot,	G.A.	Parker,	R.E.	White,	K.	Paschos,	and	M.J.	Allday.	2017.	EBV	epigenetically	suppresses	the	B	cell-to-plasma	cell	differentiation	pathway	while	establishing	long-term	latency.	PLOS	Biol.	15:e2001992.	doi:10.1371/journal.pbio.2001992.	Sugiyama,	T.,	H.	Kohara,	M.	Noda,	and	T.	Nagasawa.	2006.	Maintenance	of	the	hematopoietic	stem	cell	pool	by	CXCL12-CXCR4	chemokine	signaling	in	bone	marrow	stromal	cell	niches.	
Immunity.	25:977–88.	doi:10.1016/j.immuni.2006.10.016.	Supek,	F.,	M.	Bošnjak,	N.	Škunca,	and	T.	Šmuc.	2011.	REVIGO	summarizes	and	visualizes	long	lists	of	Gene	Ontology	terms.	PLoS	One.	6:e21800.	doi:10.1371/journal.pone.0021800.	
 8 Literature           
 
 
125 
Sychev,	Z.E.,	A.	Hu,	T.A.	DiMaio,	A.	Gitter,	N.D.	Camp,	W.S.	Noble,	A.	Wolf-Yadlin,	and	M.	Lagunoff.	2017.	Integrated	systems	biology	analysis	of	KSHV	latent	infection	reveals	viral	induction	and	reliance	on	peroxisome	mediated	lipid	metabolism.	PLOS	Pathog.	13:e1006256.	doi:10.1371/journal.ppat.1006256.	Tagawa,	T.,	M.	Albanese,	M.	Bouvet,	A.	Moosmann,	J.	Mautner,	V.	Heissmeyer,	C.	Zielinski,	D.	Lutter,	J.	Hoser,	M.	Hastreiter,	M.	Hayes,	B.	Sugden,	and	W.	Hammerschmidt.	2016.	Epstein-Barr	viral	miRNAs	inhibit	antiviral	CD4+	T	cell	responses	targeting	IL-12	and	peptide	processing.	J.	Exp.	Med.	213:2065–80.	doi:10.1084/jem.20160248.	Takada,	K.,	N.	Shimizu,	S.	Sakuma,	and	Y.	Ono.	1986.	trans	activation	of	the	latent	Epstein-Barr	virus	(EBV)	genome	after	transfection	of	the	EBV	DNA	fragment.	J.	Virol.	57:1016–22.	Takahashi,	K.,	and	S.	Yamanaka.	2006.	Induction	of	pluripotent	stem	cells	from	mouse	embryonic	and	adult	fibroblast	cultures	by	defined	factors.	Cell.	126:663–76.	doi:10.1016/j.cell.2006.07.024.	Tanackovic,	G.,	and	A.	Krämer.	2005.	Human	splicing	factor	SF3a,	but	not	SF1,	is	essential	for	pre-mRNA	splicing	in	vivo.	Mol.	Biol.	Cell.	16:1366–77.	doi:10.1091/mbc.E04-11-1034.	Teague,	T.K.,	L.	Munn,	K.	Zygourakis,	and	B.W.	McIntyre.	1993.	Analysis	of	lymphocyte	activation	and	proliferation	by	video	microscopy	and	digital	imaging.	Cytometry.	14:772–782.	doi:10.1002/cyto.990140710.	Tempera,	I.,	A.	Wiedmer,	J.	Dheekollu,	and	P.M.	Lieberman.	2010.	CTCF	prevents	the	epigenetic	drift	of	EBV	latency	promoter	Qp.	PLoS	Pathog.	6:e1001048.	doi:10.1371/journal.ppat.1001048.	Thomas,	J.O.,	and	R.D.	Kornberg.	1975.	An	octamer	of	histones	in	chromatin	and	free	in	solution.	
Proc.	Natl.	Acad.	Sci.	U.	S.	A.	72:2626–30.	Thorvaldsdottir,	H.,	J.T.	Robinson,	and	J.P.	Mesirov.	2013.	Integrative	Genomics	Viewer	(IGV):	high-performance	genomics	data	visualization	and	exploration.	Brief.	Bioinform.	14:178–192.	doi:10.1093/bib/bbs017.	Toth,	Z.,	K.	Brulois,	and	J.U.	Jung.	2013.	The	chromatin	landscape	of	Kaposi’s	sarcoma-associated	herpesvirus.	Viruses.	5:1346–73.	doi:10.3390/v5051346.	Tsai,	K.,	L.	Chan,	R.	Gibeault,	K.	Conn,	J.	Dheekollu,	J.	Domsic,	R.	Marmorstein,	L.M.	Schang,	and	P.M.	Lieberman.	2014.	Viral	reprogramming	of	the	Daxx	histone	H3.3	chaperone	during	early	Epstein-Barr	virus	infection.	J.	Virol.	88:14350–63.	doi:10.1128/JVI.01895-14.	Valvona,	C.J.,	H.L.	Fillmore,	P.B.	Nunn,	and	G.J.	Pilkington.	2016.	The	regulation	and	function	of	lactate	dehydrogenase	A:	Therapeutic	potential	in	brain	tumor.	Brain	Pathol.	26:3–17.	doi:10.1111/bpa.12299.	Vanacova,	S.,	and	R.	Stefl.	2007.	The	exosome	and	RNA	quality	control	in	the	nucleus.	EMBO	Rep.	8:651–7.	doi:10.1038/sj.embor.7401005.	Vastag,	L.,	E.	Koyuncu,	S.L.	Grady,	T.E.	Shenk,	and	J.D.	Rabinowitz.	2011.	Divergent	effects	of	Human	Cytomegalovirus	and	Herpes	Simplex	Virus-1	on	cellular	metabolism.	PLoS	Pathog.	7:e1002124.	doi:10.1371/journal.ppat.1002124.	Venkatesh,	S.,	and	J.L.	Workman.	2015.	Histone	exchange,	chromatin	structure	and	the	regulation	of	transcription.	Nat.	Rev.	Mol.	Cell	Biol.	16:178–189.	doi:10.1038/nrm3941.	Verdone,	L.,	M.	Caserta,	and	E.	Di	Mauro.	2005.	Role	of	histone	acetylation	in	the	control	of	gene	expression.	Biochem.	Cell	Biol.	83:344–353.	doi:10.1139/o05-041.	Viollet,	C.,	D.A.	Davis,	M.	Reczko,	J.M.	Ziegelbauer,	F.	Pezzella,	J.	Ragoussis,	and	R.	Yarchoan.	2015.	Next-Generation	Sequencing	analysis	reveals	differential	expression	profiles	of	miRNA-mRNA	target	pairs	in	KSHV-infected	cells.	PLoS	One.	10:e0126439.	doi:10.1371/journal.pone.0126439.	Viollet,	C.,	D.A.	Davis,	S.S.	Tekeste,	M.	Reczko,	J.M.	Ziegelbauer,	F.	Pezzella,	J.	Ragoussis,	and	R.	Yarchoan.	2017.	RNA	sequencing	reveals	that	Kaposi	Sarcoma-associated	herpesvirus	
 8 Literature  
 
 
126 
infection	mimics	hypoxia	gene	expression	signature.	PLoS	Pathog.	13:e1006143.	doi:10.1371/journal.ppat.1006143.	Voon,	H.P.J.,	and	L.H.	Wong.	2016.	New	players	in	heterochromatin	silencing:	histone	variant	H3.3	and	the	ATRX/DAXX	chaperone.	Nucleic	Acids	Res.	44:1496–501.	doi:10.1093/nar/gkw012.	Wang,	Z.,	M.	Gerstein,	and	M.	Snyder.	2009.	RNA-Seq:	a	revolutionary	tool	for	transcriptomics.	
Nat.	Rev.	Genet.	10:57–63.	doi:10.1038/nrg2484.	Warburg,	O.	1925.	The	metabolism	of	carcinoma	cells.	J.	Cancer	Res.	9:148–163.	doi:10.1158/jcr.1925.148.	Weber,	C.M.,	and	S.	Henikoff.	2014.	Histone	variants:	dynamic	punctuation	in	transcription.	
Genes	Dev.	28:672–82.	doi:10.1101/gad.238873.114.	Wei,	G.,	G.	Hu,	K.	Cui,	and	K.	Zhao.	2012.	Genome-wide	mapping	of	nucleosome	occupancy,	histone	modifications,	and	gene	expression	using	next-generation	sequencing	technology.	
Methods	Enzymol.	513:297–313.	doi:10.1016/B978-0-12-391938-0.00013-6.	Wei,	H.,	and	M.-M.	Zhou.	2010.	Viral-encoded	enzymes	that	target	host	chromatin	functions.	
Biochim.	Biophys.	Acta	-	Gene	Regul.	Mech.	1799:296–301.	doi:10.1016/J.BBAGRM.2009.08.007.	Weinberg,	S.E.,	L.A.	Sena,	and	N.S.	Chandel.	2015.	Mitochondria	in	the	regulation	of	innate	and	adaptive	immunity.	Immunity.	42:406–17.	doi:10.1016/j.immuni.2015.02.002.	Weinhold,	B.	2006.	Epigenetics:	the	science	of	change.	Environ.	Health	Perspect.	114:A160-7.	White,	R.E.,	P.C.	Rämer,	K.N.	Naresh,	S.	Meixlsperger,	L.	Pinaud,	C.	Rooney,	B.	Savoldo,	R.	Coutinho,	C.	Bödör,	J.	Gribben,	H.A.	Ibrahim,	M.	Bower,	J.P.	Nourse,	M.K.	Gandhi,	J.	Middeldorp,	F.Z.	Cader,	P.	Murray,	C.	Münz,	and	M.J.	Allday.	2012.	EBNA3B-deficient	EBV	promotes	B	cell	lymphomagenesis	in	humanized	mice	and	is	found	in	human	tumors.	J.	Clin.	
Invest.	122:1487–502.	doi:10.1172/JCI58092.	Winter,	J.,	and	S.	Diederichs.	2011.	Argonaute	proteins	regulate	microRNA	stability:	Increased	microRNA	abundance	by	Argonaute	proteins	is	due	to	microRNA	stabilization.	RNA	Biol.	8:1149–1157.	doi:10.4161/rna.8.6.17665.	Woellmer,	A.,	J.M.	Arteaga-Salas,	and	W.	Hammerschmidt.	2012.	BZLF1	governs	CpG-methylated	chromatin	of	Epstein-Barr	Virus	reversing	epigenetic	repression.	PLoS	Pathog.	8:e1002902.	doi:10.1371/journal.ppat.1002902.	Woellmer,	A.,	and	W.	Hammerschmidt.	2013.	Epstein-Barr	virus	and	host	cell	methylation:	regulation	of	latency,	replication	and	virus	reactivation.	Curr.	Opin.	Virol.	3:260–5.	doi:10.1016/j.coviro.2013.03.005.	Wu,	L.,	E.	Fossum,	C.H.	Joo,	K.-S.	Inn,	Y.C.	Shin,	E.	Johannsen,	L.M.	Hutt-Fletcher,	J.	Hass,	and	J.U.	Jung.	2009.	Epstein-Barr	virus	LF2:	an	antagonist	to	type	I	interferon.	J.	Virol.	83:1140–6.	doi:10.1128/JVI.00602-08.	Xiao,	L.,	Z.-Y.	Hu,	X.	Dong,	Z.	Tan,	W.	Li,	M.	Tang,	L.	Chen,	L.	Yang,	Y.	Tao,	Y.	Jiang,	J.	Li,	B.	Yi,	B.	Li,	S.	Fan,	S.	You,	X.	Deng,	F.	Hu,	L.	Feng,	A.M.	Bode,	Z.	Dong,	L.-Q.	Sun,	and	Y.	Cao.	2014.	Targeting	Epstein-Barr	virus	oncoprotein	LMP1-mediated	glycolysis	sensitizes	nasopharyngeal	carcinoma	to	radiation	therapy.	Oncogene.	33:4568–78.	doi:10.1038/onc.2014.32.	Xu,	D.,	K.	Brumm,	and	L.	Zhang.	2006.	The	latent	membrane	protein	1	of	Epstein-Barr	virus	(EBV)	primes	EBV	latency	cells	for	type	I	interferon	production.	J.	Biol.	Chem.	281:9163–9.	doi:10.1074/jbc.M511884200.	Xu,	D.,	M.	Holko,	A.J.	Sadler,	B.	Scott,	S.	Higashiyama,	W.	Berkofsky-Fessler,	M.J.	Mcconnell,	P.P.	Pandolfi,	J.D.	Licht,	and	B.R.G.	Williams.	Promyelocytic	leukemia	zinc	finger	protein	regulates	interferon-mediated	innate	immunity.	Immunity.	30:802–816.	doi:10.1016/j.immuni.2009.04.013.	
 8 Literature           
 
 
127 
Yao,	H.,	K.	Brick,	Y.	Evrard,	T.	Xiao,	R.D.	Camerini-Otero,	and	G.	Felsenfeld.	2010.	Mediation	of	CTCF	transcriptional	insulation	by	DEAD-box	RNA-binding	protein	p68	and	steroid	receptor	RNA	activator	SRA.	Genes	Dev.	24:2543–2555.	doi:10.1101/gad.1967810.	Yogev,	O.,	D.	Lagos,	T.	Enver,	and	C.	Boshoff.	2014.	Kaposi’s	Sarcoma	Herpesvirus	microRNAs	induce	metabolic	transformation	of	infected	cells.	PLoS	Pathog.	10:e1004400.	doi:10.1371/journal.ppat.1004400.	Yoshida,	N.,	D.	Kitayama,	M.	Arima,	A.	Sakamoto,	A.	Inamine,	H.	Watanabe-Takano,	M.	Hatano,	T.	Koike,	and	T.	Tokuhisa.	2011.	CXCR4	expression	on	activated	B	cells	is	downregulated	by	CD63	and	IL-21.	J.	Immunol.	186:2800–8.	doi:10.4049/jimmunol.1003401.	Young,	L.S.,	J.R.	Arrand,	and	P.G.	Murray.	2007.	EBV	gene	expression	and	regulation.	Cambridge	University	Press.	Young,	L.S.,	and	A.B.	Rickinson.	2004.	Epstein–Barr	virus:	40	years	on.	Nat.	Rev.	Cancer.	4:757–768.	doi:10.1038/nrc1452.	Young,	L.S.,	L.F.	Yap,	and	P.G.	Murray.	2016.	Epstein–Barr	virus:	more	than	50	years	old	and	still	providing	surprises.	Nat.	Rev.	Cancer.	16:789–802.	doi:10.1038/nrc.2016.92.	Yu,	Y.,	A.J.	Clippinger,	and	J.C.	Alwine.	2011a.	Viral	effects	on	metabolism:	changes	in	glucose	and	glutamine	utilization	during	human	cytomegalovirus	infection.	Trends	Microbiol.	19:360–7.	doi:10.1016/j.tim.2011.04.002.	Yu,	Y.,	T.G.	Maguire,	and	J.C.	Alwine.	2011b.	Human	cytomegalovirus	activates	glucose	transporter	4	expression	to	increase	glucose	uptake	during	infection.	J.	Virol.	85:1573–80.	doi:10.1128/JVI.01967-10.	Yusuf,	I.,	and	D.A.	Fruman.	2003.	Regulation	of	quiescence	in	lymphocytes.	Trends	Immunol.	24:380–6.	doi:10.1016/S1471-4906(03)00141-8.	Yusuf,	I.,	M.G.	Kharas,	J.	Chen,	R.Q.	Peralta,	A.	Maruniak,	P.	Sareen,	V.W.	Yang,	K.H.	Kaestner,	and	D.A.	Fruman.	2008.	KLF4	is	a	FOXO	target	gene	that	suppresses	B	cell	proliferation.	Int.	
Immunol.	20:671–681.	doi:10.1093/intimm/dxn024.	Zeidler,	R.,	G.	Eissner,	P.	Meissner,	S.	Uebel,	R.	Tampé,	S.	Lazis,	and	W.	Hammerschmidt.	1997.	Downregulation	of	TAP1	in	B	lymphocytes	by	cellular	and	Epstein-Barr	Virus–encoded	Interleukin-10.	Blood.	90.	Zentner,	G.E.,	and	S.	Henikoff.	2013.	Regulation	of	nucleosome	dynamics	by	histone	modifications.	Nat.	Struct.	Mol.	Biol.	20:259–266.	doi:10.1038/nsmb.2470.	Zhang,	Q.,	M.-M.	Lai,	Y.-Y.	Lou,	B.-H.	Guo,	H.-Y.	Wang,	and	X.-Q.	Zheng.	2016.	Transcriptome	altered	by	latent	human	cytomegalovirus	infection	on	THP-1	cells	using	RNA-seq.	Gene.	594:144–150.	doi:10.1016/J.GENE.2016.09.014.	Zhang,	Y.,	L.	Yang,	and	L.-L.	Chen.	2014.	Life	without	A	tail:	New	formats	of	long	noncoding	RNAs.	Int.	J.	Biochem.	Cell	Biol.	54:338–349.	doi:10.1016/j.biocel.2013.10.009.	Zhao,	B.,	J.	Zou,	H.	Wang,	E.	Johannsen,	C.	Peng,	J.	Quackenbush,	J.C.	Mar,	C.C.	Morton,	M.L.	Freedman,	S.C.	Blacklow,	J.C.	Aster,	B.E.	Bernstein,	and	E.	Kieff.	2011.	Epstein-Barr	virus	exploits	intrinsic	B-lymphocyte	transcription	programs	to	achieve	immortal	cell	growth.	
Proc.	Natl.	Acad.	Sci.	U.	S.	A.	108:14902–7.	doi:10.1073/pnas.1108892108.	Zhao,	Y.,	H.	Sun,	and	H.	Wang.	2016.	Long	noncoding	RNAs	in	DNA	methylation:	new	players	stepping	into	the	old	game.	Cell	Biosci.	6:45.	doi:10.1186/s13578-016-0109-3.	Zhou,	J.,	C.M.	Chau,	Z.	Deng,	R.	Shiekhattar,	M.-P.	Spindler,	A.	Schepers,	and	P.M.	Lieberman.	2005.	Cell	cycle	regulation	of	chromatin	at	an	origin	of	DNA	replication.	EMBO	J.	24:1406–17.	doi:10.1038/sj.emboj.7600609.	Zou,	Y.-R.,	A.H.	Kottmann,	M.	Kuroda,	I.	Taniuchi,	and	D.R.	Littman.	1998.	Function	of	the	chemokine	receptor	CXCR4	in	haematopoiesis	and	in	cerebellar	development.	Nature.	393:595–599.	doi:10.1038/31269.		
 9 Appendix  
 
 
128 
9. Appendix 
 
9.1. Outlier sample from RNA-seq data 
 Supplementary	figure	1.			RNA-seq	data	analysis	and	identification	of	an	outlier	sample	(Day8_1)	in	the	polyA	
enriched	libraries.	
A. Principal	 component	 analysis	 (PCA)	 of	 all	 RNA-seq	 samples.	 The	 percentage	 of	 variance	 explained	 by	principal	component	1	and	2	(PC1,	PC2)	are	indicated.	Sample	at	day	8	(Day8_1)	appears	to	be	an	outlier	and	determines	all	variances	between	sequencing	samples	indicated	by	PC1.	Further	RNA-seq	analysis	was	performed	without	Day8_1	sample	to	minimize	bias	in	the	final	results.	
B. Expression	levels	of	the	four	genes	with	the	most	negative	loadings	on	PC1	of	the	PCA	plot	(panel	A).	The	depicted	genes	show	very	high	expression	levels	only	in	the	Day8_1	sample	and	were	found	to	be	involved	
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in	 different,	 biologically	 unrelated	 processes	 from	 various	 types	 of	 the	 cells	 such	 as	MUC16	 in	 epithelia	cells	or	RELN	and	SH3TC2	in	neuronal	cells.	These	results	confirm	that	sample	Day8_1	had	to	be	excluded	from	further	RNA-seq	analysis.	
 
9.2. Quality controls of rRNA depleted sequencing libraries  
 
 
 Supplementary	figure	2.	Quality	controls	of	rRNA	depleted,	hexamer	enriched	RNA-seq	libraries.		The	statistics	for	quality	controls	of	the	sequencing	libraries	were	performed	as	described	in	Fig.	11.	
A. Detection	of	the	ERCC	spike-in	RNAs	in	rRNA	depleted	sequencing	libraries.	The	depicted	three	graphs	are	representative	examples	of	regression	curves.	The	x-axis	 indicates	the	log2	concentrations	of	the	spike-in	RNAs	added	to	the	samples,	the	y-axis	depicts	the	log2	of	Fragments	Per	Kilobase	of	transcript	per	 Million	 mapped	 reads	 (FPKM)	 per	 individual	 ERCC	 spike-in	 RNA.	 The	 square	 coefficient	 of	determination	(R2),	 the	slope	of	 the	regression	 line,	and	the	numbers	of	spike-in	RNAs	(n)	 identified	out	of	92	added	to	the	samples	are	indicated.		
B. The	 graph	 shows	 the	 sizes	 of	 the	 sequenced	 rRNA	 depleted	 libraries	 prepared	 from	 the	 different	samples	 from	 two	 independent	 donors.	 The	majority	 of	 the	 samples	 shows	 comparable	 sequencing	depth,	but	sample	Day8_2	obtained	fewer	reads.	This	sample	was	excluded	from	further	bioinformatics	analysis	because	of	its	possible	bias	in	the	final	results.		
C. The	 bar	 plot	 illustrates	 the	 numbers	 of	 detected	 genes	 in	 each	 sequenced	 sample	 with	 reads	 per	million	(RPM)	>10.	The	numbers	of	detected	genes	are	very	comparable	between	samples.	
D. The	 graph	displays	 the	 ratio	 of	 the	numbers	 of	 reads	 from	viral	 genes	 versus	 the	numbers	 of	 reads	from	cellular	genes	at	each	day	p.i..	Viral	genes	are	absent	in	the	uninfected	cells	(Day	0)	as	expected.	Initially	after	infection,	the	cells	display	higher	viral	genes	ratios,	especially	at	day	one	and	two,	which	decrease	gradually	at	the	later	time	points.		
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9.3. Genes contributing to PC1 and PC2 in the polyA-enriched sequencing 
libraries 
 Supplementary	table	1.	The	list	of	the	top	30	genes	with	the	highest	loadings	of	the	principal	component	
	(PC1	or	2).		
 
Genes	contributing	to	PC1	 Genes	contributing	to	PC2	
Gene		 PC1	loading	score	 Gene		 PC2	loading	score	LOC643401		 0.03461165		 ZBTB16	 -0.04016592	TIMD4			 0.03461143	 VAV3-AS1	 -0.03945671	HRASLS2	 0.03205240	 CXCR4	 -0.03768658	SPARC	 0.03136722	 HTR3A	 -0.03694487	BC005081	 0.03116985	 SOX5	 -0.03678185	CCL25	 0.03008670	 COBLL1	 -0.03532114	GPR15	 0.02972569	 FOSB			 -0.03410085	TMEM173			 0.02961373	 SDK2	 -0.03405426	PLA2G4A			 0.02949812	 VAV3	 -0.03327525	LAMP5	 0.02942003	 KLF4		 -0.03300732									BCAR1		 0.02920159		 CLIC3	 -0.03177428	LIPH	 0.02884333	 NR4A2	 -0.03131990	COL16A1	 0.02874806	 FOS	 -0.03125702	QPRT	 0.02860624	 SNORA70F	 -0.03040951	BCAN	 0.02834911	 SERPINA9	 -0.02900152	CCDC74A	 0.02833998	 GPRIN3	 -0.02899787	CD276				 0.02831831	 GRASP	 -0.02892397	PYGL	 0.02816162	 KIAA1683		 -0.02891723	APOBEC3B	 0.02811052	 FAM49A	 -0.02863372	IGF1	 0.02791771		 CXCR5	 -0.02861571	IFNA2	 0.02760686	 GYLTL1B	 -0.02846314	PLEKHG6	 0.02737123	 JUN	 -0.02833765	IPCEF1	 0.02702188	 FCRL1	 -0.02792099	LINC00029	 0.02699818	 DUSP1	 -0.02791355	PIR	 0.02681159	 AK026379					 -0.02757292	SAMD7			 0.02670240	 ADAM28	 -0.02743359	SPC24			 0.02661545	 RGS2	 -0.02734632	MIR148A	 0.02657479	 LINC00304	 -0.02724341	EMID1	 0.02656506	 FCRL2	 -0.02721448	CMBL	 0.02626588	 EHD3	 -0.02718472	
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9.4.  Time-course expression of EBV genes during the pre-latent phase of 
infection 
 
 
 
 Supplementary	figure	3.	Expression	of	selected	viral	genes	in	the	course	of	EBV	infection.		The	plots	display	the	expression	of	nine	selected	EBV	genes	at	different	days	p.i..	The	x-axis	depicts	the	days	p.i.	and	the	 y-axis	 shows	 the	 numbers	 of	 normalized	 counts	 (mean	 from	 three	 independent	 donors).	 The	 first	 five	 plots	display	known	EBV	latent	genes	with	relatively	high	expression	levels	in	particular	EBNA-2.	The	latent	genes	were	either	highly	expressed	at	the	very	early	time	points	and	then	their	expression	decreased	such	as	EBNA2,	EBNA3A,	miR-BHRF1-1,	or	 the	expression	of	viral	genes	gradually	 increased	over	 time	such	as	LMP1	and	LMP2A.	BMRF1,	BZLF2,	BaRF1	and	BLRF2	are	described	as	lytic	genes	and	displayed	overall	 lower	expression	levels	compared	to	the	latent	genes.	EBV	lytic	genes	showed	higher	expression	levels	very	early	after	infection,	which	were	repressed	at	the	later	time	points	after	infection.		 	
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9.5.  Cell cycle phase prediction from RNA-seq data 
 	Supplementary	figure	4.	Assignment	of	cell	cycle	phases	
within	 samples	 from	 different	 days	 after	 EBV	
infection	according	to	the	RNA-seq	data.	The	 pie	 chart	 illustrates	 the	 average	 scores	 and	predictions	 across	 the	 three	 replicates	 for	 each	 day	 p.i..	Samples	 resting	 in	 the	 G1	 phase	 (dark	 grey)	 were	detected	in	the	uninfected	cells	and	cells	infected	for	one	or	two	days.	Samples	collected	from	day	three,	 four,	 five,	eight	 and	 14	 were	 predicted	 to	 be	 in	 the	 S	 phase	 (light	red)	 of	 the	 cell	 cycle	 as	 actively	 replicating	 cells.	 The	assignment	 is	 based	 on	 the	 analysis	 using	 algorithm	described	in	chapter	6.4.4.		
 
 		
 10 Curriculum vitae           
 
 
133
10. Curriculum vitae 
Personal information:  
 
Name: 
 
Paulina Mrozek-Górska 
 
Nationality: polish 
  
Email: mrozek.paulina@gmail.com 
  
Education:  
 
Since 02/2014 
 
Doctoral studies on the topic: “Time-course analysis of human 
primary B cells infected with EBV” 
 
Research Unit Gene Vectors, Helmholtz Center Munich, Germany 
Prof. Dr. Wolfgang Hammerschmidt 
Prof. Dr. Dirk Eick 
  
 11 Acknowledgment  
 
 
134 
11. Acknowledgment 
 I	would	like	to	thank	all	people,	who	helped	and	supported	me	on	the	way	to	complete	my	PhD	thesis!		
Wolfgang:	Thank	you	for	your	enormous	patience	and	great	mentoring!	I	really	appreciate	your	priceless	help	in	correcting	my	thesis	and	solving	THE	problems,	which	occur	on	the	way.	Thank	you	for	an	opportunity	to	discuss	basically	everything,	what	bothered	me	during	my	PhD	thesis,	for	your	always	“open	doors”	and	for	the	valuable	advice.			
Dirk:	 Thank	 you	 very	 much	 for	 your	 constant	 support	 during	 my	 TAC	 meetings,	 your	 nice	suggestions	and	advice	for	writing	my	thesis.		
Sandra	Hake:	Thank	you	for	taking	part	 in	my	TAC	meeting,	 for	your	valuable	suggestions	as	well	as	nice	atmosphere	during	these	meetingsJ		Big	thank	you	to	all	smart	and	skilled	people,	who	helped	me	a	lot	with	bioinformatic	analyses!		
Thomas	Schwarzmayr:	Thank	you	very	much	for	your	help	and	dedication	to	my	“exotic”	RNA-seq	project.	 I	 really	 appreciate	 your	patience	 in	 answering	 all	my	 emails	 and	 for	 trying	 to	 go	even	deeper	into	the	analysis	of	my	data.		
Dr.	Antonio	Scialdone:	I	would	like	to	express	my	gratitude	for	this	wonderful	opportunity	to	discuss	 with	 you	 and	 analyse	 my	 RNA-seq	 data.	 Thank	 you	 for	 sharing	 with	 me	 your	 great	bioinformatic	 knowledge,	 your	 open	 mind,	 and	 understanding	 my	 important,	 but	 difficult	biological	tasks!	Thank	you	also	for	your	advice	and	suggestions	to	my	thesis!		
Stefan	 Krebs,	 LAFUGA	 Team:	 Thank	 you	 for	 all	 help	 during	 preparation	 of	 my	 MNase-seq	samples,	for	giving	new	and	nice	ideas	for	solving	some	technical	problems.	Thank	you	also	for	an	 opportunity	 to	 work	 in	 your	 lab,	 while	 preparing	 the	 libraries	 and	 having	 access	 to	 all	necessary	lab	equipment.	
 11 Acknowledgment           
 
 
135 
My	 beloved	 group	 of	 “Hammerschmidts”	 I	 would	 like	 to	 thank	 all	 of	 you	 together	 and	everyone	 one	 by	 one	 for	 great	 and	 inspiring	working	 atmosphere,	 for	 being	 something	more	than	just	colleagues	from	work!	Dagi	-	thank	you	for	amazing	help	with	some	experiments	e.g.	sorting	or	cell	culture	problems	J,	Christine	 -	 thank	you	for	motivating	me	and	for	help	with	long	and	laborious	sonication	J,	Mika	-	 	thank	you	for	sharing	a	bench	with	me,	it	is	always	a	pleasure,	whatever	I	say	J	and	also	for	hugs	and	sweets,	when	I	am	mad	J,	Adam	and	Manuel	-	thank	you	for	nice	chatting	time,	but	also	for	very	important	help	with	some	experiments	and	scientific	problems	J,	Marisa	-	thank	you	for	introducing	me	to	the	lab,	for	your	patience	in	the	beginning	and	nice	cooperation	later!!!			And	Alex:	I	told	you	I	will	make	a	special	30	pages	to	thank	you…	I	really	should	J.	Thank	you	for	 your	 enormous	 help	 with	 data	 analysis,	 advice,	 patience	 in	 solving	 my	 small	 or	 big	 R	problems.	Thank	you	for	always	being	there	with	an	open	mind	and	will	to	cooperate!	I	really	appreciate	 our	 formal	 and	 informal	meeting	 times,	 thank	 you	 for	 trying	 to	 explain	me	 some	German	“things”	and	for	extreme	fun	from	some	nerdy	jokes!	I	know	that	I	can	always	rely	on	you	in	science,	and	outside	it	J.	Just	thank	you,	Alex!		 Special	thanks	go	to	people	from	the	2nd	floor	(AG	Zeidler,	AG	Moosmann,	AG	Mautner	and	AG	Strobl)	 for	nice	conversations	during	 lunch	 time,	but	also	 for	kindly	sharing	with	me	with	your	experience	and	skills	J	Dear	Kathrin,	 thank	you	for	your	exceptional	support	during	my	PhD	with	sweets,	coffee,	and	your	always	positive	attitude!	Thank	you	for	great	time	that	we	always	spend	together!			Thanks	to	my	beloved	family	and	husband	for	your	everlasting	support!		
Kochani	 rodzice,	 kochana	 siostro,	 kochana	 rodzinko	 Górskich:	 dziękuję,	 że	 wspieraliście,	
wspieracie	 i	 jestem	 pewna,	 że	 będziecie	 mnie	 wspierać	 w	 moich	 marzeniach	 i	 dążeniach	
naukowych,	ale	nie	tylko.	Dziękuję	Wam,	za	każdą	duchową	formę	wsparcia	i	wiarę	we	mnie!	
Kochany	mężu,	dziękuję	Ci	za	Twoją	nieocenioną	cierpliwość	i	wsparcie	w	ważnych	i	trudnych	dla	
mnie	momentach.	Z	Tobą	wszystko	staje	się	możliwe!	
Dziękuję	wszystkim,	którzy	wspierali	mnie	dobrym	słowem,	żartem	i	jedzeniem:) 
 
 
 
